Document

0000105770-19-000020.txt : 20190508 0000105770-19-000020.hdr.sgml : 20190508 20190508165506 ACCESSION NUMBER: 0000105770-19-000020 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 94 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190508 DATE AS OF CHANGE: 20190508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 19807418 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 10-Q 1 wst10q33119.htm 10-Q Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)



þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 1-8036

WEST PHARMACEUTICAL SERVICES, INC.

(Exact name of registrant as specified in its charter)



Pennsylvania	23-1210010
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

530 Herman O. West Drive, Exton, PA	19341-0645
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: 610-594-2900

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer	þ	Accelerated filer	o
Non-accelerated filer	o	Smaller reporting company	o
		Emerging growth company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o No þ

Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, par value $0.25 per share	WST	New York Stock Exchange

As of March 31, 2019, there were 73,483,687 shares of the registrant’s common stock outstanding.

Table of Contents

TABLE OF CONTENTS



		Page
PART I. FINANCIAL INFORMATION
ITEM 1.	FINANCIAL STATEMENTS (UNAUDITED)
	Condensed Consolidated Statements of Income for the Three Months ended March 31, 2019 and 2018	3
	Condensed Consolidated Statements of Comprehensive Income for the Three Months ended March 31, 2019 and 2018	4
	Condensed Consolidated Balance Sheets at March 31, 2019 and December 31, 2018	5
	Condensed Consolidated Statements of Cash Flows for the Three Months ended March 31, 2019 and 2018	6
	Notes to Condensed Consolidated Financial Statements	7
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	25
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	35
ITEM 4.	CONTROLS AND PROCEDURES	35

PART II. OTHER INFORMATION
ITEM 1.	LEGAL PROCEEDINGS	36
ITEM 1A.	RISK FACTORS	36
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	36
ITEM 5.	OTHER INFORMATION	37
ITEM 6.	EXHIBITS	37

SIGNATURE		38

EXHIBIT INDEX		F-1

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

West Pharmaceutical Services, Inc. and Subsidiaries

(in millions, except per share data)



	Three Months Ended March 31,
	2019			2018
Net sales	$	443.5		$	415.7
Cost of goods and services sold	296.7			281.3
Gross profit	146.8			134.4
Research and development	9.8			9.6
Selling, general and administrative expenses	68.6			68.3
Other (income) expense (Note 15)	(2.3		)	3.1
Operating profit	70.7			53.4
Interest expense	2.3			1.9
Interest income	(0.9		)	(0.6		)
Other nonoperating income	(0.6		)	(1.6		)
Income before income taxes	69.9			53.7
Income tax expense	16.1			12.5
Equity in net income of affiliated companies	(1.6		)	(2.4		)
Net income	$	55.4		$	43.6

Net income per share:
Basic	$	0.75		$	0.59
Diluted	$	0.73		$	0.58

Weighted average shares outstanding:
Basic	74.1			73.9
Diluted	75.3			75.5

See accompanying notes to condensed consolidated financial statements.

Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

West Pharmaceutical Services, Inc. and Subsidiaries

(in millions)



	Three Months Ended March 31,
	2019			2018
Net income	$	55.4		$	43.6
Other comprehensive income, net of tax:
Foreign currency translation adjustments	4.4			20.0
Defined benefit pension and other postretirement plan adjustments, net of tax of $0 and $(0.3)	(0.3		)	(0.7		)
Net (loss) gain on derivatives, net of tax of $(1.6) and $0.8	(3.3		)	2.2
Other comprehensive income, net of tax	0.8			21.5
Comprehensive income	$	56.2		$	65.1

See accompanying notes to condensed consolidated financial statements.

Table of Contents

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

West Pharmaceutical Services, Inc. and Subsidiaries

(in millions, except per share data)



	March 31, 2019			December 31, 2018
ASSETS
Current assets:
Cash and cash equivalents	$	265.5		$	337.4
Accounts receivable, net	318.2			288.2
Inventories	226.1			214.5
Other current assets	57.8			54.3
Total current assets	867.6			894.4
Property, plant and equipment	1,759.9			1,752.7
Less: accumulated depreciation and amortization	945.2			930.7
Property, plant and equipment, net	814.7			822.0
Operating lease right-of-use assets	75.2			—
Investments in affiliated companies	94.9			91.2
Goodwill	105.2			105.8
Deferred income taxes	32.7			24.7
Intangible assets, net	19.5			20.3
Other noncurrent assets	26.4			20.5
Total Assets	$	2,036.2		$	1,978.9

LIABILITIES AND EQUITY
Current liabilities:
Notes payable and other current debt	$	—		$	0.1
Accounts payable	137.7			130.4
Pension and other postretirement benefits	2.2			2.3
Accrued salaries, wages and benefits	53.5			64.5
Income taxes payable	17.3			9.8
Operating lease liabilities	10.2			—
Other current liabilities	80.2			76.6
Total current liabilities	301.1			283.7
Long-term debt	195.5			196.0
Deferred income taxes	14.3			13.1
Pension and other postretirement benefits	54.3			56.2
Operating lease liabilities	67.4			—
Other long-term liabilities	34.1			33.6
Total Liabilities	666.7			582.6

Commitments and contingencies (Note 17)

Equity:
Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding	—			—
Common stock, par value $0.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million; shares outstanding: 73.5 million and 74.1 million	18.8			18.8
Capital in excess of par value	278.5			282.0
Retained earnings	1,398.2			1,353.4
Accumulated other comprehensive loss	(153.4		)	(154.2		)
Treasury stock, at cost (1.8 million and 1.2 million shares)	(172.6		)	(103.7		)
Total Equity	1,369.5			1,396.3
Total Liabilities and Equity	$	2,036.2		$	1,978.9

See accompanying notes to condensed consolidated financial statements.

Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

West Pharmaceutical Services, Inc. and Subsidiaries

(in millions)



	Three Months Ended March 31,
	2019			2018
Cash flows from operating activities:
Net income	$	55.4		$	43.6
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	24.9			25.7
Amortization	0.6			0.7
Stock-based compensation	6.2			3.4
Non-cash restructuring charges	0.3			0.1
Contingent consideration payments in excess of acquisition-date liability	(0.2		)	(0.2		)
Other non-cash items, net	(0.8		)	(2.7		)
Changes in assets and liabilities	(38.8		)	(25.6		)
Net cash provided by operating activities	47.6			45.0

Cash flows from investing activities:
Capital expenditures	(28.8		)	(28.0		)
Other, net	0.1			(0.7		)
Net cash used in investing activities	(28.7		)	(28.7		)

Cash flows from financing activities:
Borrowings under revolving credit agreements	28.0			—
Repayments under revolving credit agreements	(28.0		)	—
Debt issuance costs	(0.8		)	—
Dividend payments	(11.1		)	(10.4		)
Proceeds from stock-based compensation awards	3.3			0.3
Employee stock purchase plan contributions	1.2			1.1
Shares purchased under share repurchase programs	(83.1		)	(47.9		)
Net cash used in financing activities	(90.5		)	(56.9		)
Effect of exchange rates on cash	(0.3		)	4.5
Net decrease in cash and cash equivalents	(71.9		)	(36.1		)

Cash, including cash equivalents at beginning of period	337.4			235.9
Cash, including cash equivalents at end of period	$	265.5		$	199.8

See accompanying notes to condensed consolidated financial statements.

Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Note 1: Summary of Significant Accounting Policies

Basis of Presentation: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three months ended March 31, 2019 should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”). The results of operations for any interim period are not necessarily indicative of results for the full year.

As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, Other Expense, to the consolidated financial statements in our 2018 Annual Report for further discussion.

Note 2: New Accounting Standards

Recently Adopted Standards

In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, Shareholders’ Equity.

In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate.

In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

Table of Contents

In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, Leases, for additional information.

Standards Issued Not Yet Adopted

In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.

Note 3: Revenue

The following table presents the approximate percentage of our net sales by market group:



	Three Months Ended March 31,
	2019		2018
Biologics	26	%	21	%
Generics	20	%	21	%
Pharma	31	%	36	%
Contract-Manufactured Products	23	%	22	%
	100	%	100	%

Table of Contents

The following table presents the approximate percentage of our net sales by product category:



	Three Months Ended March 31,
	2019		2018
High-Value Components	43	%	41	%
Standard Packaging	30	%	34	%
Delivery Devices	4	%	3	%
Contract-Manufactured Products	23	%	22	%
	100	%	100	%

The following table presents the approximate percentage of our net sales by geographic location:



	Three Months Ended March 31,
	2019		2018
Americas	46	%	45	%
Europe, Middle East, Africa	47	%	47	%
Asia Pacific	7	%	8	%
	100	%	100	%

Contract Assets and Liabilities

The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:



	($ in millions)
Contract assets, December 31, 2018	$	9.1
Contract assets, March 31, 2019	11.9
Change in contract assets - increase (decrease)	$	2.8

Deferred income, December 31, 2018	$	(33.4	)
Deferred income, March 31, 2019	(36.5		)
Change in deferred income - decrease (increase)	$	(3.1	)

The increase in deferred income during the three months ended March 31, 2019 was primarily due to additional cash payments of $30.6 million received in advance of satisfying future performance obligations, partially offset by the recognition of revenue of $25.8 million, including $11.1 million of revenue that was included in deferred income at the beginning of the year, and $1.7 million in other adjustments.

The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose^® technology platform within a specific therapeutic area. As of March 31, 2019, there was $6.3 million of unearned income related to this payment, of which $0.9 million was included in other current liabilities and $5.4 million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.

Table of Contents

Supply Chain Financing

We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of March 31, 2019, we derecognized $1.8 million of accounts receivable under these agreements. Discount fees related to the sale of such accounts receivable on our condensed consolidated income statements for the three months ended March 31, 2019 were not material.

Voluntary Recall

On January 24, 2019, we issued a voluntary recall of our Vial2Bag^® product line due to reports of potential unpredictable or variable dosing under certain conditions. Our 2018 results included an $11.3 million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During the three months ended March 31, 2019, following the completion of certain tests and studies related to the voluntary recall, we recorded a $4.5 million provision for potential inventory returns from our customers and related in-house inventory, partially offset by a reduction in our provision for product returns. We continue to work to get the products back on the market.

Note 4: Net Income Per Share

The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:



	Three Months Ended March 31,
(in millions)	2019		2018
Net income	$	55.4	$	43.6
Weighted average common shares outstanding	74.1		73.9
Dilutive effect of equity awards, based on the treasury stock method	1.2		1.6
Weighted average shares assuming dilution	75.3		75.5

During the three months ended March 31, 2019 and 2018, there were 0.6 million and 0.7 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive.

In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to 800,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under the Securities Exchange Act of 1934 Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. During the three months ended March 31, 2019, we purchased 800,000 shares of our common stock under the now-completed program at a cost of $83.1 million, or an average price of $103.89 per share.

Table of Contents

Note 5: Inventories

Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. Inventory balances were as follows:



($ in millions)	March 31, 2019		December 31, 2018
Raw materials	$	100.1	$	90.4
Work in process	39.0		42.2
Finished goods	87.0		81.9
	$	226.1	$	214.5

Note 6: Leases

Adoption of ASC 842

On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of March 31, 2019, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases include options to extend the lease term for up to five years, and certain of our operating leases include options to terminate the leases within one year. We had no finance leases as of March 31, 2019.

As a result of our adoption of ASC 842, we recorded operating lease right-of-use assets of $71.0 million and operating lease liabilities of $73.1 million for operating leases where we are the lessee in our condensed consolidated balance sheet as of January 1, 2019. The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.

Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments

Table of Contents

that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.

The components of lease expense were as follows:



($ in millions)	Three Months Ended March 31, 2019
Operating lease cost	$	3.2
Short-term lease cost	0.2
Variable lease cost	0.6
Total lease cost	$	4.0

Lease expense for the three months ended March 31, 2018 was $3.7 million.

Supplemental information related to leases was as follows:



($ in millions)	Three Months Ended March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	3.1

Right-of-use assets obtained in exchange for new operating lease liabilities	6.8

As of March 31, 2019, the weighted average remaining lease term for operating leases was 12.1 years, and the weighted average discount rate was 3.74%.

Maturities of lease liabilities as of March 31, 2019 were as follows:



($ in millions)	Operating
Year	Leases
2019 (remaining nine months)	$	9.6
2020	11.5
2021	9.8
2022	8.1
2023	7.6
Thereafter	49.0
	95.6
Less: imputed lease interest	(18.0		)
Total lease liabilities	$	77.6

Table of Contents

Maturities of future minimum rental payments under non-cancelable operating leases as of December 31, 2018 were as follows:



($ in millions)	Operating
Year	Leases
2019	$	13.0
2020	10.5
2021	7.8
2022	6.9
2023	5.5
Thereafter	37.8
Total	$	81.5

Practical Expedients and Exemptions

We have elected to adopt the leasing package of practical expedients, which allow us to not retroactively reassess: i) any expired or existing contracts containing leases under the new definition of a lease; ii) the lease classification for any expired or existing leases; and iii) initial direct costs for any expired or existing leases. We have also elected to adopt practical expedients around land easements, the combination of lease and non-lease components, and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases.

We have elected not to recognize operating lease right-of-use assets and lease liabilities for all short-term leases (leases with an initial lease term of 12 months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.

Note 7: Affiliated Companies

At March 31, 2019 and December 31, 2018, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $81.5 million and $77.8 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $13.4 million at both period-ends. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.

Our purchases from, and royalty payments made to, affiliates totaled $24.6 million for the three months ended March 31, 2019, as compared to $23.1 million for the same period in 2018. As of March 31, 2019 and December 31, 2018, the payable balance due to affiliates was $17.2 million and $12.9 million, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $2.2 million for the three months ended March 31, 2019, as compared to $2.4 million for the same period in 2018. As of March 31, 2019 and December 31, 2018, the receivable balance due from affiliates was $1.4 million and $1.6 million, respectively.

Please refer to Note 6, Affiliated Companies, to the consolidated financial statements in our 2018 Annual Report for additional details.

Table of Contents

Note 8: Debt

The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of March 31, 2019.



($ in millions)	March 31, 2019		December 31, 2018
Note payable, due December 31, 2019	$	—	$	0.1
Credit Facility, due October 15, 2020 (1.00%)	—		28.6
Credit Facility, due March 28, 2024 (0.875%)	28.1		—
Series A notes, due July 5, 2022 (3.67%)	42.0		42.0
Series B notes, due July 5, 2024 (3.82%)	53.0		53.0
Series C notes, due July 5, 2027 (4.02%)	73.0		73.0
	196.1		196.7
Less: unamortized debt issuance costs	0.6		0.6
Total debt	195.5		196.1
Less: current portion of long-term debt	—		0.1
Long-term debt, net	$	195.5	$	196.0

In March 2019, we entered into a new senior unsecured, multi-currency revolving credit facility agreement (the “Credit Agreement”) that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains a senior unsecured, multi-currency revolving credit facility (the “Credit Facility”) of $300.0 million, with sublimits of up to $30.0 million for swing line loans for domestic borrowers in U.S. Dollars (“USD”) and a $20.0 million swing line loan for our German Holding Company and up to $30.0 million for the issuance of standby letters of credit, which Credit Facility may be increased from time-to-time by the greater of $350.0 million and earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus 50 basis points or the daily London Interbank Offered Rate (“LIBOR”), plus 1.00%) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from 0 to 37.5 basis points for base rate loans and 87.5 to 137.5 basis points for LIBOR rate loans. The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to 4.0 to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of March 31, 2019 and December 31, 2018, total unamortized debt issuance costs of $1.1 million and $0.6 million, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.

At March 31, 2019, we had $28.1 million in outstanding long-term borrowings under the Credit Facility, of which $4.5 million was denominated in Japanese Yen (“Yen”) and $23.6 million was denominated in Euro. These borrowings, together with outstanding letters of credit of $2.5 million, resulted in a borrowing capacity available under the Credit Facility of $269.4 million at March 31, 2019. Please refer to Note 9, Derivative Financial Instruments, for a discussion of the foreign currency hedges associated with the Credit Facility.

Please refer to Note 9, Debt, to the consolidated financial statements in our 2018 Annual Report for additional details regarding our debt agreements.

Table of Contents

Note 9: Derivative Financial Instruments

Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our condensed consolidated balance sheet at fair value.

Foreign Exchange Rate Risk

We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of March 31, 2019, the total amount of these forward exchange contracts was Singapore Dollar (“SGD”) 601.5 million and $13.4 million. As of December 31, 2018, the total amount of these forward exchange contracts was €10.0 million, SGD 601.5 million and $13.4 million. During the three months ended March 31, 2019, we recognized foreign exchange transaction gains of $4.8 million within other (income) expense in our condensed consolidated statements of income related to these fair value hedges. We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge.

In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of March 31, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:



(in millions)		Sell
Currency	Purchase	USD	Euro
USD	31.5	—	26.8
Yen	5,232.0	24.4	20.5
SGD	44.0	25.1	6.4

At March 31, 2019, a portion of our debt consisted of borrowings denominated in currencies other than USD. We have designated our €21.0 million ($23.6 million) Euro-denominated borrowings under our Credit Facility as a hedge of our net investment in certain European subsidiaries. A cumulative foreign currency translation loss of less than $0.1 million for both pre- and after tax on this debt was recorded within accumulated other comprehensive loss as of March 31, 2019. We have also designated our ¥500.0 million ($4.5 million) Yen-denominated borrowings under our Credit Facility as a hedge of our net investment in Daikyo Seiko, Ltd. (“Daikyo”). At March 31, 2019, there was a cumulative foreign currency translation loss of $0.4 million pre-tax ($0.3 million after tax) on this Yen-denominated debt, which was also included within accumulated other comprehensive loss.

Commodity Price Risk

Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.

In November 2017, we purchased a series of call options for a total of 125,166 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases through May 2019. In April 2018, we purchased a series of call options for a total of 30,612 barrels of crude oil from December 2018 through August 2019. In January 2019, we purchased a series of call options for a total of 81,459 barrels of crude oil from February 2019 through May 2020.

Table of Contents

During the three months ended March 31, 2019, the loss recorded in cost of goods and services sold related to these call options was less than $0.1 million.

As of March 31, 2019, we had outstanding contracts to purchase 108,891 barrels of crude oil from April 2019 to May 2020 at a weighted-average strike price of $66.22 per barrel.

Effects of Derivative Instruments on Financial Position and Results of Operations

Please refer to Note 10, Fair Value Measurements, for the balance sheet location and fair values of our derivative instruments as of March 31, 2019 and December 31, 2018.

The following table summarizes the effects of derivative instruments designated as hedges on other comprehensive income (“OCI”) and earnings, net of tax:



	Amount of Gain (Loss) Recognized in OCI for the						Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the					Location of (Gain) Loss Reclassified from Accumulated OCI into Income
	Three Months Ended March 31,						Three Months Ended March 31,
($ in millions)	2019			2018			2019			2018
Cash Flow Hedges:
Foreign currency hedge contracts	$	0.5		$	(0.4	)	$	(0.2	)	$	0.5	Net sales
Foreign currency hedge contracts	(0.1		)	1.6			(0.1		)	0.4		Cost of goods and services sold
Forward treasury locks	—			—			—			0.1		Interest expense
Total	$	0.4		$	1.2		$	(0.3	)	$	1.0
Net Investment Hedges:
Foreign currency-denominated debt	$	0.1		$	(0.7	)	$	—		$	—	Other (income) expense
Total	$	0.1		$	(0.7	)	$	—		$	—

For the three months ended March 31, 2019 and 2018, there was no material ineffectiveness related to our hedges.

Note 10: Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:


•	Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.


•	Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.


•	Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

Table of Contents

The following tables present the assets and liabilities recorded at fair value on a recurring basis:



	Balance at		Basis of Fair Value Measurements
($ in millions)	March 31, 2019		Level 1		Level 2		Level 3
Assets:
Deferred compensation assets	$	9.2	$	9.2	$	—	$	—
Foreign currency contracts	17.7		—		17.7		—
Commodity call options	0.2		—		0.2		—
	$	27.1	$	9.2	$	17.9	$	—
Liabilities:
Contingent consideration	$	1.7	$	—	$	—	$	1.7
Deferred compensation liabilities	10.5		10.5		—		—
Foreign currency contracts	0.8		—		0.8		—
	$	13.0	$	10.5	$	0.8	$	1.7



	Balance at		Basis of Fair Value Measurements
($ in millions)	December 31, 2018		Level 1		Level 2		Level 3
Assets:
Deferred compensation assets	$	8.7	$	8.7	$	—	$	—
Foreign currency contracts	6.5		—		6.5		—
	$	15.2	$	8.7	$	6.5	$	—
Liabilities:
Contingent consideration	$	1.7	$	—	$	—	$	1.7
Deferred compensation liabilities	9.8		9.8		—		—
Foreign currency contracts	0.2		—		0.2		—
	$	11.7	$	9.8	$	0.2	$	1.7

Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees’ investment selections and is included within other long-term liabilities. Please refer to Note 9, Derivative Financial Instruments, for further discussion of our derivatives.

Level 3 Fair Value Measurements

The fair value of the contingent consideration liability related to the SmartDose technology platform (the “SmartDose contingent consideration”) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other (income) expense in our condensed consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose

Table of Contents

contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.

The following table provides a summary of changes in our Level 3 fair value measurements:



	($ in millions)
Balance, December 31, 2017	$	4.9
Decrease in fair value recorded in earnings	(2.6		)
Payments	(0.6		)
Balance, December 31, 2018	1.7
Increase in fair value recorded in earnings	0.2
Payments	(0.2		)
Balance, March 31, 2019	$	1.7

Other Financial Instruments

We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.

The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At March 31, 2019, the estimated fair value of long-term debt was $197.4 million compared to a carrying amount of $195.5 million. At December 31, 2018, the estimated fair value of long-term debt was $192.6 million and the carrying amount was $196.0 million.

Note 11: Accumulated Other Comprehensive Loss

The following table presents the changes in the components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2019:



($ in millions)	Losses on derivatives			Unrealized gains on investment securities		Defined benefit pension and other postretirement plans			Foreign currency translation			Total
Balance, December 31, 2018	$	(0.4	)	$	0.4	$	(40.4	)	$	(113.8	)	$	(154.2	)
Other comprehensive (loss) income before reclassifications	(3.0		)	—		(0.2		)	4.4			1.2
Amounts reclassified out	(0.3		)	—		(0.1		)	—			(0.4		)
Other comprehensive (loss) income, net of tax	(3.3		)	—		(0.3		)	4.4			0.8
Balance, March 31, 2019	$	(3.7	)	$	0.4	$	(40.7	)	$	(109.4	)	$	(153.4	)

Table of Contents

A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table:



($ in millions)	Three Months Ended March 31,						Location on Statement of Income
Detail of components	2019			2018			Location on Statement of Income
Losses on derivatives:
Foreign currency contracts	$	0.2		$	(0.6	)	Net sales
Foreign currency contracts	0.2			(0.6		)	Cost of goods and services sold
Forward treasury locks	(0.1		)	(0.1		)	Interest expense
Total before tax	0.3			(1.3		)
Tax expense	—			0.3
Net of tax	$	0.3		$	(1.0	)
Amortization of defined benefit pension and other postretirement plans:
Prior service credit	$	0.2		$	0.5		(a)
Actuarial losses	—			(0.4		)	(a)
Total before tax	0.2			0.1
Tax expense	(0.1		)	—
Net of tax	$	0.1		$	0.1
Total reclassifications for the period, net of tax	$	0.4		$	(0.9	)

(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 14, Benefit Plans, for additional details.

Table of Contents

Note 12: Shareholders’ Equity

The following table presents the changes in shareholders’ equity for the three months ended March 31, 2019:



	Common Shares Issued	Common Stock		Capital in Excess of Par Value			Number of Treasury Shares		Treasury Stock			Retained earnings			Accumulated other comprehensive loss			Total
($ in millions)	Common Shares Issued	Common Stock		Capital in Excess of Par Value			Number of Treasury Shares		Treasury Stock			Retained earnings			Accumulated other comprehensive loss			Total
Balance, December 31, 2018	75.3	$	18.8	$	282.0		1.2		$	(103.7	)	$	1,353.4		$	(154.2	)	$	1,396.3
Net income	—	—		—			—		—			55.4			—			55.4
Activity related to stock-based compensation	—	—		(3.5		)	(0.2	)	14.2			—			—			10.7
Shares purchased under share repurchase program	—	—		—			0.8		(83.1		)	—			—			(83.1		)
Dividends declared ($0.15 per share)	—	—		—			—		—			(10.6		)	—			(10.6		)
Other comprehensive income, net of tax	—	—		—			—		—			—			0.8			0.8
Balance, March 31, 2019	75.3	$	18.8	$	278.5		1.8		$	(172.6	)	$	1,398.2		$	(153.4	)	$	1,369.5

The following table presents the changes in shareholders’ equity for the three months ended March 31, 2018:



	Common Shares Issued	Common Stock		Capital in Excess of Par Value			Number of Treasury Shares		Treasury Stock			Retained earnings			Accumulated other comprehensive loss			Total
($ in millions)	Common Shares Issued	Common Stock		Capital in Excess of Par Value			Number of Treasury Shares		Treasury Stock			Retained earnings			Accumulated other comprehensive loss			Total
Balance, December 31, 2017	75.2	$	18.8	$	309.3		1.3		$	(109.1	)	$	1,178.2		$	(117.3	)	$	1,279.9
Effect of modified retrospective application of a new accounting standard	—	—		—			—		—			11.4			—			11.4
Net income	—	—		—			—		—			43.6			—			43.6
Activity related to stock-based compensation	0.1	—		(0.8		)	(0.1	)	8.0			—			—			7.2
Shares purchased under share repurchase program	—	—		—			0.5		(47.9		)	—			—			(47.9		)
Dividends declared ($0.14 per share)	—	—		—			—		—			(10.4		)	—			(10.4		)
Other comprehensive income, net of tax	—	—		—			—		—			—			21.5			21.5
Balance, March 31, 2018	75.3	$	18.8	$	308.5		1.7		$	(149.0	)	$	1,222.8		$	(95.8	)	$	1,305.3

Table of Contents

Note 13: Stock-Based Compensation

The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the “2016 Plan”) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At March 31, 2019, there were 3,162,428 shares remaining in the 2016 Plan for future grants.

During the three months ended March 31, 2019, we granted 344,616 stock options at a weighted average exercise price of $102.51 per share based on the grant-date fair value of our stock to employees under the 2016 Plan. The weighted average grant date fair value of options granted was $24.51 per share as determined by the Black-Scholes option valuation model using the following weighted average assumptions: a risk-free interest rate of 2.3%; expected life of 5.6 years based on prior experience; stock volatility of 22.5% based on historical data; and a dividend yield of 0.7%. Stock option expense is recognized over the vesting period, net of forfeitures.

During the three months ended March 31, 2019, we granted 82,458 stock-settled performance share unit (“PSU”) awards at a weighted average grant-date fair value of $102.51 per share to eligible employees. These awards are earned based on the Company’s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock. Shares earned under PSU awards may vary from 0% to 200% of an employee’s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures.

During the three months ended March 31, 2019, we granted 7,266 stock-settled restricted share unit (“RSU”) awards at a weighted average grant-date fair value of $102.51 per share to eligible employees. These awards are earned over a specified performance period. The fair value of stock-settled RSU awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period, net of forfeitures.

Total stock-based compensation expense was $6.2 million and $3.4 million for the three months ended March 31, 2019 and 2018, respectively.

Table of Contents

Note 14: Benefit Plans

The components of net periodic benefit cost for the three months ended March 31 were as follows:



	Pension benefits						Other retirement benefits						Total
($ in millions)	2019			2018			2019			2018			2019			2018
Service cost	$	0.4		$	2.8		$	—		$	—		$	0.4		$	2.8
Interest cost	2.4			2.3			0.1			0.1			2.5			2.4
Expected return on assets	(2.9		)	(3.9		)	—			—			(2.9		)	(3.9		)
Amortization of prior service credit	—			(0.3		)	(0.2		)	(0.2		)	(0.2		)	(0.5		)
Recognized actuarial losses (gains)	0.5			0.9			(0.5		)	(0.5		)	—			0.4
Net periodic benefit cost	$	0.4		$	1.8		$	(0.6	)	$	(0.6	)	$	(0.2	)	$	1.2



	Pension benefits					Other retirement benefits						Total
($ in millions)	2019			2018		2019			2018			2019			2018
U.S. plans	$	(0.1	)	$	1.3	$	(0.6	)	$	(0.6	)	$	(0.7	)	$	0.7
International plans	0.5			0.5		—			—			0.5			0.5
Net periodic benefit cost	$	0.4		$	1.8	$	(0.6	)	$	(0.6	)	$	(0.2	)	$	1.2

Effective January 1, 2019, except for interest crediting, benefit accruals under our U.S. qualified and non-qualified defined benefit pension plans ceased.

Note 15: Other (Income) Expense

Other (income) expense consists of:



	Three Months Ended March 31,
($ in millions)	2019			2018
Restructuring and related charges:
Severance and post-employment benefits	$	0.3		$	2.0
Asset-related charges	—			0.1
Other charges	0.3			1.2
Total restructuring and related charges	0.6			3.3
Development and licensing income	(0.2		)	(0.2		)
Contingent consideration	0.2			0.3
Other items	(2.9		)	(0.3		)
Total other (income) expense	$	(2.3	)	$	3.1

Restructuring and Related Charges

In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes are expected to be implemented over a period of up to twenty-four months from the date of approval. The plan will require restructuring and related charges of approximately $15.0 million.

Table of Contents

During the three months ended March 31, 2019, we recorded $0.6 million in restructuring and related charges associated with this plan, consisting of $0.3 million for severance charges and $0.3 million for other charges. During the three months ended March 31, 2018, we recorded $3.3 million in restructuring and related charges associated with this plan, consisting of $2.0 million for severance charges, $0.1 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $1.2 million for other non-cash charges.

The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:



($ in millions)	Severance and benefits			Asset-related charges		Other charges			Total
Balance, December 31, 2018	$	2.3		$	—	$	—		$	2.3
Charges	0.3			—		0.3			0.6
Cash payments	(1.1		)	—		—			(1.1		)
Non-cash asset write-downs	—			—		(0.3		)	(0.3		)
Balance, March 31, 2019	$	1.5		$	—	$	—		$	1.5

On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. Our remaining restructuring obligations related to the 2016 restructuring plan as of March 31, 2019 were $0.3 million.

Other Items

During both the three months ended March 31, 2019 and 2018, we recorded development income of $0.2 million related to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, Revenue, for additional information.

Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 10, Fair Value Measurements, for additional details.

Other items consist of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, and miscellaneous income and charges. Other items increased by $2.6 million for the three months ended March 31, 2019, as compared to the same period in 2018, primarily as a result of foreign exchange transaction gains of $3.8 million during the three months ended March 31, 2019, as compared to foreign exchange transaction losses of $0.4 million during the three months ended March 31, 2018.

Note 16: Income Taxes

The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items.

The provision for income taxes was $16.1 million and $12.5 million for the three months ended March 31, 2019 and 2018, respectively, and the effective tax rate was 23.1% and 23.3%, respectively.

During the three months ended March 31, 2018, we recorded a net tax charge of $0.3 million for the estimated impact of the 2017 Tax Act. Please refer to Note 16, Income Taxes, to the consolidated financial statements in our 2018 Annual Report for further discussion.

Table of Contents

Note 17: Commitments and Contingencies

From time to time, we are involved in product liability matters and other legal proceedings and claims generally incidental to our normal business activities. We accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. While the outcome of current proceedings cannot be accurately predicted, we believe their ultimate resolution should not have a material adverse effect on our business, financial condition, results of operations or liquidity.

There have been no significant changes to the commitments and contingencies included in our 2018 Annual Report.

On January 1, 2019, we adopted ASC 842. Please refer to Note 6, Leases, for additional information.

Note 18: Segment Information

Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.

We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.

Table of Contents

The following table presents information about our reportable segments, reconciled to consolidated totals:



	Three Months Ended March 31,
($ in millions)	2019			2018
Net sales:
Proprietary Products	$	340.4		$	326.2
Contract-Manufactured Products	103.1			89.5
Consolidated net sales	$	443.5		$	415.7
Operating profit (loss):
Proprietary Products	$	77.0		$	62.8
Contract-Manufactured Products	10.5			9.5
Corporate	(16.2		)	(15.6		)
Other unallocated items	(0.6		)	(3.3		)
Total operating profit	$	70.7		$	53.4
Interest expense	2.3			1.9
Interest income	(0.9		)	(0.6		)
Other nonoperating income	(0.6		)	(1.6		)
Income before income taxes	$	69.9		$	53.7

Other unallocated items during the three months ended March 31, 2019 and 2018, consisted of $0.6 million and $3.3 million, respectively, in restructuring and related charges. Please refer to Note 15, Other (Income) Expense, for further discussion of these items.

Note 19: Subsequent Event

In April 2019, we acquired the business of our distributor in South Korea. We believe that the acquisition will not have a material impact on our financial statements.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

OVERVIEW

The following discussion is intended to further the reader’s understanding of the consolidated financial condition and results of operations of our Company. It should be read in conjunction with our condensed consolidated financial statements and accompanying notes elsewhere in this Quarterly Report on Form 10-Q (“Form 10-Q”) as well as Management’s Discussion and Analysis of Financial Condition and Results of Operations and the consolidated financial statements and accompanying notes included in our 2018 Annual Report. Our historical financial statements may not be indicative of our future performance. This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risks discussed in Part I, Item 1A of our 2018 Annual Report and in Part II, Item 1A of this Form 10-Q.

Throughout this section, references to “Notes” refer to the notes to our condensed consolidated financial statements (unaudited) in Part I, Item 1 of this Form 10-Q, unless otherwise indicated.

Table of Contents

Non-U.S. GAAP Financial Measures

For the purpose of aiding the comparison of our year-over-year results, we may refer to net sales and other financial results excluding the effects of changes in foreign currency exchange rates. The constant-currency amounts are calculated by translating the current year’s functional currency results at the prior-year period’s exchange rate. We may also refer to consolidated operating profit and consolidated operating profit margin excluding the effects of unallocated items. The re-measured results excluding effects from currency translation and excluding the effects of unallocated items are not in conformity with U.S. GAAP and should not be used as a substitute for the comparable U.S. GAAP financial measures. The non-U.S. GAAP financial measures are incorporated into our discussion and analysis as management uses them in evaluating our results of operations, and believes that this information provides users a valuable insight into our results.

Our Operations

We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing and analytical lab services. Our customers include the leading biologic, generic, pharmaceutical, diagnostic, and medical device companies in the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes excellence in manufacturing, scientific and technical expertise and management, so we can partner with our customers to deliver safe, effective drug products to patients quickly and efficiently. The Company was incorporated under the laws of the Commonwealth of Pennsylvania on July 27, 1923.

2019 Financial Performance Summary

Consolidated net sales increased by $27.8 million, or 6.7%, for the three months ended March 31, 2019, as compared to the same period in 2018. Excluding foreign currency translation effects, consolidated net sales for the three months ended March 31, 2019 increased by $47.4 million, or 11.4%, as compared to the same period in 2018.

Net income for the three months ended March 31, 2019 was $55.4 million, or $0.73 per diluted share, as compared to $43.6 million, or $0.58 per diluted share, for the same period in 2018. Net income for the three months ended March 31, 2019 included the impact of restructuring and related charges of $0.4 million (net of $0.2 million in tax), or $0.01 per diluted share and a tax benefit of $1.4 million, or $0.02 per diluted share, associated with stock-based compensation. Net income for the three months ended March 31, 2018 included the impact of restructuring and related charges of $2.7 million (net of $0.6 million in tax), or $0.03 per diluted share, a net tax charge of $0.3 million, or $0.01 per diluted share, for the estimated impact of the 2017 Tax Act, and a tax benefit of $2.1 million, or $0.03 per diluted share, associated with stock-based compensation.

Table of Contents

At March 31, 2019, our cash and cash equivalents balance totaled $265.5 million and our available borrowing capacity under our Credit Facility was $269.4 million.

RESULTS OF OPERATIONS

Percentages in the following tables and throughout the Results of Operations section may reflect rounding adjustments.

Net Sales

The following table presents net sales, consolidated and by reportable segment, for the three months ended March 31, 2019 and 2018:



	Three Months Ended March 31,				% Change
($ in millions)	2019		2018		As-Reported		Ex-Currency
Proprietary Products	$	340.4	$	326.2	4.3	%	9.4	%
Contract-Manufactured Products	103.1		89.5		15.3	%	18.9	%
Consolidated net sales	$	443.5	$	415.7	6.7	%	11.4	%

Consolidated net sales increased by $27.8 million, or 6.7%, for the three months ended March 31, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $19.6 million. Excluding foreign currency translation effects, consolidated net sales for the three months ended March 31, 2019 increased by $47.4 million, or 11.4%, as compared to the same period in 2018.

Proprietary Products – Proprietary Products net sales increased by $14.2 million, or 4.3%, for the three months ended March 31, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $16.3 million. Excluding foreign currency translation effects, net sales for the three months ended March 31, 2019 increased by $30.5 million, or 9.4%, as compared to the same period in 2018, primarily due to growth in our high-value product offerings, including our NovaPure^® products, our ready-to-use seals, stoppers, and plungers, and our Envision^® line of vision-inspected components, as well as sales price increases.

Contract-Manufactured Products – Contract-Manufactured Products net sales increased by $13.6 million, or 15.3%, for the three months ended March 31, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $3.3 million. Excluding foreign currency translation effects, net sales for the three months ended March 31, 2019 increased by $16.9 million, or 18.9%, as compared to the same period in 2018, due to an increase in the sale of healthcare-related injection and diagnostic devices.

Table of Contents

Gross Profit

The following table presents gross profit and related gross profit margins, consolidated and by reportable segment:



	Three Months Ended March 31,
($ in millions)	2019			2018
Proprietary Products:
Gross Profit	$	132.3		$	121.2
Gross Profit Margin	38.9		%	37.1		%
Contract-Manufactured Products:
Gross Profit	$	14.5		$	13.2
Gross Profit Margin	14.0		%	14.8		%
Consolidated Gross Profit	$	146.8		$	134.4
Consolidated Gross Profit Margin	33.1		%	32.3		%

Consolidated gross profit increased by $12.4 million, or 9.2%, for the three months ended March 31, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $6.2 million. Consolidated gross profit margin increased by 0.8 margin points for the three months ended March 31, 2019, as compared to the same period in 2018.

Proprietary Products – Proprietary Products gross profit increased by $11.1 million, or 9.2%, for the three months ended March 31, 2019, respectively, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $5.7 million. Proprietary Products gross profit margin increased by 1.8 margin points for the three months ended March 31, 2019, as compared to the same period in 2018, due to a favorable mix of products sold, sales price increases and lower raw material costs, partially offset by increased labor costs and the impact of the voluntary recall of Vial2Bag products.

Contract-Manufactured Products – Contract-Manufactured Products gross profit increased by $1.3 million, or 9.8%, for the three months ended March 31, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $0.5 million. Contract-Manufactured Products gross profit margin decreased by 0.8 margin points for the three months ended March 31, 2019, as compared to the same period in 2018, due to an unfavorable mix of product sales, increased labor costs and under-absorbed overhead costs, partially offset by production efficiencies and lower raw material costs.

Research and Development (“R&D”) Costs

The following table presents R&D costs, consolidated and by reportable segment:



	Three Months Ended March 31,
($ in millions)	2019		2018
Proprietary Products	$	9.8	$	9.6
Contract-Manufactured Products	—		—
Consolidated R&D Costs	$	9.8	$	9.6

Consolidated R&D costs increased by $0.2 million, or 2.1%, for the three months ended March 31, 2019, as compared to the same period in 2018. Efforts remain focused on the continued investment in self-injection systems development, elastomeric packaging components, and formulation development.

Table of Contents

All of the R&D costs incurred during the three months ended March 31, 2019 related to Proprietary Products.

Selling, General and Administrative (“SG&A”) Costs

The following table presents SG&A costs, consolidated and by reportable segment and corporate:



	Three Months Ended March 31,
($ in millions)	2019			2018
Proprietary Products	$	48.8		$	48.4
Contract-Manufactured Products	4.0			4.3
Corporate	15.8			15.6
Consolidated SG&A costs	$	68.6		$	68.3
SG&A as a % of net sales	15.5		%	16.4		%

Consolidated SG&A costs increased by $0.3 million, or 0.4%, for the three months ended March 31, 2019, as compared to the same period in 2018, including the impact of foreign currency translation, which decreased SG&A costs by $1.4 million for the three months ended March 31, 2019.

Proprietary Products – Proprietary Products SG&A costs increased by $0.4 million, or 0.8%, for the three months ended March 31, 2019, as compared to the same period in 2018, due to incremental costs associated with our voluntary recall and increases in compensation costs, primarily related to merit increases, both of which were partially offset by decreases in travel and miscellaneous costs. Foreign currency translation decreased Proprietary Products SG&A costs by $1.4 million for the three months ended March 31, 2019.

Contract-Manufactured Products – Contract-Manufactured Products SG&A costs decreased by $0.3 million, or 7.0%, for the three months ended March 31, 2019, as compared to the same period in 2018, due to a decrease in miscellaneous costs.

Corporate – Corporate SG&A costs increased by $0.2 million, or 1.3%, for the three months ended March 31, 2019, as compared to the same period in 2018, primarily due to an increase in stock-based compensation costs, offset by a decrease in U.S. pension costs due to the cessation of our U.S. qualified and non-qualified defined benefit pension plans as of January 1, 2019 (except for interest crediting).

Other (Income) Expense

The following table presents other income and expense items, consolidated and by reportable segment and unallocated items:



(Income) Expense	Three Months Ended March 31,
($ in millions)	2019			2018
Proprietary Products	$	(3.3	)	$	0.4
Contract-Manufactured Products	—			(0.6		)
Corporate	0.4			—
Unallocated items	0.6			3.3
Consolidated other (income) expense	$	(2.3	)	$	3.1

Table of Contents

Other income and expense items, consisting of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, development and licensing income, contingent consideration, and miscellaneous income and charges, are generally recorded within segment results.

Consolidated other (income) expense changed by $5.4 million for the three months ended March 31, 2019, as compared to the same period in 2018.

Proprietary Products – Proprietary Products other (income) expense changed by $3.7 million for the three months ended March 31, 2019, as compared to the same period in 2018, primarily due to foreign exchange transaction gains in Europe.

Contract-Manufactured Products – Contract-Manufactured Products other income decreased by $0.6 million for the three months ended March 31, 2019, as compared to the same period in 2018, due to gains on the sale of fixed assets during the three months ended March 31, 2018.

Corporate – Corporate other expense increased by $0.4 million for the three months ended March 31, 2019, as compared to the same period in 2018.

Unallocated items – During the three months ended March 31, 2019 and 2018 we recorded $0.6 million and $3.3 million, respectively, in restructuring and related charges. Once fully completed, we expect that our 2018 restructuring plan will provide annualized savings of approximately $14.0 million. Please refer to Note 15, Other (Income) Expense, for further discussion of these items.

Operating Profit

The following table presents adjusted operating profit, consolidated and by reportable segment, corporate and unallocated items:



	Three Months Ended March 31,
($ in millions)	2019			2018
Proprietary Products	$	77.0		$	62.8
Contract-Manufactured Products	10.5			9.5
Corporate	(16.2		)	(15.6		)
Adjusted consolidated operating profit	$	71.3		$	56.7
Adjusted consolidated operating profit margin	16.1		%	13.6		%
Unallocated items	(0.6		)	(3.3		)
Consolidated operating profit	$	70.7		$	53.4
Consolidated operating profit margin	15.9		%	12.8		%

Consolidated operating profit increased by $17.3 million, or 32.4%, for the three months ended March 31, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $5.0 million for the three months ended March 31, 2019.

Proprietary Products – Proprietary Products operating profit increased by $14.2 million, or 22.6%, for the three months ended March 31, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $4.6 million, due to the factors described above.

Contract-Manufactured Products – Contract-Manufactured Products operating profit increased by $1.0 million, or 10.5%, for the three months ended March 31, 2019, as compared to the same period in 2018, including an unfavorable foreign currency translation impact of $0.4 million, due to the factors described above.

Table of Contents

Corporate – Corporate costs increased by $0.6 million, or 3.8%, for the three months ended March 31, 2019, as compared to the same period in 2018, due to the factors described above.

Unallocated items – Please refer to the Other (Income) Expense section for details.

Interest Expense, Net

The following table presents interest expense, net, by significant component:



	Three Months Ended March 31,
($ in millions)	2019			2018
Interest expense	$	2.5		$	2.2
Capitalized interest	(0.2		)	(0.3		)
Interest income	(0.9		)	(0.6		)
Interest expense, net	$	1.4		$	1.3

Interest expense, net, increased by $0.1 million, or 7.7%, for the three months ended March 31, 2019, as compared to the same period in 2018, due to a decrease in capitalized interest during the three months ended March 31, 2019.

Other Nonoperating Income

Other nonoperating income decreased by $1.0 million for the three months ended March 31, 2019, as compared to the same period in 2018, due to a decrease in the expected return on pension plan assets.

Income Taxes

The provision for income taxes was $16.1 million and $12.5 million for the three months ended March 31, 2019 and 2018, respectively, and the effective tax rate was 23.1% and 23.3%, respectively.

Equity in Net Income of Affiliated Companies

Equity in net income of affiliated companies represents the contribution to earnings from our 25% ownership interest in Daikyo and our 49% ownership interest in four companies in Mexico. Equity in net income of affiliated companies decreased by $0.8 million, for the three months ended March 31, 2019, as compared to the same period in 2018, primarily due to an increase in manufacturing costs at Daikyo.

Net Income

Net income for the three months ended March 31, 2019 was $55.4 million, which included the impact of restructuring and related charges of $0.4 million (net of $0.2 million in tax) and a tax benefit of $1.4 million associated with stock-based compensation.

Net income for the three months ended March 31, 2018 was $43.6 million, which included the impact of restructuring and related charges of $2.7 million (net of $0.6 million in tax), a net tax charge of $0.3 million for the estimated impact of the 2017 Tax Act, and a tax benefit of $2.1 million associated with stock-based compensation.

Table of Contents

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

Cash Flows

The following table presents cash flow data for the three months ended March 31:



($ in millions)	2019			2018
Net cash provided by operating activities	$	47.6		$	45.0
Net cash used in investing activities	$	(28.7	)	$	(28.7	)
Net cash used in financing activities	$	(90.5	)	$	(56.9	)

Net Cash Provided by Operating Activities – Net cash provided by operating activities increased by $2.6 million for the three months ended March 31, 2019, as compared to the same period in 2018, primarily due to improved operating results, partially offset by changes in asset and liability balances.

Net Cash Used in Investing Activities – Net cash used in investing activities remained constant for the three months ended March 31, 2019, as compared to the same period in 2018, as an $0.8 million increase in capital expenditures was offset by a decrease in other investing activities.

Net Cash Used in Financing Activities – Net cash used in financing activities increased by $33.6 million for the three months ended March 31, 2019, as compared to the same period in 2018, primarily due to an increase in purchases under our share repurchases programs.

Liquidity and Capital Resources

The table below presents selected liquidity and capital measures:



($ in millions)	March 31, 2019		December 31, 2018
Cash and cash equivalents	$	265.5	$	337.4
Accounts receivable, net	$	318.2	$	288.2
Inventories	$	226.1	$	214.5
Accounts payable	$	137.7	$	130.4
Debt	$	195.5	$	196.1
Equity	$	1,369.5	$	1,396.3
Working capital	$	566.5	$	610.7

Cash and cash equivalents include all instruments that have maturities of ninety days or less when purchased. Working capital is defined as current assets less current liabilities.

Cash and cash equivalents – Our cash and cash equivalents balance at March 31, 2019 consisted of cash held in depository accounts with banks around the world and cash invested in high-quality, short-term investments. The cash and cash equivalents balance at March 31, 2019 included $77.7 million of cash held by subsidiaries within the U.S., and $187.8 million of cash held by subsidiaries outside of the U.S. During the three months ended March 31, 2019, we purchased 800,000 shares of our common stock under our now-completed calendar-year 2019 share repurchase program at a cost of $83.1 million, or an average price of $103.89 per share.

Working capital – Working capital at March 31, 2019 decreased by $44.2 million, or 7.2%, as compared to December 31, 2018, including an increase of $0.4 million due to foreign currency translation. Excluding the impact

Table of Contents

of currency exchange rates, accounts receivable, inventories and total current liabilities increased by $32.3 million, $13.1 million and $19.6 million, respectively, while cash and cash equivalents decreased by $71.6 million. The increase in accounts receivable was due to increased sales activity and longer customer payment terms. The increase in total current liabilities was primarily due to our adoption of ASC 842, which required us to record operating lease liabilities for operating leases where we are the lessee in our condensed consolidated balance sheet as of March 31, 2019, as well as an increase in income taxes payable.

Debt and credit facilities – The $0.6 million decrease in total debt at March 31, 2019, as compared to December 31, 2018, primarily resulted from foreign currency rate fluctuations.

Our sources of liquidity include our Credit Facility. At March 31, 2019, we had $28.1 million in outstanding long-term borrowings under this facility, of which $4.5 million was denominated in Yen and $23.6 million was denominated in Euro. These borrowings, together with outstanding letters of credit of $2.5 million, resulted in a borrowing capacity available under our Credit Facility of $269.4 million at March 31, 2019. We do not expect any significant limitations on our ability to access this source of funds.

The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to 4.0 to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. At March 31, 2019, we were in compliance with all of our debt covenants.

We believe that cash on hand and cash generated from operations, together with availability under our Credit Facility, will be adequate to address our foreseeable liquidity needs based on our current expectations of our business operations, capital expenditures and scheduled payments of debt obligations.

Commitments and Contractual Obligations

A table summarizing the amounts and estimated timing of future cash payments resulting from commitments and contractual obligations was provided in our 2018 Annual Report. During the three months ended March 31, 2019, there were no material changes outside of the ordinary course of business to our commitments and contractual obligations.

In March 2019, we entered into the Credit Agreement that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement expires in March 2024. Please refer to Note 8, Debt, for additional information.

On January 1, 2019, we adopted ASC 842. Please refer to Note 6, Leases, for additional information.

OFF-BALANCE SHEET ARRANGEMENTS

At March 31, 2019, we had no off-balance sheet financing arrangements other than unconditional purchase obligations incurred in the ordinary course of business, and outstanding letters of credit related to various insurance programs, as noted in our 2018 Annual Report.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

There have been no changes to the Critical Accounting Policies and Estimates disclosed in Part II, Item 7 of our 2018 Annual Report.

Table of Contents

NEW ACCOUNTING STANDARDS

For information on new accounting standards that were adopted, and those issued but not yet adopted, during the three months ended March 31, 2019, and the impact, if any, on our financial position or results of operations, see Note 2, New Accounting Standards.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Our disclosure and analysis in this Form 10-Q contains some forward-looking statements that are based on management’s beliefs and assumptions, current expectations, estimates and forecasts. We also provide forward-looking statements in other materials we release to the public, as well as oral forward-looking statements. Such statements provide our current expectations or forecasts of future events. They do not relate strictly to historical or current facts. We have attempted, wherever possible, to identify forward-looking statements by using words such as “plan,” “expect,” “believe,” “intend,” “will,” “estimate,” “continue” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance, as well as our strategy for growth, product development, market position and expenditures. All statements that address operating performance or events or developments that we expect or anticipate will occur in the future - including statements relating to sales and earnings per share growth, cash flows or uses, and statements expressing views about future operating results - are forward-looking statements.

Forward-looking statements are based on current expectations of future events. The forward-looking statements are, and will be, based on management’s then-current views and assumptions regarding future events and operating performance, and speak only as of their dates. Investors should realize that, if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. Investors are therefore cautioned not to place undue reliance on any forward-looking statements.

The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements:


•	sales demand and our ability to meet that demand;


•	competition from other providers in our businesses, including customers’ in-house operations, and from lower-cost producers in emerging markets, which can impact unit volume, price and profitability;


•	customers’ changing inventory requirements and manufacturing plans that alter existing orders or ordering patterns for the products we supply to them;


•	the timing, regulatory approval and commercial success of customer products that incorporate our products and systems;

•

whether customers agree to incorporate our products and delivery systems with their new and existing drug products, the ultimate timing and successful commercialization of those products and systems, which involves substantial evaluations of the functional, operational, clinical and economic viability of our products, and the rate, timing and success of regulatory approval for the drug products that incorporate our components and systems;


•	the timely and adequate availability of filling capacity, which is essential to conducting definitive stability trials and the timing of first commercialization of customers’ products in Daikyo Crystal Zenith^® prefilled syringes;


•	average profitability, or mix, of the products sold in any reporting period, including lower-than-expected sales growth of our high-value proprietary product offerings;


•	maintaining or improving production efficiencies and overhead absorption;

Table of Contents


•	dependence on third-party suppliers and partners, some of which are single-source suppliers of critical materials and products, including our Japanese partner and affiliate, Daikyo;


•	the loss of key personnel or highly-skilled employees;


•	the availability and cost of skilled employees required to meet increased production, managerial, research and other needs, including professional employees and persons employed under collective bargaining agreements;

•

interruptions or weaknesses in our supply chain, including from reasons beyond our control such as extreme weather, longer-term climate changes, natural disasters, pandemic, war, accidental damage, or unauthorized access to our or our customers’ information and systems, which could cause delivery delays or restrict the availability of raw materials, key purchased components and finished products;


•	the successful and timely implementation of price increases necessary to offset rising production costs, including raw material prices, particularly petroleum-based raw materials;


•	the cost and progress of development, regulatory approval and marketing of new products;


•	our ability to obtain and maintain licenses in any jurisdiction in which we do business;


•	the relative strength of USD in relation to other currencies, particularly the Euro, SGD, the Danish Krone, Yen, Colombian Peso, and Brazilian Real; and


•	the potential adverse effects of global healthcare legislation on customer demand, product pricing and profitability.

This list sets forth many, but not all, of the factors that could affect our ability to achieve results described in any forward-looking statements. Investors should understand that it is not possible to predict or identify all of the factors and should not consider this list to be a complete statement of all potential risks and uncertainties. For further discussion of these and other factors, see the risk factors disclosed in Part I, Item 1A of our 2018 Annual Report. Except as required by law or regulation, we do not intend to update any forward-looking statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in our exposure to market risk or the information provided in Part II, Item 7A of our 2018 Annual Report.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this quarterly report, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Our disclosure controls include some, but not all, components of our internal control over financial reporting.

Evaluation of Disclosure Controls and Procedures

An evaluation was performed under the supervision and with the participation of our management, including our CEO and CFO, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under

Table of Contents

the Securities Exchange Act of 1934), as of the end of the period covered by this quarterly report on Form 10-Q. Based on this evaluation, our CEO and CFO have concluded that, as of March 31, 2019, our disclosure controls and procedures are effective.

Changes in Internal Controls

During the quarter ended March 31, 2019, there have been no changes to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

On January 1, 2019, we adopted ASC 842. Although our adoption of ASC 842 resulted in no change to our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, we did implement changes to our internal controls relating to leases. These changes included the development of new policies, enhanced contract review requirements, and other ongoing monitoring activities. These controls were designed to provide assurance at a reasonable level of the fair presentation of our condensed consolidated financial statements and related disclosures.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

There are no material changes to the risk factors disclosed in Part I, Item 1A of our 2018 Annual Report.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table shows information with respect to purchases of our common stock made during the three months ended March 31, 2019 by us or any of our “affiliated purchasers” as defined in Rule 10b-18(a)(3) under the Exchange Act:



Period	Total number of shares purchased (1)	Average price paid per share (1)		Total number of shares purchased as part of publicly announced plans or programs (1)	Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs (1)
January 1 – 31, 2019	—	$	—	—	—
February 1 – 28, 2019	—	—		—	800,000
March 1 – 31, 2019	800,000	103.89		800,000	—
Total	800,000	$	103.89	800,000	—

(1)

Table of Contents

ITEM 5. OTHER INFORMATION

Our 2019 Annual Meeting of Shareholders was held on May 7, 2019 at our corporate headquarters. Our shareholders voted on three proposals at the Annual Meeting. The proposals are described in detail in our proxy statement filed on March 22, 2019. As of March 12, 2019, the record date, there were 73,737,479 shares outstanding. Shareholders representing 68,175,507 or 92.5%, of the common shares outstanding were present in person or were represented by proxy at the Annual Meeting. The final results for the votes on each proposal are set forth below.

Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2020 Annual Meeting of Shareholders:



Name	For	Against	Abstain	Broker Non-Votes
Mark A. Buthman	65,648,515	101,085	105,928	2,319,979
William F. Feehery	65,677,503	72,037	105,988	2,319,979
Eric M. Green	65,601,559	143,775	110,194	2,319,979
Thomas W. Hofmann	65,501,887	249,252	104,389	2,319,979
Paula A. Johnson	65,459,266	290,683	105,579	2,319,979
Deborah L. V. Keller	65,679,725	71,666	104,137	2,319,979
Myla P. Lai-Goldman	65,616,760	135,793	102,975	2,319,979
Douglas A. Michels	65,582,680	169,559	103,289	2,319,979
Paolo Pucci	65,656,003	94,575	104,950	2,319,979
Patrick J. Zenner	65,377,202	372,985	105,341	2,319,979

Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation:



For	Against	Abstain	Broker Non-Votes
64,498,770	1,199,052	157,706	2,319,979

Proposal 3: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2019 fiscal year. The votes regarding this proposal were as follows:



For	Against	Abstain	Broker Non-Votes
66,421,973	1,641,381	112,153	Not applicable

ITEM 6. EXHIBITS

The list of exhibits in the Exhibit Index to this report is incorporated herein by reference.

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, West Pharmaceutical Services, Inc. has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

WEST PHARMACEUTICAL SERVICES, INC.

(Registrant)

By: /s/ Bernard J. Birkett

Bernard J. Birkett

Senior Vice President, Chief Financial Officer and Treasurer

May 8, 2019

Table of Contents

EXHIBIT INDEX



Exhibit #	Description
3.1	Our Amended and Restated Articles of Incorporation are incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2015.
3.2	Our Bylaws, as amended through May 5, 2015, are incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2015.
4.1	Form of stock certificate for common stock is incorporated by reference from our annual report on Form 10-K dated May 6, 1999.
4.2	Article 5, 6, 8(c) and 9 of our Amended and Restated Articles of Incorporation are incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2015.
4.3	Article I and V of our Bylaws, as amended through May 5, 2015, are incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2015.
4.4 ⁽¹⁾	Instruments defining the rights of holders of long-term debt securities of West and its subsidiaries have been omitted.
10.1	Credit Agreement, dated as of March 28, 2019, between West, certain of its subsidiaries, the lenders party thereto from time to time, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an Issuing Lender; Merrill Lynch, Pierce, Fenner & Smith Incorporated, Wells Fargo Securities, LLC, MUFG Bank, Ltd., and JPMorgan Chase Bank, N.A., as Joint Lead Arrangers and Joint Bookrunners, and Wells Fargo Bank, National Association, MUFG Bank, Ltd., and JPMorgan Chase Bank, N.A., as Co-Syndication Agents, is incorporated by reference from our Form 8-K dated April 1, 2019.
10.2	Form of 2019 Performance Stock Unit (PSU) Award issued under the 2016 Omnibus Incentive Compensation Plan.
10.3	Form of 2019 Stock Option Award issued under the 2016 Omnibus Incentive Compensation Plan.
31.1	Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification by the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification by the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document

⁽¹⁾ We agree to furnish to the SEC, upon request, a copy of each instrument with respect to issuances of long-term debt of the Company and its subsidiaries.

* Furnished, not filed.

F-1

EX-10.2 2 ex1022019psuawardagreement.htm EXHIBIT 10.2 Exhibit

Performance Stock Unit (PSU) Award Agreement

On <<GRANT DATE>>, West Pharmaceutical Services granted <<name>> a performance stock unit award (PSU) of <<UNITS>> PSUs based on target achievement. The award is granted under the terms of the West 2016 Omnibus Incentive Compensation Plan (the “Plan”).

The terms and conditions of the award follows.

Signed for and on behalf of the Company:

Annette Favorite

Sr VP & Chief HR Officer

West Pharmaceutical Services

——————————————————————————————————————————————————

What is a performance stock unit?

A PSU represents the conditional right to receive a distribution of shares. The number of shares you will receive depends on how well the Company’s actual performance compares to specified performance goals at the end of the performance period.

What are the performance goals applicable to the PSU award?

The performance levels are based on two equally weighted performance measures. The two measures of Company performance are:


•	Average return on invested capital - also called “ROIC” - is measured by dividing the average of the Company’s net operating profit (without regard to taxes) over the performance period by the average outstanding equity plus debt over that period.


•	Compounded annual revenue growth - also called “CAGR” - is the compound annual growth rate in net sales for the Company over the same period.

What is the performance period for this PSU award and what are the performance targets?

The Company’s performance against the goals is measured over a three-year period that begins January 1, 20xx and ends December 31, 20xx.

Your target PSU award presented on the first page of this agreement is the number of shares of West Common Stock that you would receive if the Company obtains 100% of both of the ROIC and CAGR performance targets. Additional shares of Common Stock will be distributed under this PSU award if actual performance exceeds the target performance level, and fewer shares of Common Stock will be distributable if actual performance falls short of the target performance level. No shares of Common Stock will be paid out if actual performance falls below the threshold level described below.

The following table shows the performance targets for CAGR and Average ROIC and the corresponding PSU payouts for the 20XX-20xx performance period.

Table Removed due to Confidentiality

If actual CAGR or ROIC falls between any of the performance range percentages above, the payout for that portion of your PSUs will be determined by applying a mathematical formula to estimate the value based on the two nearest percentages.

What restrictive covenants apply to the receipt of this award?

This award is consideration for your services to West Pharmaceutical Services, Inc., a corporation incorporated under the laws of the Commonwealth of Pennsylvania in the United States of America. As consideration for receipt of this award, to the maximum extent permitted by applicable law by accepting this award you agree to the restrictive covenants contained below.

During the Restrictive Period, you will not, and you will not permit any of your Affiliates, or any other Person, directly or indirectly, to:


1.	engage in competition with, or acquire a direct or indirect interest or an option to acquire such an interest in any Person engaged in competition with, the Company’s Business (other than an interest of not more than 5 percent of the outstanding stock of any publicly traded company);


2.	serve as a director, officer, employee or consultant of, or furnish information to, or otherwise facilitate the efforts of, any Person engaged in competition with the Company’s Business;


3.	solicit, employ, interfere with or attempt to entice away from the Company any employee who has been employed by the Company or a Subsidiary in connection with the conduct of the Company’s Business within one year prior to such solicitation, employment, interference or enticement; or


4.	approach, solicit or deal with in competition with the Company or any Subsidiary any Person which at any time during the year immediately preceding the date of your termination of employment:


a.	was a customer, client, supplier, agent or distributor of the Company or any Subsidiary;


b.	was a customer, client, supplier, agent or distributor of the Company or any Subsidiary with whom employees reporting to or under your direct control had personal contact on behalf of the Company or any Subsidiary; or


c.	was a Person with whom you had regular, substantial or a series of business dealings on behalf of the Company or any Subsidiary (whether or not a customer, client, supplier, agent or distributor of the Company or any Subsidiary).


d.	As used in this Agreement, the capitalized terms have the meanings set forth below:


i.	An “Affiliate” of any Person means any Person directly or indirectly controlling, controlled by or under common control with such Person.

ii.

Company or any Affiliate of the Company during the Restrictive Period in which you have been actively involved while an employee of the Company or any such Affiliate. In addition to the foregoing, and not as a limitation, employment by or rendering services to any of the following entities, or their Affiliates, will be deemed to be competitive: Specific names omitted.

iii. “Person” means an individual, a corporation, a partnership, an association, a trust or other entity or organization.

iv. “Restrictive Period” means the entirety of the term of your employment with the Company and its affiliates plus a period of one year following your termination for any reason.

v. “Subsidiary” has the meaning ascribed to the term by section 425(f) of the United States Internal Revenue Code of 1986, as amended (the “Code”).

The Company represents, and you agree that you would not have received this award without agreeing to the foregoing restrictive covenants. You further agree that a breach of the covenants contained in this Agreement will cause the Company and its Affiliates immediate and irreparable harm for which the Company’s remedies at law (such as money damages) will be inadequate. The Company shall have the right, in addition to any other rights it may have, to obtain an injunction to restrain any breach or threatened breach of such agreements. You also agree that the Company may contact any Person with or for whom you work after your employment by the Company ends and may send that Person a copy of this award agreement.

When will I know how many shares I am eligible to receive?

The West Board’s Compensation Committee will approve the ROIC and CAGR performance for the period after they have reviewed and approved the Company’s audited financial statements for the final year of the performance period. Achievement against the ROIC and CAGR metrics will be expressed as a percentage indicating the number of shares to be issued to you. This will generally be completed in February of the year following the end of the Performance Period.

What will be the value of the PSU shares I receive?

The value of the shares will be determined using the closing price of West stock on the date the Committee approves achievement against the performance of the award. The income realized will be equal to the number of shares issued based on performance achievement percentage, multiplied by the closing price on the approval date. Shares will be withheld to cover any applicable taxes and the net shares will be made available in your account at our stock plan administrator.

What happens if I terminate employment during the performance period?

You will not be entitled to receive a distribution with respect to any PSUs granted by this award if your employment terminates for a reason other than a Qualifying Retirement (as defined below), death or Disability (as defined in the Plan), before the final vest date.

What happens if I have a Qualifying Retirement during the performance period?

If you have a Qualifying Retirement during the performance period and after October of the grant year, your PSUs will continue to vest based on the approved performance criteria as if you remained actively employed by the Company. To be a Qualifying Retirement, the following criteria must be met at the time of your termination of employment:


1.	You have reached age 57;


2.	You have rendered 10 years of service to the Company and its Affiliates; and


3.	Your termination must not be due to “Cause” as defined in the Plan and not due to death or Disability.

The same vesting cessation provisions applicable to your option awards upon a Qualifying Retirement also apply to this award, including the Incentive Compensation Recovery Policy set forth in Exhibit I. You also agree that the restrictive covenants set forth above are extended during the entirety of your continued vesting following a Qualifying Retirement, and that any breach of the covenants will immediately and retroactively result in the forfeiture of any continued vesting.

What happens if I become disabled during the performance period?

If you become disabled during the performance period, your PSUs will continue to vest based on the approved performance criteria as if you remained actively employed by the Company. The same vesting cessation provisions applicable to your option awards upon a Qualifying Retirement also apply to this award, including the Incentive Compensation Recovery Policy set forth in Exhibit I and the non-competition covenant set forth above.

What happens to my PSU in the case of my death?

Your target PSUs will vest as of the date of your death and be distributed to your estate / beneficiary.

Can my PSU award be adjusted?

Yes, the Committee can change or revise the targets as it considers appropriate and make adjustments for budgeted exchange rates or an “extraordinary or special item” on a case-by-case basis. Extraordinary or special items include (1) settlement of litigation or actions brought by governmental agencies, (2) changes to the Company’s capital structure, including changes to dividend policy, share repurchase programs, mergers, acquisitions, divestitures, reorganizations and restructurings; and (3) new legislation or governmental regulations enacted or promulgated during the performance period.

Will I receive dividends on my PSUs?

During the performance period, your account will be credited with additional PSUs as if the target PSU award had been reinvested in dividends paid on Common Stock during the period. At the end of the performance period, you may receive additional shares of Common Stock equal to the number of PSUs credited through this dividend-reinvestment feature. If performance falls below the target levels, you will forfeit some or all of these PSUs based on the applicable payout percentage.

May I defer receipt of my shares?

Delivery of shares upon payout may be deferred under the Deferred Compensation Plan for eligible participants in certain countries. If you are eligible, you will receive details on this deferral opportunity before the end of each performance period and the distribution provisions of the applicable plan will contain additional restrictions. Any election will similarly defer receipt of additional shares you would otherwise receive due to the deemed dividend reinvestment feature.

Are there other circumstances that would lead to a forfeiture of my award or the proceeds that I receive from exercising my award?

Yes. All awards are subject to our Incentive Compensation Recovery Policy, which is attached to this award letter as Exhibit I. You are encouraged to carefully read that policy and contact me or the Law Department if you have any questions. The policy generally provides that in addition to forfeitures of all or part of your award due to your termination of employment discussed above, in certain other situations you will forfeit your award and may be required to reimburse us for the amounts you receive as a result of any option that you exercise or share of stock that you sell. Your acceptance of this award is expressly conditioned on your agreement to be subject to the

Incentive Compensation Recovery Policy, including the provisions that allow us to deduct any proceeds from other sources of income payable to you. This award would not be made if you did not agree to be subject to that policy.

The clawback period described in the Incentive Compensation Recovery policy is extended for the full duration of the period of post-termination continued vesting described in this award. The Compensation Committee may determine in its sole and absolute discretion that if circumstances exist that would permit the recovery of incentive compensation paid to you during the vesting period, in addition to recovering this compensation, all vesting will immediately cease and the remainder of your awards will be forfeited immediately.

Does the Securities Trading Policy apply to my award?

Yes. All sales of shares of company stock (including shares earned under the PS Unit award) are subject to our Securities Trading Policy. Stock sales by West’s officers who are subject to Section 16 U.S. of the Securities and Exchange Act of 1934 or on the designated persons list under our policy also must meet the review and written pre-approval by our General Counsel requirements of that policy.

Does my acceptance of this award guarantee me any future awards, continued employment or additional severance pay?

No. This award is granted at the sole discretion of West. Your receipt of this award does not guarantee any future awards, nor does it guarantee your continued employment with the Company. Subject to applicable law, your employment may be terminated for any reason. Additionally, this award is not part of your base pay or compensation for determination of any severance pay or benefits you may be entitled to upon termination of employment unless that is specifically agreed to in writing between you and the Company.

What other legal provisions cover this award and the related restrictive covenants?

The laws of the Commonwealth of Pennsylvania in the United States of America (without giving effect to its conflict of laws principles) govern all matters arising out of or relating to this award and the restrictive covenants contained in it (including, without limitation, its interpretation, construction, performance, and enforcement).

You and the Company submit to the exclusive jurisdiction of the state and federal courts sitting in Pennsylvania, with respect to actions or proceedings arising out of or relating to this award. Each party agrees that all claims in respect of such action or proceeding may be heard and determined only in these courts, and each party also agrees not to bring actions in other courts.

If a court of competent jurisdiction holds that all or a portion of this Agreement is unenforceable for any reason, including any expressed time or geographic provision, you and the Company agree to modify such provision, or allow a court of competent jurisdiction to have the power to modify such provision, to reduce the duration or area of such provision or both, or to delete specific words or phrases (this act be known as "blue-penciling"), and, in its blue-penciled form, the provision shall then be enforced.

The Company’s failure to insist upon strict compliance with any provision of this agreement shall not be deemed to be waiver of such provision or any other provision thereof.

Where can I find additional information about my award?

This is a summary of the terms of your PSU award. Your award is subject to the terms of the 2016 Omnibus Incentive Compensation Plan. This award is being delivered with an Information Statement, which gives additional information about your award and the 2016 Omnibus Incentive Compensation Plan under which it was granted. We encourage you to read the Information Statement. Additional terms and conditions may apply to your award under the terms of the Omnibus Plan.

EXHIBIT I

Incentive Compensation Recovery Policy

The Company may seek to recover incentive compensation awarded to any recipient in accordance with the terms of this policy. Each award of annual or long-term equity-based or performance-based compensation must specify that the award is subject to this policy.

Restatement of Financial Results. The Company will cancel or will seek to recover all or a portion of an award from any executive officer of the Company if the Company is required to significantly or materially restate its financial statements (other than to comply with changes to applicable accounting principles) with respect to any of the three fiscal years before the payment of the award. The Company also will not pay or will seek to recover all or a portion of an award from any award recipient whose fraud or misconduct causes the restatement of the Company’s financial statements with respect to any of the three fiscal years before the payment of the award.

Calculation Errors. Even if no financial results are restated, if an award is paid or distributed, and it is subsequently determined that the award should have been less than the amount calculated due to mathematical errors, fraud, misconduct or gross negligence, the Company may seek repayment of the award from any award recipient during the three-year period following the payment of the award.

Detrimental Conduct. If an award recipient directly or indirectly engages in conduct that competes with the Company, or any conduct that is materially inimical, contrary, harmful to, or not in the best interests of the Company or if the award recipient fails to comply with any of the material terms and conditions of the award (unless the failure is remedied within ten days after having been notified of such failure), then the Company has the discretion to immediately cancel any and all outstanding awards and require that the award recipient repay all or any portion of an award, including the gain realized on the exercise of a stock option, stock appreciation right or the disposition of any other equity-based award. To be subject to this policy, the detrimental conduct must have occurred while the award recipient was rendering service to the Company, or during the six-month period following the later of (1) the date the recipient ceases rendering service to the Company or, (2) the date the award is paid (or an option or stock appreciation right is exercised).

Exercise of Discretion. With respect to executive officers and members of the board of directors, the compensation committee has the sole and absolute authority (unless the board determines that the whole board should have such authority) to determine whether to exercise its discretion to seek repayment or cancel an award and what portion of an award should be recovered or canceled. With respect to all other award recipients, the officers of the Company have sole and absolute authority. The compensation committee, board or officers, as appropriate, will consider all relevant facts and circumstances in exercising their discretion. These facts and circumstances include: (1) the materiality of any changes to calculations or financial results, (2) the potential windfall received by recipients, (3) the culpability and involvement of the award recipients, (4) the controls in place to limit misconduct or incorrect reporting, (5) the period during which any misconduct occurred, (6) any other negative repercussions experienced by the award recipient, (7) the period that has elapsed since the date of any misconduct and (8) the feasibility and costs of recovering the compensation.

Enforcement. The board intends that this policy will be applied to the fullest extent permitted by applicable law. The Company has the authority to seek recovery through any available means including litigation or the filing of liens, if necessary. The Company also has the authority, to the extent permitted by law, to deduct the amount to be repaid from any amounts otherwise owed to the recipient, including wages or other compensation, fringe benefits, or vacation paid. Whether or not the Company elects to make any deduction, if the Company does not recover the full amount that it has determined should be recovered, the recipient must immediately repay the unpaid balance. By agreeing to accept an award, each award recipient consents to the Company’s right to make these deductions.

EX-10.3 3 ex1032019stockoptionawarda.htm EXHIBIT 10.3 Exhibit

Stock Option Award Agreement

On <<GRANT DATE>>, West Pharmaceutical Services granted <<name>> an award of <<#OPTIONS>> stock options at an exercise price (option cost) of <<GRANT PRICE>>. The award is granted under the terms of the West 2016 Omnibus Incentive Compensation Plan (the “Plan”).

The terms and conditions of the award follows.

Signed for and on behalf of the Company:

Annette Favorite

Senior Vice President & Chief HR Officer

_____________________________________________________________________________________

What is a stock option?

A stock option is the right to purchase a fixed number of shares at a set exercise price. The option granted by this award is a non-qualified stock option. The stock option gains value when the price of our common stock exceeds the exercise price.

How many shares may I purchase and what is the price?

The number of shares you may purchase and the exercise price are as follows:



Exercise Price		Total shares that may be purchased upon exercise
###GRANT_PRICE###		###TOTAL_AWARDS###

May I purchase the shares immediately?

No. However, as long as your employment with us continues (except as described below in the event of retirement, death or disability), your option becomes exercisable - or “vests” - according to the schedule below. At the end of the period, you may exercise the entire option. The following chart shows when and what portion of your option is exercisable each year.

###VEST_SCHEDULE_TABLE###

However, in no event will your option be exercisable after the Expiration Date set forth below.

What restrictive covenants apply to the receipt of this award?

During the Restrictive Period, you will not, and you will not permit any of your Affiliates, or any other Person, directly or indirectly, to:


1.	engage in competition with, or acquire a direct or indirect interest or an option to acquire such an interest in any Person engaged in competition with, the Company’s Business (other than an interest of not more than 5 percent of the outstanding stock of any publicly traded company);


2.	serve as a director, officer, employee or consultant of, or furnish information to, or otherwise facilitate the efforts of, any Person engaged in competition with the Company’s Business;


3.	solicit, employ, interfere with or attempt to entice away from the Company any employee who has been employed by the Company or a Subsidiary in connection with the conduct of the Company’s Business within one year prior to such solicitation, employment, interference or enticement; or


4.	approach, solicit or deal with in competition with the Company or any Subsidiary any Person which at any time during the year immediately preceding the date of your termination of employment:


a.	was a customer, client, supplier, agent or distributor of the Company or any Subsidiary;


b.	was a customer, client, supplier, agent or distributor of the Company or any Subsidiary with whom employees reporting to or under your direct control had personal contact on behalf of the Company or any Subsidiary; or


c.	was a Person with whom you had regular, substantial or a series of business dealings on behalf of the Company or any Subsidiary (whether or not a customer, client, supplier, agent or distributor of the Company or any Subsidiary).


d.	As used in this Agreement, the capitalized terms have the meanings set forth below:


i.	An “Affiliate” of any Person means any Person directly or indirectly controlling, controlled by or under common control with such Person.

ii.

The “Company’s Business” means, in the relevant geographic scope for which you had responsibility or oversight: (A) the development and manufacture of devices to connect, interface and mix injectable drugs in all forms of drug packaging, being conducted by the Company and its Affiliates; (B) the development, manufacture and sale of stoppers, closures, containers, medical devices and medical device components and assemblies made from elastomer, metal and plastic for the healthcare and consumer products industries being carried on by the Company and its Affiliates; and (C) any other business conducted by the Company or any Affiliate of the Company during the Restrictive Period in which you have been actively involved while an employee of the Company or any such Affiliate. In addition to the foregoing, and not as a limitation, employment by or rendering services to any of the following entities, or their Affiliates, will be deemed to be competitive: Names omitted.

iii. "Person” means an individual, a corporation, a partnership, an association, a trust or other entity or organization.

iv. “Restrictive Period” means the entirety of the term of your employment with the Company and its affiliates plus a period of one year following your termination for any reason.

v. “Subsidiary” has the meaning ascribed to the term by section 425(f) of the United States Internal Revenue Code of 1986, as amended.

Will my options vest if I retire?

Your options will continue to vest, even if you terminate employment due to retirement, if you have a “Qualifying Retirement” on or after October 1 of the grant year. To be a Qualifying Retirement, the following criteria must be met the time of your termination of employment:


1.	You have reached age 57;


2.	You have rendered 10 years of service to the Company and its affiliates; and


3.	Your termination must not be due to “Cause” as defined in the Plan and not due to death or disability.

Vesting will cease and all outstanding awards will be immediately forfeited if the Committee determines in its sole and absolute discretion that any of the following circumstances have occurred:


1.	To the extent permitted by applicable law, you compete with the Company during the period of post-termination continued vesting as described in this Award;


2.	You fail to comply with any confidentiality agreements with the Company before or after your termination of employment;


3.	The Company determines that it could have terminated you for “Cause” due to facts or circumstances discovered after your termination of employment.

During the entire period of continued vesting upon Qualifying Retirement, you remain subject to the Incentive Compensation Recovery Policy described in Exhibit I. If you violate the terms of that policy, vesting will also immediately cease.

What happens if I die or become Disabled before the award is fully vested?

Your options will vest immediately 100% if you die or become Disabled (as defined in the Plan) during the vesting period.

What happens if I terminate employment for any reason other than a Qualifying Retirement, death or Disability?

Your options will immediately cease vesting upon your termination of employment.

When will my option expire?

If you remain employed, the option expires on ###EXPIRY_DATE###, which will be referred to as the “Expiration Date.” This means that once it becomes exercisable, the option may be exercised until ###EXPIRY_DATE###. In addition,


•	if you die, the option will remain exercisable for one year from your date of death;


•	if you terminate employment due to Disability or a Qualifying Retirement, the option will remain exercisable until the Expiration Date;


•	if your employment terminates for any reason other than a Qualifying Retirement, Disability, death or removal for cause, the option will expire 90 days after your termination date;


•	if we terminate your employment for cause, the option will expire on the commencement of business on your termination date.

How do I exercise my stock option?

There are four ways to exercise a stock option, the first is the most common.


•	Same-Day-Sale (Cashless). You may elect to sell all or a portion of your vested stock options in the open market. The proceeds generated from the sale will be used to pay for the option cost and any applicable tax withholding. The net proceeds will be deposited in your account at our stock plan administrator.


•	Cash. You write a check to the Company for the exercise price, plus any applicable withholding taxes.


•	Already owned shares. You may deliver or attest vested shares of common stock that you own with a fair market value equal to the exercise price, plus any applicable withholding taxes.


•	Combination of shares and cash. You may use a combination of cash and stock.

When do I have to pay for the exercise?

The full exercise price and applicable taxes must be paid within two business days of exercise.

Will I receive dividends on my unexercised options?

Stock options are not eligible for dividends.

Are there other circumstances that would lead to a forfeiture of my award or the proceeds that I receive from exercising my award?

Does the Securities Trading Policy apply to my award?

Yes. All sales of shares of company stock (including shares received upon exercise of an option) and all option exercise transactions are subject to our Securities Trading Policy. Option exercises by West’s officers who are subject to Section 16 of the Securities and Exchange Act of 1934 or on the designated persons list under our policy also must meet the review and written pre-approval by our General Counsel requirements of that policy.

Does my acceptance of this award guarantee me any future awards, continued employment or additional severance pay?

What other legal provisions cover this award and the related restrictive covenants?

The Company’s failure to insist upon strict compliance with any provision of this agreement shall not be deemed to be waiver of such provision or any other provision thereof.

Where can I find additional information about my award?

This is a summary of the terms of your stock option award. Your award is subject to the terms of the 2016 Omnibus Incentive Compensation Plan. This award is being delivered with an Information Statement, which gives additional information about your award and the 2016 Omnibus Incentive Compensation Plan under which it was granted. We encourage you to read the Information Statement. Additional terms and conditions may apply to your award under the terms of the Omnibus Plan.

EXHIBIT I

Incentive Compensation Recovery Policy

EX-31.1 4 ex311q12019.htm EXHIBIT 31.1 Exhibit

EXHIBIT 31.1

CERTIFICATION

I, Eric M. Green, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of West Pharmaceutical Services, Inc.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

/s/ Eric M. Green

Eric M. Green

President and Chief Executive Officer

Date: May 8, 2019

EX-31.2 5 ex312q12019.htm EXHIBIT 31.2 Exhibit

EXHIBIT 31.2

CERTIFICATION

I, Bernard J. Birkett, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of West Pharmaceutical Services, Inc.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

/s/ Bernard J. Birkett

Bernard J. Birkett

Senior Vice President, Chief Financial Officer and Treasurer

Date: May 8, 2019

EX-32.1 6 ex321q12019.htm EXHIBIT 32.1 Exhibit

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of West Pharmaceutical Services, Inc. (the “Company”) for the period ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Eric M. Green, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Eric M. Green

Eric M. Green

President and Chief Executive Officer

Date: May 8, 2019

EX-32.2 7 ex322q12019.htm EXHIBIT 32.2 Exhibit

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of West Pharmaceutical Services, Inc. (the “Company”) for the period ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bernard J. Birkett, Senior Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Bernard J. Birkett

Bernard J. Birkett

Senior Vice President, Chief Financial Officer and Treasurer

Date: May 8, 2019

EX-101.INS 8 wst-20190331.xml XBRL INSTANCE DOCUMENT 0000105770 2019-01-01 2019-03-31 0000105770 2019-03-31 0000105770 2018-01-01 2018-03-31 0000105770 2018-12-31 0000105770 2018-03-31 0000105770 2017-12-31 0000105770 wst:DeliveryDevicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 wst:DeliveryDevicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 wst:StandardPackagingMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 wst:ContractManufacturedProductsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 wst:StandardPackagingMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 wst:HighValueComponentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 wst:ContractManufacturedProductsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 wst:HighValueComponentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 2018-01-01 2018-12-31 0000105770 wst:SmartDoseMember 2019-03-31 0000105770 2019-01-01 2019-01-01 0000105770 wst:SmartDoseMember 2013-06-30 0000105770 srt:AsiaPacificMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 srt:AsiaPacificMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 us-gaap:EMEAMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 us-gaap:EMEAMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 srt:AmericasMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 srt:AmericasMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 wst:BiologicsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 wst:BiologicsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 wst:PharmaCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 wst:ContractManufacturedCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 wst:GenericsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 wst:ContractManufacturedCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-03-31 0000105770 wst:GenericsCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 wst:PharmaCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0000105770 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0000105770 wst:SeniorCNotesDue2027Member 2018-12-31 0000105770 wst:Revolvingcreditfacilitydue2020Member 2018-12-31 0000105770 wst:SeniorBNotesDue2024Member 2019-03-31 0000105770 wst:SeniorCNotesDue2027Member 2019-03-31 0000105770 us-gaap:NotesPayableOtherPayablesMember 2018-12-31 0000105770 wst:Revolvingcreditfacilitydue2020Member 2019-03-31 0000105770 wst:SeniorNotesDue2022Member 2018-12-31 0000105770 us-gaap:NotesPayableOtherPayablesMember 2019-03-31 0000105770 wst:Revolvingcreditfacilitydue2024Member 2019-03-31 0000105770 wst:SeniorNotesDue2022Member 2019-03-31 0000105770 wst:SeniorBNotesDue2024Member 2018-12-31 0000105770 srt:MinimumMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-03-31 0000105770 us-gaap:LondonInterbankOfferedRateLIBORMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-03-31 0000105770 wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-03-31 0000105770 srt:MaximumMember us-gaap:BaseRateMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-03-31 0000105770 us-gaap:DomesticLineOfCreditMember wst:Revolvingcreditfacilitydue2024Member 2019-03-31 0000105770 srt:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-03-31 0000105770 srt:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-03-31 0000105770 us-gaap:ForeignLineOfCreditMember wst:Revolvingcreditfacilitydue2024Member 2019-03-31 0000105770 srt:MinimumMember us-gaap:BaseRateMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-03-31 0000105770 us-gaap:LetterOfCreditMember wst:Revolvingcreditfacilitydue2024Member 2019-03-31 0000105770 srt:MaximumMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-03-31 0000105770 wst:Revolvingcreditfacilitydue2024Member 2018-01-01 2018-12-31 0000105770 us-gaap:FederalFundsEffectiveSwapRateMember wst:Revolvingcreditfacilitydue2024Member 2019-01-01 2019-03-31 0000105770 us-gaap:OptionMember 2019-03-31 0000105770 wst:DebtYenDenominatedMember 2019-01-01 2019-03-31 0000105770 us-gaap:DebtMember 2019-01-01 2019-03-31 0000105770 us-gaap:DebtMember 2019-03-31 0000105770 currency:EUR us-gaap:ForwardContractsMember 2018-12-31 0000105770 currency:SGD us-gaap:ForwardContractsMember 2019-03-31 0000105770 wst:DebtYenDenominatedMember 2019-03-31 0000105770 currency:USD us-gaap:ForwardContractsMember 2019-03-31 0000105770 us-gaap:OptionMember 2018-04-24 0000105770 us-gaap:OptionMember 2017-11-22 0000105770 us-gaap:OptionMember 2019-01-31 0000105770 currency:SGD us-gaap:ForwardContractsMember 2018-12-31 0000105770 currency:USD us-gaap:ForwardContractsMember 2018-12-31 0000105770 us-gaap:OptionMember 2019-01-01 2019-03-31 0000105770 us-gaap:CashFlowHedgingMember 2019-01-01 2019-03-31 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember wst:NetSalesMember 2018-01-01 2018-03-31 0000105770 us-gaap:NetInvestmentHedgingMember 2018-01-01 2018-03-31 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-01-01 2018-03-31 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember wst:NetSalesMember 2019-01-01 2019-03-31 0000105770 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2018-01-01 2018-03-31 0000105770 wst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignCurrencyGainLossMember 2018-01-01 2018-03-31 0000105770 us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-03-31 0000105770 us-gaap:CashFlowHedgingMember 2018-01-01 2018-03-31 0000105770 wst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignCurrencyGainLossMember 2019-01-01 2019-03-31 0000105770 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-03-31 0000105770 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-03-31 0000105770 currency:SGD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-03-31 0000105770 currency:SGD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-03-31 0000105770 currency:USD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-03-31 0000105770 currency:USD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-03-31 0000105770 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-03-31 0000105770 us-gaap:FairValueInputsLevel1Member 2019-03-31 0000105770 us-gaap:FairValueInputsLevel2Member 2019-03-31 0000105770 us-gaap:FairValueInputsLevel3Member 2019-03-31 0000105770 us-gaap:FairValueInputsLevel2Member 2018-12-31 0000105770 us-gaap:FairValueInputsLevel1Member 2018-12-31 0000105770 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000105770 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-03-31 0000105770 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000105770 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000105770 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-03-31 0000105770 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0000105770 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-03-31 0000105770 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0000105770 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000105770 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-03-31 0000105770 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000105770 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000105770 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-03-31 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-03-31 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-03-31 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-03-31 0000105770 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-03-31 0000105770 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-03-31 0000105770 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000105770 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-03-31 0000105770 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0000105770 us-gaap:RetainedEarningsMember 2017-12-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000105770 us-gaap:TreasuryStockMember 2017-12-31 0000105770 us-gaap:CommonStockMember 2018-03-31 0000105770 us-gaap:CommonStockMember 2017-12-31 0000105770 us-gaap:TreasuryStockMember 2018-01-01 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0000105770 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0000105770 us-gaap:TreasuryStockMember 2018-03-31 0000105770 us-gaap:RetainedEarningsMember 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000105770 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000105770 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000105770 us-gaap:RetainedEarningsMember 2018-12-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000105770 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000105770 us-gaap:TreasuryStockMember 2018-12-31 0000105770 us-gaap:TreasuryStockMember 2019-03-31 0000105770 us-gaap:CommonStockMember 2018-12-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000105770 us-gaap:CommonStockMember 2019-03-31 0000105770 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000105770 us-gaap:RetainedEarningsMember 2019-03-31 0000105770 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000105770 us-gaap:PerformanceSharesMember 2019-01-01 2019-03-31 0000105770 us-gaap:PerformanceSharesMember 2019-03-31 0000105770 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0000105770 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-03-31 0000105770 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-03-31 0000105770 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000105770 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000105770 us-gaap:ForeignPlanMember 2018-01-01 2018-03-31 0000105770 us-gaap:ForeignPlanMember 2019-01-01 2019-03-31 0000105770 us-gaap:DomesticPlanMember 2019-01-01 2019-03-31 0000105770 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000105770 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-03-31 0000105770 us-gaap:DomesticPlanMember 2018-01-01 2018-03-31 0000105770 us-gaap:DomesticPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000105770 us-gaap:DomesticPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000105770 us-gaap:DomesticPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-03-31 0000105770 us-gaap:DomesticPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-03-31 0000105770 us-gaap:OtherRestructuringMember wst:A2018RestructuringPlanMember 2019-03-31 0000105770 us-gaap:OtherRestructuringMember wst:A2018RestructuringPlanMember 2019-01-01 2019-03-31 0000105770 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-03-31 0000105770 wst:AssetRelatedChargesMember wst:A2018RestructuringPlanMember 2019-03-31 0000105770 us-gaap:OtherRestructuringMember wst:A2018RestructuringPlanMember 2018-12-31 0000105770 wst:AssetRelatedChargesMember wst:A2018RestructuringPlanMember 2019-01-01 2019-03-31 0000105770 wst:AssetRelatedChargesMember 2019-01-01 2019-03-31 0000105770 wst:A2018RestructuringPlanMember 2019-01-01 2019-03-31 0000105770 wst:A2018RestructuringPlanMember 2018-12-31 0000105770 us-gaap:OtherRestructuringMember 2019-01-01 2019-03-31 0000105770 wst:AssetRelatedChargesMember wst:A2018RestructuringPlanMember 2018-12-31 0000105770 wst:A2018RestructuringPlanMember 2019-03-31 0000105770 us-gaap:EmployeeSeveranceMember 2018-12-31 0000105770 us-gaap:EmployeeSeveranceMember 2019-03-31 0000105770 wst:A2018RestructuringPlanMember 2018-01-01 2018-03-31 0000105770 srt:MaximumMember wst:A2018RestructuringPlanMember 2019-12-31 0000105770 wst:SmartDoseMember 2019-01-01 2019-03-31 0000105770 wst:A2016RestructuringPlanMemberMember 2019-03-31 0000105770 wst:SmartDoseMember 2018-01-01 2018-03-31 0000105770 wst:DeliverySystemsMember 2018-01-01 2018-03-31 0000105770 wst:PackagingSystemsMember 2019-01-01 2019-03-31 0000105770 wst:CorporateAndEliminationsMember 2019-01-01 2019-03-31 0000105770 wst:PackagingSystemsMember 2018-01-01 2018-03-31 0000105770 wst:DeliverySystemsMember 2019-01-01 2019-03-31 0000105770 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-03-31 0000105770 us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-03-31 0000105770 wst:CorporateAndEliminationsMember 2018-01-01 2018-03-31 iso4217:EUR iso4217:USD xbrli:shares utreg:MBbls wst:segment iso4217:SGD xbrli:shares xbrli:pure iso4217:JPY iso4217:USD iso4217:USD wst:bbl false --12-31 Q1 2019 2019-03-31 10-Q 0000105770 73483687 Yes false Large Accelerated Filer WEST PHARMACEUTICAL SERVICES INC false 108891 125166 30612 81459 10000000 601500000 13400000 5232000000 24400000 20500000 44000000 6400000 25100000 601500000 31500000 26800000 0 13400000

130400000

137700000

288200000

318200000

9800000

17300000

930700000

945200000

-154200000

-40400000

-400000

400000

-113800000

-153400000

-40700000

-3700000

400000

-109400000

282000000

278500000

700000

600000

3400000

6200000

700000

600000

100000

1978900000

2036200000

894400000

867600000

15200000

8700000

6500000

27100000

9200000

17900000

300000

200000

1700000

235900000

199800000

337400000

265500000

-36100000

-71900000

0.14

0.15

0.25

100000000

75300000

74100000

73500000

18800000

65100000

56200000

1.00

0.21

0.22

0.21

0.36

0.22

0.03

0.41

0.34

0.45

0.08

0.47

0.26

0.23

0.20

0.31

0.23

0.04

0.43

0.30

0.46

0.07

0.47

1.00

9100000

11900000

20000000

33400000

36500000

6300000

-3100000

900000

1.7

5400000

11100000

25800000

30.6

13400000

281300000

600000

-200000

296700000

11400000

100000

0.375

1.375

0.875

0.5

0.0

196700000

100000

28600000

53000000

73000000

42000000

196100000

28100000

53000000

73000000

42000000

0.01

0.0382

0.0402

0.0367

0.00875

0.0382

0.0402

0.0367

2024-03-28

9800000

10500000

8700000

9200000

600000

1100000

24700000

32700000

13100000

14300000

-400000

500000

-900000

500000

-500000

-200000

-300000

-200000

3900000

2900000

2400000

100000

2300000

100000

2400000

2500000

1200000

700000

-600000

1300000

500000

-600000

1800000

-700000

-600000

-100000

500000

-600000

400000

-200000

2800000

400000

25700000

24900000

66.22

400000

500000

100000

1000000

-100000

-200000

-300000

10400000

10600000

-10600000

1600000

1400000

12900000

17200000

0.59

0.75

0.58

0.73

4500000

-300000

0.233

0.231

64500000

53500000

77800000

81500000

-2600000

200000

600000

200000

4900000

1700000

6500000

17700000

200000

800000

400000

-3800000

4800000

100000

105800000

105200000

134400000

146800000

53700000

100000

-1300000

200000

300000

69900000

2400000

1600000

12500000

-300000

100000

16100000

2700000

800000

1600000

1200000

20300000

19500000

1900000

100000

2300000

81900000

87000000

214500000

226100000

90400000

100100000

42200000

39000000

600000

900000

91200000

94900000

3700000

4000000

95600000

49000000

7600000

8100000

9800000

11500000

9600000

18000000

582600000

666700000

1978900000

2036200000

283700000

301100000

11700000

9800000

200000

1700000

13000000

10500000

800000

1700000

2500000

300000000.0

269400000

196100000

195500000

192600000

197400000

196000000

195500000

28100000

-56900000

-90500000

-28700000

45000000

47600000

23600000

21000000

4500000

500000000

53400000

-3300000

-15600000

9500000

62800000

-600000

-16200000

10500000

77000000

70700000

3200000

77600000

73100000

10200000

67400000

3100000

75200000

71000000

0.0374

P12Y1M5D

81500000

13000000

5500000

6900000

7800000

10500000

37800000

54300000

57800000

200000

20500000

26400000

1200000

-200000

-3000000

4400000

2200000

-3300000

800000

1600000

20000000

4400000

21500000

800000

-300000

-3300000

800000

4400000

700000

300000

-300000

1600000

-400000

-700000

1200000

-700000

-100000

500000

100000

400000

100000

76600000

80200000

33600000

34100000

25600000

38800000

1600000

600000

300000

2900000

1200000

300000

200000

700000

-100000

47900000

83100000

1100000

800000

10400000

11100000

28000000

28800000

2300000

2200000

56200000

54300000

3000000

1100000

1200000

28000000

300000

3300000

43600000

-900000

100000

-1000000

43600000

400000

100000

300000

55400000

1752700000

1759900000

822000000

814700000

400000

100000

300000

28000000

9600000

9800000

15000000

3300000

600000

300000

600000

3300000

600000

2300000

1500000

300000

1500000

100000

300000

1353400000

1398200000

11300000

4500000

415700000

-600000

89500000

326200000

200000

103100000

340400000

443500000

6800000

68300000

68600000

2000000

300000

3400000

6200000

82458

7266

102.51

0.007

0.225

0.0230

3162428

344616

24.51

102.51

P5Y7M

75200000

1300000

75300000

1700000

75300000

1200000

75300000

1800000

200000

100000

-100000

-200000

7200000

-800000

8000000

10700000

-3500000

14200000

800000

1279900000

-117300000

309300000

18800000

1178200000

-109100000

1305300000

-95800000

308500000

18800000

1222800000

-149000000

1396300000

-154200000

282000000

18800000

1353400000

-103700000

1369500000

-153400000

278500000

18800000

1398200000

-172600000

1800000

-100000

-300000

103.89

1200000

1800000

500000

800000

103700000

172600000

47900000

83100000

600000

75500000

75300000

73900000

74100000

100000 2800000 30000000.0 30000000.0 20000000.0 200000 200000 200000 200000 -2600000 23600000 4500000 350000000 -3100000 2300000 23100000 24600000 2 0 4.0 3.5 2400000 2200000 300000 -100000 -400000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font><font style="font-family:inherit;font-size:10pt;">: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> (the “</font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> Annual Report”). The results of operations for any interim period are not necessarily indicative of results for the full year.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Expense</font><font style="font-family:inherit;font-size:10pt;">, to the consolidated financial statements in our 2018 Annual Report for further discussion.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, we are involved in product liability matters and other legal proceedings and claims generally incidental to our normal business activities. We accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. While the outcome of current proceedings cannot be accurately predicted, we believe their ultimate resolution should not have a material adverse effect on our business, financial condition, results of operations or liquidity.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There have been no significant changes to the commitments and contingencies included in our </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> Annual Report.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2019, we adopted ASC 842. Please refer to Note 6, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">, for additional information.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract assets, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract assets, March 31, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in contract assets - increase (decrease)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income, March 31, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in deferred income - decrease (increase)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Note payable, due December 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit Facility, due October 15, 2020 (1.00%)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Credit Facility, due March 28, 2024 (0.875%)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Series A notes, due July 5, 2022 (3.67%)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Series B notes, due July 5, 2024 (3.82%)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Series C notes, due July 5, 2027 (4.02%) </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">195.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">195.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2019, we entered into a new senior unsecured, multi-currency revolving credit facility agreement (the “Credit Agreement”) that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in </font><font style="font-family:inherit;font-size:10pt;">March 2024</font><font style="font-family:inherit;font-size:10pt;">, contains a senior unsecured, multi-currency revolving credit facility (the “Credit Facility”) of </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;">, with sublimits of up to </font><font style="font-family:inherit;font-size:10pt;">$30.0 million</font><font style="font-family:inherit;font-size:10pt;"> for swing line loans for domestic borrowers in U.S. Dollars (“USD”) and a </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;"> swing line loan for our German Holding Company and up to </font><font style="font-family:inherit;font-size:10pt;">$30.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the issuance of standby letters of credit, which Credit Facility may be increased from time-to-time by the greater of </font><font style="font-family:inherit;font-size:10pt;">$350.0 million</font><font style="font-family:inherit;font-size:10pt;"> and earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus </font><font style="font-family:inherit;font-size:10pt;">50</font><font style="font-family:inherit;font-size:10pt;"> basis points or the daily London Interbank Offered Rate (“LIBOR”), plus </font><font style="font-family:inherit;font-size:10pt;">1.00%</font><font style="font-family:inherit;font-size:10pt;">) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from </font><font style="font-family:inherit;font-size:10pt;">0</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">37.5</font><font style="font-family:inherit;font-size:10pt;"> basis points for base rate loans and </font><font style="font-family:inherit;font-size:10pt;">87.5</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">137.5</font><font style="font-family:inherit;font-size:10pt;"> basis points for LIBOR rate loans. The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than </font><font style="font-family:inherit;font-size:10pt;">3.5</font><font style="font-family:inherit;font-size:10pt;"> to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to </font><font style="font-family:inherit;font-size:10pt;">4.0</font><font style="font-family:inherit;font-size:10pt;"> to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of March 31, 2019 and December 31, 2018, total unamortized debt issuance costs of </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">$28.1 million</font><font style="font-family:inherit;font-size:10pt;"> in outstanding long-term borrowings under the Credit Facility, of which </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> was denominated in Japanese Yen (“Yen”) and </font><font style="font-family:inherit;font-size:10pt;">$23.6 million</font><font style="font-family:inherit;font-size:10pt;"> was denominated in Euro. These borrowings, together with outstanding letters of credit of </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">, resulted in a borrowing capacity available under the Credit Facility of </font><font style="font-family:inherit;font-size:10pt;">$269.4 million</font><font style="font-family:inherit;font-size:10pt;"> at March 31, 2019. Please refer to Note 9, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">, for a discussion of the foreign currency hedges associated with the Credit Facility.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Please refer to Note 9, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt</font><font style="font-family:inherit;font-size:10pt;">, to the consolidated financial statements in our </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> Annual Report for additional details regarding our debt agreements.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative Financial Instruments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our condensed consolidated balance sheet at fair value.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Exchange Rate Risk</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the total amount of these forward exchange contracts was Singapore Dollar (“SGD”) </font><font style="font-family:inherit;font-size:10pt;">601.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$13.4 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the total amount of these forward exchange contracts was </font><font style="font-family:inherit;font-size:10pt;">€10.0 million</font><font style="font-family:inherit;font-size:10pt;">, SGD </font><font style="font-family:inherit;font-size:10pt;">601.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$13.4 million</font><font style="font-family:inherit;font-size:10pt;">. During the three months ended March 31, 2019, we recognized foreign exchange transaction gains of </font><font style="font-family:inherit;font-size:10pt;">$4.8 million</font><font style="font-family:inherit;font-size:10pt;"> within other (income) expense in our condensed consolidated statements of income related to these fair value hedges. We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</font></div><div style="line-height:120%;text-align:left;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(in millions)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sell</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Currency</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Purchase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">USD</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Euro</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">USD</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Yen</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,232.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SGD</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, a portion of our debt consisted of borrowings denominated in currencies other than USD. We have designated our </font><font style="font-family:inherit;font-size:10pt;">€21.0 million</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">$23.6 million</font><font style="font-family:inherit;font-size:10pt;">) Euro-denominated borrowings under our Credit Facility as a hedge of our net investment in certain European subsidiaries. A cumulative foreign currency translation loss of less than </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> for both pre- and after tax on this debt was recorded within accumulated other comprehensive loss as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">. We have also designated our </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">¥500.0 million</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;">) Yen-denominated borrowings under our Credit Facility as a hedge of our net investment in Daikyo Seiko, Ltd. (“Daikyo”). At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, there was a cumulative foreign currency translation loss of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> pre-tax (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> after tax) on this Yen-denominated debt, which was also included within accumulated other comprehensive loss.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commodity Price Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2017, we purchased a series of call options for a total of </font><font style="font-family:inherit;font-size:10pt;">125,166</font><font style="font-family:inherit;font-size:10pt;"> barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases through May 2019. In April 2018, we purchased a series of call options for a total of </font><font style="font-family:inherit;font-size:10pt;">30,612</font><font style="font-family:inherit;font-size:10pt;"> barrels of crude oil from December 2018 through August 2019. In January 2019, we purchased a series of call options for a total of </font><font style="font-family:inherit;font-size:10pt;">81,459</font><font style="font-family:inherit;font-size:10pt;"> barrels of crude oil from February 2019 through May 2020. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the loss recorded in cost of goods and services sold related to these call options was less than </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we had outstanding contracts to purchase </font><font style="font-family:inherit;font-size:10pt;">108,891</font><font style="font-family:inherit;font-size:10pt;"> barrels of crude oil from April 2019 to May 2020 at a weighted-average strike price of </font><font style="font-family:inherit;font-size:10pt;">$66.22</font><font style="font-family:inherit;font-size:10pt;"> per barrel.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effects of Derivative Instruments on Financial Position and Results of Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Please refer to Note 10, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:inherit;font-size:10pt;">, for the balance sheet location and fair values of our derivative instruments as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the effects of derivative instruments designated as hedges on other comprehensive income (“OCI”) and earnings, net of tax:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Gain (Loss) Recognized in OCI for the</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Flow Hedges:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward treasury locks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Investment Hedges:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency-denominated debt</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:0.8547008547008548%;border-collapse:collapse;text-align:left;"><tr><td colspan="1" rowspan="1"></td></tr><tr><td style="width:100%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, there was no material ineffectiveness related to our hedges.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by market group:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Biologics</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Generics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharma</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by product category: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">High-Value Components</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Standard Packaging</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delivery Devices</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by geographic location: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Americas</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe, Middle East, Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia Pacific</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Stock-Based Compensation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the “2016 Plan”) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">3,162,428</font><font style="font-family:inherit;font-size:10pt;"> shares remaining in the 2016 Plan for future grants.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we granted </font><font style="font-family:inherit;font-size:10pt;">344,616</font><font style="font-family:inherit;font-size:10pt;"> stock options at a weighted average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$102.51</font><font style="font-family:inherit;font-size:10pt;"> per share based on the grant-date fair value of our stock to employees under the 2016 Plan. The weighted average grant date fair value of options granted was </font><font style="font-family:inherit;font-size:10pt;">$24.51</font><font style="font-family:inherit;font-size:10pt;"> per share as determined by the Black-Scholes option valuation model using the following weighted average assumptions: a risk-free interest rate of </font><font style="font-family:inherit;font-size:10pt;">2.3%</font><font style="font-family:inherit;font-size:10pt;">; expected life of </font><font style="font-family:inherit;font-size:10pt;">5.6</font><font style="font-family:inherit;font-size:10pt;"> years based on prior experience; stock volatility of </font><font style="font-family:inherit;font-size:10pt;">22.5%</font><font style="font-family:inherit;font-size:10pt;"> based on historical data; and a dividend yield of </font><font style="font-family:inherit;font-size:10pt;">0.7%</font><font style="font-family:inherit;font-size:10pt;">. Stock option expense is recognized over the vesting period, net of forfeitures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we granted </font><font style="font-family:inherit;font-size:10pt;">82,458</font><font style="font-family:inherit;font-size:10pt;"> stock-settled performance share unit (“PSU”) awards at a weighted average grant-date fair value of </font><font style="font-family:inherit;font-size:10pt;">$102.51</font><font style="font-family:inherit;font-size:10pt;"> per share to eligible employees. These awards are earned based on the Company’s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock. Shares earned under PSU awards may vary from </font><font style="font-family:inherit;font-size:10pt;">0%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">200%</font><font style="font-family:inherit;font-size:10pt;"> of an employee’s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we granted </font><font style="font-family:inherit;font-size:10pt;">7,266</font><font style="font-family:inherit;font-size:10pt;"> stock-settled restricted share unit (“RSU”) awards at a weighted average grant-date fair value of </font><font style="font-family:inherit;font-size:10pt;">$102.51</font><font style="font-family:inherit;font-size:10pt;"> per share to eligible employees. These awards are earned over a specified performance period. The fair value of stock-settled RSU awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period, net of forfeitures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stock-based compensation expense was </font><font style="font-family:inherit;font-size:10pt;">$6.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.4 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Income Per Share</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dilutive effect of equity awards, based on the treasury stock method</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares assuming dilution</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">0.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">0.7 million</font><font style="font-family:inherit;font-size:10pt;"> shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to </font><font style="font-family:inherit;font-size:10pt;">800,000</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under the Securities Exchange Act of 1934 Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. During the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we purchased </font><font style="font-family:inherit;font-size:10pt;">800,000</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock under the now-completed program at a cost of </font><font style="font-family:inherit;font-size:10pt;">$83.1 million</font><font style="font-family:inherit;font-size:10pt;">, or an average price of </font><font style="font-family:inherit;font-size:10pt;">$103.89</font><font style="font-family:inherit;font-size:10pt;"> per share.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Affiliated Companies</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was </font><font style="font-family:inherit;font-size:10pt;">$81.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$77.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was </font><font style="font-family:inherit;font-size:10pt;">$13.4 million</font><font style="font-family:inherit;font-size:10pt;"> at both period-ends. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our purchases from, and royalty payments made to, affiliates totaled </font><font style="font-family:inherit;font-size:10pt;">$24.6 million</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended March 31, 2019, as compared to </font><font style="font-family:inherit;font-size:10pt;">$23.1 million</font><font style="font-family:inherit;font-size:10pt;"> for the same period in 2018. As of March 31, 2019 and December 31, 2018, the payable balance due to affiliates was </font><font style="font-family:inherit;font-size:10pt;">$17.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$12.9 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were </font><font style="font-family:inherit;font-size:10pt;">$2.2 million</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended March 31, 2019, as compared to </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> for the same period in 2018. As of March 31, 2019 and December 31, 2018, the receivable balance due from affiliates was </font><font style="font-family:inherit;font-size:10pt;">$1.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Please refer to Note 6, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Affiliated Companies</font><font style="font-family:inherit;font-size:10pt;">, to the consolidated financial statements in our </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> Annual Report for additional details.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Level 1</font><font style="font-family:inherit;font-size:10pt;">: Unadjusted quoted prices in active markets for identical assets or liabilities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Level 2</font><font style="font-family:inherit;font-size:10pt;">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Level 3</font><font style="font-family:inherit;font-size:10pt;">: Unobservable inputs that reflect the reporting entity’s own assumptions.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Fair Value Measurements</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commodity call options</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Fair Value Measurements</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees’ investment selections and is included within other long-term liabilities. Please refer to Note 9, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">, for further discussion of our derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3 Fair Value Measurements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the contingent consideration liability related to the SmartDose technology platform (the “SmartDose contingent consideration”) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other (income) expense in our condensed consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a summary of changes in our Level 3 fair value measurements:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in fair value recorded in earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase in fair value recorded in earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Financial Instruments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the estimated fair value of long-term debt was </font><font style="font-family:inherit;font-size:10pt;">$197.4 million</font><font style="font-family:inherit;font-size:10pt;"> compared to a carrying amount of </font><font style="font-family:inherit;font-size:10pt;">$195.5 million</font><font style="font-family:inherit;font-size:10pt;">. At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the estimated fair value of long-term debt was </font><font style="font-family:inherit;font-size:10pt;">$192.6 million</font><font style="font-family:inherit;font-size:10pt;"> and the carrying amount was </font><font style="font-family:inherit;font-size:10pt;">$196.0 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a summary of changes in our Level 3 fair value measurements:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in fair value recorded in earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase in fair value recorded in earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provision for income taxes was </font><font style="font-family:inherit;font-size:10pt;">$16.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, and the effective tax rate was </font><font style="font-family:inherit;font-size:10pt;">23.1%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">23.3%</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended March 31, 2018, we recorded a net tax charge of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> for the estimated impact of the 2017 Tax Act. Please refer to Note 16, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;">, to the consolidated financial statements in our 2018 Annual Report for further discussion.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. Inventory balances were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">226.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">214.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of lease expense were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Variable lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Leases</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adoption of ASC 842</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of March 31, 2019, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases include options to extend the lease term for up to five years, and certain of our operating leases include options to terminate the leases within one year. We had no finance leases as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of our adoption of ASC 842, we recorded operating lease right-of-use assets of </font><font style="font-family:inherit;font-size:10pt;">$71.0 million</font><font style="font-family:inherit;font-size:10pt;"> and operating lease liabilities of </font><font style="font-family:inherit;font-size:10pt;">$73.1 million</font><font style="font-family:inherit;font-size:10pt;"> for operating leases where we are the lessee in our condensed consolidated balance sheet as of January 1, 2019. The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of lease expense were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Variable lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lease expense for the three months ended March 31, 2018 was </font><font style="font-family:inherit;font-size:10pt;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplemental information related to leases was as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the weighted average remaining lease term for operating leases was </font><font style="font-family:inherit;font-size:10pt;">12.1</font><font style="font-family:inherit;font-size:10pt;"> years, and the weighted average discount rate was </font><font style="font-family:inherit;font-size:10pt;">3.74%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maturities of lease liabilities as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019 (remaining nine months)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: imputed lease interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maturities of future minimum rental payments under non-cancelable operating leases as of December 31, 2018 were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Practical Expedients and Exemptions </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have elected to adopt the leasing package of practical expedients, which allow us to not retroactively reassess: i) any expired or existing contracts containing leases under the new definition of a lease; ii) the lease classification for any expired or existing leases; and iii) initial direct costs for any expired or existing leases. We have also elected to adopt practical expedients around land easements, the combination of lease and non-lease components, and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have elected not to recognize operating lease right-of-use assets and lease liabilities for all short-term leases (leases with an initial lease term of </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;"> months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maturities of lease liabilities as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019 (remaining nine months)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: imputed lease interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Standards</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Shareholders</font><font style="font-family:inherit;font-size:10pt;">’</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Equity</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">, for additional information.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Standards Issued Not Yet Adopted</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Shareholders</font><font style="font-family:inherit;font-size:10pt;">’</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Equity</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">, for additional information.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Standards Issued Not Yet Adopted</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other (Income) Expense</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense consists of:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring and related charges:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Severance and post-employment benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset-related charges</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total restructuring and related charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Development and licensing income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other items</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other (income) expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restructuring and Related Charges</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes are expected to be implemented over a period of up to twenty-four months from the date of approval. The plan will require restructuring and related charges of approximately </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we recorded </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> in restructuring and related charges associated with this plan, consisting of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> for severance charges and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> for other charges. During the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we recorded </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;"> in restructuring and related charges associated with this plan, consisting of </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> for severance charges, </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> for non-cash asset write-downs associated with the discontinued use of certain equipment, and </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> for other non-cash charges.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.78632478632478%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Severance</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset-related charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charges</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash asset write-downs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. Our remaining restructuring obligations related to the 2016 restructuring plan as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Items</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During both the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and 2018, we recorded development income of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> related to a nonrefundable customer payment of </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;"> received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue</font><font style="font-family:inherit;font-size:10pt;">, for additional information. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 10, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:inherit;font-size:10pt;">, for additional details. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other items consist of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, and miscellaneous income and charges. Other items increased by </font><font style="font-family:inherit;font-size:10pt;">$2.6 million</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended March 31, 2019, as compared to the same period in 2018, primarily as a result of foreign exchange transaction gains of </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;"> during the three months ended March 31, 2019, as compared to foreign exchange transaction losses of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> during the three months ended March 31, 2018.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Benefit Plans</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of net periodic benefit cost for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other retirement benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized actuarial losses (gains)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other retirement benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International plans</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:0.8547008547008548%;border-collapse:collapse;text-align:left;"><tr><td colspan="1" rowspan="1"></td></tr><tr><td style="width:100%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:0.8547008547008548%;border-collapse:collapse;text-align:left;"><tr><td colspan="1" rowspan="1"></td></tr><tr><td style="width:100%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective January 1, 2019, except for interest crediting, benefit accruals under our U.S. qualified and non-qualified defined benefit pension plans ceased.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:30%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location on Statement of Income</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Detail of components</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Losses on derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward treasury locks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total before tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net of tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of defined benefit pension and other postretirement plans:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actuarial losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total before tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net of tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total reclassifications for the period, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 14, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Benefit Plans</font><font style="font-family:inherit;font-size:10pt;">, for additional details.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents information about our reportable segments, reconciled to consolidated totals:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:81.19658119658119%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proprietary Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">326.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">443.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">415.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating profit (loss):</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proprietary Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other unallocated items</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating profit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other nonoperating income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by market group:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Biologics</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Generics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharma</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by product category: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">High-Value Components</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Standard Packaging</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delivery Devices</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the approximate percentage of our net sales by geographic location: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Americas</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe, Middle East, Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia Pacific</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contract Assets and Liabilities</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract assets, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract assets, March 31, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in contract assets - increase (decrease)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income, March 31, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in deferred income - decrease (increase)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The increase in deferred income during the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> was primarily due to additional cash payments of </font><font style="font-family:inherit;font-size:10pt;">$30.6 million</font><font style="font-family:inherit;font-size:10pt;"> received in advance of satisfying future performance obligations, partially offset by the recognition of revenue of </font><font style="font-family:inherit;font-size:10pt;">$25.8 million</font><font style="font-family:inherit;font-size:10pt;">, including </font><font style="font-family:inherit;font-size:10pt;">$11.1 million</font><font style="font-family:inherit;font-size:10pt;"> of revenue that was included in deferred income at the beginning of the year, and </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;"> in other adjustments.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;"> received in June 2013 in return for the exclusive use of the SmartDose</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> technology platform within a specific therapeutic area. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$6.3 million</font><font style="font-family:inherit;font-size:10pt;"> of unearned income related to this payment, of which </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> was included in other current liabilities and </font><font style="font-family:inherit;font-size:10pt;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;"> was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Supply Chain Financing</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we derecognized </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable under these agreements. Discount fees related to the sale of such accounts receivable on our condensed consolidated income statements for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> were not material.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Voluntary Recall</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 24, 2019, we issued a voluntary recall of our Vial2Bag</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> product line due to reports of potential unpredictable or variable dosing under certain conditions. Our 2018 results included an </font><font style="font-family:inherit;font-size:10pt;">$11.3 million</font><font style="font-family:inherit;font-size:10pt;"> provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During the three months ended March 31, 2019, following the completion of certain tests and studies related to the voluntary recall, we recorded a </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> provision for potential inventory returns from our customers and related in-house inventory, partially offset by a reduction in our provision for product returns. We continue to work to get the products back on the market.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax, for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Losses on</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Unrealized gains </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">on investment </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Defined benefit</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">pension and other </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">postretirement plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">currency </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(113.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(154.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive (loss) income before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified out</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive (loss) income, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(109.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(153.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Note payable, due December 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit Facility, due October 15, 2020 (1.00%)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Credit Facility, due March 28, 2024 (0.875%)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Series A notes, due July 5, 2022 (3.67%)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Series B notes, due July 5, 2024 (3.82%)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Series C notes, due July 5, 2027 (4.02%) </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">195.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">195.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the effects of derivative instruments designated as hedges on other comprehensive income (“OCI”) and earnings, net of tax:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.57264957264957%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of Gain (Loss) Recognized in OCI for the</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Flow Hedges:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency hedge contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods and services sold</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward treasury locks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Investment Hedges:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency-denominated debt</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:0.8547008547008548%;border-collapse:collapse;text-align:left;"><tr><td colspan="1" rowspan="1"></td></tr><tr><td style="width:100%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</font></div><div style="line-height:120%;text-align:left;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(in millions)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sell</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Currency</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Purchase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">USD</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Euro</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">USD</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Yen</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,232.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SGD</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dilutive effect of equity awards, based on the treasury stock method</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares assuming dilution</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Fair Value Measurements</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commodity call options</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Fair Value Measurements</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of December 31, 2018 were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. Inventory balances were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">226.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">214.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.78632478632478%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Severance</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset-related charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charges</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash asset write-downs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the changes in shareholders’ equity for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.69135802469135%;border-collapse:collapse;text-align:left;"><tr><td colspan="30" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Shares Issued</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital in Excess of Par Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Treasury Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Treasury Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance, December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(103.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,353.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(154.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,396.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares purchased under share repurchase program</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(83.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(83.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Dividends declared ($0.15 per share)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income, net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance, March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(172.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,398.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(153.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,369.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the changes in shareholders’ equity for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.69135802469135%;border-collapse:collapse;text-align:left;"><tr><td colspan="30" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Shares Issued</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital in Excess of Par Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Treasury Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Treasury Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(109.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,178.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(117.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,279.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of modified retrospective application of a new accounting standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares purchased under share repurchase program</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividends declared ($0.14 per share)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income, net of tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">308.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(149.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,222.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(95.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,305.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Information</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our business operations are organized into </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents information about our reportable segments, reconciled to consolidated totals:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:81.19658119658119%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proprietary Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">326.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">443.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">415.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating profit (loss):</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proprietary Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract-Manufactured Products</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other unallocated items</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating profit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other nonoperating income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other unallocated items during the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, consisted of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, in restructuring and related charges. Please refer to Note 15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (Income) Expense</font><font style="font-family:inherit;font-size:10pt;">, for further discussion of these items.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Summary of Significant Accounting Policies</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font><font style="font-family:inherit;font-size:10pt;">: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> (the “</font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> Annual Report”). The results of operations for any interim period are not necessarily indicative of results for the full year.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Expense</font><font style="font-family:inherit;font-size:10pt;">, to the consolidated financial statements in our 2018 Annual Report for further discussion.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shareholders</font><font style="font-family:inherit;font-size:10pt;">’</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Equity</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the changes in shareholders’ equity for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.69135802469135%;border-collapse:collapse;text-align:left;"><tr><td colspan="30" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Shares Issued</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital in Excess of Par Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Treasury Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Treasury Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance, December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(103.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,353.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(154.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,396.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares purchased under share repurchase program</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(83.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(83.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Dividends declared ($0.15 per share)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income, net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance, March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(172.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,398.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(153.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,369.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the changes in shareholders’ equity for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.69135802469135%;border-collapse:collapse;text-align:left;"><tr><td colspan="30" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Shares Issued</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital in Excess of Par Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Treasury Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Treasury Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(109.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,178.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(117.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,279.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of modified retrospective application of a new accounting standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Activity related to stock-based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares purchased under share repurchase program</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividends declared ($0.14 per share)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income, net of tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">308.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(149.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,222.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(95.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,305.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplemental information related to leases was as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense consists of:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended<br clear="none"/>March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring and related charges:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Severance and post-employment benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset-related charges</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total restructuring and related charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Development and licensing income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other items</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other (income) expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> These components are included in the computation of net periodic benefit cost. Please refer to Note 14, Benefit Plans, for additional details.

EX-101.SCH 9 wst-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2111100 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Accumulated Other Comprehensive Loss Components (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Accumulated Other Comprehensive Loss Reclassifications (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Accumulated Other Comprehensive Loss Reclassifications (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Affiliated Companies link:presentationLink link:calculationLink link:definitionLink 2407401 - Disclosure - Affiliated Companies (Details) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1003001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1002501 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Contracts and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Credit Facility (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Derivative Financial Instruments (Textuals) (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Effects of Derivative Instruments on OCI and Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Fair Value Measurements Level 3 (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Fair Value Measurements Other Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2416401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Leases Adoption of ASC 842 (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Leases Lease Cash Flow and Supplemental Information (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Leases Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 2406405 - Disclosure - Leases Lease Weighted Average (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Leases Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2406406 - Disclosure - Leases Maturities of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Net Income Per Share link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Net Income Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Net Income Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - New Accounting Standards link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Other Expense link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Other Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Other Expense Items (Details) link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - Other Expense Other (Income) Development and Licensing Income (Details) link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - Other Expense Restructuring and Related Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Other Expense (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - Revenue Supply Chain Financing (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 2403405 - Disclosure - Revenue Voluntary Recall (Details) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Shareholders' Equity Change in Shareholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Shareholders' Equity Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Shareholders' Equity Supplemental Equity Information (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2413401 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Subsequent Event (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 wst-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 wst-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 wst-20190331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Fair Value Disclosures [Abstract] Schedule of Assets and Liabilities Measured at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Summary of Changes in Level 3 Fair Value Measurements Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Assets, Fair Value Disclosure [Abstract] Deferred compensation assets Deferred Compensation Plan Assets Foreign currency contracts Foreign Currency Contract, Asset, Fair Value Disclosure Commodity call options Other Assets, Fair Value Disclosure Total assets at fair value Assets, Fair Value Disclosure Liabilities: Liabilities, Fair Value Disclosure [Abstract] Contingent consideration Business Combination, Contingent Consideration, Liability Deferred compensation liabilities Deferred Compensation Liability, Classified, Noncurrent Foreign currency contracts Foreign Currency Contracts, Liability, Fair Value Disclosure Total liabilities at fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure Statement of Cash Flows [Abstract] Statement [Table] Statement [Table] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Statement [Line Items] Statement [Line Items] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation Depreciation Amortization Amortization Stock-based compensation Share-based Compensation Non-cash restructuring charges Restructuring Reserve, Settled without Cash Contingent consideration payments in excess of acquisition-date liability Payment for Contingent Consideration Liability, Operating Activities Other non-cash items, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Changes in assets and liabilities Other Noncash Income (Expense) Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Other, net Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Borrowings under revolving credit agreements Proceeds from Long-term Lines of Credit Repayments under revolving credit agreements Repayments of Long-term Lines of Credit Repayments of long-term debt Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities Debt issuance costs Payments of Debt Issuance Costs Dividend payments Payments of Ordinary Dividends, Common Stock Contingent consideration payments up to amount of acquisition-date liability Proceeds from (Payments for) Other Financing Activities Proceeds from stock-based compensation awards Proceeds from Stock Options Exercised Employee stock purchase plan contributions Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Excluding Stock Options Shares purchased under share repurchase programs Payments for Repurchase of Common Stock Shares repurchased for employee tax withholdings Payments Related to Tax Withholding for Share-based Compensation Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rates on cash Effect of Exchange Rate on Cash and Cash Equivalents Net decrease in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents at beginning of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at end of period Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract] Benefit Plans Pension and Other Postretirement Benefits Disclosure [Text Block] Debt Disclosure [Abstract] Debt Debt Disclosure [Text Block] Segment Reporting [Abstract] Segment Information Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Equity Method Investments and Joint Ventures [Abstract] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Purchases and royalty payments made to affiliates Purchases and Royalty Payments from Equity Method Investees Purchases and Royalty Payments from Equity Method Investees Amount due and payable to affiliates Due to Affiliate Sales to affiliates Sales to Equity Method Investees Sales to Equity Method Investees Amount receivable from affiliates Due from Affiliates Carrying amount, equity-method investments Equity Method Investments Carrying amount, cost-method investments Cost Method Investments Level 3 Fair Value Measurements [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Balance, beginning of period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Increase (decrease) in fair value recorded in earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Balance, end of period Earnings Per Share [Abstract] Reconciliation of Basic to Diluted Net Income Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Lease Cash Flow and Supplemental Information [Abstract] Lease Cash Flow and Supplemental Information [Abstract] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Inventory Disclosure [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventories Inventory, Net Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract Type [Domain] Derivative Contract [Domain] Foreign Currency Hedge Contracts [Member] Foreign Exchange Contract [Member] Interest Rate Swap Contracts [Member] Interest Rate Swap [Member] Forward Treasury Locks [Member] Treasury Lock [Member] Foreign Currency - Denominated Debt [Member] Foreign Currency, Denominated Debt [Member] Foreign currency-denominated debt designated as a hedge of our net investments in foreign operations. Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Net sales [Member] Net Sales [Member] Net sales member Cost of goods and services sold [Member] Cost of Sales [Member] Interest expense [Member] Interest Expense [Member] Other expense [Member] Foreign Currency Gain (Loss) [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Cash Flow Hedges [Member] Cash Flow Hedging [Member] Net Investment Hedges [Member] Net Investment Hedging [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Amount of gain (loss) recognized in OCI Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Amount of (gain) loss reclassified from accumulated OCI into income Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Inventories Inventory Disclosure [Text Block] Number of reportable segments Number of Reportable Segments Restructuring and related charges Restructuring Charges Argentina currency devaluation Foreign Currency Transaction Loss, before Tax Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Segments [Axis] Segments [Axis] Segment [Domain] Segments [Domain] Proprietary Products [Member] Packaging Systems [Member] A component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Contract-Manufactured Products [Member] Delivery Systems [Member] A component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Intersegment sales elimination [Member] Intersegment Eliminations [Member] Corporate [Member] Corporate and Eliminations [Member] Corporate headquarter items not allocated to segments and intersegment transactions (e.g. intersegment profits). Reconciliation of the total of reportable segments' amounts of revenues, measures of profits or loss, assets, or amounts for every other significant item of information disclosed, to the consolidated amount. Other unallocated items [Member] Segment Reconciling Items [Member] Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Net sales Revenues Total operating (loss) profit Operating Income (Loss) Interest expense Interest Expense Interest income Investment Income, Net Other nonoperating income Other Nonoperating Income (Expense) Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Document and Entity Information [Abstract] -- None. No documentation exists for this element. -- Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Emerging Growth Company Entity Emerging Growth Company Entity Small Business Entity Small Business Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Equity [Abstract] Accumulated Other Comprehensive Loss Comprehensive Income (Loss) Note [Text Block] Segment Information Segment Reporting Disclosure [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Affiliated Companies Equity Method Investments and Joint Ventures Disclosure [Text Block] New Accounting Pronouncements and Changes in Accounting Principles [Abstract] New Accounting Standards New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Revenue [Abstract] Revenue [Abstract] Revenue from Contract with Customer [Text Block] Revenue from Contract with Customer [Text Block] Balance Sheet Related Disclosures [Abstract] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Treasury stock, at cost (in shares) Treasury Stock, Shares Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Long-term Debt Obligations, Net of Current Maturities Schedule of Debt [Table Text Block] Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events [Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Dividends declared per share Common Stock, Dividends, Per Share, Declared Other Financial Instruments [Abstract] Other Financial Instruments [Abstract] -- None. No documentation exists for this element. -- Long-term debt, fair value Long-term Debt, Fair Value Long-term debt Long-term Debt, Excluding Current Maturities Net income Weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Dilutive effect of equity awards, based on the treasury stock method (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Weighted average shares assuming dilution (in shares) Weighted Average Number of Shares Outstanding, Diluted Antidilutive options excluded from computation of diluted net income per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Stock repurchase program, shares authorized Stock Repurchase Program, Number of Shares Authorized to be Repurchased Stock repurchase program, shares purchased Treasury Stock, Shares, Acquired Stock purchase program, cost of shares purchased Treasury Stock, Value, Acquired, Cost Method Stock repurchase program, average price per share Treasury Stock Acquired, Average Cost Per Share Net Income Per Share Earnings Per Share [Text Block] Supply Chain Financing [Abstract] Supply Chain Financing [Abstract] Sales of certain accounts receivable Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount EX-101.PRE 13 wst-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 psuaward1.jpg begin 644 psuaward1.jpg M_]C_X 02D9)1@ ! 0$ > !X #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" !) -H# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]4Z*** "N M+G^*.@KJ=Q8PSW-]<6LK12K864UQAE^5E_=JV[:S*K;?NLRJVW=7:5YY\!69 MOA3HF_\ U_[[SM_WO-\Z3S-W^UNW4 =?I.M6.N68NM/NH[NW9F7?&V[YA]Y? M9A_=K4JM':P032211+')*=SLJ_>^M6: "BBB@ HHHH **** "BJ.K27$>EW< MEFGFW:Q.T*_WI-ORURG@75[J[T+1+J[U0ZW_ &G'O^U%(X_)DV[FCVJJ_+\K M?[6Y?^^0#N:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSWX89T M?6/&?AMOD6QU9[^W_P"N%Y_I'_HYKE?^ UZ%7FOQ F?P7XPT+QFN5TZ4KH^L MA1TAD;]Q,W_7.9MO^[.U 'I5%,9MOWJ;'*LT:LC*R-T930!+1110!R'Q \<6 M?@/P[?7[M#/J$<.ZUT]IE1IY&=8XU_W3(R+N_AW5M:'!>6VGQ1ZC=1W=Y\QD MDC3RUZ]%7^Z,XKPWXAPR76G_ !JL[B-[F;3?L&OVK;5W>3'''(L:_P"SYEE) M7OUK=1WD$5Q"WF12*LB,O=6H LT444 %>1>*])O/AGJ$WB#1+3[;HEQZYA9IE:2:V_O;F;YH?XF;-_#^-:= %"/5+234I[!+B-KV%%DDA4_,BMNV MEOKM:K]>;Z:ITWX]ZW'G,>K:!:7&UO[]O/-&VW_@,R5Z!=74-C TUQ*D,2_> MDD;:HH L45'&ZRQJZ-N5N0R]ZDH **** "BBB@ HHKF-1T75X;B6[TC4,/(^ M^2VO69XO^ _W?\_=H Z>N5NM7\/>,;K6_"3&T M,RM]W=NK#FUKQW'<-')X/M[Z(+Y?F0:XJK)_M;6A5EKC(/AC\2;P:W#IVO:5 MX$TO5KC[5)9V\;ZC/#(W$OES?N-N[:K?Q,K;MK+0!#IOB#^V-%\9?#SQ#JL+ MG0-.N+1]7O)=WVZ"2/RUD;;]YHUD\N3^+S-O]ZNB^'_CVVM?@K+X@33YC/IL M4TFH:1:C;+:S1L6FA56Z;>RM_#M]:B7X%%=!T6.;5]^LZ))YFESV]IY-I#\R MLRM;[V\Q9-OS-(S-_%N5JUO%_P .=4DUF^UCPO=6-M-JMO\ 9M7TS5(6DL[] M=NU9&"LK+(JY7=_$ORM]U< %[4OB[X>L889EDN+ZVN-)?6K6>QCWKC:4UOXWBO-076HY/,6PFM+Y;A;EML;;E:%I%^[NW+N;[W\(!7T MGXV^&_%'Q62_AL=8N+37?#S:=/I\>FS33":&X8[66+=,K?-"T3?=_BK+L-0N M]5T_2=3TW3+YOB##K7+M6.%ONR*R_>_AKUNW\SR8_. MV^;CYMGWZEH]S;:??MI=W(N([I8_,*'_=H LWUXFGVLL\@9EC7=M4?,?9: M\AT7Q%XNU_Q-?:Y%X+U!;SR_L>G0:M,EG:V4.[]XTC'=(TC,J[O+C9=J+M9O MO-<7P#XVALVM[C4+?56D7;)/_;5_9?\ ?*KYFW_OJL(_ ?Q3?2?N_&%YH,3' M=)]GUG5;R3Z*TETJ_P# MM %7XW0^)1X)N;;Q1XLL=+34I%AAL-%L>%56\R2 M22:3ZQ<>(/$UZUJUI+>:KKETS30M]^-E615V MM_=V[:@O?@/),WRLW^] M0!Z+9^(M-U!M6CCN%7^R9_LUXTORK%)Y:2=6_P!F16W>]9OC;Q_IW@C1[2_N MXYKLWUS'96=M9A&ENII/N1Q[F5+[6+7O$4,MM MK?FZ=^[DCC7Y6W-N^;=46N_!_Q?JWARS\'3:IIEWH=E=VUQ M8:[)YD>J6"PLK1!8U5HY)%V[?,W+\I^96YW '877QL\/:2/(UQ+S0M5\R&-- M,OXU6XD\R18U:/:S+(NYEW;&;;_%BM#4=%OVOWLW\=ZM8W%[N:V@AAL=T:K] M[;NMVW?>7[U>=2_ ?Q1XX\46EW\1/$EAK>G:?'-':1Z=:/:R?O(VC9OO?*WS M*V[YOF5=NWYMW31_!G47U2TU.Z\?:^^JV$36MG>0I:*T=NVWS%96A99&?9'N M9E_Y9KMVT 8RI-''NM_*P MK?9Y/E_B95J.2VTC1/C%IGAOP]X4TJ]-M)";W5M3>2ZN4D97D:*-I-S*RQ*L MC2;O^6D2[?FKU36/ ECX@\*KH=_<7URBLLB:@;C_ $M)U?S%G63^%U;YEV_* M/N[=ORUSO@CX3W?@WQ]KOB&7Q!-K@U>)?.:_MXUN!,JQKN5H]L:KMC7Y5C5F MVKN9MBT >G4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "!=M+110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_ !V0$! end GRAPHIC 15 psuaward3.gif begin 644 psuaward3.gif M1TE&.#EAK03? 7 "'Y! $ H + "M!-\!@P !4E@!4E0!5E !5 ME@!7EP!5E0!/CP!3EP!6E0 2I4,E)J[TXZ\V[ M_V HCF1IGFBJKFSKOG LSW1MWWBN[WR/%P6?<$@L&H_(I'+);#J?T*AT2JV* M@$"K=LOM>K_@L'A,+IO/:.PAB&Z[W_"X?$ZOV^]X'W"-S?O_@(&"@X2%AH=S M6 5K:XB.CY"1DI.4E99M>XI]EYR=GI^@H:*CAYF+IXVDJJNLK:ZOL+$GBGQ\ MF[*XN;J[O+V^:8RFP;_$Q<;'R,G*(YJUS8C+T-'2T]35D:BGV<%LUMW>W^#A MXDVTPJ:+X^GJZ^SM[AF9SMJF[_7V]_CYN>?R"/S<^@(*'$BP8)Y_V?PYXV.P MH<.'$"-",9?0EC\U621JW,BQHT<3V>85N*@0VZF/*%.J7/D0H[PU);'$1,>R MILV;.+O)RW01YIZ9#',*'4JT*"R,)OWU5*14G9[1IU"C2D6$U.+(4TH7Q5PZ MM:O7KV#-( S&9^95!-MHAEW+MJW;(RZ!7&2*56M(>F_SZMW+=\5=;&A'6B4Y M$H%AO'T3*UZ\>.'=K%QH&O?SGU5.=ZPZ]8][&SRR>[HTZN?-#;\]=;332U%^GN]_?OXY4B/ M!UIW89'*Q7=>?@06:* 8^Q'VFH"0-6B2+?4=*.&$%,)EBW%V+2C9>*Z9Y]-2 MJ50HXH@DYA"7;UF]9AZ#F@2H28DPQBBC"N>$I%!,E,6V38H!>ACAC$ &*>0\ MY86G8&>@M3982!#^*.234%)X(5(^NFB8B23HF.5>.1 [HYIY\"J?:F71]%IAX 7ZX6IT9]:GH MHJ6IEM6=XK'F7G^0SD=6)HQFJFEB[5%VEI*]^6?EIQA"FMVFJ*;:59YI]@=? M68;Y T)AAI%EGJJXYFH4?8S$JNNOP 8K[+#$IH=1L<@FB\^:,-2HR;/?,:OL MM-1& ^VUT4I %[;8#@KG3K;0P*VT_]66:^X=WU56RWSI[N?8:-(Y(T,SN)UK M[[T'/8C;E*#"ZR]KW]8HKPLGPIDHO@@G?,9= ?\DH*O_&MC0,L!&R#U\**.A^7''(XMTR"(A/ >[$"7(^M]]X8-PRHIZ*IK#.:*Z=L MW:0 GWI%WGB+=$[=>O(M^>0?L$PXSUDZ:%>E3!(:'XB3#EP"XPKVQ0Q^8H>:M/%/ZB:L5@AJM M1_X[0+Y[;S_2%)G:4Z$]+H_1H\\R6Y+$LR$("4UN'2 =]EH6DJ]E[WX03%B\ M7*4_M)4L2_$1E)IJU1LLD6R 4V)&Y)Q5CM8!+X(HQ%?G_K*EW;!/=^NR4= R M-,-XT&EY[-(:WJZWPJ/%3X8 MW24Q4E@#7&RJYCGV7>F,Z_O'^TEX." %=NV$TC#8@Y[YJNM-+<7','H7)'SP% MDX8*^J4]W2:F2WX*='"\@#,7*)N\X?*=" V2OKYYOG#Z+%!,J],=M_D\<':3 MG&89J >&=E"F 3&A(,U/D^29/#3N,Y]PVR,D2U9 %Q*P5>,Q"\<:Z '1A?2F M)3I1*S^'MMK=[GE;V=$,@=HOC"+.,6MD)CNSB-.F'LAU[QDG]0[GH&#FT(^D M,N-+*[F;OZR1IC\TIU/'FA^$L$BJA"E<&%$).)\:,"Z'(6$GA/HIU@WL)(!N M)*M>";1"P #S=6=+B_]N&"FJ3A)KRB/C<;I9UW,Z)BU5!-FX)DO9REKVLGJX MK&8WR]EH[J"SH VM9O=:5M>I,I!&PHH!U0HJ/C:TADYSI!ZC1CM$SO([_S83 MF;MVJ]O>^HTB/; <;W_KV^$"-[/$3:YQB\M_6&FM@VD%#VQ*!CITQ?? \%UN9A,LWP83U[T(=C"#&T9?]>Q+3L,DYJ6N MZ*:#ZSFLULYFG6X,)=C/]SC7%,9QV;Q+UE_@>;]VV42EYQG7F\Z&@QVL[,^6R8)FU?)G?YQ>\:L91UJFA( M/_K3C@[U<06=0 F;FLJ]!=,3W;PP0.M+75"U+\Y@_>IZ??:*@]HCFGQ:)H;N M.M?;RMJ8;?!>6L]:UJS*=++;0^J-QAC5T*X&M*Z7!NA25H SWD+GL,/0GLXS M3IKK]C:_W;YASZ!%]%GIU )Y3PQ;1ZX^@AAR<9-:;@8[>O8>][::*))FEQK: MSXXQ->BEIFM[=@G3%NZ2-Y:(6FLP5$YL:$,W#/&)1_QOKN)!/?_SVK.D)7R# M^3C$QT14B/;$Q?WH(,4I/\-R)[;P?X64]?CM,31VT;%"F'__FN3,G3HJU79Z7] MJ[K5.8.=V("[WNC6M]GSZVT:UMSF7HX[IBEMZ2_+O<72H/MOCUW<@D]6J?]^ M[YIY>?!JP\YJJE6YX@NU>-C]=/'EM/*YX5K$*T4M?,#&'-([7O20AYUUWAXS(IIVH;!/\Y]'UF>B_^+%,L80>8&^G[\8/"-O8[I% M.1X7)%_]?V?G]]NBGMAR2A1Z8I^\8+OJ2!99O_H8UN0D6=4#DLXNOH-40WK^^MU#_:DM$VPV38%__*! M(MHT>H<31$H&YU<0D( M417H$\S>KJ#34[#>!I%;&0'*P;H@:9'B7JTB+*% M !IG=$A'B8\G.!#%B$R$>JQ5AF^4/P^W!%.Q* +/\WW5N'P PXQ%J$S"9WMO%S>^Q'90UW9KMX;M^'3N)GF] M('C'"!F=1V";0X5MDV'V-D;2M7$HIEBGYUV8"(=?X$5FXX.RQ72 8E25QT0[ MR'(.R!_* 7*6>)&5:(\>QU.T%5DFXE>*B$EB!)&?HR(A29&T98JG^$&)AW@9 M*3V>J'JIUT=[H SM 9)+5&0,J%B.B$2YUI!5&'Z$Z$NN]8&$53@^! S[N&_[ M2(2XV)24DCS[&%>2XH"R6;:4WYB5U B&.U5'S[.))C-2()1)0=E3AQ.6T1-% M*FD!!J,Y#D*.?M5T0JDYTX-)VQ@*+L@Y>*272'$\,_VO2'!;B( M. )&,E-M7Z2("XDV'*210,,^>UB($\F!C=F2DYB1L64^5]F)=WE;!.9*Q/>) M,+E?,UB7BC==:QD_EE==ATB2>5@EN8. &DE\.((,-]9Q1D6:(+:$]U5=M05Y M_8B9U*> O?9!#?(>+_^(!JQD?G\YE> %AO]H2$1";7B!%* M8\@7?IL9HI3(?*_HA9+&4X5(3HAYF#*8:_YE3* H$_!I115!DI*(.!4)&!PZ M>AC*;R5Q#/H)BF&WFQMG;3Y#FJV%7QQJ?0&VF9[CC=%WD.80F,"IEUP70WX9 MANK6>?QA(L9(>=X9IC[Z*OT3-$=R:S IF63I3^9W?8E)@%%ICF_W&(E321K_ MFI[4.)>#M41)>7OR]X,'FA BF&!LC]OJDHHPS80DT:"&9?*]T7'%#<+HWN: M.8IIZH=GDXZ_R6V(IVED@Y"MTI BRIG8!V*Z>"8G^@I04Q(2M18$IZH82 MESPS>CI/B%:6>I8]*5>%N59,D:J\X'H6T:.H^1@&1%LP52F;6H@*VFM!!C0B MN'A!=EJ&V&J$^HVC\J0:%H]%0EWE1(SS,C%;1:5:.:9CN:7Z]JT=N@)"A99> MF4-LVIWDYB$9U2JUFDX&RDJX&J_\9*#(IX05&1/$0*1O*G*#L160U*CU-T;8 MF";C,YZ&M4\EETSJVE=B\9E76*/U&(K+NDKMPXP___ =&!6;6$6R.NJ&\12" M%W*9MODPON2JNUJIV10XDGD1]RI-VJI*M(B(K'16XI.9OPF-KF!?FD>%60>: M_,4346A'<*E5H\EQ(E>J%OB8EP=.48VL%*,(NI'B6/GM' M_(5Z?#LU< NJRIEN.^6R+/I-G=E:@N&E#\F+T1,P M$]5K#$@]5)FALA2L>LA33>9\;JC)AJF,BP\P*,8!X M6G!;'FW%=I58K!\WM;K(>*!QLSB;CHE:IRT7JZY"5*0K54 %K/PIEELXFX^7 MH3Y+%SQ8N]:U9Y,IDD)%6"Q2-;>8-2+_/ 1,X;5JVSX-*\/E&Z>]2YX>FC9F M<9Y'JR%D KC[6W]8!6(?^4?N2YW=YL<<;*Y9DJ>0L1] MF'5@-XZ88U)Q_WI$38I!5SK/A\!HU,&=>[JV3]B^2^S&]P1B/,9'+R6YX&FR M!?H2_<>PZ^H$2;&ZUQ612ALZ ]C+]W9)Q):0*:RDF>JZB -]/PLKA7FZ.MVC M1823 %*C2ZJK0LMZF,-!]#DX+:#)MS*&KK*]X:BLXR/B/^8HQ;Z MEW@ME3G[F#E\UJ^LKE4#HM+JGY:4S%XDF^=Z>*&8ENRHD25Z9$.K9D7=FS,( M7B*-@;>,A*BZH:%;4IM-NT=+R+"E@50 2P^%LHC]?();GWOLSV_FBRUMR5RI MT'[(L)',QNXLIRE D +JL6,MUZ6GUM"*1LJ=&_;<4DK4N@>,DV8TKRO="7T5 MRJ?T=\'-AI!> M:^>,:I;#G: B+L3D@Z+3BAUO=GPV3*TZS&LG6XZ4MX E1.?(R(SWR=N'/>0,;V M?,=Z:K SN>,-=12LHM4Z#:B@.9FWFSDF3@5TBJV$9^/_L7Y,[BF0%QZ(B%SH MYJGIX$HPVQ:X&6;M@37&'TKNX7GG CO?@VW)?9W;PJ3(ERJ5MY+@S1/:J&W6 MHRSN$IZ?30?M%ZW?7SM,!3K'R#1D0;CAYZOB_HUPW<7LTUEZUOL/8NRQ:;*! M?W4BM1S;R/IPAJAXUQS5<&SFR%D^=RZ\WGJIF-"SPZ+#7#1W6NEOV[ M:.E09@VXJAJY5IQ=.FYG'MQN4)IQ (_;*5U=Y;>_?ZFG*%J60_NGF7/QJ[*B M'6^[.<^<)PG2D"N>O$Z:^D[K_Q8*E*3[S44=@5IA[_UKFALYL7Y&IF0X2V-RDQ1SQR4>93 M3\E57_]7/J?7[7=\7K_G]_U_P,".MS6XI!C$E"*=&JH,MX%;ID]/I6NP ?#JULO9JU*A2 15R@$?0ARD?)Q9RH71,BZ$GRVRY:+;H M5L:/CF@ Q.-R2$L2ZI ^W(#XL581J*8V?&)FQ1Y/9#EG 31ITQ8]'!,)%K4 MZ%&D2>M($VFR8\M&KW26X:ARA)ACE91N51#1*\13-QW",WAMD! %K@+/MDKI M\U5:$-SXY:@JK26W9A_M"9LE=>:N:H18PK+6;XE5-[P2TVN"V"Y:DO7B'1J' MLE=6-&2?\DT(U_-GT*%% WDIAI+TDCIXX\*N]8+?3C.7= MR6QNR* ;>ET&&_^1YYXIJ22S==G15"4HBCT*:N80-4":HB^_S(,[QI0S+7?' MBB\\]D#$USS.'*GJRI,N]4*UQ8OV??SY]0/$#"W]O+"I;.T+CLMLX?:6*R8ZY"(S8J/-/2# M+-9Z:E&;5=U]^CXK6"L.P98G=>:N= M[J9YC.GW1S"CQ&>]NTSB81L4*#;V7=V"S9A!@RILL]>#X$5-C?Z.VPHV! ?6 M#IH1B7ET*E=5#2Y.UBJ\80P#;2QM(W*TK!<.6!T)C*;#1#JOSTV92P1?Y^I< M^&FHHP9E!J8S/1?3@06,"C4_\RSC.JGSP!BL_T1O4MH)+N5C;+U&AW4$9 K7 MA%!8-!NK=9,^(2&XW85R.5B<.3/[&ZAP@+*+2DLR_-,V?[Y>M\6:?=-Q&BE2 MK">R;&8TDF=U!5^"Y,$([C9LTDLWO8MH/]VV94H\;LY:V"M[]_0Y"&%+L)GL MK9%5#F>D=K)'[^;U8C9[*_Y,4B[47)9Q"K%3*=;S3/2D;%O=]D@3:9Q9%5VI MEV0[$G-/HD<;PRF0R$?Y?H<-9Y&9EH?U^_.^W2CSKQ8O5B;RY MYV45>5O^2 ,CJ$AB:Y[J3B>>HI%$E2>"!!P;AWY5P;%U+$P2 I_S:O0"^8 ( M*?^:SY2< 3I=2,8GB_\QV#6VIQ;)*0XOX]+97H+BL>I)15KS&%UV,F>NQL4J M<.S"RM\ A:I:(," 2V1BO]P4HQ/1Y3]MZ!RY$B:B$ZHO?QF\O M(L]GOO/JP3UM45)"PN?:F(G/1FJL+QN?%[3 M&-,J>:@J4OD51YG5UJ=]SOB@4MD%JECWJU"(WJ4-@%2V84<&9 M^/1FG9HD!1Y_JV/K=D@N,SY3D[**DW:F-;AXY*6.E ,<''%I1!T,K8S ZR)' M*4/""P\J!G;S^&0[W:D?Y3$F'&A0S0^[^;GX18\%[^Q*G=2IBS4^+&)S05(0 M)V>99M"06ZL!XA2E>"Z^N%%E;CSG*36SN!?_]@U/V#O<8 29B]:U"GTQD&0A M_3C&25I-I(A\ X;>Y+[#H/10$6IX<1(RD80VJIO2JRJ[# M#66:S6O@T%84C9@ME(*3.MY2$PI91S@UYC4%KOLAY< E5SR^"#>:H^%@B<4( M<3E&#=CX:6,="]14.8Z;ND.D[+2)TDNBYI'N'";/NED5='F,CNLTJSE11M"A MZ@.-#GRE,ZTZ37RJR*MG,4P*R3!"7$+U=C$:8.@6>-)8I><-MCRI+5EZ03)] M,(I#LB1)!8$R2N[._W$ *228(LI#SM%>#2][ M-5=> NH,3S"*JQ)@+G?BJS6H>$ZZA'FE)^?0(G0:6 M#LSP&EF8EG2=@GHS=OLW7RMY[<5[YO./7,E#E[*,DGW\Y4HV*=4!VX?'$O]2 MFDMPEK7[XK5<6C,SPJ++O)1.=1\B?1]K!=35&-.GAM^!KW.A-<,A@M2+IR)B MD=*5LZQD)X9V-;'9U&6%R)66K2G$48@I4AB$!?)<)./U_N2+:5/W6=G+%C%; M;) DAMYSJTDLF=O6G.PE(D]Q';DK<5@G;%/6)4OQ]9RZTGC"*ED$Q3IFZZK_ MT[S:KC.P 6G?1:0$(*$>MWSIB\G[(LD]4\1RPI[=JLO$U#7J%=./*A)NSPC$ M5N.]F;IK'/(8GE069+V)V0#/>,>WJ)A?J?7 :-.5_R2S'705(B^=C-LQ%=F3 M(QEUD;G>6,GO;*1 )QK-Q)9)I^WX/BPU*L_3RB'_K_+XU0!)D[SZD)8P3 @Y;?U;-+]);+$V=I"- M"R%D;G<[O! B-7\"^7^[,79.96;-TV;Q#$W,4%]'/"B#AYEB^(0ZWA8';GA3 M@LUW7)J)=^)TA[=,JR6LG&)]TT.%./[DX6KDHA0Y]"GP-S[8=A<65>DJ3>N, M\D O^BFQJW:U'+RE^GV?-\CK4B+MTKDD[QD.VQ#.A>"L0KY,[57,+9JJRLM.[S3." M VLU\6BX-AJMTA*,E!$2)[.G) @1X@,.NVFYX[.F'Q.3[@(\CD$@Y\N[.,*X M!$2.!8L\5%,ALG,E2T,G 0,Q$B"\@O"9"PFM7:DH-J(D81*WK% Q]JH(0'L;]S$,'1G"=*,8^IG_ CKFM/;,8##EC"$+P;B0C#\H_8Y(F5*GCDZGN;[,PQ*O@GI/P,*P8\Y M0V'1H'AJ&-@X%B<)MGK;HPDCO>JXA3O4GM^+05*YFSVBMDKC/%!#0"PB0_.C MO0;2GIIAH;V[O !!+\R#O?K()*=RAMM!A;X)MA,)$)%+PC%QN-4R0D[T GFI M0EJ[P5RJP=A+F)03-'O!O4QX,BJKU(\0C,.IL%*["8*R!9@\,?VYVVL+^J23C_VD"AT2@3Q" . M$D=&#,2W>Y#6VJ*=;*\67,0@:;FZ0[YDX8^.FSOI<0RB>2T_X8F>RZ_4B[FG MQ! F^3P$8S/PTI1*0B;?@[2//$OTHB5=@Y0WBS'4([^V22))0;-+ M*IS#ZP?"U+)S!$=M*SX<^D,Y,L$J%P3L M(AUL1&_\4A"4T =IQV-0*[V;H#!*GPHE%C8](-]\OF;<-STJ@?,#HNN0IVLL M)Q84TQ&UT&)<)B*M*XIKO!S"L!U*NH5BSJ6YAWBLHB:C3"B@M_>J2J=CT2[K MR)13(-X:"C-<(4QLR@J+P'R"7K3 M1+XT.XN"_YF@09\'6H'"S$@O5+H=U"Q ;2@ADIABVPA8J:8B"2("FRVWHM$K ME0ZY2 >O_-A;U$R(U#S;PB=B_2LQF8)K#1(O^3%B&0L(HBC P8F$Q:K/,;<% M=!80+4>Z"E$&0<)I!$:&HB5SDB]T,EHZ4T&A)+/\<%DE7BG">P4YVVX ^QY*T&"L7Q^LYP.2J&FT-16T7Y:Q54\DMQKJLTHD6$*!L?L%%L8,(:(J.$T\L6/-,XR0MY^$AZ8E MP>!4C^\Z5D\3TDAU-/O*2FX-$HU)7_.T-#P$"6(J79@R4\H]$EZ%3TXAVA4N MCBS$W^$K#)5K"0=^8'JSUW.43:3EIL3DL&U2E.AIWZ#(7V<#WL1\JZW+ICC5 M*U_DN@:C5;%)+"8[E<,$LX843LS[A.W]F X#2V#T7XNE/KXC5$$.LN$H"-I0 MVG04V2-"%9AKV.L,DFI\!G9U-?$+S2_XU:^T5#2\-)(M)UXB5-DI68S__61LX$\V;K$';-=%I9*JZK=\M#^00"L^D%,RCB>\I1]VJ26.7%MZ/*3, M/:!C(63_DK]8[F!\,+E_F)0;_LOQBQ2KF;WF>BU;=$\ABUV=,N+%';[6@MF_ MA(_2U;E,L\J93.>NZIH@UF?79.%#!J9TSKLN!C5WOAWQBA^$5C'/U"N@4%#Z_P4RJVT/C-9HMS;/ MMN8X&PT&],1*1O6TO"'A>F[AJ;-/K=Y$]^3=:I69K)R7N-X 1J7D5E8=P\TO M7;BC]RF4SWP=AW+&SH&D6P+/^Q/7;ZZ:634>>Y9BL2NV*'92@9N>-///W2(, M]T0Y_S1-$/8CFXS ,68/6%FQ3'K024(7XN)AMH2(MPU87S2 M3C;HVD'AQNS0:^OO^IM9=:Y,D?^M00.G:DOMU>#&TXPSX^$&4[,0TU=6A[0Y MIE%RW(G.K-ML/Y%<'Z9,O#1^KSKIS<(>RQ5^6W0^;,1^U2P]N=,-'S\6X1Z5 MNI6E(&9N/ 6"4>"Z8E/48;6ID>%19M9,)G]IUA&\EVFBN4I!5/FA!H)"UD+J&)JH;P/6\ MH;614E[_5G#K;)#6JY;]VY'Q]5\7XCP[I@K=+,6(?'+Z1=6E9L2D_ML#]XNM MW/.?DN2S2]PV$?%:?-TC*EYCLM/+3%II*6FB&O<8'XA)HVR8P;=5_C^STF$V@2Q@%=IE M3B\I).=#N%-&#/L_0[6!S7[BQ7IE9-N%VGGA9S.I!%0[B MH;P&^1D9 K3+=1;CAO5L>\&L4G+?$/&D96!"-Y@I@_1A6YM@OZAXCL#J\%)$ M'K( YL;D)?/(?#I=WSKJ-E,T3&$4^M+6[.G'BUJC)ZZ;1/6X6\*O;SKJ)[8@ M&]MK] )OBM W9O93O81'^&*]4/AAF/36 MU:1RDG%J*HRL2 MBBHCFQ\AEB3E&!/A*2X18$J:8B5A7S$K+V,LUVL,Y!CNF2?;5MTPL23V'/&Q MI:ENV2]J!2WIXFISNOJ*8*"[< CU[I9OO/*I"#LY9(I@_[(_@,N,N"A81!W" M&?/XC=+RR=Z1A'O"T:*W:E6J"V_H<:N%#)2(A"S*463R!-"G:AZLC1SG4,Q* M#YRJ#+D3460^3H 0#3*7H2:IFD)1W<$@44'!?_F4Q=2G*->IE2B[F*E346,' M,Y@L^OPP$^2@IBEN'G55I%VUA5B]T;D*4BS-A39Y#:%4%!R^M%*[;D-V\)4M M62Q7%1T*2J_6C/\<=\54^5'7D''R9I$M:UGA(L&Z?EK%:A=R,4QXK\:M<[8E M9WT,3ZM6ZEJ@"H(&7ZRX'# 4,9)^:U_>85+VTZ(28UO)%M6G M-D:BH_7$$BX-+X^F\RSOLY9Z XD MS<0VDR1N^,$?;CL]B-USV4!Q#80E,:@)-])M<5I)9/9Q&<92Y)G8E*$8I3*5 M85$E5AZH]L"3YI>2=;39H7Q.-&5F^]%YGY,)N" ^DQ$:63+%%D;42#JE9NP@H1)V)&I>EK=DD^6RYJ23S#V3U$-SLE3? M9B= NP2"MTTSG&SV;437&IUUFL%Z/;I4BC"F1LC@5[E5A]JX4*FJ87?&4'=% MPV,TQU-QL)YW1\'/.)?DCWC9>O%" 9KV#F4-_\$T2DG"QBN-7XO<:T,L)Q@W M''FF77A,2QO+"+%3^SHWW"4&.YPBEL-(8Z\C$!E"'=7*L)@P7LOVHMBM6R<= MK,(MLTS"S2%K]\Z%?J"U#RZ&\!@PRR=>29_517,XY&-!B:=D>Q"U:P24I:+6 M;CN441VST?F4K_6M78G!MY>TA"=6"D9MX3G9GK(0R'*.<6)GC MK7@F+A=,I+J!'I90KS_4.:1&K9-NW_[VAREN>[G:T6)FMK2@GGD&S.*>K/)$ MN;F5W:=&FQEDZF555MVNSN4YD %*PP[$&4EN6YK>_VQI_N M4Z]G0E[.K%T4*EG]SO\O;N!JF%:[M?$B(QKCR$- 012(CAWO+I]35Z .XYJ MGC2@UR!**>X*G!C" K!Y]61&4+N9P73T&!*1:WWEPU(MS+>.HOV 6AF,-;%S U_K(;3]+<_6$#O"FRQ R11)*36 M9X8HOA,5K3F3#;JZGEU!""R&IB5/%'S M*X[)I>G0VB$(>\.^*E>1L[+@-G44/6XI;.QL0VWMO6A$?] 6-*3S.>;6@S=4&2I6@?>5=[%X[OV@2*!VH-&=J/!5/]6'WN_"36'3\ MZ@E245&JXXR7"]?&F-,_XD.G)MZKCW"AKC2W>58CR1G9B/( M/YF:=HM_H":P1EA.0&8WP/ ]F/8J"B[2*@&#SV2*9ET6TA0[+$T#X1X2.3*I MV1++6Y#C%%OW5J=$/N7%L^SFIGZ)Y.FEKJ\; ML7'Z4+>B]PF'IF&CK<_DY^[Q/OEO!Z=E7IAET7FFE]\"HU^D!?S2^55U3"!. M!C,,BE*"TQ-]-?;WP 9X4FQWLY8)4DE\]L*15]$;UDA1DL5'8^;Z_X$2FO"N M$S&)0_+$3CPN+,4>ZC9HPL<%"N;X03'W/,S,SEC+%(YZ'BB'AK=<8[._?E;U M&Y7*PX*@#(++TDV>D/+'S1'T8OZY9W5_REF3Q$\G[E[[2B=PQ%/F\!Y3G*.L MP,+ WO:RT&5RT8$Q!FI+WBJU8;::";C$JSJ:E69STV[2&AMI_"Y&11D<."+K MIC9FRU'0AE43(\\F)VD4?>2!R^MDIU? M*'-8FW:SB37GN4;LLA>7(U53ZSDN.J\::?^G-8?%0!5>KY5IB\D9V19[ $9 MR,7C 1K!^5B(Y4J:N$VX%<>#C1/YP,4 [P?)Z&]8:TQ!G3F1(ER<\(#,H' M_DJR9-W+$14! ="':9 M'=PKY<"+=XF( ^C_"6P0V8$0-@P$8V<0A?\0)/:1M.P0S= (P!.M;E=59" ML0>BH1GE?1GYA9+_@PRB=D7:J@%)KHU,F1P-Q%6*+'Q:*.D&_KG (-J0NVF= MTJ!=VA#71@W6?PR?;&!6% 4ASI";I2D-B(B?JMG2W;A6*3*?9UE1TP@;K*3@ M&LK6T\U'BQQ6S_%+U035%*I&3; M$08/\PA'N[#5.:D?I(1).QW%X"B=1!D>9YS;1-83<3AA(]I7:*5'P*';CT$7 M)4J;"ZI?OOV.=NP,BN5//CY0+UHAOVD1".+>7 @C#;S&XPB!2TF@@XF@_[$\ M7T25)-,TR/J(G_84#X8%%+RY)!?^)+>(C4)BDX[MG.D 42U9P;1I52XEX]\H MR"1Z7HAY@3&XESBTX=Q9UH&)G0T^"!-^'4 J0_JMBI^E'%2&EC@Q2M*8!4/ MARD25]:IEXH( Y'IT9U!E)056$7FB!^I3)!0DG_]%8#H M(:.$6C(NH1D-'!PE#C3D(L/%9& P5=C,W"K^7XZ=(JJYIO=DAY+=84!L(JS5 MU%81&M(L9$+NAEZVT)IA3?(A3A;V&4(^) .ZE?AEWMGE%&@PBA()$J;QF/6= MWB@.%SD>$7(.8K5%%(ILG@4N9 ON"OF9)$O.&__S1(1,O@S3M9S70(=P)@&X MW<]?"MLC6=Q 2(3:!;[(CU#,A^D4^7U0DY^0YKE*<2 MH ,4GA>&S$>$LE\Y.6&;Y!,[\5;_G6%"T23]V=$C%)PD+A@R@8Y\X9%[ MCLLLQ-Q*SI(YJ>M1!>9?.5\9>C&P6#Y MD<2U6>FF ,JI[43O6,IO_==ZE=(HZ6&.8[39EN#@UOG@%AI8AG,MJE M9=QGN9:>Z5;&@.3M<6!KG)+*<%G'_I%BFTJ:GYD9!#'I,_K+>[2FZ_&4Z G6 M)#E'O54A[(GB=[X-$09>:2Y%I]H/>G[B<331ITZ;(1X70Q'FVX#E)IU83ARI MQZFEI'(3T'B,1=KJ4Y:58EWD:3H!)1C4SP1;7#W1;@C_QY.)$:K*H+IR&5-1 MB[#!93^=GU=:28PQG$4!2F]BR]D4#UQR%,H-U#_,$GPY(:=DU+LP'6]]EQ#% MRDD]5^>EJBQAZ?QM(!..*;RYZ%4HY'NZ5^#8V(5MT\*VIM,5C[!(Y_*HYEQX M3OAD$\$&G4WU9PPTJU4=!OG%%.A!% +ZF#WJY]XL6)>V2DX*)7?)0FK1*+3* MZZR().71Q"%Q#R[A4GUM%#5(%^VXR\@"*#DQEXG)Q+=^'_$(D)F%%(L65+0H M:2 =S;KZD5#%:JF1[?G\BJG1:3)"!DC(@(-$K*Z9RI9-I]@)(-N 9G,@IG>Z MW:5N2&R*''HD(N$-'VLVGZZ]_XPM?NGAB=$5WD($=5*X0B'0H"=DK4F9Q8%4 MJL^7V@=[P-5@,LT7?EEBJ5,F@1]>?AA>;>0P2JGT8:I;GMX5MF4N7N2__B;$ M<0QC=FX0OM>(4))>XAUEQIB*/24D3B,:U*[O7NOT.:2L=:W0UB-RYV>I(,?:IH*DEQ@ M.F51MH0C:*)V?@I)6G"1 MD2\FR?\@QPAC3?DF^4!*;_ZN!]97N>'/R%6MGCP@CN0ER=[@]?+AB1&9;TX? M^OJMJ#T;+S*DFLWE-[IMA]Z0.C+B._#MW=BM6LP,=?)7\P)!H%+K[8Z,'@;: MAL0M/WXQDAB2U@G5J33-'Z1PI?*IHXZ;KJ;CW7;G6]%>XPYRR,6=;XF0Q8;G M&]D5ZU15%R^?T2ZK9H!6)-=K)3EJS>6>(J>L8K9,8N5MXNCA^ T:SPEB)O6M MS9'2HTHB1&SGTJ!MI@!;:+HN/(VB9ZWEOSTQ:3UBC7GCF*9+HMF7G:Y<0L8< MW$;B1"+#WOD?S=H6$2DI'@P?9K8L) /O.Z@ X%3J-[_R*>DU0:\+;@M M<7H.\%,ER(W6S-4:):!=USTB\ @?D#XUY"JC"'EAZUGLQ+V>&,T^(/QHL368 M6F926^91#TL2;.L]<\.DK]3NLZ906V"J+.[)2T#],#?C4P1S6\EY[R*]TU$^ MX]2)LT/^7/N&Y8SI"T6FTT8 LTSS'AGGX[9I&KB5[7T:P2##804,W+MFB-ZD1U?K!]/*MHB%??" M:H8Y1BQ""" =(0/5"C'/'7]4,:F\(/@TT^ AYC:V+0GA2(?.6/:Z(MLU8NP" MT>^)M!F?&NI.;A@O%F!"YVQ:W36!_W6?DK))>\+N7:Y9EF#!037;(NNV;FXB MM<>_S#1H+]6B.6)S>2@_EX71/JPX9>O$$;0(6T!!FHQ'<,6AQC7J.8,"IU.8 M:*4I?YS]=LP""I)M0N*_S*Q[QJFT+&0%>F0DFL=M=IR!GD^)5L3[S3;@_):K M2:V\"C:X@F%%]YM>)^&; "26X:ETHT_H-F!#7US$99@HIZ] ;J'1H=?G+88K MD3?WC2C])6QTYD]8OO)I))YM4>PXQE_)+1O7L1*$W?\HJ^&NR11BXNF2 Y(0'@]=Y:"O+)7/:'XOR.7.D#=_DN>CS4@Y:H<AK>GIP$:=@K&>5&U]E0\[YKMLYMW?[1-R@SK"34TYS9.$9 M+D1]VNAEMEQ20*5[USA_^A:[LY9C4HFWG27OU@<9K''".E0K]G2$&ISW$+OS M#WE.FF5JJBP^MY4A8B&(!.8I-/$)? #9[*].JWG?4;N:4&L%N5UM\@.Q95E4 M8=PB7"([W_'H=4'+9HO[U;)9=:]5(V@0#219GD3EI5-H.$FPF+E\Q[\A@+?_ M/-!WNT9L_[NG5>=->^%!?U3]V?-=6'%/QJA](U@=.\,&/KV"J8^SL49!%M:* M;AP.[SPSIT\ZQ[A"O,OL.17%@R"#V>9*?8'#W^>U-"5M=S,,#L70^46*QVNP MIQO=AR1(>Q-!'3.RO1<(OPR&TI+VQF3@F*VT-X[@^4B 0W9&PG 1W[?]G> & M!KWF;S[G=S[O=04V/B?;"O$M5FNE:_88:[B&TYXK'WI>4CSCZ>RBTIA_THYE]&.\DZQ9EKZ/OM+KD+LT1B27G+E]3YJAB-L9+5-+TJ>S@L%(9FY&3CV1SFOQR_DZ[HFAKH1D ]!2$DPV JS6_N0\0^11Z3C=9LW//1; M!253_:(8.H2^GSL\WJQ#]FR->/U< M=@1XR%02'E^F&!R!C6>O:G>&8@14%!/#<@4&/)6A$7%FU:M6O9 MMN5@MFS#0I(JB(+$(R"=Q\$\XXIR,L)J,X M47!#ZS""D2!OJ)(3T$#=9,RM ^W+S,!#2120K!C^>Q322-E-J(^[AK0%"E=/T=87Z&S=%+-, MLWT-)NK(>M$0;J5*82TNOS,7,6@]W2&1,K,A25>T.JRWH^4<%+5:+LU38KWQ MK&-$TF-$*M +]1@6[N%$#614MFD3OAAC-O=9V*P3)%*4U'R-85J+5.-]B>FCIFC)Q!QQ^2TQ(M+BIZMX MM"(6-:L>"AI($]02+LOP.G%#\6T0 (K-10N MBN%*'/-")[\VS.\FVDG'S)!9^266J SXLSNGFMI&TTAD-=H??>(9%#952PPU M45@VJY;6Q\DL/F73FT:BB,Q5 Z$;.PYGW#EFW# TXV./?GAPBYSW,>PC\_AC M;YC+-#%C$R3N5W?WA0UB>_G"W=?+WIX50^8,R?.6W%\EW66%%T32P&6SMS8= M;OZ0.4I ;G+2F1^Z"!8QCU&F8INC'.7 1S%<&!"#<HG9QB>I4RSVQ M"DYE_"$3DY6(1AN"'CR8-Y +00TO/B$;=F@V*16RC6 MHG9BN*_PR'#GJ=P0.!A_[7&HZ(2@B=YR"OBV>O$QE>5)@Q^7G MGFSN<0W58:83V+,H41)Q3)(3SH<^F1$W%?0I](0SXXI?8!=(#S22E (C\FS0V(1%U;C5K[SAE0L?AFF1G*)GOHL,3LX%() M2KM#L1C;N'01+)>=8*Z!V"FW(D(/GM!B4JOT8-5U'M!@Y6$->[)6(U<>AVJ/ M7$MPCZ?'S=P+0X^HS%=\^L(RY7*^)'Q,>J,K&N1]:+ 9D!A59(&MZJ$V-S < MID/PFY=R9A=EG>/_&.1&2>'+2K""FOUN'7,YSW]4(YR+L

@Z& M].J1+BWSK5U%A ^AM#=TGE26_6+IU=!D$AE)F8X!'B28<$4]0&.Y9$=B\J M>1(?D;7,6Y;D$"]LT8I6&I(3/IQ$,ZMA*BN RX&-Y9SW9Y=]Z"/*YHCN=6!J MK;]>]W()69B';<%DT%332]M+KV)V.L"O@'DDKQ,Q.9F(4#1.I*%@[([J_[9J M)HET8CJ!3&(PA M\G#W@=[: X>-3;?L(H^N(#:*2[HXL'H.=G&)/JZIX)5=;AXJSNT1MJ=>9-#H MN-=S+81+9":F:-=\; 6]4U7^4B'\B$P"S^;MB6, M+[[]WG*,7-2;;]/8SW3EKY\$F^3NQ8NNBU 5.@F'Y<\<4U5\TV>?8G?=7^XN MMB&I8U1]2&M8'B&.NMCHO@5]FO3+X?=H4, MP?VTK!^.%7WVM=&F)#12Z7<#0K[UL$SY-ZR9Q>OJ M^]ZBQZ;,7'?-.PXO[.I=2>78!D2^"J3MZ7:[:J753(_Z'1?ZMMLM[O4]W3DQ M=<0-+J]3>JMH9%/OL6IYF-45&+7,?Y##8SSW9^RTP&0\-RQK=+Y:O?A+3=?^ MLQ6^W.H1<+0!# 7 A9IT=XLJWV8*W_9I> 1N9EJKN!HB9A2N;NJ-N#H*G&ZE MN)Q'%%2.OG:O@2INTR9KP(8->PKL/LC%@_K/VY*"\4;$SUXGX\+.<.PFU-1, M+- )L2+LT/)*ZVX.2M+_JFQF@85>(=!*#/I**>M@9>MRZFQX NG0)_*$2IC: M3-2XB*R:1 6F;DH8KWM43P<+B4Q8A\!@4(,0I6>R3XS,"([*BO%RS.\"3 UA M[.FN8VTT:G%*!U\H;1/&:' X"8M,ZNM*S\U*B)/*< \A M;]\\:>S&"'1$#UBF"[/P)$P410,O3JUP:G]@ID3"3/)\ZPTNA>SN"_04KGI MCOYB#*R(KW<<#*!XA[H(X0&9$/GZ8"]6PYB23 G-3F4X3!HY?APJY/> M2]QXJJ':BYQDJ07H#;)&44_::1;/*VB447QX22%2D>7R8FA:1L^""II <0W7 M^7#6Y@?\2*HPQNSE=$;FKH -*01NM"H@\.9$$&$5C?&&XHEKGG#%\@L("ZE)S(BI) O1 M'NT*BPW^XL^HY ?6=&Y60*O+D.7&;J2PKL0I"/'AHH-'>O*TO' R9W/.D:,0CP\.X0"P]IJ"<8M6[Z%HWMW(JF=K)I;"V\"*T1K423 MSFK!J#)8+-#-'B^2PLRQ)D3'FNP$I? GK/]R.PQR^!+*RT+*%9!#U=XP%WDI MG^:'I(SHF?0)QNX-Y&0+8O2,FOH2)(.'M>#K/K:+_9PF#;&1%OUM_D3PHZX* MF*RI-*J+",6C? [L&_T/N89*' $$])"G%R=FH9S+N,@M9$KP*C,(#'&(GG2O M1WKM&:V+'IDS818),?)1(A,2E@*0.I>-9+H2%B?PV%AE??Y+-"+.)S=H,](A M:\ZI,QQS718*+_^/:EB'N:0*.PF+/%$P\KIMF. ,2+1N*5WS/VNF MPGQXJF,A33AJJ0).60S-XRDS8Q MZ/:OJK8KS;0R[JK_,^D>*Z+0I+ZJL+SX$J'ZK(M([2Y=[AG'LCGQD,V*S4%1 MZM7\*HJ8*M%,R#DWT 8]5(YL8"_USPE;;"XS*9J\AB -+TG-T S,JD"%E(F* M#.X:<"I5P1?%TDW1DT]_"<;FP$%ZFC!3O8BR*=+!@,V92 9Q$K6#< M#1BSAU::D;,N;1?[LIW:L5ARBS[ID?X&QCRGZX/B8SWEU/+"CYJLZ"A^_R7> M/F?H-I62["\+^@4!C^LUE"/]WL^::F=#RQ!5=?+GGK(-T''FC@_GR*9&&\U* MTTRHJ MK"M1'\Q&M4^ZW T/DA :6TB@B/0D3?\KU9JO KO+E@XU;9V%"@GU MP#K/%"^0&VFLG9*LH"I0<*D17+<2P3PJ4V*6++'OE.P5(!:Q;0,FG.C2^S8, M8S!LN.P-N,2KNTH%85^14O_Q^GQU;0$7MK(%1(,U C=(5(NW=6^W^OZ+%WY. MIVIO_6PCA!I.0B,U,.XP!O\T;I24)+$UJ^3L'Y1-*?.FZA)4#LTG>P$6*?&( M=] L0 >*T\P4)U'6%AF*)-) M*P>S(G]KY1!-AE[M1*,@:AOQZR")=!/G?K.J)LX*Q(I)9&.CPV#B6 D)@@86 M^NS7R.[.)5RP[[[41*?_9*RFE[:@B,M,2B_Q1&I&CUM;M"K(8#IDR4#YC6-# M;V-1-,3P"$_A0%6F%Q8)C[S:YF#04WE=M6Q-S0A_=2:7#PU^JV4DAC%MMUS# M)ZE"JWE3=U7[%#.UYWI3(E.1]G;6TA5\=0"/ UU!E6Q'1WFWM3FX#7@Z"3(C M&+E,+WM_]SQ&D$YJM6)"=_TT)8$R^&*0<[D>MYEVPUS+-4;G #F4,G,TM7F. MT8[GBL&>EY)'LR/_D9@$:(R?T0(/ZE;J-UM%CJ4N<$EVK@"%JXICZ"-Y2=H" M2SVU3;D,+CRTA3R>U&'8%=%882%1%V>K>%]1" M__9IPZI6C&V.3$>TCL@U$ZC-M"Q(5C)]B$Y.GVJ7JPJ7J2"H8=T EHS]:YR=@=F%YV.J!S-.\Q(V?7,EW??=^HN_F/.HOYE23 MJS$#;;53@X_C"+J@F>'S)//Y9JJN'SYVXN!>6A L,81]#*8)\:2#W$G-@FMF6CS@1UI/W:T&3J M2J"RD'I8:,+!SHQWIA4ZMX^[:;4TA=PX?X-M!DL5M\.TC*C2D SP5P,3K_,: M&9:&(=JT#NDWDPQQ!A40MB+:$NT%A=M/#J?F-B861_6M)-,5IEM99[W"FW;JRL*.;68 M]9,']$B\0I\/23;SECK_;Y4-%\?$;&\+%:3G-@HF,VW/6,(UPFQM+#>_9-%.I7\F;5M E+)'"XY!J6HM-"/T+[=$T=)^7W5N[KE3A6PCH$A<05*%F , M^-C>DM^0F(IG!'P^(;IEI\@DTP"5XU)%U'N3*LQ*A^+L5&\3#Z"[BF$E3E// M>\[_WQ5HG>2L[D[(;1@+/;=D8);')R@'Z??.>A2MV0B;3!J%^'EP!"[629#T M:O8=OF'7"V6DV5<4"^,B[&6\J>) MXTNE9W41[5&?W[-1TT.;**3-B45S=1@R+?K:7(VGO86(T@XOI[R:#HY!9+)V MNZ?(*96T-?( _9OM\FK+SM8 5NFIGF;N=NW-T'+>O!LL2.G M"MTI9M"]'5$43X!!-]JE4XHOZ5)#39 F,9H\3;;+*E04_U8QP+O5J*0U[RJ9 M[4J*[%KZ,%LRBO^7?W+2U+'5Z(538:TP"P'VKSS6[7<,=!UYD;&WYX$&1]69 M:E-[W?PS@! :?R'E\N"0U'Z;E;'[MGO51 A;-@.[$Q3\\ MZT#*Y@->W5@C1 M93?\+*HG=D% I!4M-J+ ML]Z\^P^&XDAN1W$6B(JR4KNRQ_]*%RULK[.]IVF,T@%MFIN.I_K9DCG63;:L M0:.Q8U/I\RQ/W*BR&7TRJ\_J"0%:AE_G%!-:19Q;\V.;]:$C<<[IL687=B85 MJ&+U%;*E-Z=DA30X=N-C-*58-S8'AE>2IH<3*-='@Q7F4@9W!4[OX.'V\!VV15$TWKQ$QMB@KFG$&8$RG/MN1C0XX7 MD!Y\^*#3(J92D(G[*M$ZI"8-%U!J['V:V/!>J1AY.M:CA>O)I'#Z9.3C(U*$ MLSXIH^W_4!0C91]_^<8M#)1"'@4Q"[]=<12+8T)]& FB; %BUL!R./EF- M&XP7>/,:/HPXL>(+ZA89!,D#)5MP8S'L>?HB%+EZGK"M) -')%QEDB(U!B,R M5"[1A$XDFII*];2YJ&:%8@11W!M9NX"AADGI;T'905^#8[DJ!V&/NN]4N\22 MIZ#"\'RKYEB1QEM".)-SIJ=YZFMGT)3'\CWKG$1LMR6"&O;FJ3E+?)>IH;XX M_]"QZ_\(9-Y1>6:T1-<=K-&AWWYD_48*>G+)D6"$$DY(88+*_R'5FUM[638. M.L(44E-+4C!R46 8X7$-U%H'3TL;0B M*EA%TXH8,][(4(N]E#)144($M^)6:%'"WUT@1AF$5S0]\TMO*!:1TI#V@5;. M$+@<9*0++[F563EU# &90 O.5"%BGB#T)#J$W633$!K^E^%.??4186>#J%-G MHHHNRFBC"LR 4''SL'>GAB.:%MQ4C=QY"E0<>),I47[4(=47N71BA'< ZN31 M27M^.8^].),*:;(C)YX(R#:N:1+P=&=%^RRBZ;K(':$1B- M43FN)*1[[1'K:4FSSBK!*MPZ5]MSRB=!&]N"P,&UV5ZO($N,H^[%3 M;BWV;E9(;.?!XFZ__OX+<,#_4PXK*F5JF:EIO?DZ9 5IPIW;F$Z7<2IE5#TB M)5FO6T4,%TF?/M8/5CEZXV=I)Q1"YJ-&\/2EM/=P!BCP"/H MIDF2.[U<=#_?Z :DH+]V[77;;K\-M[\WVK./:"2OQ)M_\+YJ*=(*T%Z^TZMJGY-G[1YO=XDLY@[Y1 8F.QDV\K555#Z;YW9N! M"YVXONK,<^NG[$L/;&3JBJU4OUR.H=^3ANA3>K'?RYW/)2N><'N=CU76N(;6 MM]=]_W%_;'*8QVG(D[#(A@9>L"I8V"S;SW\/?OCOF+0LAX_]X&1#2OI1C4\M#D$H:-"SY*XU6EK*(B MBOS/!_A+5P&] K^9@6IGK.O@SFQ2O$!I96Q;$LF9]O*L;'E@!Q4\%\M"IJ6@ MA01_Z6,(G%@T.QFR$%VN YO^O#:Q&HX-;7$*T@[94*+.!*EA%N(:LY1E"_%) M<8J+NMX3Z2.8#-QH<[;ZC'6< Z[)E-!LT#-8;+I(N25F[H?[P=LUR# @[%W+ M,4Q0!MINYJ?H7"MP&6R<)7CENU0E+F1,H][F0E>-]-VG<_^7\F /<88];C7$ M(MZJ%C&CD!TFB,14$YS6L+W;/>CB5W((=2PH1JC-8Z4E92-\N@E0&?R3R<:TRK#K&E^ M9NJTEZI4IW3TG&4X13BZ=%- DD3_WV_X YHR!NYW& 'C;#:' @>J)Y9T45?C M<+=&26E15A9)#)7:BLCV9 ELHXY.=JA9ZBDI M@SU:O>X4F?2DK0@%2/(-M:H9;174]EH[<@ (>'BM%^^JZ;J(P&V#2^)-2F?I MHE4UC3K8 M>L(S*RI,4[P1T^E.6<^*?81F>U0I>A\73PM%D'8 M8)-$$FQLV&AV&K\TM+O3S)-Y@Z9*C-8O3H4;[_DZA2Z';I*\("%,S2IKRZ'= M [D[4Z,B_YMYB]HJUY%<!*I3?6/$ZTV>&\S%4*F<8RD*3SO#T]+" MB!C&-*=JI[BNYL6EM'K\KEH@I8B/YJFE140U3Q3:)GNZV 3B,E>W$A,CAP8Z#U43&U=:TG7+ M5#9)>F\,U=60T[YLDJ3]M%J2HQY2%4)%K+C ?%?0X-*27_T+RKK!N!"[*,+N M"NE_5LRZ*]/2RI02B(>B2B%OE =?+4L3SG*AX=&N:\.LY>AI/?SA*E;Z,C M MY)MK%2VX^JW&Y0(AC_B+G&>IY6F]]6W="/C@)-K%E-;4"),:+/_<6V/32S16 M:4''Z="NLK9'%2N2-!]J6[+1(8GIFRM8R(L=%DEMA,!>DD87F#4\X3"M!OL? M2_]V8AD"0J3\(YHO:5,5H.V4P5F#(!*QS9D34;K _ZH2!2'8:*>H$Z*I4U4T M@5 A9$43/C$[5O+V+*\+ZSFG\P8M92^=D4RWE*.3WMLCN'DV\C5S@KH#'1>3 M\\E3\D^DIMOQI+P\ADL%#I-B?<-J18Y6',=+L2%?AHIQ4CDO=6G-7N4:@P0TFB=).'$3W>R&K=B1Q&6Q>B'$C>ENK) MB(05ZB::N6S-M65\5ZG>>?MY4'7UXULSCWLF8>E0_NJ4R"-E$EUFURO7 REH M8C^:LA6/*"0=S4L.^A*G6)>X%H6N/*H.T:K$$AYN__5GLLLH\+=RNF M7K^Z)35B$G,'-=^$-SOMC83H4I#VH2T2,;KXU%0+^=UJ^16,T$@*\+(;B\I= MY_E7U+8+NY&:;,$@V+ZOY].!SYMNIGAVDR?^==AH>+JB-VVS=H,H_!I9EP0& M'W^3:_BW)5R?]]7SU."U U"6 ;F?-3?@QU:U195KM--\5!QP)=T M9R4U#4%]G66!2"=)G#8:12 Z"+8&S#9(+U8U?1-%#K1&F"%E&KG)67TLS6P5!>^@5?=%R3T&C%(V7&X(B:TIB M?^;U7_LF?0AF:A?Q;^F2/+3A4$JQ-%N!8FOA<,4X?8#4@+>(;//S;K,&,:NH M;5^A'6W"@((00R:$(93F"8BH:/ES7^QS4EPB;4'"8+)8*/ W80U&-0HT4'M& M4CK_!$N0H1(85UZQY4P[R'!A"%"(-X@'2(",%XD3%UOO1B^Z>#4TD7^.$5@5 MZ'1L]HY)1T@^"'"/1Q1TMX%;9Q[$MUHM8Y%N]A5' MD'JJ(R("5"QB5SS86%#[<]!0_"6E- M]I1A$'3)MGK5%9:-M%^99W_JB"-(9E 'E$[+Y89%YHRG_VA2F<>.2F.,7]*# M9K)UQ&-]#@5"%QE8*:E!=/:8"P:+W79QP-1LR#%0:Z)L%K9^#S:;VC:;4&*. MX?9YR\A0"S:)V3$RD1&90T9Z##EX]/2.JH>'Q@=@_?=!V9 H]^:*EG=\GR!0YY<7H?E=]@=@!Y%M<&6+>.44XR5>RB8VLF.:YYB;PJ9V001)+O)/ MK26/_OEPYH> RT)WP]4B*G>=O\%Q+/&15=45B/5BL:.;N$D3&%F%B@6(WR%+ M;Y(#)>!::_-TGR:B@/53/A028/@G@E1B):1*2&E&IB.';!9'/:)>7_16)]*( M4*:*(C(@=O-4.LI7@E1A76?_ "?=2CS52A_JWCYAR7TL6/>R8@WBB4^H* $4D9Q%+A45=F GDB"H4'\U.P)" M.J+UG&CY+6L!-M[8CL/VA^4G6X7'EX+QGSK&U))"/CH,@33!26@B)9D80CD?CFFCNLR0:7Z?Y-DH=R83 79":NI M5M)8F]8%;Z_7G'/E@REE%&67CKU29Y9H0G0EFJI:F_-S#,)):+*V5[[IFYWE M#\W'(\,I?5HF/5:"G^(0EJ!2(=3DJ73DB?ZDE.$75DK"I>>YFRKJ:_]S0_U4 M+\EW6/S_"%P;UW_?)6WJ%(&$9#:BJ2S(U6ZL.'DBJGCS,[";UI>0E7 NP88" M-G@*Y'H@VI6E-EQ'!YA MM*@LFZQ'9G=?)F; FG(HEQRC-)AN)@V']DP@J5 '&V*)AGRF1*E,59U6EK4* MI3AH:I; 5)=]E(C3L&CEF7-=!PBJ\J?;$;3C*K'@D8$F4I53%6:BU:?BJ'B# MRK7,TVD!A6.+)SVF(I->Q@G>86ZL>&>=&H[!Z7W&V48H]YL7_^1@R:>.*Q2F MW3231,0FF=& 6U5AA3D9ZW-]K%J9Y$,"FCJ-;79>K%L31=L1M3B-DSMN"\2@ MF4E2C]6[R[9-XSJ?:WFNX.9[+D24F;HGWA9NF[=^<)*E+Q07T)I\T'HF[-J? MFVD8]T9?G JFQ!6>]==[<4!/8RB;AJ1!,/AS&3<7DEJM6P%64Q.AQ[HVKN=\ M[&MNMW-Y +*NFJ/SA>(K<<\C*-FSVLYMR(1&S.!24H\&\B''1D=UXNT M1]@$*-MSHF&-TMAB20J?F3*LL*:*"8LB7DI8\JICWF6G/PH0+PF&EF=7PHJ% MA8E6Q%B54(IG+-J&?)-1&<)*6!8R&VA(6!"R#2>I+[/A5Q%EBM6+DV72MT\U M2$'%M$VC64*T4.N(JDN,H$R,DI>IM<$*''V&"U/\:>]GM'LT:$P'FAEJ:;47 MQ"UIM2'4:0K,QE=VK9479P34M@+K:6Y++JV%.TMX4>MDQ=BRP?_&0'!S(ZG3 M$G^U>U\KA;ID.$+2Y'X,>Q<2C'+HZ(K V3H1[&I >Q)9XF7H&)GI"5_FZ9VB M-H>1PB-] IHLC',Z*+L-!B?F!KXC&9RB$)?(6)]1NB7)NS^U2JH8LVWFV(P0 M2AN=Q[+$&FVB%+_0.8_KLHXD;(_+_'I^9FVY9932][E>^X6^O%[DXYC/;)02 M$VOM]:YDIXN>F*J6NZDJS)(.J+/.QEU TV6I3$W& C+7"Z=K \34-L:Y)E9]]U/8[,$I6LOJBF;&(7D 7+6K@']BMXF]:Z%O-G5Z5U0X MBK9/UF;C2'7#NGQV3,OOERM@*KQVI6__0B64L<-YY)1]8*:$VN!NOH-/'5LZ MHZM$40EJ,$>%O=HF!QJQ;#8NN?,*;ZBALQ3 /G$:?16R9DK"]"(W=;C#;L2C M>LM8&MVR2K3&( >$LK1.?#A.9%K%AC#%DM<+&$B4SYG1SY:S/YL9V='06"NT M$ATF-I$,%X5.,'6I%EVJ2BP6)]J7"@9MO3G,XA[4LEJ!XK#9<.<4CLV>:;#,&@SX6M[DGG9D=0QG8Q%[' T M^[M2;$':;4T54298>ZTN4Z-]67SME0Y2A#1"F]WRQ#]>9N< 72 M_X#*&E>>W?D=_PT*OTKT;(UV0EJQL!D;VNLGH5M0R<*U M=8'W3D#]V4C\DDT]+6J5J' -AU-I6]UIA0Z8M&AI-OGYP5,*28MEMRG=@9Q\ M6U,;W#F,MT&80I@1USG39/;CU$%XA$_,-/&#?@!-DI-+H6N@.'F\?ZM+S(=! ME3Q<<@FIXXSEJ#ON<:C#E#YK'WZ-7Y.7J'T-#)EQWJ-Y^Z[JG-WK.3BEQRL;*B%J$*@>%' MG.SS931N''=8!J>SE[2.H<>*)=P4GI$'KE?_@$%"VWK14\+.7TUR+7W3BFR3 M97LG)[R6-%]WEX4>*C@[P1,+P MW+SEJI^)H* M28/;$\QJBC3WYIL/(,M5:^]?]],EZ"C@K>W"D^RPX"46^3B:">J9KWSBH.TS MU=$(-,1Q-,,J<6O"^4R]EQ=C])KG@7[YN4I?>Z88EKQ3AQ5L>9M9_4CHFFC= MG^C QV6.N5^\VLQEZ8X5PY69V!C,!(LU*Y]]=1M2Y1).J:3MUH.;AS+R'NAK MNE6;&/1>^J3H[X+I_S0-^7[DBRO;TJ/\9U*CP%&8\,G+XQ7*F)CCIC5(_0X, MU&[--Y^=Y($#LMF4-F2]&_(. >@45*;%<];=Z2U"CJK&C2*Q2D2U3\5"=%Y+ M61Y9&(];U65Y>*""PGA$)I7+8^@$6D$ODA]J1(5F7KD.A>.*>0NY8VQTK-/J6?%9$T+T4=NX M0K,9&SO<^0P#NZ':@3/MG"&J,DG9 SL)XG-=>P,RPQT<+'KT;0*Q3+S1,CVM M4HE:_(4,7J79/."8MJ!VRO&$V71-NIB:/'WJI-;;R6%N8MFL9B.[Q81K ?\? M27+/@R[SDR7:?[:A/,>LG35VG^YI*W-)UK][_Q05#(4J31Y7)\ M+$A.H[EP MVR+%\SA+62]T==9)8]=EG@Z+0T!>LX=-AQM[_M1!W$>NIDV;>E#^) :BY"\R M#8<%X6)"F:I(N)Y!7"J"EXNA5=&5HG2LI8]<\>(Y\[EJ$D:@$6TXO%%6;$:7 M44GP,AK5Z4.HSYQ1'#3!ZEXZ@N#(RCA)\#^4DK*2Y(L'81M=:!R[1VSU-XQHK)J.FM"6R M )^&?6AK8B+!Q*X0YO.8IJI4'+M(/:T:&;;$2V9BL;0R*JMJUZV*9R:TY6-( M87\EFMDNLIU+'JXR5+RDY[(YJ:O*B!IBK%H@@FF=/I#3"XF@&OP+LIC,VNFP M) 4:QIJID$/*L/.(;)&CG<1):RWS8#2/0K9^J@B])UT 5'36=%ASM)):'FHD )"*1E%%=)V-Q#*<#)4DA!-%;P8E/I@*HN!8R]..*:* NX%E6LSD0B'#:9 MZ_:[D+EDJ9Q"M[F^#=5$[8I[Y\_>F')M_RSQ+C%W%L#"]:J6?-D;4D1QF](4 M.NX(!#58]9R:"3V$X\5SMV/O9*K5T83#3$H,:%5580N-HDDZ>E]Q[[@,-Z:U MNH]>N&L/Y@R\]]JNPGCGL*1$BD7#?<]@32H/4P8::/[^N):?0&PSYPL40#QJ M.#W/G.9/4%:SIA_$V QYM (/@C*@DOP4L52*0"Y,7RV0D&XS1R7E4>,X-9:5 MD98I'/76;1\J*^_2V'X*RPS0LE1O^J FG#)O@7)K[%,&/6A6YX1=R]:I0$53 MBVPR1$DN+;$9QU,AQU[G,R+!=Z758Z$"IHO:, YNBR/L%Y; M)820=O) +]VJ,__6V(//WJ?W(V;.CJ];2C=^ 2%EW?M$4!9I"+^Z M7D%R;YBV3MAPSLZH+M?@3UG_6ADQL\PXO#X]2;XF[MKN*WBA:\8/6M/L1:D'V"QRVP6A,>G M?":!&A;1B%0R#KNZ8QKWC&A#TG)>L;8&BK9Y:2508=P< MH38HF8\=+$I)V#)E!#36[5*AH1T'\:2*KUV()X"[$DN(!8\9%P8@PD23$29 M0>+8JW0 )*";;*(3R91Q6^?;70^.>)7OP(M(3>S3\ZXGQ6H(;Y:_!&9B_F9) ML.&J61=$30I;N,OOV:]CQ=+=A93$'B &.W099E['$\.8(#6TZ1C&-?AI(\Q$H(HN#\/.T&JACU#] M)783W,+ZB!#"Q1UPAA&QF,EZR(J52>RAN1,@;T0H1F&FJ)'>?,Y9X#>^:+XJ M)E ,9HB4%L(*)?$QN-#$SU(Z4YHZKD.2Z*>)_]A5S10<0J6GI-^5PD'UAQL2Q'2-%(- ?$K70-)HWD:'Q,MU3YV&LD MM^KC,:$WF5)@47F<^2I$>Z*_7"*R+J+[IB/3>-7AX7-US'/D)?7J*+.J4V!? M;!)"WL8V7E1R2UA2YA;_6@Z+*,RP.1XE(-74[34/@9 8XL;:6R5*^&M5GL'5=J7?Y-3F^]P MY*0,X8U2455%F[@%I#MQ229U$QQ\O>@CS?1N?R')8XP^%]0QC0O$MWV;(1^Y MV>*Q%SJ)C)Q@.^D5U7"PI51D4#F&[!)"]L^A"V(R@"R%N@K3"%6'XIM?X.>8 MW3[8S6^&T'_ M5J%](QR?^_J'4H$NFN[3^MR]$#2*F8-YQ):OTW)8+ \EG][L>YXGT(7%2R2,G+*"1[MR:<2>3S"%3 MLW2)(E;"9;)^'NNN]06KX># ;*Z-V-\?!SDC. SF&1=,W-!K]7GR)1F+B.\I M?"Y&<"."],,7RS)ED MG$3(I9XHE0P5@3%6.,=)#F9V2MWNT'@W$#BRRG8GJ/LJK5G(-YF +_^K*^>8CUD[LK44N MK*L4V@O7(G)V4RR8MO&M]J M0V?DJ3;5[,NH"[,P-W?'R#>=KGMO?:I2U>PP_C:,>=>[LE&__-KH_2[&[S+? MDRDTTU7P]R=F^KU\'81%-T9RFD>Y3LU[\W?5Q&1["Y;+ U)<1K?GN-;-.0R! M101YQX9$,QR2EK/?,D_'3YO,_[@EF;SV^JSN,H[^@Y83D9EFL1I_,(2Q0R]3 MH#25Z3.1:37O:R;\2XZ7F)!9*SO2LCCI,QWH(S3I2+X%J3L !+GC:0H1-+ZS M\H:^\J1#N#$/Z[(<&[>3*XI&:?\MS?DS\ZN^-J.?+;(@LB*H8UB;C1&ERM$& M.W.=MWJ;Z!NGJQ J+A*Q'U0J8L('*RFC2%!!J2N;]4BX:!.3"E.+HKHL15([ MLJD:A[N]D? 5-2F]E$8JM>%FHK+,])P*7*+",G1N-F7DM7=O!02/$\L,P9](N68NZ M,/FR >R9?"FI!YF!;2JS1=I$!>1$1\N3VLFD#T3$!Q..("+ .\,OERDZ0(FG MDQ&Z-P277EN%30DV5$([(/._-SH#]P.Z972V))H>9E(4$AR)EG&Z%G3!0C3$ MDMM%9@3_1Q.YBPY&;')S O,;BL,?+-MG[,+;CB3.[.'TK@DX*/FFTI<6H163C-V90E_7RL-6+*UQCH"7I1DZTAG($0UUBK(%C M*BV\)7,P)" ,(E;BQ"5+B ,2H0"QP'4*%8MYMY=XE,_+1UTLK::H"*E1G,TC M,Q@4H10Q%#]$(^DCQ!-$0?#12)&+F$D\HUPR&' [*'%!LX7"KL";+C$4Q:49 MFMM0AU8R0?_!&MG)+P1,FES#LD?KA$QDRJ]#.^PRPTW$1%@L:%_S[ MOJ;KAZ2<.O2[O7IL,3T9-@UY'JK$"L)<'QZ"0-.80+%\)B9A_Z3W0SEA6S<^ MB#\B>C8"\@I;,R#W$B\?,CY!#,?1-)H_%$I6H"BC/,2^;"-G@HN=<9?[*")M M&Z86B<+@2ZVYG"'XJ3H6&95XC$>DW L+A*O(&+* R4>/4A!3$;(B,S$KXA"H MI+'DTVFJK)*ZP>\QP3:SN5S#U0 MA*J]FJO6+-2B@D.'6K_S#EMI5AQDS@1K!^,$MBXQ[6, M(T*YHZ 43JM@#/92"TE)O\ZDFC-:PH[H)8S:'2>+E+V$4DW:O'E +-OA+OW# M%'G:NQ]EO@MB)2P[R2""M_M(SU8U24!%R3=U1?\1R88@*)IYK<7, M5VVET2H$H7]4Q^A)(OTK,PW$3%,]5>L1F))\5IW,+CLA18##T.=*(">-0']M MKE#$'Y(:4W0:QL.,_U*:6\'V4@8TV]& JQ>$$4:V0I]R?2FYNU;YXIH%I581 MY+#2!$J;C=/&6;2B28X]%9;QR=-'E*Q97+S)X]2LT"!XLT-<)<.XNDCZ2XQ% M+1*T.M2W8 C[BC2>C-2+3!S4\5));4B'A [<9#N%8)4AH13?J1F%_<*GM+Q M?8P@,TV_0".>S+\<_%0W1* IY(M;O3JPPX>,FT=J^RM@#4 R#$/"V9)[[4)0 MK:SR$K?3[MV2@!%%E2&[A.M$E@TR]:>%D+ M8CGW(S!$E;EZ$UM\R@\AE$N\)= (U2GD6A<*H2 4]3%^C5B-#9&'#2]-*_\] MB+1*%DW2Z(7;.-L]BZPQ\;I>*55=EKU*=<,C*^A06V26S-4JEZ/22BE*G!U@T17*G/76 M*!4P[K'?_P"F]M05??14WV3!N-(D7LIU.J4+.%+:;'/0SKC-8[IG>I)RRF*3#5:V6X[I/3VE*>71*6/-9 M>)6C2S4X+[&5O#1)O!H#N^O(RLE"A8NJYK7-^ODMY)"+%YXJVM$QR[$KU'11 MIO3: P[@SM59/YQ99'K($"5;TTRIQWRH7E2Z)@S_06?Q0".UOW74(6,-*19N MOG5<0! ZD765S(DK/PJJN90L(57ZM:=R4X $+A4%5)9EH4ET5Q^]X:07G!NWT=0-U^E-FAL&'C;8GJ=2D8+"4ZQNN&L/JH9*G.;R8D\ MWDXY6:[8Y!]UM="#6(^88JI[XX;+SF5625GP8#%0KKB766W'V4_Q*)W:<=BU2]$3&[_0J"(&*UZ%U$55./(EW-7,\& M1+=@,J-DRS13#%!,UE%[OLONP;K\Z9&%'KG$60FL6]GPDKGP<,D.LZC1JVDH M361\G:U:_"27VSI?S(Q^-E4DS:QD3:>,L:7>C6 ?P8\FQ1@Q6V+X0C9]I'^:HM^0KBY%.,H>;E+]:PY;,)/\ MZ5RH:F0/C2Y4F+.GG>7E"6B)'=$E!3] ^J36],+JR.'S6[+2GAC6V=&8'E8U MZ^:47$BCNKDV/EL8J\5+=JG'!=%3X.KI15)8ULQ7B]K KJKU'.+;TUU(MNPW M[LZ"Y%5+:G[O0^CX@GGM-&X;78WM<=G5K MVQ-P(@7OP3EJ";1O(SNPIP+>(]V:31-H5):0;U):_NK9#>?P#J]E[QRST&EE M@_#?6!0HI+-PZB!J^KY%!PP\ZMH;_Z8660-2OYKP!L?;_]%7-93$[ZI=^HHE M_,;8(\5&^:5(7<;K=?2T9$[)WTUG*AMRWTJO+?^MJ4ZU,"'"IFJA::V8##2\ M6N\&TVIC1R!-U2

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end GRAPHIC 16 pswaward2.gif begin 644 pswaward2.gif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end GRAPHIC 17 stockoptionaward1.jpg begin 644 stockoptionaward1.jpg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end GRAPHIC 18 stockoptionaward2.gif begin 644 stockoptionaward2.gif M1TE&.#EAK03? 7 "'Y! $ H + "M!-\!@P !4E@!4E0!5E !5 ME@!7EP!5E0!/CP!3EP!6E0 2I4,E)J[TXZ\V[ M_V HCF1IGFBJKFSKOG LSW1MWWBN[WR/%P6?<$@L&H_(I'+);#J?T*AT2JV* M@$"K=LOM>K_@L'A,+IO/:.PAB&Z[W_"X?$ZOV^]X'W"-S?O_@(&"@X2%AH=S M6 5K:XB.CY"1DI.4E99M>XI]EYR=GI^@H:*CAYF+IXVDJJNLK:ZOL+$GBGQ\ MF[*XN;J[O+V^:8RFP;_$Q<;'R,G*(YJUS8C+T-'2T]35D:BGV<%LUMW>W^#A MXDVTPJ:+X^GJZ^SM[AF9SMJF[_7V]_CYN>?R"/S<^@(*'$BP8)Y_V?PYXV.P MH<.'$"-",9?0EC\U621JW,BQHT<3V>85N*@0VZF/*%.J7/D0H[PU);'$1,>R MILV;.+O)RW01YIZ9#',*'4JT*"R,)OWU5*14G9[1IU"C2D6$U.+(4TH7Q5PZ MM:O7KV#-( S&9^95!-MHAEW+MJW;(RZ!7&2*56M(>F_SZMW+=\5=;&A'6B4Y M$H%AO'T3*UZ\>.'=K%QH&O?SGU5.=ZPZ]8][&SRR>[HTZN?-#;\]=;332U%^GN]_?OXY4B/ M!UIW89'*Q7=>?@06:* 8^Q'VFH"0-6B2+?4=*.&$%,)EBW%V+2C9>*Z9Y]-2 MJ50HXH@DYA"7;UF]9AZ#F@2H28DPQBBC"N>$I%!,E,6V38H!>ACAC$ &*>0\ MY86G8&>@M3982!#^*.234%)X(5(^NFB8B23HF.5>.1 [HYIY\"J?:F71]%IAX 7ZX6IT9]:GH MHJ6IEM6=XK'F7G^0SD=6)HQFJFEB[5%VEI*]^6?EIQA"FMVFJ*;:59YI]@=? M68;Y T)AAI%EGJJXYFH4?8S$JNNOP 8K[+#$IH=1L<@FB\^:,-2HR;/?,:OL MM-1& ^VUT4I %[;8#@KG3K;0P*VT_]66:^X=WU56RWSI[N?8:-(Y(T,SN)UK M[[T'/8C;E*#"ZR]KW]8HKPLGPIDHO@@G?,9= ?\DH*O_&MC0,L!&R#U\**.A^7''(XMTR"(A/ >[$"7(^M]]X8-PRHIZ*IK#.:*Z=L MW:0 GWI%WGB+=$[=>O(M^>0?L$PXSUDZ:%>E3!(:'XB3#EP"XPKVQ0Q^8H>:M/%/ZB:L5@AJM M1_X[0+Y[;S_2%)G:4Z$]+H_1H\\R6Y+$LR$("4UN'2 =]EH6DJ]E[WX03%B\ M7*4_M)4L2_$1E)IJU1LLD6R 4V)&Y)Q5CM8!+X(HQ%?G_K*EW;!/=^NR4= R M-,-XT&EY[-(:WJZWPJ/%3X8 MW24Q4E@#7&RJYCGV7>F,Z_O'^TEX." %=NV$TC#8@Y[YJNM-+<7','H7)'SP% MDX8*^J4]W2:F2WX*='"\@#,7*)N\X?*=" V2OKYYOG#Z+%!,J],=M_D\<':3 MG&89J >&=E"F 3&A(,U/D^29/#3N,Y]PVR,D2U9 %Q*P5>,Q"\<:Z '1A?2F M)3I1*S^'MMK=[GE;V=$,@=HOC"+.,6MD)CNSB-.F'LAU[QDG]0[GH&#FT(^D M,N-+*[F;OZR1IC\TIU/'FA^$L$BJA"E<&%$).)\:,"Z'(6$GA/HIU@WL)(!N M)*M>";1"P #S=6=+B_]N&"FJ3A)KRB/C<;I9UW,Z)BU5!-FX)DO9REKVLGJX MK&8WR]EH[J"SH VM9O=:5M>I,I!&PHH!U0HJ/C:TADYSI!ZC1CM$SO([_S83 MF;MVJ]O>^HTB/; <;W_KV^$"-[/$3:YQB\M_6&FM@VD%#VQ*!CITQ?? \%UN9A,LWP83U[T(=C"#&T9?]>Q+3L,DYJ6N MZ*:#ZSFLULYFG6X,)=C/]SC7%,9QV;Q+UE_@>;]VV42EYQG7F\Z&@QVL[,^6R8)FU?)G?YQ>\:L91UJFA( M/_K3C@[U<06=0 F;FLJ]!=,3W;PP0.M+75"U+\Y@_>IZ??:*@]HCFGQ:)H;N M.M?;RMJ8;?!>6L]:UJS*=++;0^J-QAC5T*X&M*Z7!NA25H SWD+GL,/0GLXS M3IKK]C:_W;YASZ!%]%GIU )Y3PQ;1ZX^@AAR<9-:;@8[>O8>][::*))FEQK: MSXXQ->BEIFM[=@G3%NZ2-Y:(6FLP5$YL:$,W#/&)1_QOKN)!/?_SVK.D)7R# M^3C$QT14B/;$Q?WH(,4I/\-R)[;P?X64]?CM,31VT;%"F'__FN3,G3HJU79Z7] MJ[K5.8.=V("[WNC6M]GSZVT:UMSF7HX[IBEMZ2_+O<72H/MOCUW<@D]6J?]^ M[YIY>?!JP\YJJE6YX@NU>-C]=/'EM/*YX5K$*T4M?,#&'-([7O20AYUUWAXS(IIVH;!/\Y]'UF>B_^+%,L80>8&^G[\8/"-O8[I% M.1X7)%_]?V?G]]NBGMAR2A1Z8I^\8+OJ2!99O_H8UN0D6=4#DLXNOH-40WK^^MU#_:DM$VPV38%__*! M(MHT>H<31$H&YU<0D( M417H$\S>KJ#34[#>!I%;&0'*P;H@:9'B7JTB+*% M !IG=$A'B8\G.!#%B$R$>JQ5AF^4/P^W!%.Q* +/\WW5N'P PXQ%J$S"9WMO%S>^Q'90UW9KMX;M^'3N)GF] M('C'"!F=1V";0X5MDV'V-D;2M7$HIEBGYUV8"(=?X$5FXX.RQ72 8E25QT0[ MR'(.R!_* 7*6>)&5:(\>QU.T%5DFXE>*B$EB!)&?HR(A29&T98JG^$&)AW@9 M*3V>J'JIUT=[H SM 9)+5&0,J%B.B$2YUI!5&'Z$Z$NN]8&$53@^! S[N&_[ M2(2XV)24DCS[&%>2XH"R6;:4WYB5U B&.U5'S[.))C-2()1)0=E3AQ.6T1-% M*FD!!J,Y#D*.?M5T0JDYTX-)VQ@*+L@Y>*272'$\,_VO2'!;B( M. )&,E-M7Z2("XDV'*210,,^>UB($\F!C=F2DYB1L64^5]F)=WE;!.9*Q/>) M,+E?,UB7BC==:QD_EE==ATB2>5@EN8. &DE\.((,-]9Q1D6:(+:$]U5=M05Y M_8B9U*> O?9!#?(>+_^(!JQD?G\YE> %AO]H2$1";7B!%* M8\@7?IL9HI3(?*_HA9+&4X5(3HAYF#*8:_YE3* H$_!I115!DI*(.!4)&!PZ M>AC*;R5Q#/H)BF&WFQMG;3Y#FJV%7QQJ?0&VF9[CC=%WD.80F,"IEUP70WX9 MANK6>?QA(L9(>=X9IC[Z*OT3-$=R:S IF63I3^9W?8E)@%%ICF_W&(E321K_ MFI[4.)>#M41)>7OR]X,'FA BF&!LC]OJDHHPS80DT:"&9?*]T7'%#<+HWN: M.8IIZH=GDXZ_R6V(IVED@Y"MTI BRIG8!V*Z>"8G^@I04Q(2M18$IZH82 MESPS>CI/B%:6>I8]*5>%N59,D:J\X'H6T:.H^1@&1%LP52F;6H@*VFM!!C0B MN'A!=EJ&V&J$^HVC\J0:%H]%0EWE1(SS,C%;1:5:.:9CN:7Z]JT=N@)"A99> MF4-LVIWDYB$9U2JUFDX&RDJX&J_\9*#(IX05&1/$0*1O*G*#L160U*CU-T;8 MF";C,YZ&M4\EETSJVE=B\9E76*/U&(K+NDKMPXP___ =&!6;6$6R.NJ&\12" M%W*9MODPON2JNUJIV10XDGD1]RI-VJI*M(B(K'16XI.9OPF-KF!?FD>%60>: M_,4346A'<*E5H\EQ(E>J%OB8EP=.48VL%*,(NI'B6/GM' M_(5Z?#LU< NJRIEN.^6R+/I-G=E:@N&E#\F+T1,P M$]5K#$@]5)FALA2L>LA33>9\;JC)AJF,BP\P*,8!X M6G!;'FW%=I58K!\WM;K(>*!QLSB;CHE:IRT7JZY"5*0K54 %K/PIEELXFX^7 MH3Y+%SQ8N]:U9Y,IDD)%6"Q2-;>8-2+_/ 1,X;5JVSX-*\/E&Z>]2YX>FC9F M<9Y'JR%D KC[6W]8!6(?^4?N2YW=YL<<;*Y9DJ>0L1] MF'5@-XZ88U)Q_WI$38I!5SK/A\!HU,&=>[JV3]B^2^S&]P1B/,9'+R6YX&FR M!?H2_<>PZ^H$2;&ZUQ612ALZ ]C+]W9)Q):0*:RDF>JZB -]/PLKA7FZ.MVC M1823 %*C2ZJK0LMZF,-!]#DX+:#)MS*&KK*]X:BLXR/B/^8HQ;Z MEW@ME3G[F#E\UJ^LKE4#HM+JGY:4S%XDF^=Z>*&8ENRHD25Z9$.K9D7=FS,( M7B*-@;>,A*BZH:%;4IM-NT=+R+"E@50 2P^%LHC]?();GWOLSV_FBRUMR5RI MT'[(L)',QNXLIRE D +JL6,MUZ6GUM"*1LJ=&_;<4DK4N@>,DV8TKRO="7T5 MRJ?T=\'-AI!> M:^>,:I;#G: B+L3D@Z+3BAUO=GPV3*TZS&LG6XZ4MX E1.?(R(SWR=N'/>0,;V M?,=Z:K SN>,-=12LHM4Z#:B@.9FWFSDF3@5TBJV$9^/_L7Y,[BF0%QZ(B%SH MYJGIX$HPVQ:X&6;M@37&'TKNX7GG CO?@VW)?9W;PJ3(ERJ5MY+@S1/:J&W6 MHRSN$IZ?30?M%ZW?7SM,!3K'R#1D0;CAYZOB_HUPW<7LTUEZUOL/8NRQ:;*! M?W4BM1S;R/IPAJAXUQS5<&SFR%D^=RZ\WGJIF-"SPZ+#7#1W6NEOV[ M:.E09@VXJAJY5IQ=.FYG'MQN4)IQ (_;*5U=Y;>_?ZFG*%J60_NGF7/QJ[*B M'6^[.<^<)PG2D"N>O$Z:^D[K_Q8*E*3[S44=@5IA[_UKFALYL7Y&IF0X2V-RDQ1SQR4>93 M3\E57_]7/J?7[7=\7K_G]_U_P,".MS6XI!C$E"*=&JH,MX%;ID]/I6NP ?#JULO9JU*A2 15R@$?0ARD?)Q9RH71,BZ$GRVRY:+;H M5L:/CF@ Q.-R2$L2ZI ^W(#XL581J*8V?&)FQ1Y/9#EG 31ITQ8]'!,)%K4 MZ%&D2>M($VFR8\M&KW26X:ARA)ACE91N51#1*\13-QW",WAMD! %K@+/MDKI M\U5:$-SXY:@JK26W9A_M"9LE=>:N:H18PK+6;XE5-[P2TVN"V"Y:DO7B'1J' MLE=6-&2?\DT(U_-GT*%% WDIAI+TDCIXX\*N]8+?3C.7= MR6QNR* ;>ET&&_^1YYXIJ22S==G15"4HBCT*:N80-4":HB^_S(,[QI0S+7?' MBB\\]D#$USS.'*GJRI,N]4*UQ8OV??SY]0/$#"W]O+"I;.T+CLMLX?:6*R8ZY"(S8J/-/2# M+-9Z:E&;5=U]^CXK6"L.P98G=>:N= M[J9YC.GW1S"CQ&>]NTSB81L4*#;V7=V"S9A!@RILL]>#X$5-C?Z.VPHV! ?6 M#IH1B7ET*E=5#2Y.UBJ\80P#;2QM(W*TK!<.6!T)C*;#1#JOSTV92P1?Y^I< M^&FHHP9E!J8S/1?3@06,"C4_\RSC.JGSP!BL_T1O4MH)+N5C;+U&AW4$9 K7 MA%!8-!NK=9,^(2&XW85R.5B<.3/[&ZAP@+*+2DLR_-,V?[Y>M\6:?=-Q&BE2 MK">R;&8TDF=U!5^"Y,$([C9LTDLWO8MH/]VV94H\;LY:V"M[]_0Y"&%+L)GL MK9%5#F>D=K)'[^;U8C9[*_Y,4B[47)9Q"K%3*=;S3/2D;%O=]D@3:9Q9%5VI MEV0[$G-/HD<;PRF0R$?Y?H<-9Y&9EH?U^_.^W2CSKQ8O5B;RY MYV45>5O^2 ,CJ$AB:Y[J3B>>HI%$E2>"!!P;AWY5P;%U+$P2 I_S:O0"^8 ( M*?^:SY2< 3I=2,8GB_\QV#6VIQ;)*0XOX]+97H+BL>I)15KS&%UV,F>NQL4J M<.S"RM\ A:I:(," 2V1BO]P4HQ/1Y3]MZ!RY$B:B$ZHO?QF\O M(L]GOO/JP3UM45)"PN?:F(G/1FJL+QN?%[3 M&-,J>:@J4OD51YG5UJ=]SOB@4MD%JECWJU"(WJ4-@%2V84<&9 M^/1FG9HD!1Y_JV/K=D@N,SY3D[**DW:F-;AXY*6.E ,<''%I1!T,K8S ZR)' M*4/""P\J!G;S^&0[W:D?Y3$F'&A0S0^[^;GX18\%[^Q*G=2IBS4^+&)S05(0 M)V>99M"06ZL!XA2E>"Z^N%%E;CSG*36SN!?_]@U/V#O<8 29B]:U"GTQD&0A M_3C&25I-I(A\ X;>Y+[#H/10$6IX<1(RD80VJIO2JRJ[# M#66:S6O@T%84C9@ME(*3.MY2$PI91S@UYC4%KOLAY< E5SR^"#>:H^%@B<4( M<3E&#=CX:6,="]14.8Z;ND.D[+2)TDNBYI'N'";/NED5='F,CNLTJSE11M"A MZ@.-#GRE,ZTZ37RJR*MG,4P*R3!"7$+U=C$:8.@6>-)8I><-MCRI+5EZ03)] M,(I#LB1)!8$R2N[._W$ *228(LI#SM%>#2][ M-5=> NH,3S"*JQ)@+G?BJS6H>$ZZA'FE)^?0(G0:6 M#LSP&EF8EG2=@GHS=OLW7RMY[<5[YO./7,E#E[*,DGW\Y4HV*=4!VX?'$O]2 MFDMPEK7[XK5<6C,SPJ++O)1.=1\B?1]K!=35&-.GAM^!KW.A-<,A@M2+IR)B MD=*5LZQD)X9V-;'9U&6%R)66K2G$48@I4AB$!?)<)./U_N2+:5/W6=G+%C%; M;) DAMYSJTDLF=O6G.PE(D]Q';DK<5@G;%/6)4OQ]9RZTGC"*ED$Q3IFZZK_ MT[S:KC.P 6G?1:0$(*$>MWSIB\G[(LD]4\1RPI[=JLO$U#7J%=./*A)NSPC$ M5N.]F;IK'/(8GE069+V)V0#/>,>WJ)A?J?7 :-.5_R2S'705(B^=C-LQ%=F3 M(QEUD;G>6,GO;*1 )QK-Q)9)I^WX/BPU*L_3RB'_K_+XU0!)D[SZD)8P3 @Y;?U;-+]);+$V=I"- M"R%D;G<[O! B-7\"^7^[,79.96;-TV;Q#$W,4%]'/"B#AYEB^(0ZWA8';GA3 M@LUW7)J)=^)TA[=,JR6LG&)]TT.%./[DX6KDHA0Y]"GP-S[8=A<65>DJ3>N, M\D O^BFQJW:U'+RE^GV?-\CK4B+MTKDD[QD.VQ#.A>"L0KY,[57,+9JJRLM.[S3." M VLU\6BX-AJMTA*,E!$2)[.G) @1X@,.NVFYX[.F'Q.3[@(\CD$@Y\N[.,*X M!$2.!8L\5%,ALG,E2T,G 0,Q$B"\@O"9"PFM7:DH-J(D81*WK% Q]JH(0'L;]S$,'1G"=*,8^IG_ CKFM/;,8##EC"$+P;B0C#\H_8Y(F5*GCDZGN;[,PQ*O@GI/P,*P8\Y M0V'1H'AJ&-@X%B<)MGK;HPDCO>JXA3O4GM^+05*YFSVBMDKC/%!#0"PB0_.C MO0;2GIIAH;V[O !!+\R#O?K()*=RAMM!A;X)MA,)$)%+PC%QN-4R0D[T GFI M0EJ[P5RJP=A+F)03-'O!O4QX,BJKU(\0C,.IL%*["8*R!9@\,?VYVVL+^J23C_VD"AT2@3Q" . M$D=&#,2W>Y#6VJ*=;*\67,0@:;FZ0[YDX8^.FSOI<0RB>2T_X8F>RZ_4B[FG MQ! F^3P$8S/PTI1*0B;?@[2//$OTHB5=@Y0WBS'4([^V22))0;-+ M*IS#ZP?"U+)S!$=M*SX<^D,Y,L$J%P3L M(AUL1&_\4A"4T =IQV-0*[V;H#!*GPHE%C8](-]\OF;<-STJ@?,#HNN0IVLL M)Q84TQ&UT&)<)B*M*XIKO!S"L!U*NH5BSJ6YAWBLHB:C3"B@M_>J2J=CT2[K MR)13(-X:"C-<(4QLR@J+P'R"7K3 M1+XT.XN"_YF@09\'6H'"S$@O5+H=U"Q ;2@ADIABVPA8J:8B"2("FRVWHM$K ME0ZY2 >O_-A;U$R(U#S;PB=B_2LQF8)K#1(O^3%B&0L(HBC P8F$Q:K/,;<% M=!80+4>Z"E$&0<)I!$:&HB5SDB]T,EHZ4T&A)+/\<%DE7BG">P4YVVX ^QY*T&"L7Q^LYP.2J&FT-16T7Y:Q54\DMQKJLTHD6$*!L?L%%L8,(:(J.$T\L6/-,XR0MY^$AZ8E MP>!4C^\Z5D\3TDAU-/O*2FX-$HU)7_.T-#P$"6(J79@R4\H]$EZ%3TXAVA4N MCBS$W^$K#)5K"0=^8'JSUW.43:3EIL3DL&U2E.AIWZ#(7V<#WL1\JZW+ICC5 M*U_DN@:C5;%)+"8[E<,$LX843LS[A.W]F X#2V#T7XNE/KXC5$$.LN$H"-I0 MVG04V2-"%9AKV.L,DFI\!G9U-?$+S2_XU:^T5#2\-)(M)UXB5-DI68S__61LX$\V;K$';-=%I9*JZK=\M#^00"L^D%,RCB>\I1]VJ26.7%MZ/*3, M/:!C(63_DK]8[F!\,+E_F)0;_LOQBQ2KF;WF>BU;=$\ABUV=,N+%';[6@MF_ MA(_2U;E,L\J93.>NZIH@UF?79.%#!J9TSKLN!C5WOAWQBA^$5C'/U"N@4%#Z_P4RJVT/C-9HMS;/ MMN8X&PT&],1*1O6TO"'A>F[AJ;-/K=Y$]^3=:I69K)R7N-X 1J7D5E8=P\TO M7;BC]RF4SWP=AW+&SH&D6P+/^Q/7;ZZ:634>>Y9BL2NV*'92@9N>-///W2(, M]T0Y_S1-$/8CFXS ,68/6%FQ3'K024(7XN)AMH2(MPU87S2 M3C;HVD'AQNS0:^OO^IM9=:Y,D?^M00.G:DOMU>#&TXPSX^$&4[,0TU=6A[0Y MIE%RW(G.K-ML/Y%<'Z9,O#1^KSKIS<(>RQ5^6W0^;,1^U2P]N=,-'S\6X1Z5 MNI6E(&9N/ 6"4>"Z8E/48;6ID>%19M9,)G]IUA&\EVFBN4I!5/FA!H)"UD+J&)JH;P/6\ MH;614E[_5G#K;)#6JY;]VY'Q]5\7XCP[I@K=+,6(?'+Z1=6E9L2D_ML#]XNM MW/.?DN2S2]PV$?%:?-TC*EYCLM/+3%II*6FB&O<8'XA)HVR8P;=5_C^STF$V@2Q@%=IE M3B\I).=#N%-&#/L_0[6!S7[BQ7IE9-N%VGGA9S.I!%0[B MH;P&^1D9 K3+=1;CAO5L>\&L4G+?$/&D96!"-Y@I@_1A6YM@OZAXCL#J\%)$ M'K( YL;D)?/(?#I=WSKJ-E,T3&$4^M+6[.G'BUJC)ZZ;1/6X6\*O;SKJ)[8@ M&]MK] )OBM W9O93O81'^&*]4/AAF/36 MU:1RDG%J*HRL2 MBBHCFQ\AEB3E&!/A*2X18$J:8B5A7S$K+V,LUVL,Y!CNF2?;5MTPL23V'/&Q MI:ENV2]J!2WIXFISNOJ*8*"[< CU[I9OO/*I"#LY9(I@_[(_@,N,N"A81!W" M&?/XC=+RR=Z1A'O"T:*W:E6J"V_H<:N%#)2(A"S*463R!-"G:AZLC1SG4,Q* M#YRJ#+D3460^3H 0#3*7H2:IFD)1W<$@44'!?_F4Q=2G*->IE2B[F*E346,' M,Y@L^OPP$^2@IBEN'G55I%VUA5B]T;D*4BS-A39Y#:%4%!R^M%*[;D-V\)4M M62Q7%1T*2J_6C/\<=\54^5'7D''R9I$M:UGA(L&Z?EK%:A=R,4QXK\:M<[8E M9WT,3ZM6ZEJ@"H(&7ZRX'# 4,9)^:U_>85+VTZ(28UO)%M6G M-D:BH_7$$BX-+X^F\RSOLY9Z XD MS<0VDR1N^,$?;CL]B-USV4!Q#80E,:@)-])M<5I)9/9Q&<92Y)G8E*$8I3*5 M85$E5AZH]L"3YI>2=;39H7Q.-&5F^]%YGY,)N" ^DQ$:63+%%D;42#JE9NP@H1)V)&I>EK=DD^6RYJ23S#V3U$-SLE3? M9B= NP2"MTTSG&SV;437&IUUFL%Z/;I4BC"F1LC@5[E5A]JX4*FJ87?&4'=% MPV,TQU-QL)YW1\'/.)?DCWC9>O%" 9KV#F4-_\$T2DG"QBN-7XO<:T,L)Q@W M''FF77A,2QO+"+%3^SHWW"4&.YPBEL-(8Z\C$!E"'=7*L)@P7LOVHMBM6R<= MK,(MLTS"S2%K]\Z%?J"U#RZ&\!@PRR=>29_517,XY&-!B:=D>Q"U:P24I:+6 M;CN441VST?F4K_6M78G!MY>TA"=6"D9MX3G9GK(0R'*.<6)GC MK7@F+A=,I+J!'I90KS_4.:1&K9-NW_[VAREN>[G:T6)FMK2@GGD&S.*>K/)$ MN;F5W:=&FQEDZF555MVNSN4YD %*PP[$&4EN6YK>_VQI_N M4Z]G0E[.K%T4*EG]SO\O;N!JF%:[M?$B(QKCR$- 012(CAWO+I]35Z .XYJ MGC2@UR!**>X*G!C" K!Y]61&4+N9P73T&!*1:WWEPU(MS+>.HOV 6AF,-;%S U_K(;3]+<_6$#O"FRQ R11)*36 M9X8HOA,5K3F3#;JZGEU!""R&IB5/%'S M*X[)I>G0VB$(>\.^*E>1L[+@-G44/6XI;.QL0VWMO6A$?] 6-*3S.>;6@S=4&2I6@?>5=[%X[OV@2*!VH-&=J/!5/]6'WN_"36'3\ MZ@E245&JXXR7"]?&F-,_XD.G)MZKCW"AKC2W>58CR1G9B/( M/YF:=HM_H":P1EA.0&8WP/ ]F/8J"B[2*@&#SV2*9ET6TA0[+$T#X1X2.3*I MV1++6Y#C%%OW5J=$/N7%L^SFIGZ)Y.FEKJ\; ML7'Z4+>B]PF'IF&CK<_DY^[Q/OEO!Z=E7IAET7FFE]\"HU^D!?S2^55U3"!. M!C,,BE*"TQ-]-?;WP 9X4FQWLY8)4DE\]L*15]$;UDA1DL5'8^;Z_X$2FO"N M$S&)0_+$3CPN+,4>ZC9HPL<%"N;X03'W/,S,SEC+%(YZ'BB'AK=<8[._?E;U M&Y7*PX*@#(++TDV>D/+'S1'T8OZY9W5_REF3Q$\G[E[[2B=PQ%/F\!Y3G*.L MP,+ WO:RT&5RT8$Q!FI+WBJU8;::";C$JSJ:E69STV[2&AMI_"Y&11D<."+K MIC9FRU'0AE43(\\F)VD4?>2!R^MDIU? M*'-8FW:SB37GN4;LLA>7(U53ZSDN.J\::?^G-8?%0!5>KY5IB\D9V19[ $9 MR,7C 1K!^5B(Y4J:N$VX%<>#C1/YP,4 [P?)Z&]8:TQ!G3F1(ER<\(#,H' M_DJR9-W+$14! ="':9 M'=PKY<"+=XF( ^C_"6P0V8$0-@P$8V<0A?\0)/:1M.P0S= (P!.M;E=59" ML0>BH1GE?1GYA9+_@PRB=D7:J@%)KHU,F1P-Q%6*+'Q:*.D&_KG (-J0NVF= MTJ!=VA#71@W6?PR?;&!6% 4ASI";I2D-B(B?JMG2W;A6*3*?9UE1TP@;K*3@ M&LK6T\U'BQQ6S_%+U035%*I&3; M$08/\PA'N[#5.:D?I(1).QW%X"B=1!D>9YS;1-83<3AA(]I7:*5'P*';CT$7 M)4J;"ZI?OOV.=NP,BN5//CY0+UHAOVD1".+>7 @C#;S&XPB!2TF@@XF@_[$\ M7T25)-,TR/J(G_84#X8%%+RY)!?^)+>(C4)BDX[MG.D 42U9P;1I52XEX]\H MR"1Z7HAY@3&XESBTX=Q9UH&)G0T^"!-^'4 J0_JMBI^E'%2&EC@Q2M*8!4/ MARD25]:IEXH( Y'IT9U!E)056$7FB!^I3)!0DG_]%8#H M(:.$6C(NH1D-'!PE#C3D(L/%9& P5=C,W"K^7XZ=(JJYIO=DAY+=84!L(JS5 MU%81&M(L9$+NAEZVT)IA3?(A3A;V&4(^) .ZE?AEWMGE%&@PBA()$J;QF/6= MWB@.%SD>$7(.8K5%%(ILG@4N9 ON"OF9)$O.&__S1(1,O@S3M9S70(=P)@&X MW<]?"MLC6=Q 2(3:!;[(CU#,A^D4^7U0DY^0YKE*<2 MH ,4GA>&S$>$LE\Y.6&;Y!,[\5;_G6%"T23]V=$C%)PD+A@R@8Y\X9%[ MCLLLQ-Q*SI(YJ>M1!>9?.5\9>C&P6#Y MD<2U6>FF ,JI[43O6,IO_==ZE=(HZ6&.8[39EN#@UOG@%AI8AG,MJE M9=QGN9:>Z5;&@.3M<6!KG)+*<%G'_I%BFTJ:GYD9!#'I,_K+>[2FZ_&4Z G6 M)#E'O54A[(GB=[X-$09>:2Y%I]H/>G[B<331ITZ;(1X70Q'FVX#E)IU83ARI MQZFEI'(3T'B,1=KJ4Y:58EWD:3H!)1C4SP1;7#W1;@C_QY.)$:K*H+IR&5-1 MB[#!93^=GU=:28PQG$4!2F]BR]D4#UQR%,H-U#_,$GPY(:=DU+LP'6]]EQ#% MRDD]5^>EJBQAZ?QM(!..*;RYZ%4HY'NZ5^#8V(5MT\*VIM,5C[!(Y_*HYEQX M3OAD$\$&G4WU9PPTJU4=!OG%%.A!% +ZF#WJY]XL6)>V2DX*)7?)0FK1*+3* MZZR().71Q"%Q#R[A4GUM%#5(%^VXR\@"*#DQEXG)Q+=^'_$(D)F%%(L65+0H M:2 =S;KZD5#%:JF1[?G\BJG1:3)"!DC(@(-$K*Z9RI9-I]@)(-N 9G,@IG>Z MW:5N2&R*''HD(N$-'VLVGZZ]_XPM?NGAB=$5WD($=5*X0B'0H"=DK4F9Q8%4 MJL^7V@=[P-5@,LT7?EEBJ5,F@1]>?AA>;>0P2JGT8:I;GMX5MF4N7N2__B;$ M<0QC=FX0OM>(4))>XAUEQIB*/24D3B,:U*[O7NOT.:2L=:W0UB-RYV>I(,?:IH*DEQ@ M.F51MH0C:*)V?@I)6G"1 MD2\FR?\@QPAC3?DF^4!*;_ZN!]97N>'/R%6MGCP@CN0ER=[@]?+AB1&9;TX? M^OJMJ#T;+S*DFLWE-[IMA]Z0.C+B._#MW=BM6LP,=?)7\P)!H%+K[8Z,'@;: MAL0M/WXQDAB2U@G5J33-'Z1PI?*IHXZ;KJ;CW7;G6]%>XPYRR,6=;XF0Q8;G M&]D5ZU15%R^?T2ZK9H!6)-=K)3EJS>6>(J>L8K9,8N5MXNCA^ T:SPEB)O6M MS9'2HTHB1&SGTJ!MI@!;:+HN/(VB9ZWEOSTQ:3UBC7GCF*9+HMF7G:Y<0L8< MW$;B1"+#WOD?S=H6$2DI'@P?9K8L) /O.Z@ X%3J-[_R*>DU0:\+;@M M<7H.\%,ER(W6S-4:):!=USTB\ @?D#XUY"JC"'EAZUGLQ+V>&,T^(/QHL368 M6F926^91#TL2;.L]<\.DK]3NLZ906V"J+.[)2T#],#?C4P1S6\EY[R*]TU$^ MX]2)LT/^7/N&Y8SI"T6FTT8 LTSS'AGGX[9I&KB5[7T:P2##804,W+MFB-ZD1U?K!]/*MHB%??" M:H8Y1BQ""" =(0/5"C'/'7]4,:F\(/@TT^ AYC:V+0GA2(?.6/:Z(MLU8NP" MT>^)M!F?&NI.;A@O%F!"YVQ:W36!_W6?DK))>\+N7:Y9EF#!037;(NNV;FXB MM<>_S#1H+]6B.6)S>2@_EX71/JPX9>O$$;0(6T!!FHQ'<,6AQC7J.8,"IU.8 M:*4I?YS]=LP""I)M0N*_S*Q[QJFT+&0%>F0DFL=M=IR!GD^)5L3[S3;@_):K M2:V\"C:X@F%%]YM>)^&; "26X:ETHT_H-F!#7US$99@HIZ] ;J'1H=?G+88K MD3?WC2C])6QTYD]8OO)I))YM4>PXQE_)+1O7L1*$W?\HJ^&NR11BXNF2 Y(0'@]=Y:"O+)7/:'XOR.7.D#=_DN>CS4@Y:H<AK>GIP$:=@K&>5&U]E0\[YKMLYMW?[1-R@SK"34TYS9.$9 M+D1]VNAEMEQ20*5[USA_^A:[LY9C4HFWG27OU@<9K''".E0K]G2$&ISW$+OS M#WE.FF5JJBP^MY4A8B&(!.8I-/$)? #9[*].JWG?4;N:4&L%N5UM\@.Q95E4 M8=PB7"([W_'H=4'+9HO[U;)9=:]5(V@0#219GD3EI5-H.$FPF+E\Q[\A@+?_ M/-!WNT9L_[NG5>=->^%!?U3]V?-=6'%/QJA](U@=.\,&/KV"J8^SL49!%M:* M;AP.[SPSIT\ZQ[A"O,OL.17%@R"#V>9*?8'#W^>U-"5M=S,,#L70^46*QVNP MIQO=AR1(>Q-!'3.RO1<(OPR&TI+VQF3@F*VT-X[@^4B 0W9&PG 1W[?]G> & M!KWF;S[G=S[O=04V/B?;"O$M5FNE:_88:[B&TYXK'WI>4CSCZ>RBTIA_THYE]&.\DZQ9EKZ/OM+KD+LT1B27G+E]3YJAB-L9+5-+TJ>S@L%(9FY&3CV1SFOQR_DZ[HFAKH1D ]!2$DPV JS6_N0\0^11Z3C=9LW//1; M!253_:(8.H2^GSL\WJQ#]FR->/U< M=@1XR%02'E^F&!R!C6>O:G>&8@14%!/#<@4&/)6A$7%FU:M6O9 MMN5@MFS#0I(JB(+$(R"=Q\$\XXIR,L)J,X M47!#ZS""D2!OJ)(3T$#=9,RM ^W+S,!#2120K!C^>Q322-E-J(^[AK0%"E=/T=87Z&S=%+-, MLWT-)NK(>M$0;J5*82TNOS,7,6@]W2&1,K,A25>T.JRWH^4<%+5:+LU38KWQ MK&-$TF-$*M +]1@6[N%$#614MFD3OAAC-O=9V*P3)%*4U'R-85J+5.-]B>FCIFC)Q!QQ^2TQ(M+BIZMX MM"(6-:L>"AI($]02+LOP.G%#\6T0 (K-10N MBN%*'/-")[\VS.\FVDG'S)!9^266J SXLSNGFMI&TTAD-=H??>(9%#952PPU M45@VJY;6Q\DL/F73FT:BB,Q5 Z$;.PYGW#EFW# TXV./?GAPBYSW,>PC\_AC M;YC+-#%C$R3N5W?WA0UB>_G"W=?+WIX50^8,R?.6W%\EW66%%T32P&6SMS8= M;OZ0.4I ;G+2F1^Z"!8QCU&F8INC'.7 1S%<&!"#<HG9QB>I4RSVQ M"DYE_"$3DY6(1AN"'CR8-Y +00TO/B$;=F@V*16RC6 MHG9BN*_PR'#GJ=P0.!A_[7&HZ(2@B=YR"OBV>O$QE>5)@Q^7G MGFSN<0W58:83V+,H41)Q3)(3SH<^F1$W%?0I](0SXXI?8!=(#S22E (C\FS0V(1%U;C5K[SAE0L?AFF1G*)GOHL,3LX%() M2KM#L1C;N'01+)>=8*Z!V"FW(D(/GM!B4JOT8-5U'M!@Y6$->[)6(U<>AVJ/ M7$MPCZ?'S=P+0X^HS%=\^L(RY7*^)'Q,>J,K&N1]:+ 9D!A59(&MZJ$V-S < MID/PFY=R9A=EG>/_&.1&2>'+2K""FOUN'7,YSW]4(YR+L@Z& M].J1+BWSK5U%A ^AM#=TGE26_6+IU=!D$AE)F8X!'B28<$4]0&.Y9$=B\J M>1(?D;7,6Y;D$"]LT8I6&I(3/IQ$,ZMA*BN RX&-Y9SW9Y=]Z"/*YHCN=6!J MK;]>]W()69B';<%DT%332]M+KV)V.L"O@'DDKQ,Q.9F(4#1.I*%@[([J_[9J M)HET8CJ!3&(PA M\G#W@=[: X>-3;?L(H^N(#:*2[HXL'H.=G&)/JZIX)5=;AXJSNT1MJ=>9-#H MN-=S+81+9":F:-=\; 6]4U7^4B'\B$P"S^;MB6, M+[[]WG*,7-2;;]/8SW3EKY\$F^3NQ8NNBU 5.@F'Y<\<4U5\TV>?8G?=7^XN MMB&I8U1]2&M8'B&.NMCHO@5]FO3+X?=H4, MP?VTK!^.%7WVM=&F)#12Z7<#0K[UL$SY-ZR9Q>OJ M^]ZBQZ;,7'?-.PXO[.I=2>78!D2^"J3MZ7:[:J753(_Z'1?ZMMLM[O4]W3DQ M=<0-+J]3>JMH9%/OL6IYF-45&+7,?Y##8SSW9^RTP&0\-RQK=+Y:O?A+3=?^ MLQ6^W.H1<+0!# 7 A9IT=XLJWV8*W_9I> 1N9EJKN!HB9A2N;NJ-N#H*G&ZE MN)Q'%%2.OG:O@2INTR9KP(8->PKL/LC%@_K/VY*"\4;$SUXGX\+.<.PFU-1, M+- )L2+LT/)*ZVX.2M+_JFQF@85>(=!*#/I**>M@9>MRZFQX NG0)_*$2IC: M3-2XB*R:1 6F;DH8KWM43P<+B4Q8A\!@4(,0I6>R3XS,"([*BO%RS.\"3 UA M[.FN8VTT:G%*!U\H;1/&:' X"8M,ZNM*S\U*B)/*< \A M;]\\:>S&"'1$#UBF"[/P)$P410,O3JUP:G]@ID3"3/)\ZPTNA>SN"_04KGI MCOYB#*R(KW<<#*!XA[H(X0&9$/GZ8"]6PYB23 G-3F4X3!HY?APJY/> M2]QXJJ':BYQDJ07H#;)&44_::1;/*VB447QX22%2D>7R8FA:1L^""II <0W7 M^7#6Y@?\2*HPQNSE=$;FKH -*01NM"H@\.9$$&$5C?&&XHEKGG#%\@L("ZE)S(BI) O1 M'NT*BPW^XL^HY ?6=&Y60*O+D.7&;J2PKL0I"/'AHH-'>O*TO' R9W/.D:,0CP\.X0"P]IJ"<8M6[Z%HWMW(JF=K)I;"V\"*T1K423 MSFK!J#)8+-#-'B^2PLRQ)D3'FNP$I? GK/]R.PQR^!+*RT+*%9!#U=XP%WDI MG^:'I(SHF?0)QNX-Y&0+8O2,FOH2)(.'M>#K/K:+_9PF#;&1%OUM_D3PHZX* MF*RI-*J+",6C? [L&_T/N89*' $$])"G%R=FH9S+N,@M9$KP*C,(#'&(GG2O M1WKM&:V+'IDS818),?)1(A,2E@*0.I>-9+H2%B?PV%AE??Y+-"+.)S=H,](A M:\ZI,QQS718*+_^/:EB'N:0*.PF+/%$P\KIMF. ,2+1N*5WS/VNF MPGQXJF,A33AJJ0).60S-XRDS8Q MZ/:OJK8KS;0R[JK_,^D>*Z+0I+ZJL+SX$J'ZK(M([2Y=[AG'LCGQD,V*S4%1 MZM7\*HJ8*M%,R#DWT 8]5(YL8"_USPE;;"XS*9J\AB -+TG-T S,JD"%E(F* M#.X:<"I5P1?%TDW1DT]_"<;FP$%ZFC!3O8BR*=+!@,V92 9Q$K6#< M#1BSAU::D;,N;1?[LIW:L5ARBS[ID?X&QCRGZX/B8SWEU/+"CYJLZ"A^_R7> M/F?H-I62["\+^@4!C^LUE"/]WL^::F=#RQ!5=?+GGK(-T''FC@_GR*9&&\U* MTTRHJ MK"M1'\Q&M4^ZW T/DA :6TB@B/0D3?\KU9JO KO+E@XU;9V%"@GU MP#K/%"^0&VFLG9*LH"I0<*D17+<2P3PJ4V*6++'OE.P5(!:Q;0,FG.C2^S8, M8S!LN.P-N,2KNTH%85^14O_Q^GQU;0$7MK(%1(,U C=(5(NW=6^W^OZ+%WY. MIVIO_6PCA!I.0B,U,.XP!O\T;I24)+$UJ^3L'Y1-*?.FZA)4#LTG>P$6*?&( M=] L0 >*T\P4)U'6%AF*)-) M*P>S(G]KY1!-AE[M1*,@:AOQZR")=!/G?K.J)LX*Q(I)9&.CPV#B6 D)@@86 M^NS7R.[.)5RP[[[41*?_9*RFE[:@B,M,2B_Q1&I&CUM;M"K(8#IDR4#YC6-# M;V-1-,3P"$_A0%6F%Q8)C[S:YF#04WE=M6Q-S0A_=2:7#PU^JV4DAC%MMUS# M)ZE"JWE3=U7[%#.UYWI3(E.1]G;6TA5\=0"/ UU!E6Q'1WFWM3FX#7@Z"3(C M&+E,+WM_]SQ&D$YJM6)"=_TT)8$R^&*0<[D>MYEVPUS+-4;G #F4,G,TM7F. MT8[GBL&>EY)'LR/_D9@$:(R?T0(/ZE;J-UM%CJ4N<$EVK@"%JXICZ"-Y2=H" M2SVU3;D,+CRTA3R>U&'8%=%882%1%V>K>%]1" M__9IPZI6C&V.3$>TCL@U$ZC-M"Q(5C)]B$Y.GVJ7JPJ7J2"H8=T EHS]:YR=@=F%YV.J!S-.\Q(V?7,EW??=^HN_F/.HOYE23 MJS$#;;53@X_C"+J@F>'S)//Y9JJN'SYVXN!>6A L,81]#*8)\:2#W$G-@FMF6CS@1UI/W:T&3J M2J"RD'I8:,+!SHQWIA4ZMX^[:;4TA=PX?X-M!DL5M\.TC*C2D SP5P,3K_,: M&9:&(=JT#NDWDPQQ!A40MB+:$NT%A=M/#J?F-B861_6M)-,5IEM99[W"FW;JRL*.;68 M]9,']$B\0I\/23;SECK_;Y4-%\?$;&\+%:3G-@HF,VW/6,(UPFQM+#>_9-%.I7\F;5M E+)'"XY!J6HM-"/T+[=$T=)^7W5N[KE3A6PCH$A<05*%F , M^-C>DM^0F(IG!'P^(;IEI\@DTP"5XU)%U'N3*LQ*A^+L5&\3#Z"[BF$E3E// M>\[_WQ5HG>2L[D[(;1@+/;=D8);')R@'Z??.>A2MV0B;3!J%^'EP!"[629#T M:O8=OF'7"V6DV5<4"^,B[&6\J>) MXTNE9W41[5&?W[-1TT.;**3-B45S=1@R+?K:7(VGO86(T@XOI[R:#HY!9+)V MNZ?(*96T-?( _9OM\FK+SM8 5NFIGF;N=NW-T'+>O!LL2.G M"MTI9M"]'5$43X!!-]JE4XHOZ5)#39 F,9H\3;;+*E04_U8QP+O5J*0U[RJ9 M[4J*[%KZ,%LRBO^7?W+2U+'5Z(538:TP"P'VKSS6[7<,=!UYD;&WYX$&1]69 M:E-[W?PS@! :?R'E\N"0U'Z;E;'[MGO51 A;-@.[$Q3\\ MZT#*Y@->W5@C1 M93?\+*HG=D% I!4M-J+ ML]Z\^P^&XDAN1W$6B(JR4KNRQ_]*%RULK[.]IVF,T@%MFIN.I_K9DCG63;:L M0:.Q8U/I\RQ/W*BR&7TRJ\_J"0%:AE_G%!-:19Q;\V.;]:$C<<[IL687=B85 MJ&+U%;*E-Z=DA30X=N-C-*58-S8'AE>2IH<3*-='@Q7F4@9W!4[OX.'V\!VV15$TWKQ$QMB@KFG$&8$RG/MN1C0XX7 MD!Y\^*#3(J92D(G[*M$ZI"8-%U!J['V:V/!>J1AY.M:CA>O)I'#Z9.3C(U*$ MLSXIH^W_4!0C91]_^<8M#)1"'@4Q"[]=<12+8T)]& FB; %BUL!R./EF- M&XP7>/,:/HPXL>(+ZA89!,D#)5MP8S'L>?HB%+EZGK"M) -')%QEDB(U!B,R M5"[1A$XDFII*];2YJ&:%8@11W!M9NX"AADGI;T'905^#8[DJ!V&/NN]4N\22 MIZ#"\'RKYEB1QEM".)-SIJ=YZFMGT)3'\CWKG$1LMR6"&O;FJ3E+?)>IH;XX M_]"QZ_\(9-Y1>6:T1-<=K-&AWWYD_48*>G+)D6"$$DY(88+*_R'5FUM[638. M.L(44E-+4C!R46 8X7$-U%H'3TL;0B M*EA%TXH8,][(4(N]E#)144($M^)6:%'"WUT@1AF$5S0]\TMO*!:1TI#V@5;. M$+@<9*0++[F563EU# &90 O.5"%BGB#T)#J$W633$!K^E^%.??4186>#J%-G MHHHNRFBC"LR 4''SL'>GAB.:%MQ4C=QY"E0<>),I47[4(=47N71BA'< ZN31 M27M^.8^].),*:;(C)YX(R#:N:1+P=&=%^RRBZ;K(':$1B- M43FN)*1[[1'K:4FSSBK!*MPZ5]MSRB=!&]N"P,&UV5ZO($N,H^[%3 M;BWV;E9(;.?!XFZ__OX+<,#_4PXK*F5JF:EIO?DZ9 5IPIW;F$Z7<2IE5#TB M)5FO6T4,%TF?/M8/5CEZXV=I)Q1"YJ-&\/2EM/=P!BCP"/H MIDF2.[U<=#_?Z :DH+]V[77;;K\-M[\WVK./:"2OQ)M_\+YJ*=(*T%Z^TZMJGY-G[1YO=XDLY@[Y1 8F.QDV\K555#Z;YW9N! M"YVXONK,<^NG[$L/;&3JBJU4OUR.H=^3ANA3>K'?RYW/)2N><'N=CU76N(;6 MM]=]_W%_;'*8QVG(D[#(A@9>L"I8V"S;SW\/?OCOF+0LAX_]X&1#2OI1C4\M#D$H:-"SY*XU6EK*(B MBOS/!_A+5P&] K^9@6IGK.O@SFQ2O$!I96Q;$LF9]O*L;'E@!Q4\%\M"IJ6@ MA01_Z6,(G%@T.QFR$%VN YO^O#:Q&HX-;7$*T@[94*+.!*EA%N(:LY1E"_%) M<8J+NMX3Z2.8#-QH<[;ZC'6< Z[)E-!LT#-8;+I(N25F[H?[P=LUR# @[%W+ M,4Q0!MINYJ?H7"MP&6R<)7CENU0E+F1,H][F0E>-]-VG<_^7\F /<88];C7$ M(MZJ%C&CD!TFB,14$YS6L+W;/>CB5W((=2PH1JC-8Z4E92-\N@E0&?R3R<:TRK#K&E^ M9NJTEZI4IW3TG&4X13BZ=%- DD3_WV_X YHR!NYW& 'C;#:' @>J)Y9T45?C M<+=&26E15A9)#)7:BLCV9 ELHXY.=JA9ZBDI M@SU:O>X4F?2DK0@%2/(-M:H9;174]EH[<@ (>'BM%^^JZ;J(P&V#2^)-2F?I MHE4UC3K8 M>L(S*RI,4[P1T^E.6<^*?81F>U0I>A\73PM%D'8 M8)-$$FQLV&AV&K\TM+O3S)-Y@Z9*C-8O3H4;[_DZA2Z';I*\("%,S2IKRZ'= M [D[4Z,B_YMYB]HJUY%<!*I3?6/$ZTV>&\S%4*F<8RD*3SO#T]+" MB!C&-*=JI[BNYL6EM'K\KEH@I8B/YJFE140U3Q3:)GNZV 3B,E>W$A,CAP8Z#U43&U=:TG7+ M5#9)>F\,U=60T[YLDJ3]M%J2HQY2%4)%K+C ?%?0X-*27_T+RKK!N!"[*,+N M"NE_5LRZ*]/2RI02B(>B2B%OE =?+4L3SG*AX=&N:\.LY>AI/?SA*E;Z,C M MY)MK%2VX^JW&Y0(AC_B+G&>IY6F]]6W="/C@)-K%E-;4"),:+/_<6V/32S16 M:4''Z="NLK9'%2N2-!]J6[+1(8GIFRM8R(L=%DEMA,!>DD87F#4\X3"M!OL? M2_]V8AD"0J3\(YHO:5,5H.V4P5F#(!*QS9D34;K _ZH2!2'8:*>H$Z*I4U4T M@5 A9$43/C$[5O+V+*\+ZSFG\P8M92^=D4RWE*.3WMLCN'DV\C5S@KH#'1>3 M\\E3\D^DIMOQI+P\ADL%#I-B?<-J18Y6',=+L2%?AHIQ4CDO=6G-7N4:@P0TFB=).'$3W>R&K=B1Q&6Q>B'$C>ENK) MB(05ZB::N6S-M65\5ZG>>?MY4'7UXULSCWLF8>E0_NJ4R"-E$EUFURO7 REH M8C^:LA6/*"0=S4L.^A*G6)>X%H6N/*H.T:K$$AYN__5GLLLH\+=RNF M7K^Z)35B$G,'-=^$-SOMC83H4I#VH2T2,;KXU%0+^=UJ^16,T$@*\+(;B\I= MY_E7U+8+NY&:;,$@V+ZOY].!SYMNIGAVDR?^==AH>+JB-VVS=H,H_!I9EP0& M'W^3:_BW)5R?]]7SU."U U"6 ;F?-3?@QU:U195KM--\5!QP)=T M9R4U#4%]G66!2"=)G#8:12 Z"+8&S#9(+U8U?1-%#K1&F"%E&KG)67TLS6P5!>^@5?=%R3T&C%(V7&X(B:TIB M?^;U7_LF?0AF:A?Q;^F2/+3A4$JQ-%N!8FOA<,4X?8#4@+>(;//S;K,&,:NH M;5^A'6W"@((00R:$(93F"8BH:/ES7^QS4EPB;4'"8+)8*/ W80U&-0HT4'M& M4CK_!$N0H1(85UZQY4P[R'!A"%"(-X@'2(",%XD3%UOO1B^Z>#4TD7^.$5@5 MZ'1L]HY)1T@^"'"/1Q1TMX%;9Q[$MUHM8Y%N]A5' MD'JJ(R("5"QB5SS86%#[<]!0_"6E- M]I1A$'3)MGK5%9:-M%^99W_JB"-(9E 'E$[+Y89%YHRG_VA2F<>.2F.,7]*# M9K)UQ&-]#@5"%QE8*:E!=/:8"P:+W79QP-1LR#%0:Z)L%K9^#S:;VC:;4&*. MX?9YR\A0"S:)V3$RD1&90T9Z##EX]/2.JH>'Q@=@_?=!V9 H]^:*EG=\GR!0YY<7H?E=]@=@!Y%M<&6+>.44XR5>RB8VLF.:YYB;PJ9V001)+O)/ MK26/_OEPYH> RT)WP]4B*G>=O\%Q+/&15=45B/5BL:.;N$D3&%F%B@6(WR%+ M;Y(#)>!::_-TGR:B@/53/A028/@G@E1B):1*2&E&IB.';!9'/:)>7_16)]*( M4*:*(C(@=O-4.LI7@E1A76?_ "?=2CS52A_JWCYAR7TL6/>R8@WBB4^H* $4D9Q%+A45=F GDB"H4'\U.P)" M.J+UG&CY+6L!-M[8CL/VA^4G6X7'EX+QGSK&U))"/CH,@33!26@B)9D80CD?CFFCNLR0:7Z?Y-DH=R83 79":NI M5M)8F]8%;Z_7G'/E@REE%&67CKU29Y9H0G0EFJI:F_-S#,)):+*V5[[IFYWE M#\W'(\,I?5HF/5:"G^(0EJ!2(=3DJ73DB?ZDE.$75DK"I>>YFRKJ:_]S0_U4 M+\EW6/S_"%P;UW_?)6WJ%(&$9#:BJ2S(U6ZL.'DBJGCS,[";UI>0E7 NP88" M-G@*Y'H@VI6E-EQ'!YA MM*@LFZQ'9G=?)F; FG(HEQRC-)AN)@V']DP@J5 '&V*)AGRF1*E,59U6EK4* MI3AH:I; 5)=]E(C3L&CEF7-=!PBJ\J?;$;3C*K'@D8$F4I53%6:BU:?BJ'B# MRK7,TVD!A6.+)SVF(I->Q@G>86ZL>&>=&H[!Z7W&V48H]YL7_^1@R:>.*Q2F MW3231,0FF=& 6U5AA3D9ZW-]K%J9Y$,"FCJ-;79>K%L31=L1M3B-DSMN"\2@ MF4E2C]6[R[9-XSJ?:WFNX.9[+D24F;HGWA9NF[=^<)*E+Q07T)I\T'HF[-J? MFVD8]T9?G JFQ!6>]==[<4!/8RB;AJ1!,/AS&3<7DEJM6P%64Q.AQ[HVKN=\ M[&MNMW-Y +*NFJ/SA>(K<<\C*-FSVLYMR(1&S.!24H\&\B''1D=UXNT M1]@$*-MSHF&-TMAB20J?F3*LL*:*"8LB7DI8\JICWF6G/PH0+PF&EF=7PHJ% MA8E6Q%B54(IG+-J&?)-1&<)*6!8R&VA(6!"R#2>I+[/A5Q%EBM6+DV72MT\U M2$'%M$VC64*T4.N(JDN,H$R,DI>IM<$*''V&"U/\:>]GM'LT:$P'FAEJ:;47 MQ"UIM2'4:0K,QE=VK9479P34M@+K:6Y++JV%.TMX4>MDQ=BRP?_&0'!S(ZG3 M$G^U>U\KA;ID.$+2Y'X,>Q<2C'+HZ(K V3H1[&I >Q)9XF7H&)GI"5_FZ9VB M-H>1PB-] IHLC',Z*+L-!B?F!KXC&9RB$)?(6)]1NB7)NS^U2JH8LVWFV(P0 M2AN=Q[+$&FVB%+_0.8_KLHXD;(_+_'I^9FVY9932][E>^X6^O%[DXYC/;)02 M$VOM]:YDIXN>F*J6NZDJS)(.J+/.QEU TV6I3$W& C+7"Z=K \34-L:Y)E9]]U/8[,$I6LOJBF;&(7D 7+6K@']BMXF]:Z%O-G5Z5U0X MBK9/UF;C2'7#NGQV3,OOERM@*KQVI6__0B64L<-YY)1]8*:$VN!NOH-/'5LZ MHZM$40EJ,$>%O=HF!QJQ;#8NN?,*;ZBALQ3 /G$:?16R9DK"]"(W=;C#;L2C M>LM8&MVR2K3&( >$LK1.?#A.9%K%AC#%DM<+&$B4SYG1SY:S/YL9V='06"NT M$ATF-I$,%X5.,'6I%EVJ2BP6)]J7"@9MO3G,XA[4LEJ!XK#9<.<4CLV>:;#,&@SX6M[DGG9D=0QG8Q%[' T M^[M2;$':;4T54298>ZTN4Z-]67SME0Y2A#1"F]WRQ#]>9N< 72 M_X#*&E>>W?D=_PT*OTKT;(UV0EJQL!D;VNLGH5M0R<*U M=8'W3D#]V4C\DDT]+6J5J' -AU-I6]UIA0Z8M&AI-OGYP5,*28MEMRG=@9Q\ M6U,;W#F,MT&80I@1USG39/;CU$%XA$_,-/&#?@!-DI-+H6N@.'F\?ZM+S(=! ME3Q<<@FIXXSEJ#ON<:C#E#YK'WZ-7Y.7J'T-#)EQWJ-Y^Z[JG-WK.3BEQRL;*B%J$*@>%' MG.SS931N''=8!J>SE[2.H<>*)=P4GI$'KE?_@$%"VWK14\+.7TUR+7W3BFR3 M97LG)[R6-%]WEX4>*C@[P1,+P MW+SEJI^)H* M28/;$\QJBC3WYIL/(,M5:^]?]],EZ"C@K>W"D^RPX"46^3B:">J9KWSBH.TS MU=$(-,1Q-,,J<6O"^4R]EQ=C])KG@7[YN4I?>Z88EKQ3AQ5L>9M9_4CHFFC= MG^C QV6.N5^\VLQEZ8X5PY69V!C,!(LU*Y]]=1M2Y1).J:3MUH.;AS+R'NAK MNE6;&/1>^J3H[X+I_S0-^7[DBRO;TJ/\9U*CP%&8\,G+XQ7*F)CCIC5(_0X, MU&[--Y^=Y($#LMF4-F2]&_(. >@45*;%<];=Z2U"CJK&C2*Q2D2U3\5"=%Y+ M61Y9&(];U65Y>*""PGA$)I7+8^@$6D$ODA]J1(5F7KD.A>.*>0NY8VQTK-/J6?%9$T+T4=NX M0K,9&SO<^0P#NZ':@3/MG"&J,DG9 SL)XG-=>P,RPQT<+'KT;0*Q3+S1,CVM M4HE:_(4,7J79/."8MJ!VRO&$V71-NIB:/'WJI-;;R6%N8MFL9B.[Q81K ?\? M27+/@R[SDR7:?[:A/,>LG35VG^YI*W-)UK][_Q05#(4J31Y7)\ M+$A.H[EP MVR+%\SA+62]T==9)8]=EG@Z+0T!>LX=-AQM[_M1!W$>NIDV;>E#^) :BY"\R M#8<%X6)"F:I(N)Y!7"J"EXNA5=&5HG2LI8]<\>(Y\[EJ$D:@$6TXO%%6;$:7 M44GP,AK5Z4.HSYQ1'#3!ZEXZ@N#(RCA)\#^4DK*2Y(L'81M=:!R[1VSU-XQHK)J.FM"6R M )^&?6AK8B+!Q*X0YO.8IJI4'+M(/:T:&;;$2V9BL;0R*JMJUZV*9R:TY6-( M87\EFMDNLIU+'JXR5+RDY[(YJ:O*B!IBK%H@@FF=/I#3"XF@&OP+LIC,VNFP M) 4:QIJID$/*L/.(;)&CG<1):RWS8#2/0K9^J@B])UT 5'36=%ASM)):'FHD )"*1E%%=)V-Q#*<#)4DA!-%;P8E/I@*HN!8R]..*:* NX%E6LSD0B'#:9 MZ_:[D+EDJ9Q"M[F^#=5$[8I[Y\_>F')M_RSQ+C%W%L#"]:J6?-D;4D1QF](4 M.NX(!#58]9R:"3V$X\5SMV/O9*K5T83#3$H,:%5580N-HDDZ>E]Q[[@,-Z:U MNH]>N&L/Y@R\]]JNPGCGL*1$BD7#?<]@32H/4P8::/[^N):?0&PSYPL40#QJ M.#W/G.9/4%:SIA_$V QYM (/@C*@DOP4L52*0"Y,7RV0D&XS1R7E4>,X-9:5 MD98I'/76;1\J*^_2V'X*RPS0LE1O^J FG#)O@7)K[%,&/6A6YX1=R]:I0$53 MBVPR1$DN+;$9QU,AQU[G,R+!=Z758Z$"IHO:, YNBR/L%Y; M)820=O) +]VJ,__6V(//WJ?W(V;.CJ];2C=^ 2%EW?M$4!9I"+^Z M7D%R;YBV3MAPSLZH+M?@3UG_6ADQL\PXO#X]2;XF[MKN*WBA:\8/6M/L1:D'V"QRVP6A,>G M?":!&A;1B%0R#KNZ8QKWC&A#TG)>L;8&BK9Y:2508=P< MH38HF8\=+$I)V#)E!#36[5*AH1T'\:2*KUV()X"[$DN(!8\9%P8@PD23$29 M0>+8JW0 )*";;*(3R91Q6^?;70^.>)7OP(M(3>S3\ZXGQ6H(;Y:_!&9B_F9) ML.&J61=$30I;N,OOV:]CQ=+=A93$'B &.W099E['$\.8(#6TZ1C&-?AI(\Q$H(HN#\/.T&JACU#] M)783W,+ZB!#"Q1UPAA&QF,EZR(J52>RAN1,@;T0H1F&FJ)'>?,Y9X#>^:+XJ M)E ,9HB4%L(*)?$QN-#$SU(Z4YHZKD.2Z*>)_]A5S10<0J6GI-^5PD'UAQL2Q'2-%(- ?$K70-)HWD:'Q,MU3YV&LD MM^KC,:$WF5)@47F<^2I$>Z*_7"*R+J+[IB/3>-7AX7-US'/D)?7J*+.J4V!? M;!)"WL8V7E1R2UA2YA;_6@Z+*,RP.1XE(-74[34/@9 8XL;:6R5*^&M5GL'5=J7?Y-3F^]P MY*0,X8U2455%F[@%I#MQ229U$QQ\O>@CS?1N?R')8XP^%]0QC0O$MWV;(1^Y MV>*Q%SJ)C)Q@.^D5U7"PI51D4#F&[!)"]L^A"V(R@"R%N@K3"%6'XIM?X.>8 MW3[8S6^&T'_ M5J%](QR?^_J'4H$NFN[3^MR]$#2*F8-YQ):OTW)8+ \EG][L>YXGT(7%2R2,G+*"1[MR:<2>3S"%3 MLW2)(E;"9;)^'NNN]06KX># ;*Z-V-\?!SDC. SF&1=,W-!K]7GR)1F+B.\I M?"Y&<"."],,7RS)ED MG$3(I9XHE0P5@3%6.,=)#F9V2MWNT'@W$#BRRG8GJ/LJK5G(-YF +_^K*^>8CUD[LK44N MK*L4V@O7(G)V4RR8MO&M]J M0V?DJ3;5[,NH"[,P-W?'R#>=KGMO?:I2U>PP_C:,>=>[LE&__-KH_2[&[S+? MDRDTTU7P]R=F^KU\'81%-T9RFD>Y3LU[\W?5Q&1["Y;+ U)<1K?GN-;-.0R! M101YQX9$,QR2EK/?,D_'3YO,_[@EF;SV^JSN,H[^@Y83D9EFL1I_,(2Q0R]3 MH#25Z3.1:37O:R;\2XZ7F)!9*SO2LCCI,QWH(S3I2+X%J3L !+GC:0H1-+ZS M\H:^\J1#N#$/Z[(<&[>3*XI&:?\MS?DS\ZN^-J.?+;(@LB*H8UB;C1&ERM$& M.W.=MWJ;Z!NGJQ J+A*Q'U0J8L('*RFC2%!!J2N;]4BX:!.3"E.+HKHL15([ MLJD:A[N]D? 5-2F]E$8JM>%FHK+,])P*7*+",G1N-F7DM7=O!02/$\L,P9](N68NZ M,/FR >R9?"FI!YF!;2JS1=I$!>1$1\N3VLFD#T3$!Q..("+ .\,OERDZ0(FG MDQ&Z-P277EN%30DV5$([(/._-SH#]P.Z972V))H>9E(4$AR)EG&Z%G3!0C3$ MDMM%9@3_1Q.YBPY&;')S O,;BL,?+-MG[,+;CB3.[.'TK@DX*/FFTI<6H163C-V90E_7RL-6+*UQCH"7I1DZTAG($0UUBK(%C M*BV\)7,P)" ,(E;BQ"5+B ,2H0"QP'4*%8MYMY=XE,_+1UTLK::H"*E1G,TC M,Q@4H10Q%#]$(^DCQ!-$0?#12)&+F$D\HUPR&' [*'%!LX7"KL";+C$4Q:49 MFMM0AU8R0?_!&MG)+P1,FES#LD?KA$QDRJ]#.^PRPTW$1%@L:%_S[ MOJ;KAZ2<.O2[O7IL,3T9-@UY'JK$"L)<'QZ"0-.80+%\)B9A_Z3W0SEA6S<^ MB#\B>C8"\@I;,R#W$B\?,CY!#,?1-)H_%$I6H"BC/,2^;"-G@HN=<9?[*")M M&Z86B<+@2ZVYG"'XJ3H6&95XC$>DW L+A*O(&+* R4>/4A!3$;(B,S$KXA"H MI+'DTVFJK)*ZP>\QP3:SN5S#U0 MA*J]FJO6+-2B@D.'6K_S#EMI5AQDS@1K!^,$MBXQ[6, M(T*YHZ 43JM@#/92"TE)O\ZDFC-:PH[H)8S:'2>+E+V$4DW:O'E +-OA+OW# M%'G:NQ]EO@MB)2P[R2""M_M(SU8U24!%R3=U1?\1R88@*)IYK<7, M5VVET2H$H7]4Q^A)(OTK,PW$3%,]5>L1F))\5IW,+CLA18##T.=*(">-0']M MKE#$'Y(:4W0:QL.,_U*:6\'V4@8TV]& JQ>$$4:V0I]R?2FYNU;YXIH%I581 MY+#2!$J;C=/&6;2B28X]%9;QR=-'E*Q97+S)X]2LT"!XLT-<)<.XNDCZ2XQ% M+1*T.M2W8 C[BC2>C-2+3!S4\5));4B'A [<9#N%8)4AH13?J1F%_<*GM+Q M?8P@,TV_0".>S+\<_%0W1* IY(M;O3JPPX>,FT=J^RM@#4 R#$/"V9)[[4)0 MK:SR$K?3[MV2@!%%E2&[A.M$E@TR]:>%D+ M8CGW(S!$E;EZ$UM\R@\AE$N\)= (U2GD6A<*H2 4]3%^C5B-#9&'#2]-*_\] MB+1*%DW2Z(7;.-L]BZPQ\;I>*55=EKU*=<,C*^A06V26S-4JEZ/22BE*G!U@T17*G/76 M*!4P[K'?_P"F]M05??14WV3!N-(D7LIU.J4+.%+:;'/0SKC-8[IG>I)RRF*3#5:V6X[I/3VE*>71*6/-9 M>)6C2S4X+[&5O#1)O!H#N^O(RLE"A8NJYK7-^ODMY)"+%YXJVM$QR[$KU'11 MIO3: P[@SM59/YQ99'K($"5;TTRIQWRH7E2Z)@S_06?Q0".UOW74(6,-*19N MOG5<0! ZD765S(DK/PJJN90L(57ZM:=R4X $+A4%5)9EH4ET5Q^]X:07G!NWT=0-U^E-FAL&'C;8GJ=2D8+"4ZQNN&L/JH9*G.;R8D\ MWDXY6:[8Y!]UM="#6(^88JI[XX;+SF5625GP8#%0KKB766W'V4_Q*)W:<=BU2]$3&[_0J"(&*UZ%U$55./(EW-7,\& M1+=@,J-DRS13#%!,UE%[OLONP;K\Z9&%'KG$60FL6]GPDKGP<,D.LZC1JVDH M361\G:U:_"27VSI?S(Q^-E4DS:QD3:>,L:7>C6 ?P8\FQ1@Q6V+X0C9]I'^:HM^0KBY%.,H>;E+]:PY;,)/\ MZ5RH:F0/C2Y4F+.GG>7E"6B)'=$E!3] ^J36],+JR.'S6[+2GAC6V=&8'E8U MZ^:47$BCNKDV/EL8J\5+=JG'!=%3X.KI15)8ULQ7B]K KJKU'.+;TUU(MNPW M[LZ"Y%5+:G[O0^CX@GGM-&X;78WM<=G5K MVQ-P(@7OP3EJ";1O(SNPIP+>(]V:31-H5):0;U):_NK9#>?P#J]E[QRST&EE M@_#?6!0HI+-PZB!J^KY%!PP\ZMH;_Z8660-2OYKP!L?;_]%7-93$[ZI=^HHE M_,;8(\5&^:5(7<;K=?2T9$[)WTUG*AMRWTJO+?^MJ4ZU,"'"IFJA::V8##2\ M6N\&TVIC1R!-U23]\V_OG6#?Y6E$ MF!=JK> EQN->P1K3IV'_8^I7CJ^*E$6(N35S^^0&KR*NW".(@2].:U)D[U;B M%(QB:QJP;30M*X?1HO/"GMP,MN,4FUJ%K,\/"V/K1DD .4]";ZU4H91UNL@E MM39OP@V'@$/=HWG,Z_@:#$?OW71([_8Q"O>@!_2AEX[=YC,.CM>0ICV3^A/G M#*F[W3C1=BZV+!\@;-0M*Y3ES.Z*/E4ETQT8;O7&;>?'&YN*5"2/!B] -;_C M7(D,3G.=/UW0/HK:>]XY#^*'H]1+YZQ;9QC\963>68BCE;3X$]4)QF5'61%* M?JZ*,^8UE#GEP%*KOS^&>JAT*=%Z6N!*>GQ$+C0<=UL-%_?0%WH#-?ITF">? M_]'TW8NGRNU$.+*M$UGQ(OY*)'F/3=,4\] U>B3^.05NEQAK]8'_Q* MA9_[F FZ'_J.5%;2JM3 W*YO4L^H8#;-L:S&]KG)$.ZB4*I-S;<6-9_HVV(= M3I=;OHK]*,[;PK9@*%.H%Q,479KT%P?&GQ>0.RG\]$LS]"?OK./(<88 )2>M MMI2#==Z^@YSXC2%YFBE76*W[PK$\T_6;(5V.AWNGY7('H0[CP_P*NZ''!]P0 ME4:I9H6QS3Y"8I4:#5*ET=6.R&VBB^H1MNU^8[ME'OTW1WZT4#5O%%U+!8)Q M_#V%@24-FB4B/54A%FZI"/8%/BV=#5)B\MP=%@U!4O]2KEQVP*&ZZ9D:@B(= M!1H!.18AV$Z)@2PISI+KH(N/R3G61^<#:/H>137TI4_OJ!,F! MZ/@6&T]X !WY(I0<_7UN=F>:JYE5A=^4U*/83^;C[Y_,^_\#O) FUT!3LR9$?5[Z212GGSIX_@PXMFF] K&W' M*5++Y59@M:W:+G)R1C59TOX@TV)+IR(K:S^-2"H(EB/CXJD,+@M5N&/K/,&' MP>WE1&A@K*YVO-?X'=,IMM$M77VAWQR 1,-9(EE1)'+RGTSEC:R0$.?6Y= ME*%*)E%S$DHG$<(-3?SI4%QF_74!(8LI).'BBC-J)L,]-^J#(S\YPI@6,K"0 MP0H>7[5DTH+X>5)@&D4"E,P8S:U$RX0]X623D"!=.-5\6]9P0B',G8'03 JV MR!%3_T**B<:3FL"GT(<5DB(@2\VI\Y^#_=U'CBWT?2F5@4%Q.8\)XUF5E)(/ M6=3>)M$D,IU4>U2G6Z$*C61"0K!Q1TQBR:40#"CF34.H@A.>-M .3=ZIY(#2 M.3?&:LX!-V2$8Z%%E:P.UF$)8+ERTII[O6JJ%@TZ$LOCCL?>2%4]6V"IAZJR M,CHH(]#2)56M]&4:9W!I4#08AY_6;9HB[BX M!N5AP)5V,R68 A+S85 ,'OIQOC'R@N@R>DA,;CA-6";F'VZL>4340F6\DV^ M7S#6<90?O?84S/4&7>30TVTP;&;&%HLLTRGTW*ZS^UV'S2A6+.6F?Q7[@"!T M?@^.K53":U< ,LA?RIQFR&O2,H(S&D_2$KTP'6(*Q76I1 BC M;,.A&CKOP309X?]O[-&MOI-ZC&)BOOT=-&2R067==&E=NE:U4=&!C79(?TUD MMH=1&VKC]Y6V\!SH1ORK>>"!)>G6!$6=7CG!/((>[^2AYKOP( QKMZR7408A M999UC)GR+@!ZF^>M)EIT%?JUWR EQ"Q..$WUQMK M?D?^EA5M\W:\Z>M>+@=NHE ,KOY\*'A.*RF)@O_:\"-7'$(4%N):Q&:V+@[% MYA()D=IDQN*CI&#,-0C$&5[&(0GKRB M2$^*6GTF.$'5 &EE.%3*#9L C5,I;3+&DQ$1G?*B(]+H6A=,B7>,E!/_+>30 M<"MCX>V&U"18X8UD[^-#;%(8PZ T:!P%3!C()AB=S.G/:!X"T8<$]\(46JD= M $/ &.LH 9953!DSR8T=:\"/38$'.5@SWN3JA[CG,#%DN=D>I)2(JNE<:C4Y M9!6<=A4_X'AK.($D!:B(Y[U($801A_%-W1@IQ/.4RDPUJE2+YI(,3'&"";&T M'O!@&9?N%>\BR].EI7"CO#(-L9>0*4[-F(5*LQ@F=*J3A*.P&!L">NUL5Z-. M*<%@(.3H!BH-.U ?_P<[6@FGF3YQ)6&D-B,];:R;ZIR!4W[W*O<88ITV.F 8 M.RC*:+T+7%*B6KRTL221Z<5]MLH+KGSXQ)H\_R@W5JL94DHF$RVXDEX<8TH" MJP@=?HZP(8]R">QH6)\ON#*D>.&BJ6#%Q"XE,7G.6ZE*6XH\-D3MFQ,:18#B MU%*6B"NA$/TD,!!:)?NH\AG&HR([_% BE2W]4"N/\BV^#N5]$_?E2]DJIDJM\V5< BY_#P0^G M/R,A&STXW^0:@[HQ0B=P06SBI,Z1,N6S56?$S%A;(58Q[7/R+?4 M,I>-B:$)PR"/@L0LF3=;YN.2"LRM:V632XNFVI2E#IB+<=#0FV"J/=>:6BG_ M%!Z$U1MK9DE04']I4;\*)L/[ 6^*7H0PJ+/N@ M%/5HL0$R5+'YF6M)J:P$'RUTJ4)M_$"W#D.NA4<#FI-S MXHM#@SO MCF\<>[,Q3FUIE_#=(5D](6]F;5&WBUG;3UNZWC)&B" 9RO,QM6ODWCG/>]YS M5-;Z:\Z"M8.TJ(XBY93.=#U+!FC87EO'^'ALFBE'"715B-F4TH Q4,.M%E2W M'?V],X]Z9-0L*)9IL709R7"N[SN7]/E7T64TM]#I:?>Z%Q39?'KHR* E#6?C M0])4/R A[#S=RLD)?H$KZ1I+*FV?VV TQX,\Y5$QX-'_@-LJ%0&= .T1\W4U MV>&[9"RZ; >+PWXT6][=3EFO\J1I=:N+],(>KF!M!0LI^%8-D85QRQBJK M*3N1N6 F;OPN3[T;-LACK#(&Y.=W'OI71B#)N548=V$NF:O2X>H591 >JREU M@PE9N\TKS6&__'P<6GADE]F,&H^I\>?"09]T/1X MC @YVBRH" *%2(R)C= M@5/$08A9C)*T/!"-:5,@%$>A3%U.;)/C\)/MU-8A65];V8$TZ%V(_5/Y?:%T MY0W-P5OO^.&2L1:P"0X - IVZX,"N MO%]TN5,_"1KXX=H;9E*;A*'BI5*$K,/NU:$2'HYDV,O3.(T52EX>2.%:^1( MX @(HE8M%T[EF T6@&] M64B""/\-OQ&)_E&-D*30">$-1/W'NS"4%,G=],@5 X+1+!Z#,'*0]>%(,/+( M"0P1+#XA%.(BY>V2D[0)3(7;]^2'(!ZI0(#$5Q*2B'6+3)9K6 MG5#C"&H0[6'0<(BAEPF+T_56\65+,I46PBGNJ'1EU53$^Y/S\Q6TN6ARDF(";8D@=!32BHB5@7'YBU',##3;3GEC;'A MR"&D!9"-,YC9%EDA/U1<@4V"7.K21()&/,Z?,)U'AWS6N/V7II$(NR2?DT6, MVWQ=0O3=0HJ-!_*4,A)A$3*=3_5-1LT)4/TB6E%9H5CC\P#_8+=5YJC\":2A M9=G-VE_Q@;ZAC3.ZHU8>R<4MH7;QR\P\FM;0ID'>7A1B6J.(&/J(H%%MV$>D M0T NGD@$(K]L6'AU6$Q2T6V*(4 ISUJVS9A@H,U]BU8^&)M%Y-+@2V*-%U6E) MR"%V%B-Y"O.\$@!I)_+D@ROR$EY^_T;\V9[R& S-\1R..5B?K-V_*%;U&%%. M1B!7_-T_8H12/6?.$ A@K9&_01N#H6=W :*+H,PK,J%4 MPFHLRB(,:%"\Z./-^:F)6=0Z?)[Z*=F(V MDJH:ON>S*.>*OE%JQ>447_E-.XYF*N681?!CG\I>MVY>#282$8(>ISP/LCC% MN#E&F)0/.QKB3-+A7G"?OQ3I7$IETPAIPFHL1-[E_N5E_9WC[OG<:ZW@. IC M!J9>E/[@RKJK=E88AGZ:1AG_ >3Y&7R8Z9#Y51?2U1N>XCABBEFUQWSXQ<'@F2)Q M@@+-Z%B>54XQ5>WHYH801&F%'#RU3UFVSWUPXN[M*L:1 *%,[-:HEN5N*#]I MY%>FZVXUH,Z^"]ZUJ(VN:S !&+R42N]NI:ATY&JMV8"((J0@F?U@(FUD[I2M MK--DVLYYQ8+-(9V:1,:[K-QBY32A47Z M;ANE636X8+/TXS_R[&;:)M_\;&IRSYO]4*)=CE4%(&=,H\PATY9HK6CJV-R5 M3'%=R:H-H/369UTJ9#NQ8)8>8VCB[-4P#M9)7=:T[9NHH(B\,$V 40^J9*O< M_]Z,D9I3?5>0@%WJ%LZV5:;8-$P^/@5//EL!-M#%WHH&[1QFCM?04!24^>80 M#J;3/JL$&. Z^[=ZRY6Z-F6Z4 M416FC'G%#T-SG]4KV&[L&-Z?N\/7_!#<2+( M"8<$;Z+Z,?(A^PL8A1U_7D,F7[)J!O(\#1UB$88"BT^259;8?1>J,1&[<4KX MJ%YJ\F1Q$>(;C?'E/>GG$A:JGDZ0<@]^(<.Q*ONE/BP%I#C;=DV*PA)E#Y'+T M[;@MD2R(8LJ=R-A0'!H%V329# D2-0^17($PU+E:X[*?9BH2=:#.YUK.F.7* M\A8C;$EC[=;GL2W=4-L.AL8%?MKMZ% ,)8'KEHCKP=U.,(+$*D)ND9TP+$[M MJAKC&^T-Y#1@KX0H4D_G7X'*?Z)E(2'2QK$A9S .7SZU=.F>*2M@ICP19R&7 M)[XLAK:8:;W9 MJ\C&V33!:$,6,U[_@!(^&M"FW9RF;%/V,,O2[.(U$$5,5AVK;:V%7GG]E/90 M$'0:Y4L/B'E2,#UNPAC28TK+7 /GF3X%X$E<+WIL+9H*02QT2J=2[> MK&M']6NA2-FFT G+[B.O414+\#M7'99@L>()",.D%V$Z%SF>FFE[LIE6$"95 MT4F&W;VZ&)3<$U#5=UTO&SD=5QM[LIF0GBD"*(!=SVF42^TTMZR)9_CJ=)&!/AGW_G7R/J\RN?4;S\6[U5?*+;*-0R1CP9OF1JOJ M6>6<(1)]ML&$)S8J#BN?;8>:N"=O&/:+:5:/^)S-9.;3>1G2@B M[]H=U]>\.A-OO9_KODY3I^KGS6)G?)K6O79_]R)$I)8^&K0<2!L+4;G"^%KY MN@\2EZFN)K&)J'!7+^:*)TB24)319+( SI5_%Z8M)FFFU==@*K@%I_706E4" M7HBB_Q-M1KH>'G>CV]80VW6HPR)6X?>H$=5=:'.4ZYQ$;W0!^R+:!9L9Y0UP M'N&E^PSZ)4HT*QK,9FT,Z2/)R%8K4;==MA9:?.(HEM@*;K7C-7M"A9>JRX/5_? M;I^5R]'%B5OB^'ALXD[D]%%KA?MX6$958 N),>Q'DXKDMVXEG4D/DA/8W+)( MQ*5?D/T%M:0U((T37*">-,5Q)/:G'/HEO+#=D+\\;]'[C>8T@&9X*5KE2'6R M]F:3%8K7&ON*".WR\FAK[K$B#1)@)N4$0A*F5H\J!QU.11^X0C9K1QC[-Q1Q MA_\SQ/;3=BN8@\EY5CHC%HOC#;F6$$SA(P?IVSPMP +5O"+VZH+GLYE-#6G[ MK$LSM-5"M6-MBB1T!+IZ;W8ZWY]-C*,Y$!D_I*O:()59J=9LO>2/;<30D%&L MX?8Q'?DMVQZMX\\8/N/&CM?;-PN;JGQ2>!CIG\OR%R.&FNRN6T;*.K6[3_D( M\Y:FK5&7^4W_2F&Z3]EMUHE8638>$:5H6:(HM&*@&+*G;NMDVYB0DZYBB^7Q M]^?-"TJ^AV6:)[T>@L^'ER82>;2EN+&RKK=AD-+;.O2O#[X$3]D+9:9X2.A, MRBZLREMH[=/U_2C=&;:P.:SZ0X"2DU9[Y2FZH.TUS=NZ#CS)L"S%@BU1SB6] MVAUG<&W?F/QQ&.&06#0>B;><4F6;\1#17]/5JHE[4 M$6Y$Y96MV=8!O'[NMK1[ =GW_P&%PI0&=3BB9& 01$2N@&ZLH*!^TG)L#L6X M2@(!M1J[""?G8%0ZWE;L%@F_5FF:))G,VCAIP\A,[QA[,.MH:C!U_^U<8Q/Q M.(ZUDHOM1D4I7R"A66][AL%H*>Y4M1PO8Z6VXA)[6\-)I]#3D9/94%LQ*=NX MO569EZ@([_FPDSR7H*65TVJ+]MZ5#978]4V3O!U?"3O)\:P39-)S()C*I>A>S82OAC.BSHS^1Q'GF-Q M8\VM7^.P16K&S36R$[)ZM5Q)M$^2(+D76 MCNV9I3[$^0Z>>NK=M\#_K9;AEGCS=/Y65_TQFSK$)3#;P;AL; O8 M^G3;'=5!FP68SY$5[AQ=5X3KTE;B+JEEH8>ZR^INKH_%.TB5Y8Q: Z2#9"EE MG05E&#Q1@7]B$Q".P!'FO#(^&H<3J62M'FD M$I*Z$B8^+!!12Z3R#OLHN;_4FN^&(LD\0@4GW7,,'C#9B,ZO4]Z #0J8.""2 MDB[E((.:()^DR:[_L-X"4*LG?"@3M,QV^&JI/$G*2B_R"FO4C4&RXI,%_ K# M3S$X:Y-N#4P5<\JZA1J;9(I>L'2TB5*%F^:BG]AY\3+=.JVI0;AJ/?5&IW;0R M!$2SY-10+,;4PM0<7I]M-QM;XBD(RH&*-:Q'%9>]2<8L)Q<\9PQWN0(O/"P/$27&\]4BAZK? 0JR@+E@Y$X&'+* M0:$M0DYV1%B*^I*W;.%0>:"8'(H/8)/B.:A>\I(45385,W3&M2,G.?EC_X;H MH:>[I/ASUU#59%YS:4T=1$;,3T"DJ0X&!VY*WFZB2/5'I!L$6:9](WQ!ZK<] MI.K;8ZE-BVK.:.W6.#3Q]G,L.TLD%KG)*LJY6K/$$2W7 M(? 2LU<\IHZ$<847&G#;SF6DNL%<$Y_P&L=)P40S$8;:[6X+18K73CT7"T]^ MD@N?U_%V"W'4"V/.XT&'[%5M.FZWM13\2(,<++G_7,U819 UXVTRX9%6(SD% MURU5HQC,S7=<*8_4U)KW_#-773]0[FZ6$$O]^H;E!8_MZSBL5F>1L4MZK_Q= MA90BZ<5BY#D+JMZ3HM.99ST9^UP!E^ N;CQL1/^_0TB48A$E"%'?J(/MJ1$ M'\TL1#]$(]BZ2+:Q#$7'8CR<4KE6U[8SS6^ 3DR0YP!RM=$\S%)\V5J!N&BS MCX5L/*V U-Q,((5W/8X^&YL%%=O%"]^,S!GGHYLQ>H>NYBV.6S"IHB8\@IR3 M26E.A4/?\<3%)DM4Q5V(&A0,I;6_JR0.B?> 39CF14GMS7%9[C.:JMI'J>FP M4 T\VV$:2-@W, V*43R)V:S8@88T"B=Z'MN\.B)4C6 [T5[2T,<"3&TMX: Y0N_>J%@(I.J=)"NA >;YG' F(E7*E&;&QI MDRGRAS/;%3<9=L6):C#D0+P&J"<^\GXW&>"&QN%"& 6ICI883NX*1\.-G%)H M4WL%E2A2#C>FJ8'F05".&M6RYSUF1M]9&)T F<.BO$=^*0.?H[*TGC"B<()X M2-M&K1867N I5<2*ESQM,Z6[?:$&?T16&,_!-O1IU$+L*<2 .L).^Z4H2^@L MXI=,JC&$O*08GW0114^"Q)4<3D!B*)L][SG#"\)'AF,R_ZJSW@FH2!%/E>MS M'U\N%RRQLG($9**EWUB9KCNUYH>U2A/AYL*YMDH-B\ RYNM/9 U64 M/@+BB)=O6]4WI@F9@PIQ>A^\$=-44R]]PF$YKO9 M!S540_X1)4%CU3G4N6ZHJPN.$O];U,$5V#25[G0HV\1#+OC=[U,AW=],Y(H+ MZ1)8()KX1#\Q&JU*0K9L"%@Q;0A90' ]],9ERMX>/YE%4 +KQZ8,'6F/.7A''A(0-CT]Z4A\TYM="I74RE*]UB_F\B[ A?G.PH)7C@NG(,I]* M.7/,Q5!C!8Q1WLQQH/A[,7 FW)$:A_;):>5=8V*&%6OJQ:^186U_4FA+VL(4 M>G*.,C/UY>&\@:3'GZ';<&T8-U]2J<8VKC1ZE@6E(L?BT_>$FM'(.%288A>- M)9,I#&^W"/!&!3<&6S/G1M8_^RDL@0>$EQJPZMY%U94<_4UO15^80UGQ-R9S MMB\RW]O_SZF&6(ENQM RN0M<(S^*UD U+60KLPZ0:C#;47EOEGIM9*?!Z#QE M2F]*4!//O'!4D@H$10:1249E_:+4E$6JUM"23W'V&X[M \<(QZ@5@A=Q9\@% M*"=WM[#@+E;(1VJE#ZQ-%@6A 787MQUCP[31;'+77G_&6\8/#63'NE;&U^Q- MS%SJLC&RBK-ZQI^FRY&;U8(:M.$BJW'Z@HK+RLH+&\7L8!1G;OB"L M&6DHT&D'5(]F7::JB4E/BE)9FV[LPG,"U#V#G>S\Z/0*RSXT0,:5&EOFTC< MFF!OA_2D##NTE?Z3DA"]C&14#FX)/0<\BSG3G4)4&)#>7J.E_S(0;).JD(;A M6](%AK$RWNFE0W!V2+PPVP3A#;Q%IP%MP[$'8+,<& 5WFFP(-NPY#^U-LRV( M>--NMV^>][V?B,63 HR,)%SXM<*MHT)36U:ZV\R+]ISV(GZX M$F+\*V(335XFF^497M-L<_8=U:[%1R_/6)"$;E#R%B*<%O+"A*^X0#:#Y"[+Z JPZ_JLAJK+$;S#%LK%SW!#;3:E4X9.%LPIAM#N#8 ML'XHC*D8J%8>RL'@QX7$3MR:IB66:\/XBOXJCO,2KPIU:@EC0@5U;%%(@AE_ MCRX:#QF3D5)DP",M@"0S1#(J11]-_S(04)'DU.GX+FD.X:R%HL(7XZ>CCJHF M=<>"8&E)XG"QQLI-$HE9M$"Z*'%>3!'DSD9Z)NW\/HJ)EJ<:?TMV[N_(C*\8 MP6KJS*45/S'7SD*3YC%:9"E2B(HIKRZ@A,X/'RC[TJFI_$Y$MJS\ON]F'JZ+ MS,T0.=$804XEK3$D76PDA[$D*9"8)@HP0Z4E.>$=^'&]B#L94 M9,V@O(07%HS"9A#VU#&A>M$6@#-(G$^J(9H@: M$2SR(M+6&G/S_N5P=DPM8TX@*81%YJN=\ ?=<.HTR(>*$"ORX+$V&>R!UBT4 MQ:@?(^0A&?_1+17S)$\!) DQ)XL0X )3W(I!,*\";BJKP !S8T@S.Y$@$HU0 MJU0NF,Y++IB"X^YHM'3RJ-3CYYYNZ1]ESS]CR/ M7E"AQU!3-4GJO_A$%#V4*^FSOOAC-,?Q[;:L7[0OFWI*;)ST8)K_QW+V20Q' M;"$;TZ3F";Q#M$D"Q@CCI]$5_$2F5Y[:03$G098%6Z3C24K,DC4*[25V<[A02T3_O ML$&?S=%$1@QQ0\!N,K;L[Q:32=+&!T,!![<$3TAU48@."='J\Q2;3T-YQUWY MDAA0IW36FX-(X MO/K9@*FJ]3M.9^SAZ9/ M35^+9\/V2\BGHJJJ8 ;U?9N.:Z,W&U[U1RL(QHY-S4Y)''=M7(JTHI37+X/S M?V+S"BY8>IER 5G'ODS4=9SWFUC%5EH7(@;+,)/56JS2_K*61TK+*7>WTB(1 M/Q-0M)H'UJZ&57)UT M"CZME+SN<[5)?=X4B&?(!1R];UR?,*K8;81@ M)CC/=I (VVHU!N<_QD.;?%/P&RM8+>/24M=0<<0WSB.A"M^)"3D+%"-,S(7 M/4X/(Y8";0MW075E$N>;H-+H*-?7H&V+5[2SR@#L!)1O<6[IC F+U/1ZTI MN10$AW*1\4]W"19ZQ[D(^H]CL;0URVJ7NZ$\=+58672ZM%E ,7*>3SCN+-39 M='A'O"KM_,F$$"26ME2H<[;O_+3:7"^C);6#K)I9+'4(9>HD]$O_)*Q",!E; M4- RF[KLZ&)FUN5FQYJI \E0>PTJY3<$>EH!6K5]@W,*:0+X'-EM[P596_\' MB-VW@=OZ8E4MJ0-;$**X_.+B7C?(6L48&L5G3_8*9/O*:#NT=E:T7;T8^DH" MHW@/H^PHM1-E$HT05;S5V9H,C;YO4H(YE/6Y5B%QM4?F;DZ1CLW:6$%+$%]E M[5I@]]Y4^2#3I43SI9%QRC[Z:T-[G%TC6;!&NWP8BF4T7'+#ZM283PVKW 28 MB65I4"J[+!12EZG4A("RL&^R[;*N^G(OG696DJYW9W,R\9B9J.&1@&[X!1/- M]=885)VSC=H2):4VP< 2Q(P" OWG!L.4/[1.?YB3?WG-B/8PA0O$]V09!L?4 ME\]4@N=WV@3"P;$3D=G:2VB;XEJFM X\JS6\8NG_$2,ISWUWK2M=>+V#L<4- MZ%R"!"_J:I8T>=]\\>O>4KXD^K7K3_IR^WAM^+0'O#1=B3-H^WSHUUAA*[&& M28@5]*_ T#,BL.1J2$2Q)H#&&\'58WH.47(7C 3:# MQGG6N^;HUB82B=:\;)#@F#GLCDLG)JJWGUP,?9FV)KC4NIG2G"GS9H5/[%3VK M49+WFV0AZ&4C4TJ5]B)=E8S7,%W66FQKQDXY*L#P+;]AY8CDP<3J;A&4*_PU!?U72>;0WYM#CQK-/8%GBN MA/MY/(C-R)S<>;2!)4JN*9.C-.ADOU&NR6BW_>5L\HIJU1$D=H.:?;XV>7XY MC%'/S:.K$WQ-W\[8AG/7ED$=V9,Y:5'TN'JT#PR :$M,MBT=[R [@_KG3[:K MDCF$M7"RE6\TR3VZA7$NU\DGTNM]0RCXKN,NJ7B$> *4RDQ$PQ6FWS02:-\A]FN[B M(4D':M0GH[5,_Y";X2WCO-+X$S&NEI^O]I1+"$KSU;Q58X^^<7*R:D:R#@%"1G MD=3:BN[$12B"(=EQGJ2L;.N^<"S/=&W7GIAG7>R'?2-)N@ MFW1*K5JIN6%O% IN*\=NIMN55"S0G\B;.S>3W'"1/&8+/Y=T]5,8NOK_@('_ M@H.$A8:'B(F*BXQ5:AM[0D$D>)5HDDY"9CI,9(\^C:&B9 =O)2=OI6V99YA9 M*:1;(Z@^9K5Z'J*ZBK:>L+<70!H3D9FDN,,@2Y&4?;O/BU]QP9"_>7.HKVFR MTY'2W]6^;\(HJIOF2N2"M3 M)H!U.M7.Z=*7RK91:^;04SHFZ,*5(A?,J]=QU)"Y_Y1(5!@1=@*[NMVK0.;8 MAU#LNAH+$!,>PQWY6>VX=1A<=PR-Q??RY@S:]Y,C[&UB1JN9M 'Y^G-??IB#Z$@[YCNK.Z0W/OOUEN]E4.8$Z51;D MU:S6*(S;?!9AT%N1)^!%5!V7GWL()JC@@KM\(!@[9Y!$C# ,VC:A9*M .$M- M%7;HH4KXA+8/2L>0=I,2:SCG!@;@P*0'BGY)HY,8"D%FJ>667';IY9=@?I4. M>J-Y)!(;Y\C! 7GJB>?@/[HGW8693,9 M+HVQ:2!7W\4'7W=R2D?V#$PK[?>=++*'6E-(*RJ8! MI7Y@()DA0\@0:YFOV&:K[;;<=IL91>"66>.HV*Q%@9#*PLD-12?5(8>W\,8K M[[STUBL(;U.ER&%X$T9Y20GV!BSPP 07;/#!"">L\,(,-^SPPQ!'+/'$%%=L M\<489ZSQQ@H0X7$K#/9&!,@;//-..>\ M:Z@:JNSSM#.[7+,,+ ?]LW!(A\B.SDPW[?337AZ]1M(\@R5UJ-W)O$G57%.] M,M?_4(.?-E*ACBACS*V][ MO1_7<%.]4(3E_7: WHPW[OCC[I V*5=Q41-<>8KRW$F3@P->RR1S>@3YZ*27 M;KH5F+CZFQ=VC4EN62;BRY,3JVHA.TZQGJ[[[KR?WLVAV[79#-K&$G8?58Z: MU5^DPHO0^_/01U^V-M:\Z1A9I4GYJ*5DWK7;>7 PMKCTY)=O/LK#\F1G8:FW MZ\I9GU426#[>K%+_^?CGK__$W>7ES]3U*M+\&.O"! M!?,.3!13(@/6[WW0BF@-(P&&H^)'BADA,HA*_-#MKM0MQ M3S0//B@H"U/(JD #:L(2M\C%+NI(4LNSDO:.]1H7W>D_/1 +H:YX*2^Z\8UP MK$[<7(BJ"L:F**D2E@$M\K8UA$RRA*?0P8#35.* MV2 G21CQ6VZG=0M%\/ 6;)4IKRE T:23&0YS>)-(,N21K1 M6F(RQDUN I6XS*4N!U&GJ*3'&'N02&%H!+C\W'$G0]NE,I?)S!EL\AKC891V M-/&@*\8LC8Q*I+'>ULQN>K.9_PBF.AS326%.:E73M&" J-GWS7:Z$Y>*HTGR MVM221Y%EF\;[UWUT\LY^^G.267#E8H %2M]7( M$1A((I VVXFF+>;BK#<\]*,@36+B IA .*UH-<($)AEQ\\Y(#_"<*Y%_ZJ1&4FDTF4)]:E0A1X2]S%BNJ2*#P M$0^CH=RC5]_*U[X^+8/B6&$2PD!,PF9P+/MGLZQG]LM\$.$O:TIKVM*A-K6I7R]K6KB"6KHVM;.$:(J,E M#@M%F]EL=\M;;2%.<#VSB&UW UP0]O:XR.U4;ZAF5+EI2'" 2ZYTIZLIM/Y6 M,O*!;J':UD;J>O>[8)I=G*3D/><:,99[GP6O>M_ MXF)D%R3,X0Y79Y^&,0XMZSH@R7CXQ"CF#'!:2(<8RC()+;I5BF=,XZ9@U9B( MJ6G,&O73&OOXQY>T:&$3XR:Z3A'(2$XRS'PXXJG&)2P33:^2ITSE1OAL#)88 MK$KY^'R!*GOYRZ$P9"?%^.*Z6 #,:$ZS(0I(S'&A)SK=5;.X% MG8#HGP))&=.@]K+'_&*_J2XDU*B>LUJ:2LOL&C?5L*[RX&["8V*-5R_6N/:R M91<)/"WF^M>R#@B[5D4J8!M[RFF]TD6/S>PD%Q/#YFFVM'_\JA4W^=/3SG:$ M2PUC/6C[VRDF5DV7!.YRGQA/?WN(N=?-8=+@K@WLCO>V,PR46S_+^][X971+ M>HSO?JM7GWSPM\#9BT%^#_S@R0WPJQ'.\-X:R> -C_AL XIMB5MURVSHM>! .P$! end GRAPHIC 19 stockoptionaward3.gif begin 644 stockoptionaward3.gif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end XML 20 R1.htm IDEA: XBRL DOCUMENT v3.19.1

Document and Entity Information
3 Months Ended

Mar. 31, 2019

shares

Document and Entity Information [Abstract]

Entity Registrant Name WEST PHARMACEUTICAL SERVICES INC

Entity Central Index Key 0000105770

Current Fiscal Year End Date --12-31

Entity Filer Category Large Accelerated Filer

Entity Emerging Growth Company false

Entity Small Business false

Document Type 10-Q

Document Period End Date Mar. 31, 2019

Document Fiscal Year Focus 2019

Document Fiscal Period Focus Q1

Amendment Flag false

Entity Common Stock, Shares Outstanding 73,483,687

Entity Current Reporting Status Yes

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
-- None. No documentation exists for this element. --
+ References
No definition available.
+ Details

Name: wst_DocumentAndEntityInformationAbstract

Namespace Prefix: wst_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 21 R2.htm IDEA: XBRL DOCUMENT v3.19.1

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
shares in Millions, $ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Income Statement [Abstract]

Net sales $ 443.5 $ 415.7

Cost of goods and services sold 296.7 281.3

Gross profit 146.8 134.4

Research and development 9.8 9.6

Selling, general and administrative expenses 68.6 68.3

Other (income) expense (Note 15) (2.3) 3.1

Operating profit 70.7 53.4

Interest expense 2.3 1.9

Interest income (0.9) (0.6)

Other nonoperating income (0.6) (1.6)

Income before income taxes 69.9 53.7

Income tax expense 16.1 12.5

Equity in net income of affiliated companies (1.6) (2.4)

Net income $ 55.4 $ 43.6

Net income per share:

Basic (in dollars per share) $ 0.75 $ 0.59

Diluted (in dollars per share) $ 0.73 $ 0.58

Weighted average shares outstanding:

Basic (in shares) 74.1 73.9

Diluted (in shares) 75.3 75.5

X

- Definition
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(12))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(10))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(13)(f))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570
+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (210.5-03(11))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7(a),(b))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_InvestmentIncomeNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (expense) related to nonoperating activities, classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373
+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1505-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1448-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.
+ References
No definition available.
+ Details

Name: wst_OtherIncomeExpense

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 22 R3.htm IDEA: XBRL DOCUMENT v3.19.1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Statement of Comprehensive Income [Abstract]

Net income $ 55.4 $ 43.6

Other comprehensive income, net of tax:

Foreign currency translation adjustments 4.4 20.0

Defined benefit pension and other postretirement plan adjustments, net of tax of $0 and $(0.3) (0.3) (0.7)

Net (loss) gain on derivatives, net of tax of $(1.6) and $0.8 (3.3) 2.2

Other comprehensive income, net of tax 0.8 21.5

Comprehensive income $ 56.2 $ 65.1

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-Subparagraph (b,c)
-URI http://asc.fasb.org/extlink&oid=109240241&loc=d3e32211-110900
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=109228884&loc=d3e1436-108581

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (i-k)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R4.htm IDEA: XBRL DOCUMENT v3.19.1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Statement of Comprehensive Income [Abstract]

Defined benefit pension and other postretirement plan adjustments, tax $ 0.0 $ (0.3)

Net loss on investment securities, tax 0.0 0.0

Net gain (loss) on derivatives, tax $ 1.6 $ 0.8

X

- Definition
Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e640-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e640-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e640-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (i-k)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 24 R5.htm IDEA: XBRL DOCUMENT v3.19.1

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions

Mar. 31, 2019

Dec. 31, 2018

Current assets:

Cash and cash equivalents $ 265.5 $ 337.4

Accounts receivable, net 318.2 288.2

Inventories 226.1 214.5

Other current assets 57.8 54.3

Total current assets 867.6 894.4

Property, plant and equipment 1,759.9 1,752.7

Less: accumulated depreciation and amortization 945.2 930.7

Property, plant and equipment, net 814.7 822.0

Operating lease right-of-use assets 75.2 0.0

Investments in affiliated companies 94.9 91.2

Goodwill 105.2 105.8

Deferred income taxes 32.7 24.7

Intangible assets, net 19.5 20.3

Other noncurrent assets 26.4 20.5

Total Assets 2,036.2 1,978.9

Current liabilities:

Notes payable and other current debt 0.0 0.1

Accounts payable 137.7 130.4

Pension and other postretirement benefits 2.2 2.3

Accrued salaries, wages and benefits 53.5 64.5

Income taxes payable 17.3 9.8

Operating lease liabilities, current 10.2 0.0

Other current liabilities 80.2 76.6

Total current liabilities 301.1 283.7

Long-term debt 195.5 196.0

Deferred income taxes 14.3 13.1

Pension and other postretirement benefits 54.3 56.2

Operating lease liabilities, noncurrent 67.4 0.0

Other long-term liabilities 34.1 33.6

Total Liabilities 666.7 582.6

Commitments and contingencies (Note 15)

Equity:

Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding 0.0 0.0

Common stock, par value $0.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million; shares outstanding: 73.5 million and 74.1 million 18.8 18.8

Capital in excess of par value 278.5 282.0

Retained earnings 1,398.2 1,353.4

Accumulated other comprehensive loss (153.4) (154.2)

Treasury stock, at cost (1.8 million and 1.2 million shares) (172.6) (103.7)

Total Equity 1,369.5 1,396.3

Total Liabilities and Equity $ 2,036.2 $ 1,978.9

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(15)(b)(1))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(1))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedIncomeTaxesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e681-108580
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as noncurrent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31928-109318

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31958-109318

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31917-109318

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31931-109318

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsNetNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31958-109318

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31931-109318

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31917-109318
+ Details

Name: us-gaap_DeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of investment in equity method investee and investment in and advance to affiliate.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of current assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of noncurrent assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6904-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6911-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920
+ Details

Name: us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(24))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4590271-111686

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 25 R6.htm IDEA: XBRL DOCUMENT v3.19.1

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares
shares in Millions

Mar. 31, 2019

Dec. 31, 2018

Balance Sheet Related Disclosures [Abstract]

Preferred stock, shares authorized (in shares) 3.0 3.0

Preferred stock, shares issued (in shares) 0.0 0.0

Preferred stock, shares outstanding (in shares) 0.0 0.0

Common stock, par value (in dollars per share) $ 0.25 $ 0.25

Common stock, shares authorized (in shares) 100.0 100.0

Common stock, shares issued (in shares) 75.3 75.3

Common stock, shares outstanding (in shares) 73.5 74.1

Treasury stock, at cost (in shares) 1.8 1.2

X

- References
No definition available.
+ Details

Name: us-gaap_BalanceSheetRelatedDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 26 R7.htm IDEA: XBRL DOCUMENT v3.19.1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Cash flows from operating activities:

Net income $ 55.4 $ 43.6

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation 24.9 25.7

Amortization 0.6 0.7

Stock-based compensation 6.2 3.4

Non-cash restructuring charges 0.3 0.1

Contingent consideration payments in excess of acquisition-date liability (0.2) (0.2)

Other non-cash items, net (0.8) (2.7)

Changes in assets and liabilities (38.8) (25.6)

Net cash provided by operating activities 47.6 45.0

Cash flows from investing activities:

Capital expenditures (28.8) (28.0)

Other, net 0.1 (0.7)

Net cash used in investing activities (28.7) (28.7)

Cash flows from financing activities:

Borrowings under revolving credit agreements 28.0 0.0

Repayments under revolving credit agreements (28.0) 0.0

Debt issuance costs (0.8) 0.0

Dividend payments (11.1) (10.4)

Proceeds from stock-based compensation awards 3.3 0.3

Employee stock purchase plan contributions 1.2 1.1

Shares purchased under share repurchase programs (83.1) (47.9)

Net cash used in financing activities (90.5) (56.9)

Effect of exchange rates on cash (0.3) 4.5

Net decrease in cash and cash equivalents (71.9) (36.1)

Cash and cash equivalents at beginning of period 337.4 235.9

Cash and cash equivalents at end of period $ 265.5 $ 199.8

X

- Definition
The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_AdjustmentForAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906
+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_OtherNoncashIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 17
-Subparagraph (ee)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3367-108585
+ Details

Name: us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash (inflow) outflow from investing activities classified as other.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3179-108585
+ Details

Name: us-gaap_PaymentsForProceedsFromOtherInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDebtIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividendsCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow from issuance of shares under share-based compensation arrangement, excluding stock option exercises.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=SL79508275-113901
+ Details

Name: us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromLongTermLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=SL79508275-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfLongTermLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of decrease in the reserve for full or partial settlement through consideration other than cash.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.P.4(b)(2))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869
+ Details

Name: us-gaap_RestructuringReserveSettledWithoutCash2

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 27 R8.htm IDEA: XBRL DOCUMENT v3.19.1

Summary of Significant Accounting Policies
3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies
Summary of Significant Accounting Policies

Basis of Presentation: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three months ended March 31, 2019 should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”). The results of operations for any interim period are not necessarily indicative of results for the full year.

As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, Other Expense, to the consolidated financial statements in our 2018 Annual Report for further discussion.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R9.htm IDEA: XBRL DOCUMENT v3.19.1

New Accounting Standards
3 Months Ended

Mar. 31, 2019

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

New Accounting Standards
New Accounting Standards

Recently Adopted Standards

In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, Shareholders’ Equity.

In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate.

In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, Leases, for additional information.

Standards Issued Not Yet Adopted

In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-URI http://asc.fasb.org/topic&trid=2122394
+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R10.htm IDEA: XBRL DOCUMENT v3.19.1

Revenue
3 Months Ended

Mar. 31, 2019

Revenue [Abstract]

Revenue from Contract with Customer [Text Block]
Revenue

The following table presents the approximate percentage of our net sales by market group:

Three Months Ended
March 31,

2019

2018
Biologics
26
%

21
%
Generics
20
%

21
%
Pharma
31
%

36
%
Contract-Manufactured Products
23
%

22
%

100
%

100
%
The following table presents the approximate percentage of our net sales by product category:

Three Months Ended
March 31,

2019

2018
High-Value Components
43
%

41
%
Standard Packaging
30
%

34
%
Delivery Devices
4
%

3
%
Contract-Manufactured Products
23
%

22
%

100
%

100
%
The following table presents the approximate percentage of our net sales by geographic location:

Three Months Ended
March 31,

2019

2018
Americas
46
%

45
%
Europe, Middle East, Africa
47
%

47
%
Asia Pacific
7
%

8
%

100
%

100
%

Contract Assets and Liabilities
The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:

($ in millions)
Contract assets, December 31, 2018
$
9.1

Contract assets, March 31, 2019
11.9

Change in contract assets - increase (decrease)
$
2.8

Deferred income, December 31, 2018
$
(33.4
)
Deferred income, March 31, 2019
(36.5
)
Change in deferred income - decrease (increase)
$
(3.1
)

The increase in deferred income during the three months ended March 31, 2019 was primarily due to additional cash payments of $30.6 million received in advance of satisfying future performance obligations, partially offset by the recognition of revenue of $25.8 million, including $11.1 million of revenue that was included in deferred income at the beginning of the year, and $1.7 million in other adjustments.
The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose^® technology platform within a specific therapeutic area. As of March 31, 2019, there was $6.3 million of unearned income related to this payment, of which $0.9 million was included in other current liabilities and $5.4 million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.
Supply Chain Financing
We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of March 31, 2019, we derecognized $1.8 million of accounts receivable under these agreements. Discount fees related to the sale of such accounts receivable on our condensed consolidated income statements for the three months ended March 31, 2019 were not material.

Voluntary Recall
On January 24, 2019, we issued a voluntary recall of our Vial2Bag^® product line due to reports of potential unpredictable or variable dosing under certain conditions. Our 2018 results included an $11.3 million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During the three months ended March 31, 2019, following the completion of certain tests and studies related to the voluntary recall, we recorded a $4.5 million provision for potential inventory returns from our customers and related in-house inventory, partially offset by a reduction in our provision for product returns. We continue to work to get the products back on the market.

X

- Definition
The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_RevenueFromContractWithCustomerTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Revenue [Abstract]
+ References
No definition available.
+ Details

Name: wst_RevenueAbstract

Namespace Prefix: wst_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R11.htm IDEA: XBRL DOCUMENT v3.19.1

Net Income Per Share
3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Net Income Per Share
Net Income Per Share

The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:

Three Months Ended
March 31,
(in millions)
2019

2018
Net income
$
55.4

$
43.6

Weighted average common shares outstanding
74.1

73.9

Dilutive effect of equity awards, based on the treasury stock method
1.2

1.6

Weighted average shares assuming dilution
75.3

75.5

During the three months ended March 31, 2019 and 2018, there were 0.6 million and 0.7 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive.

In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to 800,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under the Securities Exchange Act of 1934 Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. During the three months ended March 31, 2019, we purchased 800,000 shares of our common stock under the now-completed program at a cost of $83.1 million, or an average price of $103.89 per share.

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-URI http://asc.fasb.org/topic&trid=2144383
+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R12.htm IDEA: XBRL DOCUMENT v3.19.1

Inventories
3 Months Ended

Mar. 31, 2019

Inventory Disclosure [Abstract]

Inventories
Inventories

Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. Inventory balances were as follows:

($ in millions)
March 31,
2019

December 31,
2018
Raw materials
$
100.1

$
90.4

Work in process
39.0

42.2

Finished goods
87.0

81.9

$
226.1

$
214.5

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-URI http://asc.fasb.org/topic&trid=2126998
+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R13.htm IDEA: XBRL DOCUMENT v3.19.1

Leases
3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Leases of Lessee Disclosure [Text Block]
Leases

Adoption of ASC 842

On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of March 31, 2019, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases include options to extend the lease term for up to five years, and certain of our operating leases include options to terminate the leases within one year. We had no finance leases as of March 31, 2019.

As a result of our adoption of ASC 842, we recorded operating lease right-of-use assets of $71.0 million and operating lease liabilities of $73.1 million for operating leases where we are the lessee in our condensed consolidated balance sheet as of January 1, 2019. The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.

Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.

The components of lease expense were as follows:
($ in millions)
Three Months Ended
March 31, 2019
Operating lease cost
$
3.2

Short-term lease cost
0.2

Variable lease cost
0.6

Total lease cost
$
4.0

Lease expense for the three months ended March 31, 2018 was $3.7 million.

Supplemental information related to leases was as follows:
($ in millions)
Three Months Ended
March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases
$
3.1

Right-of-use assets obtained in exchange for new operating lease liabilities
6.8

As of March 31, 2019, the weighted average remaining lease term for operating leases was 12.1 years, and the weighted average discount rate was 3.74%.

Maturities of lease liabilities as of March 31, 2019 were as follows:
($ in millions)
Operating
Year
Leases
2019 (remaining nine months)
$
9.6

2020
11.5

2021
9.8

2022
8.1

2023
7.6

Thereafter
49.0

95.6

Less: imputed lease interest
(18.0
)
Total lease liabilities
$
77.6

Maturities of future minimum rental payments under non-cancelable operating leases as of December 31, 2018 were as follows:
($ in millions)
Operating
Year
Leases
2019
$
13.0

2020
10.5

2021
7.8

2022
6.9

2023
5.5

Thereafter
37.8

Total
$
81.5

Practical Expedients and Exemptions

We have elected to adopt the leasing package of practical expedients, which allow us to not retroactively reassess: i) any expired or existing contracts containing leases under the new definition of a lease; ii) the lease classification for any expired or existing leases; and iii) initial direct costs for any expired or existing leases. We have also elected to adopt practical expedients around land easements, the combination of lease and non-lease components, and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases.

We have elected not to recognize operating lease right-of-use assets and lease liabilities for all short-term leases (leases with an initial lease term of 12 months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=77888251

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-URI http://asc.fasb.org/topic&trid=2208923
+ Details

Name: us-gaap_LeasesOfLesseeDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R14.htm IDEA: XBRL DOCUMENT v3.19.1

Affiliated Companies
3 Months Ended

Mar. 31, 2019

Equity Method Investments and Joint Ventures [Abstract]

Affiliated Companies
Affiliated Companies

At March 31, 2019 and December 31, 2018, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $81.5 million and $77.8 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $13.4 million at both period-ends. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.

Our purchases from, and royalty payments made to, affiliates totaled $24.6 million for the three months ended March 31, 2019, as compared to $23.1 million for the same period in 2018. As of March 31, 2019 and December 31, 2018, the payable balance due to affiliates was $17.2 million and $12.9 million, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $2.2 million for the three months ended March 31, 2019, as compared to $2.4 million for the same period in 2018. As of March 31, 2019 and December 31, 2018, the receivable balance due from affiliates was $1.4 million and $1.6 million, respectively.

Please refer to Note 6, Affiliated Companies, to the consolidated financial statements in our 2018 Annual Report for additional details.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-URI http://asc.fasb.org/topic&trid=2196965
+ Details

Name: us-gaap_EquityMethodInvestmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R15.htm IDEA: XBRL DOCUMENT v3.19.1

Debt
3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

Debt
Debt

The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of March 31, 2019.

($ in millions)
March 31,
2019

December 31,
2018
Note payable, due December 31, 2019
$
—

$
0.1

Credit Facility, due October 15, 2020 (1.00%)
—

28.6

Credit Facility, due March 28, 2024 (0.875%)
28.1

—

Series A notes, due July 5, 2022 (3.67%)
42.0

42.0

Series B notes, due July 5, 2024 (3.82%)
53.0

53.0

Series C notes, due July 5, 2027 (4.02%)
73.0

73.0

196.1

196.7

Less: unamortized debt issuance costs
0.6

0.6

Total debt
195.5

196.1

Less: current portion of long-term debt
—

0.1

Long-term debt, net
$
195.5

$
196.0

In March 2019, we entered into a new senior unsecured, multi-currency revolving credit facility agreement (the “Credit Agreement”) that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains a senior unsecured, multi-currency revolving credit facility (the “Credit Facility”) of $300.0 million, with sublimits of up to $30.0 million for swing line loans for domestic borrowers in U.S. Dollars (“USD”) and a $20.0 million swing line loan for our German Holding Company and up to $30.0 million for the issuance of standby letters of credit, which Credit Facility may be increased from time-to-time by the greater of $350.0 million and earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus 50 basis points or the daily London Interbank Offered Rate (“LIBOR”), plus 1.00%) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from 0 to 37.5 basis points for base rate loans and 87.5 to 137.5 basis points for LIBOR rate loans. The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to 4.0 to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of March 31, 2019 and December 31, 2018, total unamortized debt issuance costs of $1.1 million and $0.6 million, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.

At March 31, 2019, we had $28.1 million in outstanding long-term borrowings under the Credit Facility, of which $4.5 million was denominated in Japanese Yen (“Yen”) and $23.6 million was denominated in Euro. These borrowings, together with outstanding letters of credit of $2.5 million, resulted in a borrowing capacity available under the Credit Facility of $269.4 million at March 31, 2019. Please refer to Note 9, Derivative Financial Instruments, for a discussion of the foreign currency hedges associated with the Credit Facility.

Please refer to Note 9, Debt, to the consolidated financial statements in our 2018 Annual Report for additional details regarding our debt agreements.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R16.htm IDEA: XBRL DOCUMENT v3.19.1

Derivative Financial Instruments
3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments
Derivative Financial Instruments

Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our condensed consolidated balance sheet at fair value.

Foreign Exchange Rate Risk

We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of March 31, 2019, the total amount of these forward exchange contracts was Singapore Dollar (“SGD”) 601.5 million and $13.4 million. As of December 31, 2018, the total amount of these forward exchange contracts was €10.0 million, SGD 601.5 million and $13.4 million. During the three months ended March 31, 2019, we recognized foreign exchange transaction gains of $4.8 million within other (income) expense in our condensed consolidated statements of income related to these fair value hedges. We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge.

In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of March 31, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:
(in millions)

Sell
Currency
Purchase

USD
Euro
USD
31.5

—

26.8

Yen
5,232.0

24.4

20.5

SGD
44.0

25.1

6.4

At March 31, 2019, a portion of our debt consisted of borrowings denominated in currencies other than USD. We have designated our €21.0 million ($23.6 million) Euro-denominated borrowings under our Credit Facility as a hedge of our net investment in certain European subsidiaries. A cumulative foreign currency translation loss of less than $0.1 million for both pre- and after tax on this debt was recorded within accumulated other comprehensive loss as of March 31, 2019. We have also designated our ¥500.0 million ($4.5 million) Yen-denominated borrowings under our Credit Facility as a hedge of our net investment in Daikyo Seiko, Ltd. (“Daikyo”). At March 31, 2019, there was a cumulative foreign currency translation loss of $0.4 million pre-tax ($0.3 million after tax) on this Yen-denominated debt, which was also included within accumulated other comprehensive loss.

Commodity Price Risk

Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.

In November 2017, we purchased a series of call options for a total of 125,166 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases through May 2019. In April 2018, we purchased a series of call options for a total of 30,612 barrels of crude oil from December 2018 through August 2019. In January 2019, we purchased a series of call options for a total of 81,459 barrels of crude oil from February 2019 through May 2020.

During the three months ended March 31, 2019, the loss recorded in cost of goods and services sold related to these call options was less than $0.1 million.

As of March 31, 2019, we had outstanding contracts to purchase 108,891 barrels of crude oil from April 2019 to May 2020 at a weighted-average strike price of $66.22 per barrel.

Effects of Derivative Instruments on Financial Position and Results of Operations

Please refer to Note 10, Fair Value Measurements, for the balance sheet location and fair values of our derivative instruments as of March 31, 2019 and December 31, 2018.

The following table summarizes the effects of derivative instruments designated as hedges on other comprehensive income (“OCI”) and earnings, net of tax:

Amount of Gain (Loss) Recognized in OCI for the

Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the

Location of (Gain) Loss Reclassified from Accumulated OCI into Income

Three Months Ended
March 31,

Three Months Ended
March 31,

($ in millions)
2019

2018

2019

2018

Cash Flow Hedges:

Foreign currency hedge contracts
$
0.5

$
(0.4
)

$
(0.2
)

$
0.5

Net sales
Foreign currency hedge contracts
(0.1
)

1.6

(0.1
)

0.4

Cost of goods and services sold
Forward treasury locks
—

—

—

0.1

Interest expense
Total
$
0.4

$
1.2

$
(0.3
)

$
1.0

Net Investment Hedges:

Foreign currency-denominated debt
$
0.1

$
(0.7
)

$
—

$
—

Other (income) expense
Total
$
0.1

$
(0.7
)

$
—

$
—

For the three months ended March 31, 2019 and 2018, there was no material ineffectiveness related to our hedges.

X

- References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-URI http://asc.fasb.org/topic&trid=2229140
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R17.htm IDEA: XBRL DOCUMENT v3.19.1

Fair Value Measurements
3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements
Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:

•
Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.
•
Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
•
Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

The following tables present the assets and liabilities recorded at fair value on a recurring basis:

Balance at

Basis of Fair Value Measurements
($ in millions)
March 31,
2019

Level 1

Level 2

Level 3
Assets:

Deferred compensation assets
$
9.2

$
9.2

$
—

$
—

Foreign currency contracts
17.7

—

17.7

—

Commodity call options
0.2

—

0.2

—

$
27.1

$
9.2

$
17.9

$
—

Liabilities:

Contingent consideration
$
1.7

$
—

$
—

$
1.7

Deferred compensation liabilities
10.5

10.5

—

—

Foreign currency contracts
0.8

—

0.8

—

$
13.0

$
10.5

$
0.8

$
1.7

Balance at

Basis of Fair Value Measurements
($ in millions)
December 31,
2018

Level 1

Level 2

Level 3
Assets:

Deferred compensation assets
$
8.7

$
8.7

$
—

$
—

Foreign currency contracts
6.5

—

6.5

—

$
15.2

$
8.7

$
6.5

$
—

Liabilities:

Contingent consideration
$
1.7

$
—

$
—

$
1.7

Deferred compensation liabilities
9.8

9.8

—

—

Foreign currency contracts
0.2

—

0.2

—

$
11.7

$
9.8

$
0.2

$
1.7

Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees’ investment selections and is included within other long-term liabilities. Please refer to Note 9, Derivative Financial Instruments, for further discussion of our derivatives.

Level 3 Fair Value Measurements

The fair value of the contingent consideration liability related to the SmartDose technology platform (the “SmartDose contingent consideration”) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other (income) expense in our condensed consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.

The following table provides a summary of changes in our Level 3 fair value measurements:

($ in millions)
Balance, December 31, 2017
$
4.9

Decrease in fair value recorded in earnings
(2.6
)
Payments
(0.6
)
Balance, December 31, 2018
1.7

Increase in fair value recorded in earnings
0.2

Payments
(0.2
)
Balance, March 31, 2019
$
1.7

Other Financial Instruments

We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.

The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At March 31, 2019, the estimated fair value of long-term debt was $197.4 million compared to a carrying amount of $195.5 million. At December 31, 2018, the estimated fair value of long-term debt was $192.6 million and the carrying amount was $196.0 million.

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-URI http://asc.fasb.org/topic&trid=2155941
+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R18.htm IDEA: XBRL DOCUMENT v3.19.1

Accumulated Other Comprehensive Loss
3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss

The following table presents the changes in the components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2019:

($ in millions)
Losses on
derivatives

Unrealized gains
on investment
securities

Defined benefit
pension and other
postretirement plans

Foreign
currency
translation

Total
Balance, December 31, 2018
$
(0.4
)

$
0.4

$
(40.4
)

$
(113.8
)

$
(154.2
)
Other comprehensive (loss) income before reclassifications
(3.0
)

—

(0.2
)

4.4

1.2

Amounts reclassified out
(0.3
)

—

(0.1
)

—

(0.4
)
Other comprehensive (loss) income, net of tax
(3.3
)

—

(0.3
)

4.4

0.8

Balance, March 31, 2019
$
(3.7
)

$
0.4

$
(40.7
)

$
(109.4
)

$
(153.4
)

A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table:

($ in millions)

Three Months Ended
March 31,

Location on Statement of Income
Detail of components

2019

2018

Losses on derivatives:

Foreign currency contracts

$
0.2

$
(0.6
)

Net sales
Foreign currency contracts

0.2

(0.6
)

Cost of goods and services sold
Forward treasury locks

(0.1
)

(0.1
)

Interest expense
Total before tax

0.3

(1.3
)

Tax expense

—

0.3

Net of tax

$
0.3

$
(1.0
)

Amortization of defined benefit pension and other postretirement plans:

Prior service credit

$
0.2

$
0.5

(a)
Actuarial losses

—

(0.4
)

(a)
Total before tax

0.2

0.1

Tax expense

(0.1
)

—

Net of tax

$
0.1

$
0.1

Total reclassifications for the period, net of tax

$
0.4

$
(0.9
)

(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 14, Benefit Plans, for additional details.

X

- Definition
The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-URI http://asc.fasb.org/topic&trid=2134417
+ Details

Name: us-gaap_ComprehensiveIncomeNoteTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R19.htm IDEA: XBRL DOCUMENT v3.19.1

Shareholders' Equity
3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]
Shareholders’ Equity

The following table presents the changes in shareholders’ equity for the three months ended March 31, 2019:

Common Shares Issued

Common Stock

Capital in Excess of Par Value

Number of Treasury Shares

Treasury Stock

Retained earnings

Accumulated other comprehensive loss

Total
($ in millions)

Balance, December 31, 2018
75.3

$
18.8

$
282.0

1.2

$
(103.7
)

$
1,353.4

$
(154.2
)

$
1,396.3

Net income
—

—

—

—

—

55.4

—

55.4

Activity related to stock-based compensation
—

—

(3.5
)

(0.2
)

14.2

—

—

10.7

Shares purchased under share repurchase program
—

—

—

0.8

(83.1
)

—

—

(83.1
)
Dividends declared ($0.15 per share)
—

—

—

—

—

(10.6
)

—

(10.6
)
Other comprehensive income, net of tax
—

—

—

—

—

—

0.8

0.8

Balance, March 31, 2019
75.3

$
18.8

$
278.5

1.8

$
(172.6
)

$
1,398.2

$
(153.4
)

$
1,369.5

The following table presents the changes in shareholders’ equity for the three months ended March 31, 2018:

Common Shares Issued

Common Stock

Capital in Excess of Par Value

Number of Treasury Shares

Treasury Stock

Retained earnings

Accumulated other comprehensive loss

Total
($ in millions)

Balance, December 31, 2017
75.2

$
18.8

$
309.3

1.3

$
(109.1
)

$
1,178.2

$
(117.3
)

$
1,279.9

Effect of modified retrospective application of a new accounting standard
—

—

—

—

—

11.4

—

11.4

Net income
—

—

—

—

—

43.6

—

43.6

Activity related to stock-based compensation
0.1

—

(0.8
)

(0.1
)

8.0

—

—

7.2

Shares purchased under share repurchase program
—

—

—

0.5

(47.9
)

—

—

(47.9
)
Dividends declared ($0.14 per share)
—

—

—

—

—

(10.4
)

—

(10.4
)
Other comprehensive income, net of tax
—

—

—

—

—

—

21.5

21.5

Balance, March 31, 2018
75.3

$
18.8

$
308.5

1.7

$
(149.0
)

$
1,222.8

$
(95.8
)

$
1,305.3

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R20.htm IDEA: XBRL DOCUMENT v3.19.1

Stock-Based Compensation
3 Months Ended

Mar. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation
Stock-Based Compensation

The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the “2016 Plan”) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At March 31, 2019, there were 3,162,428 shares remaining in the 2016 Plan for future grants.

During the three months ended March 31, 2019, we granted 344,616 stock options at a weighted average exercise price of $102.51 per share based on the grant-date fair value of our stock to employees under the 2016 Plan. The weighted average grant date fair value of options granted was $24.51 per share as determined by the Black-Scholes option valuation model using the following weighted average assumptions: a risk-free interest rate of 2.3%; expected life of 5.6 years based on prior experience; stock volatility of 22.5% based on historical data; and a dividend yield of 0.7%. Stock option expense is recognized over the vesting period, net of forfeitures.

During the three months ended March 31, 2019, we granted 82,458 stock-settled performance share unit (“PSU”) awards at a weighted average grant-date fair value of $102.51 per share to eligible employees. These awards are earned based on the Company’s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock. Shares earned under PSU awards may vary from 0% to 200% of an employee’s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures.

During the three months ended March 31, 2019, we granted 7,266 stock-settled restricted share unit (“RSU”) awards at a weighted average grant-date fair value of $102.51 per share to eligible employees. These awards are earned over a specified performance period. The fair value of stock-settled RSU awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period, net of forfeitures.

Total stock-based compensation expense was $6.2 million and $3.4 million for the three months ended March 31, 2019 and 2018, respectively.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-URI http://asc.fasb.org/subtopic&trid=2208855
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 40 R21.htm IDEA: XBRL DOCUMENT v3.19.1

Benefit Plans
3 Months Ended

Mar. 31, 2019

Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]

Benefit Plans
Benefit Plans

The components of net periodic benefit cost for the three months ended March 31 were as follows:

Pension benefits

Other retirement benefits

Total
($ in millions)
2019

2018

2019

2018

2019

2018
Service cost
$
0.4

$
2.8

$
—

$
—

$
0.4

$
2.8

Interest cost
2.4

2.3

0.1

0.1

2.5

2.4

Expected return on assets
(2.9
)

(3.9
)

—

—

(2.9
)

(3.9
)
Amortization of prior service credit
—

(0.3
)

(0.2
)

(0.2
)

(0.2
)

(0.5
)
Recognized actuarial losses (gains)
0.5

0.9

(0.5
)

(0.5
)

—

0.4

Net periodic benefit cost
$
0.4

$
1.8

$
(0.6
)

$
(0.6
)

$
(0.2
)

$
1.2

Pension benefits

Other retirement benefits

Total
($ in millions)
2019

2018

2019

2018

2019

2018
U.S. plans
$
(0.1
)

$
1.3

$
(0.6
)

$
(0.6
)

$
(0.7
)

$
0.7

International plans
0.5

0.5

—

—

0.5

0.5

Net periodic benefit cost
$
0.4

$
1.8

$
(0.6
)

$
(0.6
)

$
(0.2
)

$
1.2

Effective January 1, 2019, except for interest crediting, benefit accruals under our U.S. qualified and non-qualified defined benefit pension plans ceased.

X

- References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for pension and other postretirement benefits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017
+ Details

Name: us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R22.htm IDEA: XBRL DOCUMENT v3.19.1

Other Expense
3 Months Ended

Mar. 31, 2019

Other Income and Expenses [Abstract]

Other Expense
Other (Income) Expense

Other (income) expense consists of:

Three Months Ended
March 31,
($ in millions)
2019

2018
Restructuring and related charges:

Severance and post-employment benefits
$
0.3

$
2.0

Asset-related charges
—

0.1

Other charges
0.3

1.2

Total restructuring and related charges
0.6

3.3

Development and licensing income
(0.2
)

(0.2
)
Contingent consideration
0.2

0.3

Other items
(2.9
)

(0.3
)
Total other (income) expense
$
(2.3
)

$
3.1

Restructuring and Related Charges

In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes are expected to be implemented over a period of up to twenty-four months from the date of approval. The plan will require restructuring and related charges of approximately $15.0 million.

During the three months ended March 31, 2019, we recorded $0.6 million in restructuring and related charges associated with this plan, consisting of $0.3 million for severance charges and $0.3 million for other charges. During the three months ended March 31, 2018, we recorded $3.3 million in restructuring and related charges associated with this plan, consisting of $2.0 million for severance charges, $0.1 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $1.2 million for other non-cash charges.

The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:

($ in millions)
Severance
and benefits

Asset-related charges

Other charges

Total
Balance, December 31, 2018
$
2.3

$
—

$
—

$
2.3

Charges
0.3

—

0.3

0.6

Cash payments
(1.1
)

—

—

(1.1
)
Non-cash asset write-downs
—

—

(0.3
)

(0.3
)
Balance, March 31, 2019
$
1.5

$
—

$
—

$
1.5

On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. Our remaining restructuring obligations related to the 2016 restructuring plan as of March 31, 2019 were $0.3 million.

Other Items

During both the three months ended March 31, 2019 and 2018, we recorded development income of $0.2 million related to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, Revenue, for additional information.

Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 10, Fair Value Measurements, for additional details.

Other items consist of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, and miscellaneous income and charges. Other items increased by $2.6 million for the three months ended March 31, 2019, as compared to the same period in 2018, primarily as a result of foreign exchange transaction gains of $3.8 million during the three months ended March 31, 2019, as compared to foreign exchange transaction losses of $0.4 million during the three months ended March 31, 2018.

X

- References
No definition available.
+ Details

Name: us-gaap_OtherIncomeAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-URI http://asc.fasb.org/topic&trid=2122503

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 610
-URI http://asc.fasb.org/topic&trid=49130413
+ Details

Name: us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R23.htm IDEA: XBRL DOCUMENT v3.19.1

Income Taxes
3 Months Ended

Mar. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes
Income Taxes

The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items.

The provision for income taxes was $16.1 million and $12.5 million for the three months ended March 31, 2019 and 2018, respectively, and the effective tax rate was 23.1% and 23.3%, respectively.

During the three months ended March 31, 2018, we recorded a net tax charge of $0.3 million for the estimated impact of the 2017 Tax Act. Please refer to Note 16, Income Taxes, to the consolidated financial statements in our 2018 Annual Report for further discussion.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R24.htm IDEA: XBRL DOCUMENT v3.19.1

Commitments and Contingencies
3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies
Commitments and Contingencies

From time to time, we are involved in product liability matters and other legal proceedings and claims generally incidental to our normal business activities. We accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. While the outcome of current proceedings cannot be accurately predicted, we believe their ultimate resolution should not have a material adverse effect on our business, financial condition, results of operations or liquidity.

There have been no significant changes to the commitments and contingencies included in our 2018 Annual Report.

On January 1, 2019, we adopted ASC 842. Please refer to Note 6, Leases, for additional information.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R25.htm IDEA: XBRL DOCUMENT v3.19.1

Segment Information
3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Segment Information
Segment Information

Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.

We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.

The following table presents information about our reportable segments, reconciled to consolidated totals:

Three Months Ended
March 31,
($ in millions)
2019

2018
Net sales:

Proprietary Products
$
340.4

$
326.2

Contract-Manufactured Products
103.1

89.5

Consolidated net sales
$
443.5

$
415.7

Operating profit (loss):

Proprietary Products
$
77.0

$
62.8

Contract-Manufactured Products
10.5

9.5

Corporate
(16.2
)

(15.6
)
Other unallocated items
(0.6
)

(3.3
)
Total operating profit
$
70.7

$
53.4

Interest expense
2.3

1.9

Interest income
(0.9
)

(0.6
)
Other nonoperating income
(0.6
)

(1.6
)
Income before income taxes
$
69.9

$
53.7

Other unallocated items during the three months ended March 31, 2019 and 2018, consisted of $0.6 million and $3.3 million, respectively, in restructuring and related charges. Please refer to Note 15, Other (Income) Expense, for further discussion of these items.

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510
+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R26.htm IDEA: XBRL DOCUMENT v3.19.1

Subsequent Event
3 Months Ended

Mar. 31, 2019

Subsequent Events [Abstract]

Subsequent Events [Text Block]
Subsequent Event

In April 2019, we acquired the business of our distributor in South Korea. We believe that the acquisition will not have a material impact on our financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R27.htm IDEA: XBRL DOCUMENT v3.19.1

Summary of Significant Accounting Policies (Policies)
3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Basis of Presentation
Basis of Presentation: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three months ended March 31, 2019 should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”). The results of operations for any interim period are not necessarily indicative of results for the full year.

As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, Other Expense, to the consolidated financial statements in our 2018 Annual Report for further discussion.

New Accounting Standards
Recently Adopted Standards

In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, Shareholders’ Equity.

In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate.

In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.

In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, Leases, for additional information.

Standards Issued Not Yet Adopted

In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R28.htm IDEA: XBRL DOCUMENT v3.19.1

Revenue (Tables)
3 Months Ended

Mar. 31, 2019

Revenue [Abstract]

Disaggregation of Revenue [Table Text Block]
The following table presents the approximate percentage of our net sales by market group:

Three Months Ended
March 31,

2019

2018
Biologics
26
%

21
%
Generics
20
%

21
%
Pharma
31
%

36
%
Contract-Manufactured Products
23
%

22
%

100
%

100
%
The following table presents the approximate percentage of our net sales by product category:

Three Months Ended
March 31,

2019

2018
High-Value Components
43
%

41
%
Standard Packaging
30
%

34
%
Delivery Devices
4
%

3
%
Contract-Manufactured Products
23
%

22
%

100
%

100
%
The following table presents the approximate percentage of our net sales by geographic location:

Three Months Ended
March 31,

2019

2018
Americas
46
%

45
%
Europe, Middle East, Africa
47
%

47
%
Asia Pacific
7
%

8
%

100
%

100
%

Change in Contract with Customer, Asset and Liability [Abstract]
The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:

($ in millions)
Contract assets, December 31, 2018
$
9.1

Contract assets, March 31, 2019
11.9

Change in contract assets - increase (decrease)
$
2.8

Deferred income, December 31, 2018
$
(33.4
)
Deferred income, March 31, 2019
(36.5
)
Change in deferred income - decrease (increase)
$
(3.1
)

X

- Definition
Tabular disclosure of contract balances and changes in contract balances.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130551-203045
+ Details

Name: us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045
+ Details

Name: us-gaap_DisaggregationOfRevenueTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Revenue [Abstract]
+ References
No definition available.
+ Details

Name: wst_RevenueAbstract

Namespace Prefix: wst_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R29.htm IDEA: XBRL DOCUMENT v3.19.1

Net Income Per Share (Tables)
3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Reconciliation of Basic to Diluted Net Income Per Share
The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:

Three Months Ended
March 31,
(in millions)
2019

2018
Net income
$
55.4

$
43.6

Weighted average common shares outstanding
74.1

73.9

Dilutive effect of equity awards, based on the treasury stock method
1.2

1.6

Weighted average shares assuming dilution
75.3

75.5

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R30.htm IDEA: XBRL DOCUMENT v3.19.1

Inventories (Tables)
3 Months Ended

Mar. 31, 2019

Inventory Disclosure [Abstract]

Inventories
Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. Inventory balances were as follows:

($ in millions)
March 31,
2019

December 31,
2018
Raw materials
$
100.1

$
90.4

Work in process
39.0

42.2

Finished goods
87.0

81.9

$
226.1

$
214.5

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(c))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766
+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R31.htm IDEA: XBRL DOCUMENT v3.19.1

Leases Leases (Tables)
3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Lease, Cost [Table Text Block]
The components of lease expense were as follows:
($ in millions)
Three Months Ended
March 31, 2019
Operating lease cost
$
3.2

Short-term lease cost
0.2

Variable lease cost
0.6

Total lease cost
$
4.0

Lessee, Lease Cash Flow and Supplemental Information [Table Text Block]
Supplemental information related to leases was as follows:
($ in millions)
Three Months Ended
March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases
$
3.1

Right-of-use assets obtained in exchange for new operating lease liabilities
6.8

Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Maturities of lease liabilities as of March 31, 2019 were as follows:
($ in millions)
Operating
Year
Leases
2019 (remaining nine months)
$
9.6

2020
11.5

2021
9.8

2022
8.1

2023
7.6

Thereafter
49.0

95.6

Less: imputed lease interest
(18.0
)
Total lease liabilities
$
77.6

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
of December 31, 2018 were as follows:
($ in millions)
Operating
Year
Leases
2019
$
13.0

2020
10.5

2021
7.8

2022
6.9

2023
5.5

Thereafter
37.8

Total
$
81.5

X

- Definition
Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_LeaseCostTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717
+ Details

Name: us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Lessee, Lease Cash Flow and Supplemental Information [Table Text Block]
+ References
No definition available.
+ Details

Name: wst_LesseeLeaseCashFlowandSupplementalInformationTableTextBlock

Namespace Prefix: wst_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R32.htm IDEA: XBRL DOCUMENT v3.19.1

Debt (Tables)
3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

Long-term Debt Obligations, Net of Current Maturities
The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of March 31, 2019.

($ in millions)
March 31,
2019

December 31,
2018
Note payable, due December 31, 2019
$
—

$
0.1

Credit Facility, due October 15, 2020 (1.00%)
—

28.6

Credit Facility, due March 28, 2024 (0.875%)
28.1

—

Series A notes, due July 5, 2022 (3.67%)
42.0

42.0

Series B notes, due July 5, 2024 (3.82%)
53.0

53.0

Series C notes, due July 5, 2027 (4.02%)
73.0

73.0

196.1

196.7

Less: unamortized debt issuance costs
0.6

0.6

Total debt
195.5

196.1

Less: current portion of long-term debt
—

0.1

Long-term debt, net
$
195.5

$
196.0

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 52 R33.htm IDEA: XBRL DOCUMENT v3.19.1

Derivative Financial Instruments (Tables)
3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Foreign Currency Contracts
As of March 31, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:
(in millions)

Sell
Currency
Purchase

USD
Euro
USD
31.5

—

26.8

Yen
5,232.0

24.4

20.5

SGD
44.0

25.1

6.4

Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings
The following table summarizes the effects of derivative instruments designated as hedges on other comprehensive income (“OCI”) and earnings, net of tax:

Amount of Gain (Loss) Recognized in OCI for the

Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the

Location of (Gain) Loss Reclassified from Accumulated OCI into Income

Three Months Ended
March 31,

Three Months Ended
March 31,

($ in millions)
2019

2018

2019

2018

Cash Flow Hedges:

Foreign currency hedge contracts
$
0.5

$
(0.4
)

$
(0.2
)

$
0.5

Net sales
Foreign currency hedge contracts
(0.1
)

1.6

(0.1
)

0.4

Cost of goods and services sold
Forward treasury locks
—

—

—

0.1

Interest expense
Total
$
0.4

$
1.2

$
(0.3
)

$
1.0

Net Investment Hedges:

Foreign currency-denominated debt
$
0.1

$
(0.7
)

$
—

$
—

Other (income) expense
Total
$
0.1

$
(0.7
)

$
—

$
—

X

- References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959
+ Details

Name: us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959
+ Details

Name: us-gaap_ScheduleOfDerivativeInstrumentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 R34.htm IDEA: XBRL DOCUMENT v3.19.1

Fair Value Measurements (Tables)
3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value
The following tables present the assets and liabilities recorded at fair value on a recurring basis:

Balance at

Basis of Fair Value Measurements
($ in millions)
March 31,
2019

Level 1

Level 2

Level 3
Assets:

Deferred compensation assets
$
9.2

$
9.2

$
—

$
—

Foreign currency contracts
17.7

—

17.7

—

Commodity call options
0.2

—

0.2

—

$
27.1

$
9.2

$
17.9

$
—

Liabilities:

Contingent consideration
$
1.7

$
—

$
—

$
1.7

Deferred compensation liabilities
10.5

10.5

—

—

Foreign currency contracts
0.8

—

0.8

—

$
13.0

$
10.5

$
0.8

$
1.7

Balance at

Basis of Fair Value Measurements
($ in millions)
December 31,
2018

Level 1

Level 2

Level 3
Assets:

Deferred compensation assets
$
8.7

$
8.7

$
—

$
—

Foreign currency contracts
6.5

—

6.5

—

$
15.2

$
8.7

$
6.5

$
—

Liabilities:

Contingent consideration
$
1.7

$
—

$
—

$
1.7

Deferred compensation liabilities
9.8

9.8

—

—

Foreign currency contracts
0.2

—

0.2

—

$
11.7

$
9.8

$
0.2

$
1.7

Summary of Changes in Level 3 Fair Value Measurements
The following table provides a summary of changes in our Level 3 fair value measurements:

($ in millions)
Balance, December 31, 2017
$
4.9

Decrease in fair value recorded in earnings
(2.6
)
Payments
(0.6
)
Balance, December 31, 2018
1.7

Increase in fair value recorded in earnings
0.2

Payments
(0.2
)
Balance, March 31, 2019
$
1.7

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19279-110258
+ Details

Name: us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19190-110258
+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R35.htm IDEA: XBRL DOCUMENT v3.19.1

Accumulated Other Comprehensive Loss (Tables)
3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Components of Accumulated Other Comprehensive Loss
The following table presents the changes in the components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2019:

($ in millions)
Losses on
derivatives

Unrealized gains
on investment
securities

Defined benefit
pension and other
postretirement plans

Foreign
currency
translation

Total
Balance, December 31, 2018
$
(0.4
)

$
0.4

$
(40.4
)

$
(113.8
)

$
(154.2
)
Other comprehensive (loss) income before reclassifications
(3.0
)

—

(0.2
)

4.4

1.2

Amounts reclassified out
(0.3
)

—

(0.1
)

—

(0.4
)
Other comprehensive (loss) income, net of tax
(3.3
)

—

(0.3
)

4.4

0.8

Balance, March 31, 2019
$
(3.7
)

$
0.4

$
(40.7
)

$
(109.4
)

$
(153.4
)

Reclassification out of Accumulated Other Comprehensive Loss
A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table:

($ in millions)

Three Months Ended
March 31,

Location on Statement of Income
Detail of components

2019

2018

Losses on derivatives:

Foreign currency contracts

$
0.2

$
(0.6
)

Net sales
Foreign currency contracts

0.2

(0.6
)

Cost of goods and services sold
Forward treasury locks

(0.1
)

(0.1
)

Interest expense
Total before tax

0.3

(1.3
)

Tax expense

—

0.3

Net of tax

$
0.3

$
(1.0
)

Amortization of defined benefit pension and other postretirement plans:

Prior service credit

$
0.2

$
0.5

(a)
Actuarial losses

—

(0.4
)

(a)
Total before tax

0.2

0.1

Tax expense

(0.1
)

—

Net of tax

$
0.1

$
0.1

Total reclassifications for the period, net of tax

$
0.4

$
(0.9
)

(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 14, Benefit Plans, for additional details.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).
+ References
No definition available.
+ Details

Name: us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of accumulated other comprehensive income (loss).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580
+ Details

Name: us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 55 R36.htm IDEA: XBRL DOCUMENT v3.19.1

Shareholders' Equity Shareholders' Equity (Tables)
3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Schedule of Stockholders Equity [Table Text Block]
The following table presents the changes in shareholders’ equity for the three months ended March 31, 2019:

Common Shares Issued

Common Stock

Capital in Excess of Par Value

Number of Treasury Shares

Treasury Stock

Retained earnings

Accumulated other comprehensive loss

Total
($ in millions)

Balance, December 31, 2018
75.3

$
18.8

$
282.0

1.2

$
(103.7
)

$
1,353.4

$
(154.2
)

$
1,396.3

Net income
—

—

—

—

—

55.4

—

55.4

Activity related to stock-based compensation
—

—

(3.5
)

(0.2
)

14.2

—

—

10.7

Shares purchased under share repurchase program
—

—

—

0.8

(83.1
)

—

—

(83.1
)
Dividends declared ($0.15 per share)
—

—

—

—

—

(10.6
)

—

(10.6
)
Other comprehensive income, net of tax
—

—

—

—

—

—

0.8

0.8

Balance, March 31, 2019
75.3

$
18.8

$
278.5

1.8

$
(172.6
)

$
1,398.2

$
(153.4
)

$
1,369.5

The following table presents the changes in shareholders’ equity for the three months ended March 31, 2018:

Common Shares Issued

Common Stock

Capital in Excess of Par Value

Number of Treasury Shares

Treasury Stock

Retained earnings

Accumulated other comprehensive loss

Total
($ in millions)

Balance, December 31, 2017
75.2

$
18.8

$
309.3

1.3

$
(109.1
)

$
1,178.2

$
(117.3
)

$
1,279.9

Effect of modified retrospective application of a new accounting standard
—

—

—

—

—

11.4

—

11.4

Net income
—

—

—

—

—

43.6

—

43.6

Activity related to stock-based compensation
0.1

—

(0.8
)

(0.1
)

8.0

—

—

7.2

Shares purchased under share repurchase program
—

—

—

0.5

(47.9
)

—

—

(47.9
)
Dividends declared ($0.14 per share)
—

—

—

—

—

(10.4
)

—

(10.4
)
Other comprehensive income, net of tax
—

—

—

—

—

—

21.5

21.5

Balance, March 31, 2018
75.3

$
18.8

$
308.5

1.7

$
(149.0
)

$
1,222.8

$
(95.8
)

$
1,305.3

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_ScheduleOfStockholdersEquityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 56 R37.htm IDEA: XBRL DOCUMENT v3.19.1

Benefit Plans (Tables)
3 Months Ended

Mar. 31, 2019

Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]

Schedule of Components of Net Periodic Benefit Cost
The components of net periodic benefit cost for the three months ended March 31 were as follows:

Pension benefits

Other retirement benefits

Total
($ in millions)
2019

2018

2019

2018

2019

2018
Service cost
$
0.4

$
2.8

$
—

$
—

$
0.4

$
2.8

Interest cost
2.4

2.3

0.1

0.1

2.5

2.4

Expected return on assets
(2.9
)

(3.9
)

—

—

(2.9
)

(3.9
)
Amortization of prior service credit
—

(0.3
)

(0.2
)

(0.2
)

(0.2
)

(0.5
)
Recognized actuarial losses (gains)
0.5

0.9

(0.5
)

(0.5
)

—

0.4

Net periodic benefit cost
$
0.4

$
1.8

$
(0.6
)

$
(0.6
)

$
(0.2
)

$
1.2

Pension benefits

Other retirement benefits

Total
($ in millions)
2019

2018

2019

2018

2019

2018
U.S. plans
$
(0.1
)

$
1.3

$
(0.6
)

$
(0.6
)

$
(0.7
)

$
0.7

International plans
0.5

0.5

—

—

0.5

0.5

Net periodic benefit cost
$
0.4

$
1.8

$
(0.6
)

$
(0.6
)

$
(0.2
)

$
1.2

X

- References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920
+ Details

Name: us-gaap_ScheduleOfNetBenefitCostsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 57 R38.htm IDEA: XBRL DOCUMENT v3.19.1

Other Expense (Tables)
3 Months Ended

Mar. 31, 2019

Other Income and Expenses [Abstract]

Schedule of Other Expense
Other (income) expense consists of:

Three Months Ended
March 31,
($ in millions)
2019

2018
Restructuring and related charges:

Severance and post-employment benefits
$
0.3

$
2.0

Asset-related charges
—

0.1

Other charges
0.3

1.2

Total restructuring and related charges
0.6

3.3

Development and licensing income
(0.2
)

(0.2
)
Contingent consideration
0.2

0.3

Other items
(2.9
)

(0.3
)
Total other (income) expense
$
(2.3
)

$
3.1

Schedule of Restructuring Reserve
The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:

($ in millions)
Severance
and benefits

Asset-related charges

Other charges

Total
Balance, December 31, 2018
$
2.3

$
—

$
—

$
2.3

Charges
0.3

—

0.3

0.6

Cash payments
(1.1
)

—

—

(1.1
)
Non-cash asset write-downs
—

—

(0.3
)

(0.3
)
Balance, March 31, 2019
$
1.5

$
—

$
—

$
1.5

X

- References
No definition available.
+ Details

Name: us-gaap_OtherIncomeAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b)(2))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747
+ Details

Name: us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Schedule of Other Income and Expense, by Component [Table Text Block]
+ References
No definition available.
+ Details

Name: wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock

Namespace Prefix: wst_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 58 R39.htm IDEA: XBRL DOCUMENT v3.19.1

Segment Information (Tables)
3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Segment Information
The following table presents information about our reportable segments, reconciled to consolidated totals:

Three Months Ended
March 31,
($ in millions)
2019

2018
Net sales:

Proprietary Products
$
340.4

$
326.2

Contract-Manufactured Products
103.1

89.5

Consolidated net sales
$
443.5

$
415.7

Operating profit (loss):

Proprietary Products
$
77.0

$
62.8

Contract-Manufactured Products
10.5

9.5

Corporate
(16.2
)

(15.6
)
Other unallocated items
(0.6
)

(3.3
)
Total operating profit
$
70.7

$
53.4

Interest expense
2.3

1.9

Interest income
(0.9
)

(0.6
)
Other nonoperating income
(0.6
)

(1.6
)
Income before income taxes
$
69.9

$
53.7

X

- Definition
Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599
+ Details

Name: us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 59 R40.htm IDEA: XBRL DOCUMENT v3.19.1

Revenue Recognition (Details)
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Disaggregation of Revenue [Line Items]

Percentage of net sales 100.00% 100.00%

Sales Revenue, Net [Member] | Product Concentration Risk [Member] | High-Value Components [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 43.00% 41.00%

Sales Revenue, Net [Member] | Product Concentration Risk [Member] | Standard Packaging [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 30.00% 34.00%

Sales Revenue, Net [Member] | Product Concentration Risk [Member] | Delivery Devices [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 4.00% 3.00%

Sales Revenue, Net [Member] | Product Concentration Risk [Member] | Contract-Manufactured Products [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 23.00% 22.00%

Biologics [Member] | Sales Revenue, Net [Member] | Customer Concentration Risk [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 26.00% 21.00%

Generics [Member] | Sales Revenue, Net [Member] | Customer Concentration Risk [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 20.00% 21.00%

Pharma Customers [Member] | Sales Revenue, Net [Member] | Customer Concentration Risk [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 31.00% 36.00%

Contract-Manufactured Products [Member] | Sales Revenue, Net [Member] | Customer Concentration Risk [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 23.00% 22.00%

Americas [Member] | Sales Revenue, Net [Member] | Geographic Concentration Risk [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 46.00% 45.00%

Europe, Middle East, Africa [Member] | Sales Revenue, Net [Member] | Geographic Concentration Risk [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 47.00% 47.00%

Asia Pacific [Member] | Sales Revenue, Net [Member] | Geographic Concentration Risk [Member]

Disaggregation of Revenue [Line Items]

Percentage of net sales 7.00% 8.00%

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13537-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592
+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DisaggregationOfRevenueLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ProductOrServiceAxis=wst_HighValueComponentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ProductOrServiceAxis=wst_StandardPackagingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ProductOrServiceAxis=wst_DeliveryDevicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=wst_BiologicsCustomersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=wst_GenericsCustomersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=wst_PharmaCustomersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementGeographicalAxis=srt_AmericasMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementGeographicalAxis=us-gaap_EMEAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementGeographicalAxis=srt_AsiaPacificMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 60 R41.htm IDEA: XBRL DOCUMENT v3.19.1

Contracts and Liabilities (Details) - USD ($)
$ in Millions
3 Months Ended

Jan. 01, 2019

Mar. 31, 2019

Contract assets, December 31, 2018 $ 9.1 $ 9.1

Contract assets, March 31, 2019 11.9

Change in contract assets - increase (decrease) 2.8

Deferred income, December 31, 2018 (33.4) (33.4)

Deferred income, March 31, 2019 (36.5)

Change in deferred income - decrease (increase) (3.1)

Revenue recognized that was included in the deferred income balance $ 11.1 $ 25.8

Receipt of advance cash payment 30.6

Other adjustments 1.7

SmartDose [Member]

Deferred income, March 31, 2019 $ (6.3)

Deferred income, current 0.9

Deferred income, noncurrent $ 5.4

X

- Definition
Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130533-203044
+ Details

Name: us-gaap_ContractWithCustomerAssetNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130551-203045
+ Details

Name: us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Explanation of change in obligation to transfer good or service to customer for which consideration from customer has been received or is due.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130551-203045
+ Details

Name: us-gaap_ContractWithCustomerLiabilityExplanationOfChange

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044
+ Details

Name: us-gaap_ContractWithCustomerLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiabilityRevenueRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Description of effect, from relationship that timing of satisfaction of performance obligation has on timing of payment, on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time and on obligation to transfer good or service to customer for which consideration from customer has been received or is due.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130550-203045
+ Details

Name: us-gaap_ContractWithCustomerTimingOfSatisfactionOfPerformanceObligationAndPayment

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Contract with Customer, Asset, Increase (Decrease)
+ References
No definition available.
+ Details

Name: wst_ContractwithCustomerAssetIncreaseDecrease

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: srt_ProductOrServiceAxis=wst_SmartDoseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 61 R42.htm IDEA: XBRL DOCUMENT v3.19.1

Revenue Supply Chain Financing (Details)
$ in Millions

Mar. 31, 2019

USD ($)

Supply Chain Financing [Abstract]

Sales of certain accounts receivable $ 1.8

X

- Definition
Amount, before counterparty netting, of cash proceeds received in transfers of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 20
-Section 50
-Paragraph 4D
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109247956&loc=SL51823488-111719
+ Details

Name: us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Supply Chain Financing [Abstract]
+ References
No definition available.
+ Details

Name: wst_SupplyChainFinancingAbstract

Namespace Prefix: wst_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 62 R43.htm IDEA: XBRL DOCUMENT v3.19.1

Revenue Voluntary Recall (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended

Mar. 31, 2019

Dec. 31, 2018

Revenue from Contract with Customer [Abstract]

Provision for sales returns $ 4.5 $ 11.3

X

- References
No definition available.
+ Details

Name: us-gaap_RevenueFromContractWithCustomerAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of estimated sales returns.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 63 R44.htm IDEA: XBRL DOCUMENT v3.19.1

Net Income Per Share (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Dec. 31, 2018

Earnings Per Share [Abstract]

Net income $ 55.4 $ 43.6

Weighted average common shares outstanding (in shares) 74,100,000 73,900,000

Dilutive effect of equity awards, based on the treasury stock method (in shares) 1,200,000 1,600,000

Weighted average shares assuming dilution (in shares) 75,300,000 75,500,000

Antidilutive options excluded from computation of diluted net income per share (in shares) 600,000 700,000

Stock repurchase program, shares authorized 800,000

Stock repurchase program, shares purchased 800,000

Stock purchase program, cost of shares purchased $ 83.1 $ 47.9

Stock repurchase program, average price per share $ 103.89

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 28A
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1500-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total cost of shares repurchased divided by the total number of shares repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockAcquiredAverageCostPerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_TreasuryStockValueAcquiredCostMethod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1505-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1448-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 64 R45.htm IDEA: XBRL DOCUMENT v3.19.1

Inventories (Details) - USD ($)
$ in Millions

Mar. 31, 2019

Dec. 31, 2018

Inventory Disclosure [Abstract]

Raw materials $ 100.1 $ 90.4

Work in process 39.0 42.2

Finished goods 87.0 81.9

Total inventories $ 226.1 $ 214.5

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryFinishedGoodsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryRawMaterialsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryWorkInProcessNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 65 R46.htm IDEA: XBRL DOCUMENT v3.19.1

Leases Adoption of ASC 842 (Details) - USD ($)
$ in Millions

Mar. 31, 2019

Jan. 01, 2019

Dec. 31, 2018

New Accounting Pronouncements or Change in Accounting Principle [Line Items]

Total lease liabilities $ 77.6

Operating lease right-of-use assets $ 75.2 $ 0.0

Accounting Standards Update 2016-02 [Member]

New Accounting Pronouncements or Change in Accounting Principle [Line Items]

Total lease liabilities $ 73.1

Operating lease right-of-use assets $ 71.0

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 66 R47.htm IDEA: XBRL DOCUMENT v3.19.1

Leases Lease Cost (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Lease, Cost [Abstract]

Operating lease cost $ 3.2

Short-term lease cost 0.2

Variable lease cost 0.6

Total lease cost $ 4.0 $ 3.7

X

- Definition
Amount of lease cost recognized by lessee for lease contract.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971
+ Details

Name: us-gaap_LeaseCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_LeaseCostAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_OperatingLeaseCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of short-term lease cost, excluding expense for lease with term of one month or less.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971
+ Details

Name: us-gaap_ShortTermLeaseCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971
+ Details

Name: us-gaap_VariableLeaseCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 67 R48.htm IDEA: XBRL DOCUMENT v3.19.1

Leases Lease Cash Flow and Supplemental Information (Details)
$ in Millions
3 Months Ended

Mar. 31, 2019

USD ($)

Lease Cash Flow and Supplemental Information [Abstract]

Operating lease payments $ 3.1

Right-of-use assets obtained in exchange for new operating lease liabilities $ 6.8

X

- Definition
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 5
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (g)(1)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_OperatingLeasePayments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in right-of-use asset obtained in exchange for operating lease liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Lease Cash Flow and Supplemental Information [Abstract]
+ References
No definition available.
+ Details

Name: wst_LeaseCashFlowandSupplementalInformationAbstract

Namespace Prefix: wst_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 68 R49.htm IDEA: XBRL DOCUMENT v3.19.1

Leases Lease Weighted Average (Details)

Mar. 31, 2019

Lease Cash Flow and Supplemental Information [Abstract]

Weighted average remaining lease term 12 years 1 month 5 days

Weighted average discount rate 3.74%

X

- Definition
Weighted average discount rate for operating lease calculated at point in time.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (g)(4)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971
+ Details

Name: us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (g)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition
Lease Cash Flow and Supplemental Information [Abstract]
+ References
No definition available.
+ Details

Name: wst_LeaseCashFlowandSupplementalInformationAbstract

Namespace Prefix: wst_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 69 R50.htm IDEA: XBRL DOCUMENT v3.19.1

Leases Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Millions

Mar. 31, 2019

Dec. 31, 2018

Leases [Abstract]

2019 (remaining nine months) $ 9.6

2020 11.5

2021 9.8

2022 8.1

2023 7.6

Thereafter 49.0

Operating leases liabilities payments due 95.6

Less: imputed lease interest 18.0

Total lease liabilities $ 77.6

2019 $ 13.0

2020 10.5

2021 7.8

2022 6.9

2023 5.5

Thereafter 37.8

Total $ 81.5

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 70 R51.htm IDEA: XBRL DOCUMENT v3.19.1

Affiliated Companies (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Dec. 31, 2018

Schedule of Equity Method Investments [Line Items]

Purchases and royalty payments made to affiliates $ 24.6 $ 23.1

Amount due and payable to affiliates 17.2 $ 12.9

Sales to affiliates 2.2 $ 2.4

Amount receivable from affiliates 1.4 1.6

Carrying amount, equity-method investments 81.5 77.8

Carrying amount, cost-method investments $ 13.4 $ 13.4

X

- Definition
Amount, after adjustment, of cost-method investment. Adjustments include, but are not limited to, dividends received in excess of earnings after date of investment that are considered a return of investment and other than temporary impairments.
+ References
No definition available.
+ Details

Name: us-gaap_CostMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.3)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864
+ Details

Name: us-gaap_DueFromAffiliates

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04.12(3))
-URI http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(3))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6918054&loc=d3e56071-112765
+ Details

Name: us-gaap_DueToAffiliateCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Purchases and Royalty Payments from Equity Method Investees
+ References
No definition available.
+ Details

Name: wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Sales to Equity Method Investees
+ References
No definition available.
+ Details

Name: wst_SalesToEquityMethodInvestees

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 71 R52.htm IDEA: XBRL DOCUMENT v3.19.1

Long-term Debt (Details) - USD ($)
$ in Millions

Mar. 31, 2019

Dec. 31, 2018

Debt Instrument [Line Items]

Long-term debt, gross $ 196.1 $ 196.7

Long-term debt 195.5 196.1

Unamortized debt issuance costs 0.6 0.6

Current portion of long-term debt 0.0 0.1

Long-term debt, excluding current portion 195.5 196.0

Notes payable, Due 2019 [Member]

Debt Instrument [Line Items]

Long-term debt, gross 0.0 $ 0.1

Revolving credit facility, Due 2020 [Member]

Debt Instrument [Line Items]

Debt instrument, stated interest rate 1.00%

Long-term debt, gross $ 0.0 $ 28.6

Revolving credit facility, Due 2024 [Member]

Debt Instrument [Line Items]

Debt instrument, stated interest rate 0.875%

Long-term debt, gross $ 28.1

Series A Notes, Due 2022 [Member]

Debt Instrument [Line Items]

Debt instrument, stated interest rate 3.67% 3.67%

Long-term debt, gross $ 42.0 $ 42.0

Series B Notes, Due 2024 [Member]

Debt Instrument [Line Items]

Debt instrument, stated interest rate 3.82% 3.82%

Long-term debt, gross $ 53.0 $ 53.0

Series C Notes, Due 2027 [Member]

Debt Instrument [Line Items]

Debt instrument, stated interest rate 4.02% 4.02%

Long-term debt, gross $ 73.0 $ 73.0

X

- Definition
Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(16))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_DebtInstrumentCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)(3)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_UnamortizedDebtIssuanceExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=wst_Revolvingcreditfacilitydue2020Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=wst_Revolvingcreditfacilitydue2024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=wst_SeniorNotesDue2022Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=wst_SeniorCNotesDue2027Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 72 R53.htm IDEA: XBRL DOCUMENT v3.19.1

Credit Facility (Details) - Revolving credit facility, Due 2024 [Member] - USD ($)
3 Months Ended 12 Months Ended

Mar. 31, 2019

Dec. 31, 2018

Line of Credit Facility [Line Items]

Line of Credit Facility, current borrowing capacity $ 300,000,000.0

Line of Credit Facility, additional borrowing capacity 350,000,000

Credit available for the issuance of letters of credit 30,000,000.0

Line of Credit Facility, noncurrent 28,100,000

Line of Credit Facility outstanding borrowings, Yen 4,500,000

Line of Credit Facility outstanding borrowings, Euro 23,600,000

Line of Credit Facility, unused commitment level 269,400,000

Debt issuance costs $ 1,100,000 $ 600,000

Debt instrument, maturity date Mar. 28, 2024

London Interbank Offered Rate (LIBOR) [Member]

Line of Credit Facility [Line Items]

Debt instrument, stated interest rate 0.00%

Federal Funds Effective Swap Rate [Member]

Line of Credit Facility [Line Items]

Debt instrument, stated interest rate 50.00%

Letter of Credit [Member]

Line of Credit Facility [Line Items]

Long-term Line of Credit $ 2,500,000

Foreign Line of Credit [Member]

Line of Credit Facility [Line Items]

Credit facility is available for swing-line loans 20,000,000.0

Domestic Line of Credit [Member]

Line of Credit Facility [Line Items]

Credit facility is available for swing-line loans $ 30,000,000.0

Maximum [Member]

Line of Credit Facility [Line Items]

Ratio of debt to EBITDA 4.0

Maximum [Member] | London Interbank Offered Rate (LIBOR) [Member]

Line of Credit Facility [Line Items]

Debt instrument, stated interest rate 137.50%

Maximum [Member] | Base Rate [Member]

Line of Credit Facility [Line Items]

Debt instrument, stated interest rate 37.50%

Minimum [Member]

Line of Credit Facility [Line Items]

Ratio of debt to EBITDA 3.5

Minimum [Member] | London Interbank Offered Rate (LIBOR) [Member]

Line of Credit Facility [Line Items]

Debt instrument, stated interest rate 87.50%

Minimum [Member] | Base Rate [Member]

Line of Credit Facility [Line Items]

Debt instrument, stated interest rate 0.00%

X

- Definition
Percentage points added to the reference rate to compute the variable rate on the debt instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentBasisSpreadOnVariableRate1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258
+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of any adjustment recognized to the balance of unamortized issuance costs associated with a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, due, for example, to default by the share borrower.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 2C
-URI http://asc.fasb.org/extlink&oid=7656903&loc=SL6757497-112611
+ Details

Name: us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(16))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600
+ Details

Name: us-gaap_LongTermLineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
this refers to Credit available for the issuance of letters of credit
+ References
No definition available.
+ Details

Name: wst_CreditAvailableForIssuanceOfLettersOfCredit

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
This refers to credit facility is available for swing-line loans
+ References
No definition available.
+ Details

Name: wst_CreditFacilityIsAvailableForSwingLineLoans

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line of credit facility outstanding borrowings, Euro
+ References
No definition available.
+ Details

Name: wst_LineOfCreditFacilityOutstandingBorrowingsEuro

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line of credit facility outstanding borrowings, Yen
+ References
No definition available.
+ Details

Name: wst_LineOfCreditFacilityOutstandingBorrowingsYen

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Additional borrowing capacity under the credit facility.
+ References
No definition available.
+ Details

Name: wst_LineofCreditFacilityAdditionalBorrowingCapacity

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Ratio of deb to EBITDA
+ References
No definition available.
+ Details

Name: wst_RatioofdebtoEBITDA

Namespace Prefix: wst_

Data Type: xbrli:pureItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=wst_Revolvingcreditfacilitydue2024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_FederalFundsEffectiveSwapRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_ForeignLineOfCreditMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_BaseRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R54.htm IDEA: XBRL DOCUMENT v3.19.1

Derivative Financial Instruments (Textuals) (Details)
€ in Millions, ¥ in Millions, $ in Millions, $ in Millions
3 Months Ended

Mar. 31, 2019

EUR (€)

MBbls

$ / bbl

Mar. 31, 2019

JPY (¥)

Mar. 31, 2019

USD ($)

Mar. 31, 2019

SGD ($)

MBbls

$ / bbl

Mar. 31, 2019

JPY (¥)

MBbls

$ / bbl

Mar. 31, 2019

USD ($)

MBbls

$ / bbl

Jan. 31, 2019

MBbls

Dec. 31, 2018

EUR (€)

Dec. 31, 2018

SGD ($)

Dec. 31, 2018

USD ($)

Apr. 24, 2018

MBbls

Nov. 22, 2017

MBbls

Derivative [Line Items]

Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives $ 4.8

Debt EUR Denominated [Member]

Derivative [Line Items]

Notional amount, nonderivative instruments € 21.0 23.6

Cumulative foreign currency translation loss $ 0.1

Cumulative foreign currency translation loss, net of tax 0.1

Debt Yen Denominated [Member]

Derivative [Line Items]

Notional amount, nonderivative instruments ¥ 500.0 4.5

Cumulative foreign currency translation loss 0.4

Cumulative foreign currency translation loss, net of tax $ 0.3

Options Held [Member]

Derivative [Line Items]

Derivative, nonmonetary notional amount | MBbls 108,891 108,891 108,891 108,891 81,459 30,612 125,166

Gain (Loss) related to call options $ 0.1

Derivative, Average Price Risk Option Strike Price | $ / bbl 66.22 66.22 66.22 66.22

Euro Member Countries, Euro | Forward Contracts [Member]

Derivative [Line Items]

Notional amount | € € 10.0

Singapore, Dollars | Forward Contracts [Member]

Derivative [Line Items]

Notional amount $ 601.5 $ 601.5

United States of America, Dollars | Forward Contracts [Member]

Derivative [Line Items]

Notional amount $ 13.4 $ 13.4

Long [Member] | Designated as Hedging Instrument [Member] | Singapore, Dollars | Foreign Exchange Forward [Member]

Derivative [Line Items]

Notional amount $ 44.0

Long [Member] | Designated as Hedging Instrument [Member] | United States of America, Dollars | Foreign Exchange Forward [Member]

Derivative [Line Items]

Notional amount 31.5

Long [Member] | Designated as Hedging Instrument [Member] | Japan, Yen | Foreign Exchange Forward [Member]

Derivative [Line Items]

Notional amount | ¥ ¥ 5,232.0

Short [Member] | Designated as Hedging Instrument [Member] | Singapore, Dollars | Foreign Exchange Forward [Member]

Derivative [Line Items]

Notional amount € 6.4 25.1

Short [Member] | Designated as Hedging Instrument [Member] | United States of America, Dollars | Foreign Exchange Forward [Member]

Derivative [Line Items]

Notional amount 26.8 0.0

Short [Member] | Designated as Hedging Instrument [Member] | Japan, Yen | Foreign Exchange Forward [Member]

Derivative [Line Items]

Notional amount € 20.5 $ 24.4

X

- Definition
Aggregate notional amount of derivative expressed in nonmonetary units. For example, the number of barrels specified in a fuel oil forward purchase contract.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 12
-Section 13
-Sentence Column B
+ Details

Name: invest_DerivativeNonmonetaryNotionalAmount

Namespace Prefix: invest_

Data Type: xbrli:decimalItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 12
-Section 13
-Sentence Column B
+ Details

Name: invest_DerivativeNotionalAmount

Namespace Prefix: invest_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
The average strike price on the group of price risk option contracts such as put options or call options.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeAveragePriceRiskOptionStrikePrice

Namespace Prefix: us-gaap_

Data Type: us-types:perUnitItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) from the increase (decrease) in fair value of foreign currency derivatives and nonderivative instruments designated as fair value hedging instruments which were recognized in earnings, net of offsets by the gain (loss) on the hedged item to the extent that the fair value hedge was determined to be effective.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959
+ Details

Name: us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of price risk derivatives not designated as hedging instruments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959
+ Details

Name: us-gaap_GainLossOnPriceRiskDerivativeInstrumentsNotDesignatedAsHedgingInstruments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Nominal or face amount used to calculate payments on a nonderivative instrument.
+ References
No definition available.
+ Details

Name: us-gaap_NotionalAmountOfNonderivativeInstruments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after tax, of cumulative translation adjustment attributable to gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109240241&loc=d3e32211-110900
+ Details

Name: us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Pre-tax cumulative adjustment resulting from gains and losses on foreign currency derivatives that are designated as, and are effective as, hedges of a net investment in a foreign entity, commencing as of the designation date. Adjustment reported in equity as part of accumulated other comprehensive income.
+ References
No definition available.
+ Details

Name: wst_TranslationAdjustmentForNetInvestmentHedgePreTax

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=wst_DebtYenDenominatedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_CurrencyAxis=currency_EUR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_CurrencyAxis=currency_SGD

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_CurrencyAxis=currency_USD

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PositionAxis=us-gaap_LongMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_CurrencyAxis=currency_JPY

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PositionAxis=us-gaap_ShortMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 74 R55.htm IDEA: XBRL DOCUMENT v3.19.1

Effects of Derivative Instruments on OCI and Earnings (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Cash Flow Hedges [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in OCI $ 0.4 $ 1.2

Amount of (gain) loss reclassified from accumulated OCI into income (0.3) 1.0

Net Investment Hedges [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in OCI 0.1 (0.7)

Amount of (gain) loss reclassified from accumulated OCI into income 0.0 0.0

Foreign Currency Hedge Contracts [Member] | Net sales [Member] | Cash Flow Hedges [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in OCI 0.5 (0.4)

Amount of (gain) loss reclassified from accumulated OCI into income (0.2) 0.5

Foreign Currency Hedge Contracts [Member] | Cost of goods and services sold [Member] | Cash Flow Hedges [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in OCI (0.1) 1.6

Amount of (gain) loss reclassified from accumulated OCI into income (0.1) 0.4

Forward Treasury Locks [Member] | Interest expense [Member] | Cash Flow Hedges [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in OCI 0.0 0.0

Amount of (gain) loss reclassified from accumulated OCI into income 0.0 0.1

Foreign Currency - Denominated Debt [Member] | Other expense [Member] | Net Investment Hedges [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in OCI 0.1 (0.7)

Amount of (gain) loss reclassified from accumulated OCI into income $ 0.0 $ 0.0

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsGainLossLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959
+ Details

Name: us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=wst_ForeignCurrencyDenominatedDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 75 R56.htm IDEA: XBRL DOCUMENT v3.19.1

Fair Value Measurements (Details) - USD ($)
$ in Millions

Mar. 31, 2019

Dec. 31, 2018

Assets:

Deferred compensation assets $ 9.2 $ 8.7

Foreign currency contracts 17.7 6.5

Commodity call options 0.2

Total assets at fair value 27.1 15.2

Liabilities:

Contingent consideration 1.7 1.7

Deferred compensation liabilities 10.5 9.8

Foreign currency contracts 0.8 0.2

Total liabilities at fair value 13.0 11.7

Level 1 [Member]

Assets:

Deferred compensation assets 9.2 8.7

Total assets at fair value 9.2 8.7

Liabilities:

Deferred compensation liabilities 10.5 9.8

Total liabilities at fair value 10.5 9.8

Level 2 [Member]

Assets:

Foreign currency contracts 17.7 6.5

Commodity call options 0.2

Total assets at fair value 17.9 6.5

Liabilities:

Foreign currency contracts 0.8 0.2

Total liabilities at fair value 0.8 0.2

Level 3 [Member]

Liabilities:

Contingent consideration 1.7 1.7

Total liabilities at fair value $ 1.7 $ 1.7

X

- Definition
Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258
+ Details

Name: us-gaap_AssetsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of liability recognized arising from contingent consideration in a business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476
+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).
+ References
No definition available.
+ Details

Name: us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DeferredCompensationPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.
+ References
No definition available.
+ Details

Name: us-gaap_ForeignCurrencyContractAssetFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.
+ References
No definition available.
+ Details

Name: us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value of financial and nonfinancial obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258
+ Details

Name: us-gaap_LiabilitiesFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value portion of other assets.
+ References
No definition available.
+ Details

Name: us-gaap_OtherAssetsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 76 R57.htm IDEA: XBRL DOCUMENT v3.19.1

Fair Value Measurements Level 3 (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended

Mar. 31, 2019

Dec. 31, 2018

Level 3 Fair Value Measurements [Roll Forward]

Balance, beginning of period $ 1.7 $ 4.9

Increase (decrease) in fair value recorded in earnings 0.2 (2.6)

Payments (0.2) (0.6)

Balance, end of period $ 1.7 $ 1.7

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 77 R58.htm IDEA: XBRL DOCUMENT v3.19.1

Fair Value Measurements Other Financial Instruments (Details) - USD ($)
$ in Millions

Mar. 31, 2019

Dec. 31, 2018

Other Financial Instruments [Abstract]

Long-term debt, fair value $ 197.4 $ 192.6

Long-term debt $ 195.5 $ 196.0

X

- Definition
The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermDebtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
-- None. No documentation exists for this element. --
+ References
No definition available.
+ Details

Name: wst_OtherFinancialInstrumentsAbstract

Namespace Prefix: wst_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 78 R59.htm IDEA: XBRL DOCUMENT v3.19.1

Accumulated Other Comprehensive Loss Components (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]

Balance, beginning $ (154.2)

Other comprehensive income (loss) before reclassifications 1.2

Amounts reclassified out (0.4)

Other comprehensive income, net of tax 0.8 $ 21.5

Balance, ending (153.4)

Gains (Losses) on Cash Flow Hedges [Member]

Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]

Balance, beginning (0.4)

Other comprehensive income (loss) before reclassifications (3.0)

Amounts reclassified out (0.3)

Other comprehensive income, net of tax (3.3)

Balance, ending (3.7)

Unrealized Gains on Investment Securities [Member]

Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]

Balance, beginning 0.4

Other comprehensive income (loss) before reclassifications 0.0

Amounts reclassified out 0.0

Other comprehensive income, net of tax 0.0

Balance, ending 0.4

Defined Benefit Pension and Other Postretirement Plans [Member]

Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]

Balance, beginning (40.4)

Other comprehensive income (loss) before reclassifications (0.2)

Amounts reclassified out (0.1)

Other comprehensive income, net of tax (0.3)

Balance, ending (40.7)

Foreign Currency Translation [Member]

Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]

Balance, beginning (113.8)

Other comprehensive income (loss) before reclassifications 4.4

Amounts reclassified out 0.0

Other comprehensive income, net of tax 4.4

Balance, ending $ (109.4)

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e681-108580
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInStockholdersEquityRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=109228884&loc=d3e1436-108581
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=109228884&loc=d3e1436-108581

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17B
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL34724394-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=109228884&loc=d3e1436-108581
+ Details

Name: us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 79 R60.htm IDEA: XBRL DOCUMENT v3.19.1

Accumulated Other Comprehensive Loss Reclassifications (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Reclassification out of Accumulated Other Comprehensive Loss [Line Items]

Net sales $ 443.5 $ 415.7

Cost of goods and services sold (296.7) (281.3)

Interest expense (2.3) (1.9)

Prior service cost 0.2 0.5

Actuarial losses 0.0 (0.4)

Income before income taxes 69.9 53.7

Tax expense (benefit) (16.1) (12.5)

Net income 55.4 43.6

Reclassification out of Accumulated Other Comprehensive Loss [Member]

Reclassification out of Accumulated Other Comprehensive Loss [Line Items]

Net income 0.4 (0.9)

Reclassification out of Accumulated Other Comprehensive Loss [Member] | Gains (Losses) on Cash Flow Hedges [Member]

Reclassification out of Accumulated Other Comprehensive Loss [Line Items]

Income before income taxes 0.3 (1.3)

Tax expense (benefit) 0.0 0.3

Net income 0.3 (1.0)

Reclassification out of Accumulated Other Comprehensive Loss [Member] | Amortization of Defined Benefit Pension and Other Postretirement Plans [Member]

Reclassification out of Accumulated Other Comprehensive Loss [Line Items]

Prior service cost ^[1] 0.2 0.5

Actuarial losses ^[1] 0.0 (0.4)

Income before income taxes 0.2 0.1

Tax expense (benefit) (0.1) 0.0

Net income 0.1 0.1

Foreign Currency Contract [Member] | Reclassification out of Accumulated Other Comprehensive Loss [Member] | Gains (Losses) on Cash Flow Hedges [Member]

Reclassification out of Accumulated Other Comprehensive Loss [Line Items]

Net sales 0.2 (0.6)

Cost of goods and services sold 0.2 (0.6)

Forward Treasury Locks [Member] | Reclassification out of Accumulated Other Comprehensive Loss [Member] | Gains (Losses) on Cash Flow Hedges [Member]

Reclassification out of Accumulated Other Comprehensive Loss [Line Items]

Interest expense $ (0.1) $ (0.1)

[1] These components are included in the computation of net periodic benefit cost. Please refer to Note 14, Benefit Plans, for additional details.

X

- Definition
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(4)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920
+ Details

Name: us-gaap_DefinedBenefitPlanActuarialGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(5)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(5)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920
+ Details

Name: us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (210.5-03(11))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 80 R61.htm IDEA: XBRL DOCUMENT v3.19.1

Shareholders' Equity Supplemental Equity Information (Details) - $ / shares
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Equity [Abstract]

Dividends declared per share $ 0.15 $ 0.14

X

- Definition
Aggregate dividends declared during the period for each share of common stock outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_CommonStockDividendsPerShareDeclared

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 81 R62.htm IDEA: XBRL DOCUMENT v3.19.1

Shareholders' Equity Change in Shareholders' Equity (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Balance $ 1,396.3 $ 1,279.9

Cumulative effect of new accounting principle in period of adoption 11.4

Net income 55.4 43.6

Activity related to stock-based compensation $ 10.7 7.2

Share purchased under share repurchase program (in shares) 800,000

Shares purchased under share repurchase program $ (83.1) (47.9)

Dividends declared (10.6) (10.4)

Other comprehensive income, net of tax 0.8 21.5

Balance 1,369.5 1,305.3

Common Stock [Member]

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Balance $ 18.8 $ 18.8

Balance (in shares) 75,300,000 75,200,000

Shares issued under stock plans (in shares) 0 100,000

Activity related to stock-based compensation $ 0.0 $ 0.0

Balance $ 18.8 $ 18.8

Balance (in shares) 75,300,000 75,300,000

Additional Paid-in Capital [Member]

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Balance $ 282.0 $ 309.3

Activity related to stock-based compensation (3.5) (0.8)

Balance 278.5 308.5

Treasury Stock [Member]

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Balance $ (103.7) $ (109.1)

Balance (in shares) 1,200,000 1,300,000

Shares issued under stock plans (in shares) (200,000) (100,000)

Activity related to stock-based compensation $ 14.2 $ 8.0

Share purchased under share repurchase program (in shares) 800,000 500,000

Shares purchased under share repurchase program $ (83.1) $ (47.9)

Balance $ (172.6) $ (149.0)

Balance (in shares) 1,800,000 1,700,000

Retained Earnings [Member]

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Balance $ 1,353.4 $ 1,178.2

Cumulative effect of new accounting principle in period of adoption 11.4

Net income 55.4 43.6

Dividends declared 10.6 (10.4)

Balance 1,398.2 1,222.8

AOCI Attributable to Parent [Member]

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Balance (154.2) (117.3)

Other comprehensive income, net of tax 0.8 21.5

Balance $ (153.4) $ (95.8)

X

- Definition
Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.
+ References
No definition available.
+ Details

Name: us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_DividendsCommonStockCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInStockholdersEquityRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=109228884&loc=d3e1436-108581

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_SharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4590271-111686

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_TreasuryStockValueAcquiredCostMethod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 82 R63.htm IDEA: XBRL DOCUMENT v3.19.1

Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares available for issuance under the 2016 Plan (in shares) 3,162,428

Stock options, granted (in shares) 344,616

Stock options, weighted average exercise price (in dollars per share) $ 102.51

Stock options, weighted average grant date fair value (in dollars per share) $ 24.51

Risk-free interest rate (in hundredths) 2.30%

Expected life (in years) 5 years 7 months

Stock volatility (in hundredths) 22.50%

Dividend yield (in hundredths) 0.70%

Stock-based compensation expense $ 6.2 $ 3.4

Performance Share Unit (PSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) 82,458

Grant date fair value (in dollars per share) $ 102.51

PSU payout, minimum (in hundredths) 0.00%

PSU payout, maximum (in hundredths) 200.00%

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) 7,266

Grant date fair value (in dollars per share) $ 102.51

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Net number of share options (or share units) granted during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Percent of an employee's targeted award to be paid out, Maximum.
+ References
No definition available.
+ Details

Name: wst_PvsPayoutMaximum

Namespace Prefix: wst_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Percent of an employee's targeted award to be paid out, Minimum.
+ References
No definition available.
+ Details

Name: wst_PvsPayoutMinimum

Namespace Prefix: wst_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 83 R64.htm IDEA: XBRL DOCUMENT v3.19.1

Benefit Plans (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]

Service cost $ 0.4 $ 2.8

Interest cost 2.5 2.4

Expected return on assets (2.9) (3.9)

Amortization of prior service credit (0.2) (0.5)

Recognized actuarial losses (gains) 0.0 0.4

Net periodic benefit cost (0.2) 1.2

Domestic Plan [Member]

Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]

Net periodic benefit cost (0.7) 0.7

Foreign Plan [Member]

Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]

Net periodic benefit cost 0.5 0.5

Pension Benefits [Member]

Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]

Service cost 0.4 2.8

Interest cost 2.4 2.3

Expected return on assets (2.9) (3.9)

Amortization of prior service credit 0.0 (0.3)

Recognized actuarial losses (gains) 0.5 0.9

Net periodic benefit cost 0.4 1.8

Pension Benefits [Member] | Domestic Plan [Member]

Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]

Net periodic benefit cost (0.1) 1.3

Pension Benefits [Member] | Foreign Plan [Member]

Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]

Net periodic benefit cost 0.5 0.5

Other Retirement Benefits [Member]

Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]

Service cost 0.0 0.0

Interest cost 0.1 0.1

Amortization of prior service credit (0.2) (0.2)

Recognized actuarial losses (gains) (0.5) (0.5)

Net periodic benefit cost (0.6) (0.6)

Other Retirement Benefits [Member] | Domestic Plan [Member]

Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]

Net periodic benefit cost $ (0.6) $ (0.6)

X

- Definition
Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(4)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920
+ Details

Name: us-gaap_DefinedBenefitPlanActuarialGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(5)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(5)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920
+ Details

Name: us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(3)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920
+ Details

Name: us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cost recognized for passage of time related to defined benefit plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920
+ Details

Name: us-gaap_DefinedBenefitPlanInterestCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of net periodic benefit cost (credit) for defined benefit plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920
+ Details

Name: us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920
+ Details

Name: us-gaap_DefinedBenefitPlanServiceCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_DomesticPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 84 R65.htm IDEA: XBRL DOCUMENT v3.19.1

Other Expense (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Other Income and Expenses [Abstract]

Severance and post-employment benefits $ 0.3 $ 2.0

Asset-related charges 0.0 0.1

Other charges 0.3 1.2

Total restructuring and related charges 0.6 3.3

Development and licensing income (0.2) (0.2)

Contingent consideration 0.2 0.3

Other items (2.9) (0.3)

Total other (income) expense $ (2.3) $ 3.1

X

- Definition
Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228
+ Details

Name: us-gaap_AssetImpairmentCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479
+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherIncomeAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.
+ References
No definition available.
+ Details

Name: us-gaap_OtherOperatingIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.P.3)
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_OtherRestructuringCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b)(1))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(d))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747
+ Details

Name: us-gaap_RestructuringAndRelatedCostIncurredCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.P.3)
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_SeveranceCosts1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.
+ References
No definition available.
+ Details

Name: wst_Developmentandlicensingincome

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.
+ References
No definition available.
+ Details

Name: wst_OtherIncomeExpense

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 85 R66.htm IDEA: XBRL DOCUMENT v3.19.1

Other Expense Items (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Other Income and Expenses [Abstract]

Increase (decrease) of other items $ (2.6)

Foreign exchange transaction (gain) loss $ (3.8) $ 0.4

X

- Definition
Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894
+ Details

Name: us-gaap_ForeignCurrencyTransactionGainLossBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherIncomeAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Increase (Decrease) of Other Operating Income and Expense
+ References
No definition available.
+ Details

Name: wst_IncreaseDecreaseofOtherOperatingIncomeandExpense

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 86 R67.htm IDEA: XBRL DOCUMENT v3.19.1

Other Expense Restructuring and Related Charges (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Dec. 31, 2019

Restructuring Cost and Reserve [Line Items]

Payments to acquire property, plant, and equipment $ 28.8 $ 28.0

Severance charges 0.3 2.0

Other charges 0.3 1.2

Restructuring and related charges 0.6 3.3

Restructuring Reserve [Roll Forward]

Charges 0.6 3.3

Non-cash asset-write-downs (0.3) (0.1)

Severance and benefits [Member]

Restructuring Reserve [Roll Forward]

Balance, December 31, 2018 2.3

Charges 0.3

Cash payments (1.1)

Non-cash asset-write-downs 0.0

Balance, March 31, 2019 1.5

Asset-related charges [Member]

Restructuring Reserve [Roll Forward]

Cash payments 0.0

Other charges [Member]

Restructuring Reserve [Roll Forward]

Cash payments 0.0

2018 Restructuring Plan [Member]

Restructuring Cost and Reserve [Line Items]

Severance charges 0.3 2.0

Asset impairment charges, equipment 0.1

Other charges 0.3 1.2

Restructuring and related charges 0.6 $ 3.3

Restructuring Reserve [Roll Forward]

Balance, December 31, 2018 2.3

Charges 0.6

Cash payments (1.1)

Non-cash asset-write-downs (0.3)

Balance, March 31, 2019 1.5

2018 Restructuring Plan [Member] | Asset-related charges [Member]

Restructuring Reserve [Roll Forward]

Balance, December 31, 2018 0.0

Charges 0.0

Non-cash asset-write-downs 0.0

Balance, March 31, 2019 0.0

2018 Restructuring Plan [Member] | Other charges [Member]

Restructuring Reserve [Roll Forward]

Balance, December 31, 2018 0.0

Charges 0.3

Non-cash asset-write-downs (0.3)

Balance, March 31, 2019 0.0

2018 Restructuring Plan [Member] | Maximum [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and related cost, expected cost $ 15.0

2016 Restructuring Plan [Member]

Restructuring Reserve [Roll Forward]

Balance, March 31, 2019 $ 0.3

X

- Definition
Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.P.3)
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_OtherRestructuringCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 17
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3367-108585
+ Details

Name: us-gaap_PaymentsForRestructuring

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount expected to be recognized in earnings for the specified restructuring cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b)(1))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(d))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747
+ Details

Name: us-gaap_RestructuringAndRelatedCostExpectedCost1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b)(1))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(d))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747
+ Details

Name: us-gaap_RestructuringAndRelatedCostIncurredCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.P.3)
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747
+ Details

Name: us-gaap_RestructuringCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_RestructuringCostAndReserveLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.P.4(b))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747
+ Details

Name: us-gaap_RestructuringReserve

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_RestructuringReserveRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of decrease in the reserve for full or partial settlement through consideration other than cash.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.P.4(b)(2))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869
+ Details

Name: us-gaap_RestructuringReserveSettledWithoutCash2

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.P.3)
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_SeveranceCosts1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of write-down of a patent and certain equipment, recognized in the income statement.
+ References
No definition available.
+ Details

Name: wst_AssetImpairmentChargesPatentandEquipment

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RestructuringPlanAxis=wst_A2018RestructuringPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RestructuringPlanAxis=wst_A2016RestructuringPlanMemberMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 87 R68.htm IDEA: XBRL DOCUMENT v3.19.1

Other Expense Other (Income) Development and Licensing Income (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Dec. 31, 2018

Jun. 30, 2013

Development and licensing income [Line Items]

Development and licensing income $ 0.2 $ 0.2

Deferred income 36.5 $ 33.4

SmartDose [Member]

Development and licensing income [Line Items]

Development and licensing income $ 0.2 $ 0.2

Deferred income $ 20.0

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.
+ References
No definition available.
+ Details

Name: wst_Developmentandlicensingincome

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
[Line Items] for Development and licensing income [Table]
+ References
No definition available.
+ Details

Name: wst_DevelopmentandlicensingincomeLineItems

Namespace Prefix: wst_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NatureOfExpenseAxis=wst_SmartDoseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 88 R69.htm IDEA: XBRL DOCUMENT v3.19.1

Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2019

Mar. 31, 2018

Income Tax Disclosure [Abstract]

Tax expense (benefit) $ 16.1 $ 12.5

Effective income tax rate 23.10% 23.30%

New Accounting Pronouncements or Change in Accounting Principle [Line Items]

Tax Cuts and Jobs Act of 2017, provisional income tax expense $ 0.3

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense
+ References
No definition available.
+ Details

Name: wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense

Namespace Prefix: wst_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 89 R70.htm IDEA: XBRL DOCUMENT v3.19.1

Segment Information (Details)
$ in Millions
3 Months Ended

Mar. 31, 2019

USD ($)

segment

Mar. 31, 2018

USD ($)

Segment Reporting [Abstract]

Number of reportable segments | segment 2

Restructuring and related charges $ 0.6 $ 3.3

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Net sales 443.5 415.7

Total operating (loss) profit 70.7 53.4

Interest expense 2.3 1.9

Interest income (0.9) (0.6)

Other nonoperating income (0.6) (1.6)

Income before income taxes 69.9 53.7

Proprietary Products [Member]

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Net sales 340.4 326.2

Total operating (loss) profit 77.0 62.8

Contract-Manufactured Products [Member]

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Net sales 103.1 89.5

Total operating (loss) profit 10.5 9.5

Corporate [Member]

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Total operating (loss) profit (16.2) (15.6)

Other unallocated items [Member]

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Total operating (loss) profit $ (0.6) $ (3.3)

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (210.5-03(11))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7(a),(b))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_InvestmentIncomeNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (expense) related to nonoperating activities, classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.P.3)
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747
+ Details

Name: us-gaap_RestructuringCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=wst_PackagingSystemsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=wst_DeliverySystemsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=wst_CorporateAndEliminationsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=us-gaap_MaterialReconcilingItemsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 90 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 91 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 92 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 93 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 191 281 1 true 81 0 false 10 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.westpharma.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) Sheet http://www.westpharma.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) Statements 2 false false R3.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Sheet http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Statements 3 false false R4.htm 1002501 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical) Sheet http://www.westpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical) Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 5 false false R6.htm 1003001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://www.westpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 6 false false R7.htm 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://www.westpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 7 false false R8.htm 2101100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.westpharma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 2102100 - Disclosure - New Accounting Standards Sheet http://www.westpharma.com/role/NewAccountingStandards New Accounting Standards Notes 9 false false R10.htm 2103100 - Disclosure - Revenue Sheet http://www.westpharma.com/role/Revenue Revenue Notes 10 false false R11.htm 2104100 - Disclosure - Net Income Per Share Sheet http://www.westpharma.com/role/NetIncomePerShare Net Income Per Share Notes 11 false false R12.htm 2105100 - Disclosure - Inventories Sheet http://www.westpharma.com/role/Inventories Inventories Notes 12 false false R13.htm 2106100 - Disclosure - Leases Sheet http://www.westpharma.com/role/Leases Leases Notes 13 false false R14.htm 2107100 - Disclosure - Affiliated Companies Sheet http://www.westpharma.com/role/AffiliatedCompanies Affiliated Companies Notes 14 false false R15.htm 2108100 - Disclosure - Debt Sheet http://www.westpharma.com/role/Debt Debt Notes 15 false false R16.htm 2109100 - Disclosure - Derivative Financial Instruments Sheet http://www.westpharma.com/role/DerivativeFinancialInstruments Derivative Financial Instruments Notes 16 false false R17.htm 2110100 - Disclosure - Fair Value Measurements Sheet http://www.westpharma.com/role/FairValueMeasurements Fair Value Measurements Notes 17 false false R18.htm 2111100 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 18 false false R19.htm 2112100 - Disclosure - Shareholders' Equity Sheet http://www.westpharma.com/role/ShareholdersEquity Shareholders' Equity Notes 19 false false R20.htm 2113100 - Disclosure - Stock-Based Compensation Sheet http://www.westpharma.com/role/StockBasedCompensation Stock-Based Compensation Notes 20 false false R21.htm 2114100 - Disclosure - Benefit Plans Sheet http://www.westpharma.com/role/BenefitPlans Benefit Plans Notes 21 false false R22.htm 2115100 - Disclosure - Other Expense Sheet http://www.westpharma.com/role/OtherExpense Other Expense Notes 22 false false R23.htm 2116100 - Disclosure - Income Taxes Sheet http://www.westpharma.com/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 2117100 - Disclosure - Commitments and Contingencies Sheet http://www.westpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 24 false false R25.htm 2118100 - Disclosure - Segment Information Sheet http://www.westpharma.com/role/SegmentInformation Segment Information Notes 25 false false R26.htm 2119100 - Disclosure - Subsequent Event Sheet http://www.westpharma.com/role/SubsequentEvent Subsequent Event Notes 26 false false R27.htm 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.westpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.westpharma.com/role/SummaryOfSignificantAccountingPolicies 27 false false R28.htm 2303301 - Disclosure - Revenue (Tables) Sheet http://www.westpharma.com/role/RevenueTables Revenue (Tables) Tables http://www.westpharma.com/role/Revenue 28 false false R29.htm 2304301 - Disclosure - Net Income Per Share (Tables) Sheet http://www.westpharma.com/role/NetIncomePerShareTables Net Income Per Share (Tables) Tables http://www.westpharma.com/role/NetIncomePerShare 29 false false R30.htm 2305301 - Disclosure - Inventories (Tables) Sheet http://www.westpharma.com/role/InventoriesTables Inventories (Tables) Tables http://www.westpharma.com/role/Inventories 30 false false R31.htm 2306301 - Disclosure - Leases Leases (Tables) Sheet http://www.westpharma.com/role/LeasesLeasesTables Leases Leases (Tables) Tables 31 false false R32.htm 2308301 - Disclosure - Debt (Tables) Sheet http://www.westpharma.com/role/DebtTables Debt (Tables) Tables http://www.westpharma.com/role/Debt 32 false false R33.htm 2309301 - Disclosure - Derivative Financial Instruments (Tables) Sheet http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables Derivative Financial Instruments (Tables) Tables http://www.westpharma.com/role/DerivativeFinancialInstruments 33 false false R34.htm 2310301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.westpharma.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.westpharma.com/role/FairValueMeasurements 34 false false R35.htm 2311301 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss 35 false false R36.htm 2312301 - Disclosure - Shareholders' Equity Shareholders' Equity (Tables) Sheet http://www.westpharma.com/role/ShareholdersEquityShareholdersEquityTables Shareholders' Equity Shareholders' Equity (Tables) Tables 36 false false R37.htm 2314301 - Disclosure - Benefit Plans (Tables) Sheet http://www.westpharma.com/role/BenefitPlansTables Benefit Plans (Tables) Tables http://www.westpharma.com/role/BenefitPlans 37 false false R38.htm 2315301 - Disclosure - Other Expense (Tables) Sheet http://www.westpharma.com/role/OtherExpenseTables Other Expense (Tables) Tables http://www.westpharma.com/role/OtherExpense 38 false false R39.htm 2318301 - Disclosure - Segment Information (Tables) Sheet http://www.westpharma.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.westpharma.com/role/SegmentInformation 39 false false R40.htm 2403402 - Disclosure - Revenue Recognition (Details) Sheet http://www.westpharma.com/role/RevenueRecognitionDetails Revenue Recognition (Details) Details 40 false false R41.htm 2403403 - Disclosure - Contracts and Liabilities (Details) Sheet http://www.westpharma.com/role/ContractsAndLiabilitiesDetails Contracts and Liabilities (Details) Details 41 false false R42.htm 2403404 - Disclosure - Revenue Supply Chain Financing (Details) Sheet http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails Revenue Supply Chain Financing (Details) Details 42 false false R43.htm 2403405 - Disclosure - Revenue Voluntary Recall (Details) Sheet http://www.westpharma.com/role/RevenueVoluntaryRecallDetails Revenue Voluntary Recall (Details) Details 43 false false R44.htm 2404402 - Disclosure - Net Income Per Share (Details) Sheet http://www.westpharma.com/role/NetIncomePerShareDetails Net Income Per Share (Details) Details http://www.westpharma.com/role/NetIncomePerShareTables 44 false false R45.htm 2405402 - Disclosure - Inventories (Details) Sheet http://www.westpharma.com/role/InventoriesDetails Inventories (Details) Details http://www.westpharma.com/role/InventoriesTables 45 false false R46.htm 2406402 - Disclosure - Leases Adoption of ASC 842 (Details) Sheet http://www.westpharma.com/role/LeasesAdoptionOfAsc842Details Leases Adoption of ASC 842 (Details) Details 46 false false R47.htm 2406403 - Disclosure - Leases Lease Cost (Details) Sheet http://www.westpharma.com/role/LeasesLeaseCostDetails Leases Lease Cost (Details) Details 47 false false R48.htm 2406404 - Disclosure - Leases Lease Cash Flow and Supplemental Information (Details) Sheet http://www.westpharma.com/role/LeasesLeaseCashFlowAndSupplementalInformationDetails Leases Lease Cash Flow and Supplemental Information (Details) Details 48 false false R49.htm 2406405 - Disclosure - Leases Lease Weighted Average (Details) Sheet http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails Leases Lease Weighted Average (Details) Details 49 false false R50.htm 2406406 - Disclosure - Leases Maturities of Operating Lease Liabilities (Details) Sheet http://www.westpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails Leases Maturities of Operating Lease Liabilities (Details) Details 50 false false R51.htm 2407401 - Disclosure - Affiliated Companies (Details) Sheet http://www.westpharma.com/role/AffiliatedCompaniesDetails Affiliated Companies (Details) Details http://www.westpharma.com/role/AffiliatedCompanies 51 false false R52.htm 2408402 - Disclosure - Long-term Debt (Details) Sheet http://www.westpharma.com/role/LongTermDebtDetails Long-term Debt (Details) Details 52 false false R53.htm 2408403 - Disclosure - Credit Facility (Details) Sheet http://www.westpharma.com/role/CreditFacilityDetails Credit Facility (Details) Details 53 false false R54.htm 2409402 - Disclosure - Derivative Financial Instruments (Textuals) (Details) Sheet http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails Derivative Financial Instruments (Textuals) (Details) Details http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables 54 false false R55.htm 2409403 - Disclosure - Effects of Derivative Instruments on OCI and Earnings (Details) Sheet http://www.westpharma.com/role/EffectsOfDerivativeInstrumentsOnOciAndEarningsDetails Effects of Derivative Instruments on OCI and Earnings (Details) Details 55 false false R56.htm 2410402 - Disclosure - Fair Value Measurements (Details) Sheet http://www.westpharma.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.westpharma.com/role/FairValueMeasurementsTables 56 false false R57.htm 2410403 - Disclosure - Fair Value Measurements Level 3 (Details) Sheet http://www.westpharma.com/role/FairValueMeasurementsLevel3Details Fair Value Measurements Level 3 (Details) Details 57 false false R58.htm 2410404 - Disclosure - Fair Value Measurements Other Financial Instruments (Details) Sheet http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails Fair Value Measurements Other Financial Instruments (Details) Details 58 false false R59.htm 2411402 - Disclosure - Accumulated Other Comprehensive Loss Components (Details) Sheet http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsDetails Accumulated Other Comprehensive Loss Components (Details) Details 59 false false R60.htm 2411403 - Disclosure - Accumulated Other Comprehensive Loss Reclassifications (Details) Sheet http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossReclassificationsDetails Accumulated Other Comprehensive Loss Reclassifications (Details) Details 60 false false R61.htm 2412402 - Disclosure - Shareholders' Equity Supplemental Equity Information (Details) Sheet http://www.westpharma.com/role/ShareholdersEquitySupplementalEquityInformationDetails Shareholders' Equity Supplemental Equity Information (Details) Details 61 false false R62.htm 2412403 - Disclosure - Shareholders' Equity Change in Shareholders' Equity (Details) Sheet http://www.westpharma.com/role/ShareholdersEquityChangeInShareholdersEquityDetails Shareholders' Equity Change in Shareholders' Equity (Details) Details 62 false false R63.htm 2413401 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.westpharma.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.westpharma.com/role/StockBasedCompensation 63 false false R64.htm 2414402 - Disclosure - Benefit Plans (Details) Sheet http://www.westpharma.com/role/BenefitPlansDetails Benefit Plans (Details) Details http://www.westpharma.com/role/BenefitPlansTables 64 false false R65.htm 2415402 - Disclosure - Other Expense (Details) Sheet http://www.westpharma.com/role/OtherExpenseDetails Other Expense (Details) Details http://www.westpharma.com/role/OtherExpenseTables 65 false false R66.htm 2415403 - Disclosure - Other Expense Items (Details) Sheet http://www.westpharma.com/role/OtherExpenseItemsDetails Other Expense Items (Details) Details 66 false false R67.htm 2415404 - Disclosure - Other Expense Restructuring and Related Charges (Details) Sheet http://www.westpharma.com/role/OtherExpenseRestructuringAndRelatedChargesDetails Other Expense Restructuring and Related Charges (Details) Details 67 false false R68.htm 2415405 - Disclosure - Other Expense Other (Income) Development and Licensing Income (Details) Sheet http://www.westpharma.com/role/OtherExpenseOtherIncomeDevelopmentAndLicensingIncomeDetails Other Expense Other (Income) Development and Licensing Income (Details) Details 68 false false R69.htm 2416401 - Disclosure - Income Taxes (Details) Sheet http://www.westpharma.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.westpharma.com/role/IncomeTaxes 69 false false R70.htm 2418402 - Disclosure - Segment Information (Details) Sheet http://www.westpharma.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.westpharma.com/role/SegmentInformationTables 70 false false All Reports Book All Reports wst-20190331.xml wst-20190331.xsd wst-20190331_cal.xml wst-20190331_def.xml wst-20190331_lab.xml wst-20190331_pre.xml http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/currency/2017-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://xbrl.sec.gov/invest/2013-01-31 http://fasb.org/srt/2018-01-31 true true ZIP 95 0000105770-19-000020-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000105770-19-000020-xbrl.zip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

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2019 shares
Document and Entity Information [Abstract]
Entity Registrant Name	WEST PHARMACEUTICAL SERVICES INC
Entity Central Index Key	0000105770
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding	73,483,687
Entity Current Reporting Status	Yes

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
Net sales	$ 443.5	$ 415.7
Cost of goods and services sold	296.7	281.3
Gross profit	146.8	134.4
Research and development	9.8	9.6
Selling, general and administrative expenses	68.6	68.3
Other (income) expense (Note 15)	(2.3)	3.1
Operating profit	70.7	53.4
Interest expense	2.3	1.9
Interest income	(0.9)	(0.6)
Other nonoperating income	(0.6)	(1.6)
Income before income taxes	69.9	53.7
Income tax expense	16.1	12.5
Equity in net income of affiliated companies	(1.6)	(2.4)
Net income	$ 55.4	$ 43.6
Net income per share:
Basic (in dollars per share)	$ 0.75	$ 0.59
Diluted (in dollars per share)	$ 0.73	$ 0.58
Weighted average shares outstanding:
Basic (in shares)	74.1	73.9
Diluted (in shares)	75.3	75.5

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income	$ 55.4	$ 43.6
Other comprehensive income, net of tax:
Foreign currency translation adjustments	4.4	20.0
Defined benefit pension and other postretirement plan adjustments, net of tax of $0 and $(0.3)	(0.3)	(0.7)
Net (loss) gain on derivatives, net of tax of $(1.6) and $0.8	(3.3)	2.2
Other comprehensive income, net of tax	0.8	21.5
Comprehensive income	$ 56.2	$ 65.1

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 265.5	$ 337.4
Accounts receivable, net	318.2	288.2
Inventories	226.1	214.5
Other current assets	57.8	54.3
Total current assets	867.6	894.4
Property, plant and equipment	1,759.9	1,752.7
Less: accumulated depreciation and amortization	945.2	930.7
Property, plant and equipment, net	814.7	822.0
Operating lease right-of-use assets	75.2	0.0
Investments in affiliated companies	94.9	91.2
Goodwill	105.2	105.8
Deferred income taxes	32.7	24.7
Intangible assets, net	19.5	20.3
Other noncurrent assets	26.4	20.5
Total Assets	2,036.2	1,978.9
Current liabilities:
Notes payable and other current debt	0.0	0.1
Accounts payable	137.7	130.4
Pension and other postretirement benefits	2.2	2.3
Accrued salaries, wages and benefits	53.5	64.5
Income taxes payable	17.3	9.8
Operating lease liabilities, current	10.2	0.0
Other current liabilities	80.2	76.6
Total current liabilities	301.1	283.7
Long-term debt	195.5	196.0
Deferred income taxes	14.3	13.1
Pension and other postretirement benefits	54.3	56.2
Operating lease liabilities, noncurrent	67.4	0.0
Other long-term liabilities	34.1	33.6
Total Liabilities	666.7	582.6
Commitments and contingencies (Note 15)
Equity:
Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding	0.0	0.0
Common stock, par value $0.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million; shares outstanding: 73.5 million and 74.1 million	18.8	18.8
Capital in excess of par value	278.5	282.0
Retained earnings	1,398.2	1,353.4
Accumulated other comprehensive loss	(153.4)	(154.2)
Treasury stock, at cost (1.8 million and 1.2 million shares)	(172.6)	(103.7)
Total Equity	1,369.5	1,396.3
Total Liabilities and Equity	$ 2,036.2	$ 1,978.9

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares shares in Millions	Mar. 31, 2019	Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]
Preferred stock, shares authorized (in shares)	3.0	3.0
Preferred stock, shares issued (in shares)	0.0	0.0
Preferred stock, shares outstanding (in shares)	0.0	0.0
Common stock, par value (in dollars per share)	$ 0.25	$ 0.25
Common stock, shares authorized (in shares)	100.0	100.0
Common stock, shares issued (in shares)	75.3	75.3
Common stock, shares outstanding (in shares)	73.5	74.1
Treasury stock, at cost (in shares)	1.8	1.2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 55.4	$ 43.6
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	24.9	25.7
Amortization	0.6	0.7
Stock-based compensation	6.2	3.4
Non-cash restructuring charges	0.3	0.1
Contingent consideration payments in excess of acquisition-date liability	(0.2)	(0.2)
Other non-cash items, net	(0.8)	(2.7)
Changes in assets and liabilities	(38.8)	(25.6)
Net cash provided by operating activities	47.6	45.0
Cash flows from investing activities:
Capital expenditures	(28.8)	(28.0)
Other, net	0.1	(0.7)
Net cash used in investing activities	(28.7)	(28.7)
Cash flows from financing activities:
Borrowings under revolving credit agreements	28.0	0.0
Repayments under revolving credit agreements	(28.0)	0.0
Debt issuance costs	(0.8)	0.0
Dividend payments	(11.1)	(10.4)
Proceeds from stock-based compensation awards	3.3	0.3
Employee stock purchase plan contributions	1.2	1.1
Shares purchased under share repurchase programs	(83.1)	(47.9)
Net cash used in financing activities	(90.5)	(56.9)
Effect of exchange rates on cash	(0.3)	4.5
Net decrease in cash and cash equivalents	(71.9)	(36.1)
Cash and cash equivalents at beginning of period	337.4	235.9
Cash and cash equivalents at end of period	$ 265.5	$ 199.8

Summary of Significant Accounting Policies	3 Months Ended
Summary of Significant Accounting Policies	Mar. 31, 2019
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting and U.S. Securities and Exchange Commission (“SEC”) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three months ended March 31, 2019 should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as “West”, the “Company”, “we”, “us” or “our”) appearing in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”). The results of operations for any interim period are not necessarily indicative of results for the full year. As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 15, Other Expense, to the consolidated financial statements in our 2018 Annual Report for further discussion.

New Accounting Standards	3 Months Ended
New Accounting Standards	Mar. 31, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New Accounting Standards	New Accounting Standards Recently Adopted Standards In August 2018, the SEC adopted a final release which would eliminate or modify certain disclosure requirements that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of shareholders’ equity are expanded for interim purposes. An analysis of the changes in each caption of shareholders’ equity presented in the balance sheet must be provided in a note or separate statement, as well as the amount of dividends per share for each class of shares. We provided this disclosure beginning in the first quarter of 2019. Please refer to Note 12, Shareholders’ Equity. In June 2018, the Financial Accounting Standards Board (“FASB”) issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements. In February 2018, the FASB issued guidance to address a specific consequence of the Tax Cuts and Jobs Acts (the “2017 Tax Act”) by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act’s reduction of the U.S. federal corporate income tax rate. In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements. In February 2016, the FASB issued guidance on the accounting for leases, Accounting Standards Codification (“ASC”) Topic 842 (“ASC 842”). This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, Leases, for additional information. Standards Issued Not Yet Adopted In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements. In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements. In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.

Affiliated Companies	3 Months Ended
Affiliated Companies	Mar. 31, 2019
Equity Method Investments and Joint Ventures [Abstract]
Affiliated Companies	Affiliated Companies At March 31, 2019 and December 31, 2018, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $81.5 million and $77.8 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $13.4 million at both period-ends. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable. Our purchases from, and royalty payments made to, affiliates totaled $24.6 million for the three months ended March 31, 2019, as compared to $23.1 million for the same period in 2018. As of March 31, 2019 and December 31, 2018, the payable balance due to affiliates was $17.2 million and $12.9 million, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $2.2 million for the three months ended March 31, 2019, as compared to $2.4 million for the same period in 2018. As of March 31, 2019 and December 31, 2018, the receivable balance due from affiliates was $1.4 million and $1.6 million, respectively. Please refer to Note 6, Affiliated Companies, to the consolidated financial statements in our 2018 Annual Report for additional details.

Stock-Based Compensation	3 Months Ended
Stock-Based Compensation	Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation	Stock-Based Compensation The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the “2016 Plan”) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At March 31, 2019, there were 3,162,428 shares remaining in the 2016 Plan for future grants. During the three months ended March 31, 2019, we granted 344,616 stock options at a weighted average exercise price of $102.51 per share based on the grant-date fair value of our stock to employees under the 2016 Plan. The weighted average grant date fair value of options granted was $24.51 per share as determined by the Black-Scholes option valuation model using the following weighted average assumptions: a risk-free interest rate of 2.3%; expected life of 5.6 years based on prior experience; stock volatility of 22.5% based on historical data; and a dividend yield of 0.7%. Stock option expense is recognized over the vesting period, net of forfeitures. During the three months ended March 31, 2019, we granted 82,458 stock-settled performance share unit (“PSU”) awards at a weighted average grant-date fair value of $102.51 per share to eligible employees. These awards are earned based on the Company’s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock. Shares earned under PSU awards may vary from 0% to 200% of an employee’s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures. During the three months ended March 31, 2019, we granted 7,266 stock-settled restricted share unit (“RSU”) awards at a weighted average grant-date fair value of $102.51 per share to eligible employees. These awards are earned over a specified performance period. The fair value of stock-settled RSU awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period, net of forfeitures. Total stock-based compensation expense was $6.2 million and $3.4 million for the three months ended March 31, 2019 and 2018, respectively.

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items. The provision for income taxes was $16.1 million and $12.5 million for the three months ended March 31, 2019 and 2018, respectively, and the effective tax rate was 23.1% and 23.3%, respectively. During the three months ended March 31, 2018, we recorded a net tax charge of $0.3 million for the estimated impact of the 2017 Tax Act. Please refer to Note 16, Income Taxes, to the consolidated financial statements in our 2018 Annual Report for further discussion.

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies From time to time, we are involved in product liability matters and other legal proceedings and claims generally incidental to our normal business activities. We accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. While the outcome of current proceedings cannot be accurately predicted, we believe their ultimate resolution should not have a material adverse effect on our business, financial condition, results of operations or liquidity. There have been no significant changes to the commitments and contingencies included in our 2018 Annual Report. On January 1, 2019, we adopted ASC 842. Please refer to Note 6, Leases, for additional information.

Subsequent Event	3 Months Ended
Subsequent Event	Mar. 31, 2019
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Subsequent Event In April 2019, we acquired the business of our distributor in South Korea. We believe that the acquisition will not have a material impact on our financial statements.

Revenue Recognition (Details)	3 Months Ended
Revenue Recognition (Details)	Mar. 31, 2019	Mar. 31, 2018
Disaggregation of Revenue [Line Items]
Percentage of net sales	100.00%	100.00%
Sales Revenue, Net [Member] \| Product Concentration Risk [Member] \| High-Value Components [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	43.00%	41.00%
Sales Revenue, Net [Member] \| Product Concentration Risk [Member] \| Standard Packaging [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	30.00%	34.00%
Sales Revenue, Net [Member] \| Product Concentration Risk [Member] \| Delivery Devices [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	4.00%	3.00%
Sales Revenue, Net [Member] \| Product Concentration Risk [Member] \| Contract-Manufactured Products [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	23.00%	22.00%
Biologics [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	26.00%	21.00%
Generics [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	20.00%	21.00%
Pharma Customers [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	31.00%	36.00%
Contract-Manufactured Products [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	23.00%	22.00%
Americas [Member] \| Sales Revenue, Net [Member] \| Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	46.00%	45.00%
Europe, Middle East, Africa [Member] \| Sales Revenue, Net [Member] \| Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	47.00%	47.00%
Asia Pacific [Member] \| Sales Revenue, Net [Member] \| Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	7.00%	8.00%

Contracts and Liabilities (Details) - USD ($) $ in Millions		3 Months Ended
Contracts and Liabilities (Details) - USD ($) $ in Millions	Jan. 01, 2019	Mar. 31, 2019
Contract assets, December 31, 2018	$ 9.1	$ 9.1
Contract assets, March 31, 2019		11.9
Change in contract assets - increase (decrease)		2.8
Deferred income, December 31, 2018	(33.4)	(33.4)
Deferred income, March 31, 2019		(36.5)
Change in deferred income - decrease (increase)		(3.1)
Revenue recognized that was included in the deferred income balance	$ 11.1	$ 25.8
Receipt of advance cash payment		30.6
Other adjustments		1.7
SmartDose [Member]
Deferred income, March 31, 2019		$ (6.3)
Deferred income, current		0.9
Deferred income, noncurrent		$ 5.4

Revenue Supply Chain Financing (Details) $ in Millions	Mar. 31, 2019 USD ($)
Supply Chain Financing [Abstract]
Sales of certain accounts receivable	$ 1.8

Revenue Voluntary Recall (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
Revenue Voluntary Recall (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Revenue from Contract with Customer [Abstract]
Provision for sales returns	$ 4.5	$ 11.3

Inventories (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Raw materials	$ 100.1	$ 90.4
Work in process	39.0	42.2
Finished goods	87.0	81.9
Total inventories	$ 226.1	$ 214.5

Leases Adoption of ASC 842 (Details) - USD ($) $ in Millions	Mar. 31, 2019	Jan. 01, 2019	Dec. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total lease liabilities	$ 77.6
Operating lease right-of-use assets	$ 75.2		$ 0.0
Accounting Standards Update 2016-02 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total lease liabilities		$ 73.1
Operating lease right-of-use assets		$ 71.0

Leases Lease Cost (Details) - USD ($) $ in Millions	3 Months Ended
Leases Lease Cost (Details) - USD ($) $ in Millions	Mar. 31, 2019	Mar. 31, 2018
Lease, Cost [Abstract]
Operating lease cost	$ 3.2
Short-term lease cost	0.2
Variable lease cost	0.6
Total lease cost	$ 4.0	$ 3.7

Leases Lease Cash Flow and Supplemental Information (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Lease Cash Flow and Supplemental Information [Abstract]
Operating lease payments	$ 3.1
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 6.8

Leases Lease Weighted Average (Details)	Mar. 31, 2019
Lease Cash Flow and Supplemental Information [Abstract]
Weighted average remaining lease term	12 years 1 month 5 days
Weighted average discount rate	3.74%

Leases Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Leases [Abstract]
2019 (remaining nine months)	$ 9.6
2020	11.5
2021	9.8
2022	8.1
2023	7.6
Thereafter	49.0
Operating leases liabilities payments due	95.6
Less: imputed lease interest	18.0
Total lease liabilities	$ 77.6
2019		$ 13.0
2020		10.5
2021		7.8
2022		6.9
2023		5.5
Thereafter		37.8
Total		$ 81.5

Affiliated Companies (Details) - USD ($) $ in Millions	3 Months Ended
Affiliated Companies (Details) - USD ($) $ in Millions	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Schedule of Equity Method Investments [Line Items]
Purchases and royalty payments made to affiliates	$ 24.6	$ 23.1
Amount due and payable to affiliates	17.2		$ 12.9
Sales to affiliates	2.2	$ 2.4
Amount receivable from affiliates	1.4		1.6
Carrying amount, equity-method investments	81.5		77.8
Carrying amount, cost-method investments	$ 13.4		$ 13.4

Long-term Debt (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Long-term debt, gross	$ 196.1	$ 196.7
Long-term debt	195.5	196.1
Unamortized debt issuance costs	0.6	0.6
Current portion of long-term debt	0.0	0.1
Long-term debt, excluding current portion	195.5	196.0
Notes payable, Due 2019 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.0	$ 0.1
Revolving credit facility, Due 2020 [Member]
Debt Instrument [Line Items]
Debt instrument, stated interest rate		1.00%
Long-term debt, gross	$ 0.0	$ 28.6
Revolving credit facility, Due 2024 [Member]
Debt Instrument [Line Items]
Debt instrument, stated interest rate	0.875%
Long-term debt, gross	$ 28.1
Series A Notes, Due 2022 [Member]
Debt Instrument [Line Items]
Debt instrument, stated interest rate	3.67%	3.67%
Long-term debt, gross	$ 42.0	$ 42.0
Series B Notes, Due 2024 [Member]
Debt Instrument [Line Items]
Debt instrument, stated interest rate	3.82%	3.82%
Long-term debt, gross	$ 53.0	$ 53.0
Series C Notes, Due 2027 [Member]
Debt Instrument [Line Items]
Debt instrument, stated interest rate	4.02%	4.02%
Long-term debt, gross	$ 73.0	$ 73.0

Credit Facility (Details) - Revolving credit facility, Due 2024 [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Line of Credit Facility [Line Items]
Line of Credit Facility, current borrowing capacity	$ 300,000,000.0
Line of Credit Facility, additional borrowing capacity	350,000,000
Credit available for the issuance of letters of credit	30,000,000.0
Line of Credit Facility, noncurrent	28,100,000
Line of Credit Facility outstanding borrowings, Yen	4,500,000
Line of Credit Facility outstanding borrowings, Euro	23,600,000
Line of Credit Facility, unused commitment level	269,400,000
Debt issuance costs	$ 1,100,000	$ 600,000
Debt instrument, maturity date	Mar. 28, 2024
London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Line Items]
Debt instrument, stated interest rate	0.00%
Federal Funds Effective Swap Rate [Member]
Line of Credit Facility [Line Items]
Debt instrument, stated interest rate	50.00%
Letter of Credit [Member]
Line of Credit Facility [Line Items]
Long-term Line of Credit	$ 2,500,000
Foreign Line of Credit [Member]
Line of Credit Facility [Line Items]
Credit facility is available for swing-line loans	20,000,000.0
Domestic Line of Credit [Member]
Line of Credit Facility [Line Items]
Credit facility is available for swing-line loans	$ 30,000,000.0
Maximum [Member]
Line of Credit Facility [Line Items]
Ratio of debt to EBITDA	4.0
Maximum [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Line Items]
Debt instrument, stated interest rate	137.50%
Maximum [Member] \| Base Rate [Member]
Line of Credit Facility [Line Items]
Debt instrument, stated interest rate	37.50%
Minimum [Member]
Line of Credit Facility [Line Items]
Ratio of debt to EBITDA	3.5
Minimum [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Line Items]
Debt instrument, stated interest rate	87.50%
Minimum [Member] \| Base Rate [Member]
Line of Credit Facility [Line Items]
Debt instrument, stated interest rate	0.00%

Derivative Financial Instruments (Textuals) (Details) € in Millions, ¥ in Millions, $ in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2019 EUR (€) MBbls $ / bbl	Mar. 31, 2019 JPY (¥)	Mar. 31, 2019 USD ($)	Mar. 31, 2019 SGD ($) MBbls $ / bbl	Mar. 31, 2019 JPY (¥) MBbls $ / bbl	Mar. 31, 2019 USD ($) MBbls $ / bbl	Jan. 31, 2019 MBbls	Dec. 31, 2018 EUR (€)	Dec. 31, 2018 SGD ($)	Dec. 31, 2018 USD ($)	Apr. 24, 2018 MBbls	Nov. 22, 2017 MBbls
Derivative [Line Items]
Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives			$ 4.8
Debt EUR Denominated [Member]
Derivative [Line Items]
Notional amount, nonderivative instruments	€ 21.0		23.6
Cumulative foreign currency translation loss						$ 0.1
Cumulative foreign currency translation loss, net of tax						0.1
Debt Yen Denominated [Member]
Derivative [Line Items]
Notional amount, nonderivative instruments		¥ 500.0	4.5
Cumulative foreign currency translation loss						0.4
Cumulative foreign currency translation loss, net of tax						$ 0.3
Options Held [Member]
Derivative [Line Items]
Derivative, nonmonetary notional amount \| MBbls	108,891			108,891	108,891	108,891	81,459				30,612	125,166
Gain (Loss) related to call options			$ 0.1
Derivative, Average Price Risk Option Strike Price \| $ / bbl	66.22			66.22	66.22	66.22
Euro Member Countries, Euro \| Forward Contracts [Member]
Derivative [Line Items]
Notional amount \| €								€ 10.0
Singapore, Dollars \| Forward Contracts [Member]
Derivative [Line Items]
Notional amount				$ 601.5					$ 601.5
United States of America, Dollars \| Forward Contracts [Member]
Derivative [Line Items]
Notional amount						$ 13.4				$ 13.4
Long [Member] \| Designated as Hedging Instrument [Member] \| Singapore, Dollars \| Foreign Exchange Forward [Member]
Derivative [Line Items]
Notional amount				$ 44.0
Long [Member] \| Designated as Hedging Instrument [Member] \| United States of America, Dollars \| Foreign Exchange Forward [Member]
Derivative [Line Items]
Notional amount						31.5
Long [Member] \| Designated as Hedging Instrument [Member] \| Japan, Yen \| Foreign Exchange Forward [Member]
Derivative [Line Items]
Notional amount \| ¥					¥ 5,232.0
Short [Member] \| Designated as Hedging Instrument [Member] \| Singapore, Dollars \| Foreign Exchange Forward [Member]
Derivative [Line Items]
Notional amount	€ 6.4					25.1
Short [Member] \| Designated as Hedging Instrument [Member] \| United States of America, Dollars \| Foreign Exchange Forward [Member]
Derivative [Line Items]
Notional amount	26.8					0.0
Short [Member] \| Designated as Hedging Instrument [Member] \| Japan, Yen \| Foreign Exchange Forward [Member]
Derivative [Line Items]
Notional amount	€ 20.5					$ 24.4

Effects of Derivative Instruments on OCI and Earnings (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI	$ 0.4	$ 1.2
Amount of (gain) loss reclassified from accumulated OCI into income	(0.3)	1.0
Net Investment Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI	0.1	(0.7)
Amount of (gain) loss reclassified from accumulated OCI into income	0.0	0.0
Foreign Currency Hedge Contracts [Member] \| Net sales [Member] \| Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI	0.5	(0.4)
Amount of (gain) loss reclassified from accumulated OCI into income	(0.2)	0.5
Foreign Currency Hedge Contracts [Member] \| Cost of goods and services sold [Member] \| Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI	(0.1)	1.6
Amount of (gain) loss reclassified from accumulated OCI into income	(0.1)	0.4
Forward Treasury Locks [Member] \| Interest expense [Member] \| Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI	0.0	0.0
Amount of (gain) loss reclassified from accumulated OCI into income	0.0	0.1
Foreign Currency - Denominated Debt [Member] \| Other expense [Member] \| Net Investment Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI	0.1	(0.7)
Amount of (gain) loss reclassified from accumulated OCI into income	$ 0.0	$ 0.0

Fair Value Measurements (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Assets:
Deferred compensation assets	$ 9.2	$ 8.7
Foreign currency contracts	17.7	6.5
Commodity call options	0.2
Total assets at fair value	27.1	15.2
Liabilities:
Contingent consideration	1.7	1.7
Deferred compensation liabilities	10.5	9.8
Foreign currency contracts	0.8	0.2
Total liabilities at fair value	13.0	11.7
Level 1 [Member]
Assets:
Deferred compensation assets	9.2	8.7
Total assets at fair value	9.2	8.7
Liabilities:
Deferred compensation liabilities	10.5	9.8
Total liabilities at fair value	10.5	9.8
Level 2 [Member]
Assets:
Foreign currency contracts	17.7	6.5
Commodity call options	0.2
Total assets at fair value	17.9	6.5
Liabilities:
Foreign currency contracts	0.8	0.2
Total liabilities at fair value	0.8	0.2
Level 3 [Member]
Liabilities:
Contingent consideration	1.7	1.7
Total liabilities at fair value	$ 1.7	$ 1.7

Fair Value Measurements Level 3 (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Level 3 Fair Value Measurements [Roll Forward]
Balance, beginning of period	$ 1.7	$ 4.9
Increase (decrease) in fair value recorded in earnings	0.2	(2.6)
Payments	(0.2)	(0.6)
Balance, end of period	$ 1.7	$ 1.7